Saturday 11 October
08:30

"Saturday 11 October"

Added to your list of favorites
Deleted from your list of favorites
A30
08:30 - 09:30

FT1 Oral - Low Field Technology
From physics to the clinic

Chairpersons: Mathieu SARRACANIE (Chairperson, Aberdeen, United Kingdom), Andrew WEBB (Professor) (Chairperson, Leiden, The Netherlands)
08:30 - 08:40 #47804 - PG031 In vivo imaging with a low-cost MRI scanner in low-resource settings.
PG031 In vivo imaging with a low-cost MRI scanner in low-resource settings.

Lack of access to essential medical imaging is a prominent burden on Low- and Middle-Income Countries (LMICs). Low-field MRI (LFMRI) technologies have been postulated to alleviate this [1]. However, a major hurdle with these systems is electromagnetic interference (EMI), i.e. unwanted noise caused by external sources and picked up at the receive (Rx) chain. As the number of available LFMRI systems increases, we often encounter that these scanners underperform due to low signal-to-noise ratio (SNR) caused by EMI. Challenges are amplified in LMICs, where electric power lines tend to be unreliable and components and equipment scarce. Indeed, reliable imaging with MRI scanners constructed on site in LMICs remains a pending task. In this work, we demonstrate significant improvements to an existing scanner built at Mbarara University of Science and Technology (MUST), Uganda, which enabled us to acquire the first in vivo images using a low-cost LF-MRI system in Africa.

The MUST 50 mT system is the first MRI device constructed in Africa [2]. We have revamped the system to enable in vivo image acquisition. Specifically, we have acted on the electronics, cabling, and scanner console. Electronics and cabling. We minimized EMI by shortening and separating cables by function (RF, gradients, power, digital), with shielding—especially for gradient lines near the antenna. RF components and EMI sources were boxed and grounded, following a star-ground layout referenced to the RF shield. Despite unavoidable ground-loops through the mains, all subsystems were powered from a single outlet connected to an uninterruptible power supply with a 50 Hz filter. Scanner noise was assessed via RMS voltage measures at the Rx coil, expected near 174 dBm/Hz, i.e. the thermal (Johnson) noise floor of a 50 Ohm resistor at room temperature. Control system. We updated MaRCoS [4] and MaRGE [5] to their latest stable versions and compared system performance against a commercial spectrometer (Magritek KEA2). The latter is significantly more expensive but can serve as a noise floor benchmark. We operated in four different configurations: MaRCoS with the MUST LNA and TxRx switch (MaRCoS + MUST); MaRCoS with the KEA2 duplexer electronics (MaRCoS + DUP); KEA2 + MUST; and KEA2 + DUP. The implemented upgrades made in vivo acquisitions possible. We obtained T1-weighted RARE images of the knee and brain (sequence parameters in Figs. 3-4).

The revamped system is shown in Fig. 1. To quantify the improvements, Fig. 2a presents noise measurements under various conditions: optimized for EMI, unoptimized, using a 50 Ohm resistor, and when controlled with the KEA2. Figure 2b illustrates the impact of different control systems and receive electronics on image quality. Finally, we present the in vivo images acquired: Fig. 3 shows a knee scan and Fig. 4 a brain image, both from healthy volunteers.

A key focus of this work was the characterization and mitigation of system noise. With the Rx coil and matching electronics, we achieved 2.3× Johnson with MaRCoS, which aggravates if we do not handle EMI adequately and depends on external usage of the building power grid. The scanner is particularly sensitive to the MaRCoS housing, which is not fully connectorized due to the lack of basic components. Note that this is not a fundamental limitation [3] and shall be improved shortly. The choice of control system also had a substantial impact on system performance, usability, and cost. MaRGE enabled noise measurements, calibrations, and image acquisitions, greatly enhancing user experience. With KEA2, we were able to operate at 1.7× Johnson, suggesting we have room for improvement with MaRCoS. In any case, despite the slightly higher noise observed with MaRCoS in this setup, the resulting images exhibit comparable quality, underscoring its practical viability. Lastly, the image quality is consistently sufficient for in vivo acquisitions. In the brain image, we observe a dark area at the bottom, which is due to the excitation bandwidth not being sufficient to cover the entire frequency spectrum due to magnet inhomogeneities. This could be remedied by using higher RF power or working on a shimming system to improve the homogeneity of the main magnet. This last point is key to continuing to improve the system. With a more homogeneous magnet, we will be able to decrease the acquisition bandwidth without observing major distortions, reducing noise, and therefore increasing the SNR allowing us to reduce the image time.

In conclusion, we present the first in vivo images acquired using a low-cost MRI system in Africa. This required substantial improvements to the MUST system and overcoming the additional challenges posed by operating in a low-resource setting. Our work represents a first step toward the clinical translation of low-field MRI systems in LMICs, with the potential to significantly improve access to medical imaging.
Teresa GUALLART-NAVAL (Valencia, Spain), Ronald AMODOI, Mary A. NASSAJJE, Robert ASIIMWE, Patricia TUSIIME, Maureen NAYEBARE, Leo KINYERA, Lemi ROBIN, Patience NINSIIMA, Faith NATUKUNDA, Joachim MUSIIMENTA, Heaven NAMBI, Florence NAMAYANJA, Benjamin WAMONO, José Miguel ALGARÍN, Thomas O'REILLY, Andrew WEBB, Steven J. SCHIFF, Johnes OBUNGOLOCH, Joseba ALONSO
08:40 - 08:50 #47618 - PG032 3D ULF MRI at 10 mT Enabled by Ultrasensitive SQUID Detection and High Homogeneity in an Open Environment.
PG032 3D ULF MRI at 10 mT Enabled by Ultrasensitive SQUID Detection and High Homogeneity in an Open Environment.

Recent advancements in ultra-low field (ULF) MRI systems operating at or below 10 mT present a transformative approach to reducing system costs and expanding accessibility while mitigating traditional MRI contraindications such as claustrophobia and metallic implants [1-4]. Enhanced T1 contrast in low-field regimes provides unique diagnostic opportunities [5], yet low signal intensity proportional to B0 has historically limited clinical applicability due to diminished signal-to-noise ratio (SNR). To address these limitations and make MRI more affordable and accessible, we developed a 10 mT MRI system that combines an ultrasensitive detection system using superconducting quantum interference devices (SQUIDs) coupled with a room-temperature volume gradiometer for enhanced sensitivity and with advanced denoising and reconstruction techniques [6,7]. Additionally, a resistive Merritt coil electromagnet provides B0 homogeneity superior to conventional permanent magnet systems that typically exceed 200 ppm and can reach 10,000 ppm in Halbach configurations [4,8,9]. This combination allows full-body imaging capabilities including a vast possibility in the choice of sequences that are not feasible with other low-field MRI systems. In this work, we present 3D contrast imaging of a phantom with varying concentrations and a garlic bulb at 2.5 × 2.5 × 10 mm³ resolution, demonstrating the performance of our SQUID-based MRI system for high-quality imaging in an open environment.

Our MRI system, depicted in Figure 1, operates at 10 mT using a Merritt coil electromagnet for B0 generation with stability maintained at <100 ppm through active field compensation. The RF transmit saddle coil, consisting of five turns, is tuned to 426 kHz. Signal reception is performed by a 20-turn room-temperature volume gradiometer coil connected to a low-Tc niobium SQUID operating in current sensing mode (Figure 2). The SQUID, housed in a cryogen-free cryostat and cooled to 4.2 K using a pulse tube cryocooler, achieves a 2 nA/√Hz noise floor. The system is enclosed in an aluminum shield to mitigate electromagnetic interference (EMI). Gradient coils generate a 125 µT/(A·m) gradient strength across three orthogonal axes, and three-axis shimming maintains B0 uniformity. Noise suppression is further enhanced by implementing the EDITER method [10]. 3D images of a contrast phantom with varying MnCl₂ concentrations and a garlic bulb were acquired using spin echo (SE), gradient echo (GRE), and inversion recovery GRE (IR-GRE) sequences (Figure 2).

Optimized imaging parameters derived from T1 and T2 measurements facilitated the acquisition of 3D contrast images (Figure 3). The GRE sequence provided T1-weighted and proton density-weighted images, the SE sequence produced T1-weighted and short tau inversion recovery (STIR)-like images, and IR-GRE sequences generated STIR and fluid-attenuated inversion recovery (FLAIR) images. The acquisition times varied, ranging from 15 minutes to 1 hour, depending on the sequence parameters. In addition to phantom imaging, we acquired 3D images of a garlic bulb at a spatial resolution of 2.5 × 2.5 × 10 mm³ using the T1-weighted GRE sequence, demonstrating the system’s capability for resolving structural details in biological samples at 10 mT (Figure 4).

This work presents a novel 10 mT MRI system integrating an ultrasensitive SQUID detection system and a highly homogeneous B0 field, achieved through a resistive magnet, enabling full-body imaging capabilities. Our system not only reduces operational costs by eliminating the need for cryogenic cooling but also expands diagnostic imaging capabilities. The ultra-low field regime presents opportunities for novel contrast mechanisms and imaging sequences due to enhanced T1 contrast without gadolinium-based agents, which could potentially provide additional quantitative information and diagnostic insights achieved through balanced steady-state free precession (bSSFP) or synthetic MRI techniques [11,12]. Our ongoing work focuses on further enhancing SNR toward clinical applications through optimization of the SQUID-gradiometer interface, developing a cooled receiver coil to reduce Johnson noise, and integrating CNN-based denoising techniques to mitigate environmental EMI. Additionally, k-space trajectory optimization is under investigation to accelerate acquisition times without compromising image quality.

We present a cryogen-free, SQUID-based MRI system operating at a highly homogeneous B0 field of 10 mT. This system can acquire 3D images of biological samples with a spatial resolution of 2.5 × 2.5 × 10 mm³. These results provide a promising foundation for future developments in ultra-low-field MRI as an accessible and cost-effective diagnostic modality.
Marco FIORITO, Alexandre JAOUI, Dimitri LABAT, Isabelle SANIOUR (Paris), Mustafa UTKUR
08:50 - 09:00 #47586 - PG033 Nonlinear model-based b0 field compensation in low-field mri using hall sensor arrays and spatial interpolation.
PG033 Nonlinear model-based b0 field compensation in low-field mri using hall sensor arrays and spatial interpolation.

Low-field magnetic resonance imaging (MRI) systems based on permanent-magnets below 0.1 T are increasingly utilized in portable and resource-constrained settings due to their compactness, reduced power requirements, and enhanced safety. The performance of such systems is suscepti- ble to temporal fluctuations in the B0 magnetic field, which can emerge from thermal variations and environmental disturbances. These instabilities degrade the spatial homogeneity, impairing image quality. Conventional compensation strategies, including static frequency configuration and recalibration, are insufficient under dynamic operating conditions. This study introduces a data-driven approach for continuous B0 drift correction that combines directional dispersion maps obtained from Hall effect sensors [1,2] with voxel-wise field interpolation, and nonlinear spatia model predictive control (MPC) [3,4]. The proposed methodology aims to achieve robust, real-time B0 stabilization without reliance on manual recalibration.

A 3D B0 field mapping was performed within a spherical field of view (FOV) of a 50 mm Magnet [5]. Continuous, measurements were taken every 10 min over several hours, shown in Fig. 1. Each field map consisted of 33 points in the FOV. An array of six MLX90393 Hall sensors was mounted on the outside, along the isocenter of the magnet in a circular arrangement at an angle of 30◦ shown in Fig. 2. This configuration allows the measurement of the magnetic field polarization and characterization of the dispersion field, which is on average about 1.5 mT compared to the 46 mT main field. This stray field emanating from the geometry of the Halbach magnet is shown in Fig. 3. A nonlinear quadratic regression model was fitted to the 24-hour sliding window data from the dispersion data of B0 field map. Model predictive and Spatial multipoint interpolation was used for estimation per voxel B0 value in the FOV.

The model achieved a maximum square error (MSE) of 100 μT2, an MAE of 9 μT, and a root mean squared error (RMSE) of 11 μT on the test set, with a coefficient of determination (R2) of 0.934. These results indicate strong agreement between the model predictions and the measured B0 field values shown in Fig.4. The model achieved > 99.8% of the variance in the FOV B0 maps with residuals below 50 μT. Using realtime measurement data, kept the central B0 prediction errors below 0.1 mT (0.2%) over 24-hour. Combined spatial and temporal estimation yielded voxel-wise B0 predictions with errors <80 μT over the FOV. The Larmor frequency prediction matched the ground truth and enables continuous RF retuning within 2 kHz (≈47 μT) [6]. For validation, using the B0 mapping field probe inserted in the isocenter shows a field stabilization of 0.12 mT, which demonstrates the functionality of the MPC model in this limited validation setup.

The integration of nonlinear spatial modeling, MPC, and directional dispersion field analysis provides a robust framework for real-time B0 stabilization in low-field MRI. The triaxial Hall sensor array arranged at 30◦ intervals offers directional sensitivity that allows for both tempo- ral drift estimation and spatial dispersion characterization. The model’s low prediction error, supported by sub-10 μT MAE and a strong R2 score, demonstrates that dispersion fields from Halbach magnet geometries can reliably inform both voxel-wise estimation and active shimming strategies [1]. While these results are based on synthetic and reference sample validation, further testing with dynamic imaging sequences is required to assess generalizability under operational conditions. Remaining limitations include inhomogeneities beyond the modeled volume and the need for continuous calibration under long-term environmental variation.

This study demonstrates that outside directional dispersion fields, in combination with nonlinear quadratic model predictive control, enables precise (<0.2%) B0 field drift correction in low-field MRI over 24 hours. The approach supports continuous frequency adaptation and voxel-wise field estimation with sub-10 μT accuracy. The addition of a closed-loop active drift compensation driven by the MPC actively enhances stability. These results highlight the potential for robust, compact MRI systems with minimal calibration requirements.
Marcel Werner Heinrich OCHSENDORF (Aachen, Germany, Germany), Kostiantyn LAVRONENKO, Volkmar SCHULZ
09:00 - 09:10 #46161 - PG034 Hard tissue imaging with ZTE sequences in a portable Halbach system.
PG034 Hard tissue imaging with ZTE sequences in a portable Halbach system.

The MRI community's heightened interest in low-field scanners (B0 < 100 mT) has led to the development of low-cost, lightweight and portable systems. Constrained to these attributes, Halbach arrangements play a role for both musculoskeletal applications [1,6]. In extremity imaging, details from hard tissues like bones, tendons or ligaments (with T2*<1 ms) are of medical interest. Conventional echo sequences lack this capability, but dedicated sequences for short T2 encoding, such as PETRA and other ZTE variations [3], are used clinically at clinical field strengths. However, they are not trivially applicable in low-cost Halbach systems, mostly due to challenging requirements such as high RF power and excellent field homogeneity. In this work, we demonstrate knee imaging with PETRA in our 72 mT Halbach system and report the first in vivo measurements of the T1 of hard tissues at low field.

Experiments were performed in our portable MRI scanner with a 72 mT magnet based on Halbach and conceived for extremity imaging (Fig 1.a) [1]. The B0 field can be shimmed down to 1200 ppm over a 10 cm DSV. The gradients can run stably at 25 mT/m during hundreds of ms. The RF coil employed is a solenoid with 15 cm diameter and 15 cm length. The Radio-Frequency Power Amplifier (RFPA) is rated for up to 500 W. The system is controlled by the open-source MaRCoS console [2, 4], which we have upgraded to include a PETRA sequence (Fig 1.b) [3]. Image reconstructions are performed with ART and employ prior knowledge of the B0 distribution to suppress image distortions by means of our recent Single-Point Double-Shot technique (SPDS) [5]. All images were with the shortest hard RF pulses allowed by the system (<20 us) to ensure a coherent, full bandwidth excitation. Acquisition times were taken to be compatible with the shortest expected T2 times (~1 ms), since this never produced significant gradient heating in the system. The shortest TE achievable is constrained in our setup to TE=300 us, due to long-lived transients generated by switching from transmit (Tx) to receive (Rx) mode. To estimate T1 values of hard tissues, we acquired a set of PETRA images with constant, short TR < T1 and variable flip angle (FA) to induce an incoherent steady state in all tissues. In this regime, the dependence of SNR on Mo, theta, T1, and TR is exploited to estimate Mo and T1 of every tissue according to SNR=Mo·(1-E1)·sin(FA)/(1-E1·cos(FA)), being E1=exp(-TR/T1).

Figure 2a exhibits the performance of PETRA in our Halbach system after a 24-minute scan for a T1-weighted image. Cortical bones, ligaments, and tendons are all visualized brighter than the background noise. However, ZTE sequences are heavily proton-density-weighted and do not offer much anatomical contrast compared to echo-based sequences. Figure 2b compares hard-tissue visualization with PETRA against a conventional RARE sequence with the shortest possible TE in our setup (10 ms). In Fig. 3a we show a set of PETRA images acquired with TR=50 ms and variable theta. Incidentally, this patient diagnosed with a possible Baker cist, even if this is irrelevant to our study. In Fig. 3b, we show the SNR evolution of each tissue depending on theta, together with fits according to Eq. (1) to determine T1 values. These are: T1,muscle=181.5 ms, T1,lipid=124.4 ms, T1,cortical bone=106.4 ms, T1,spongy bone=99.4 ms, T1,tendon=32.1 ms and T1,ligament=98.9 ms. The fit yields also estimates for the proton densities relative to lipid: Mo,muscle=0.94, Mo,lipid=1, Mo,cortical bone=0.47, Mo,spongy bone=0.83, Mo,muscle=0.94, Mo,tendon=0.91 and Mo,ligament=0.53.

We have obtained the first musculoskeletal images showing hard tissues of a knee in a portable, low-cost scanner. This demonstration opens a qualitative new path for low-field MRI. Our quantitative estimations for spin-lattice relaxation times for muscle and lipid at 72 mT are in acceptable agreement with those reported by Webb et al [6] at 50 mT, where they found T1,lipid=130±5 ms and T1,muscle=171±11 ms. Note, however, that we have not found T1 estimations for hard tissues in the knee in the existing literature.

Our study shows PETRA imaging is possible even in low-field, portable MRI scanners. This could be relevant for musculoskeletal applications. The main limitation encountered so far is that scan times with PETRA are rather long, meaning translation to clinical practice may still require significant hardware improvements. In our setup, the main penalty is created by the long delay needed for TxRx switching, enforcing substantial pointwise sampling at the center of k-space.
Borreguero Morata JOSE, De Castro Santhos LUIZ GUILHERME, Fernández García MARINA, Castanón García-Roves ELISA, Vega Cid LORENA, Guallart Naval TERESA, Algarín Guisado JOSE MIGUEL, Galve Conde FERNANDO, Alonso Otamendi JOSEBA (Valencia, Spain)
09:10 - 09:20 #47797 - PG035 An open-source framework for remote data processing from low-field scanners.
PG035 An open-source framework for remote data processing from low-field scanners.

As low-field MRI (LFMRI) scanners and related technologies continue to expand, the computational power provided by local control PCs becomes insufficient for advanced data processing tasks. Some examples include model-based image reconstruction, distortion correction, or tissue segmentation, more so if deep learning (DL) methods are employed, and especially in the context of affordable systems for use in low- and middle-income countries [1,2]. To our best knowledge, existing solutions for remote and cloud data processing are either proprietary or not open to the public (e.g. Cloud-MRI [3]). Unlike with high-field scanners, which are designed to be vastly multi-purpose, the hardware and software architectures of LFMRI systems are greatly dependent on the targeted applications. This makes adaptable open-source control systems and software solutions an appealing option for the laboratories and spin-off companies manufacturing these devices. Among the available alternatives, MaRCoS stands out for its high performance and versatility [4,5]. MaRGE [6] is the newest open-source graphical user interface (GUI) for MaRCoS, it is programmed in Python, and it has been designed to cover needs from both researchers and clinicians. On the other hand, Tyger is a recently released open-source platform for remote signal processing [7]. With Tyger, the MR data generated by an LFMRI scanner anywhere in the world can be streamed to the cloud (e.g. Microsoft’s Azure cloud), even through mobile networks. Signal processing code can be written in any language, as long as it can read and write to named pipes (which are file-like but do not support random access). There is no SDK, meaning one can develop, test, and debug code locally using only files, without Tyger dependencies. Once finished, a Docker container image can be generated to run the exact same code in the cloud with Tyger, and the results can be piped back to the scanner. Here we present an integration of Tyger into the MaRCoS and MaRGE ecosystem and we thereby release the first open-source framework for cloud data processing with a focus on LFMRI (Figure 1). With this development, affordable MRI systems sited anywhere in the world can now leverage the most powerful compute available in the cloud for data processing, image reconstruction and, eventually, the generation of diagnostic information.

We have expanded the post-processing window in MaRGE with new buttons for executing specific methods in the cloud through Tyger. At a lower level, the MaRCoS native data files are translated into the open MRD standard [8,9], which is then piped to the cloud, where we run specific reconstructions programmed using simple Python syntax (Figure 2). All code is publicly available on GitHub [10]. We performed two sets of reconstructions of data acquired in two different portable scanners. On the one hand, we used our 84 mT elliptical halbach scanner [11] designed for neuroimaging to test image reconstruction with the aim of correcting distortions due to magnetic field inhomogeneities (B0). These reconstructions include: iterative Algebraic Reconstruction Techniques (ART) for solving the linear set of equations determined by an encoding matrix that can optionally incorporate prior knowledge (PK) of the B0 spatial distribution [12]; and conjugate phase (CP) [13]. In both cases we used the SPDS method [12] to obtain the B0 map. In addition, we include a standard inverse Fast Fourier Transform (iFFT) protocol to compare the improvement. On the other hand, we work with our portable 72 mT LFMRI system [2] designed for extremity imaging, with which we test the application of deep learning methods computed in Tyger with the aim of improving image quality. We input an iFFT reconstruction of the knee to a Pix2Pix network [14] pre-trained with 160 pairs of knee images acquired in our system and in a Philips Achieva 3T scanner at La Fe Hospital (Valencia, Spain).

Figure 3 shows Python reconstructions of a brain acquisition from Tyger with iFFT, ART+PK and CP. Figure 4 presents an LFMRI knee reconstruction, a 3T image of the same knee, and the output of the Pix2Pix network generated by Tyger.

We have demonstrated a successful integration of Tyger with MaRGE, connecting affordable low-field MRI scanners to some of the most powerful computational cloud resources. Importantly, this work is conceived as an illustration of the potential brought along by this integration, so we have merely programmed a few selected applications that include conventional (Fourier) and advanced (compressed sensing, iterative and DL-based) image reconstruction methods. These leverage access to some of the most powerful MRI data processing toolboxes available, including BART [15]. However, this list is far from exhaustive and can eventually include strictly any tool that can be loaded into a Docker image.
Teresa GUALLART-NAVAL (Valencia, Spain), José Miguel ALGARÍN, José BORREGUERO, Fernando GALVE, John STAIRS, Michael HANSEN, Joseba ALONSO
09:20 - 09:30 #47415 - PG036 First Clinical Evaluation of a portable 47 mT Halbach MRI system for Detecting Arthritis-Related Inflammation.
PG036 First Clinical Evaluation of a portable 47 mT Halbach MRI system for Detecting Arthritis-Related Inflammation.

Rheumatoid arthritis (RA) is a chronic inflammatory disease affecting approximately 1% of the global population. Early detection and treatment are critical for improving long-term outcomes and reducing healthcare costs[1, 2]. While expert-led screening clinics could support early diagnosis[3], they are not widely available and often impractical in primary care. MRI is a reliable imaging tool for detecting joint inflammation, offering high sensitivity and specificity compared to ultrasound[4]. However, conventional MRI is costly, often inaccessible and uncomfortable, requiring full-body entry into the bore and tight hand immobilization. Portable low-field MRI has emerged as a promising alternative due to its affordability, comfort, and suitability for decentralized care[5, 6]. In this project, we evaluated a contrast-free, fluid-sensitive MRI protocol using a portable low-field scanner to assess hand inflammation in patients with clinical arthritis, aiming to support earlier, more accessible diagnosis.

All data were acquired using a 47 mT (1.98 MHz) Halbach-based MRI scanner with a Magritek Kea2 spectrometer (Aachen, Germany)[7] and a separate transmit/receive coil (Figure 1). Sixteen patients with suspected RA were assessed at the Early Arthritis Recognition Clinic (EARC) in Leiden. All patients underwent a targeted physical examination by rheumatologists to determine the presence/absence of clinically apparent inflammatory arthritis in the wrist, metacarpophalangeal (MCP), and proximal interphalangeal (PIP) joints (Figure 1d). In the presence of confirmed clinical arthritis, patients were subsequently scanned on the low-field MRI system while comfortably seated next to the scanner (Figure 1a). We applied a previously developed fluid-sensitive MRI protocol optimized for inflammation detection without contrast agents[10]. It included a T1-weighted turbo spin-echo (TSE) scan for anatomical reference and a heavily T2-weighted, fat-suppressed STIR scan for fluid sensitivity. Parameters were as follows: T1w: TR/TE = 400/16 ms – scan time approximately 4 minutes (depending on hand size). IR-T2w: TR/TE/TEeff = 1800/15/75 ms – scan time approximately 12 minutes. Both scans used a resolution of 1×1×3 mm³ and a bandwidth of 20 kHz. Additionally, the IR-T2w scan was denoised using BM4D[11]. Two experienced clinicians independently assessed the images for joint inflammation using a custom viewer developed in MeVisLab (MeVis Medical Solutions AG, Bremen, Germany). The diagnostic performance of low-field MRI was assessed by comparing image-based findings to physical examination, considered the reference standard. Sensitivity and specificity were calculated per anatomical region. A flexible scoring criterion was applied: inflammation was recorded if detected by at least one reader. A subset of patients (n = 10/16) also received a 3T MRI examination (Philips, Best, the Netherlands), using a previously published protocol[9] – these data were used for visual comparison but not for analysis.

The custom-built viewer (Figure 2) was essential for image interpretation, enabling intuitive slice navigation and real-time contrast adjustment. Figure 3 shows the image quality achieved across cases. Despite variation in noise levels, inflammation was consistently detectable, even in the most challenging cases. Comparisons with 3T highlight the diagnostic value of low-field MRI in identifying joint inflammation. Table 1 shows that the diagnostic performance varied across joint levels. Sensitivity was highest in the wrist and lowest in the PIPs, while specificity remained consistently high across all joints (range 88-100%). The system was especially effective in ruling out inflammation, as reflected by high NPVs throughout (range 93-100%). These trends suggest that low-field MRI may be well suited as a screening tool, particularly for reducing unnecessary referrals in cases without joint inflammation.

This study represents the first evaluation of low-field MRI using a Halbach-based system for detecting joint inflammation. The results are promising, particularly in terms of high specificity and NPV, supporting its potential as a screening tool. However, during the study, we identified few areas for improvement. The relatively low sensitivity observed in the PIPs reflects suboptimal initial positioning, which we corrected after scanning the first five patients. We also observed variability in image noise, likely influenced by factors such as dry skin, which can hinder effective subject grounding and limit noise reduction. Notably, older patients—who are more likely to present with drier skin[12]—seemed particularly affected, underscoring the need for tailored strategies to optimize signal quality in this population. Further technical refinement is ongoing, including the implementation of accelerated imaging protocols to shorten scan time, AI-based denoising and improvements to the grounding sleeve design to ensure more consistent image quality.
Beatrice LENA (Leiden, The Netherlands), Simonetta R.g. VAN GRIETHUYSEN, Dennis A. TON, Berend C. STOEL, Denis P. SHAMONIN, Javad PARSA, Ruben B. VAN DEN BROEK, Chloé F. NAJAC, Yiming DONG, Yanli LI, Annette H.m. VAN DER HELM - VAN MIL, Andrew WEBB
Auditorium 900

"Saturday 11 October"

Added to your list of favorites
Deleted from your list of favorites
B30
08:30 - 09:30

FT3-4 - Quality of dissemination in research outputs

Chairpersons: Marion SMITS (Chairperson, Rotterdam, The Netherlands), Oliver SPECK (Chairperson, Magdeburg, Germany)
FT3: Cycle of Quality
08:30 - 09:30 Publications, working in collaborations. Nikola STIKOV (Keynote Speaker, Montreal, Canada)
08:30 - 09:30 Quality assessment of published research. Stefano MOIA (Keynote Speaker, Maastricht, The Netherlands)
Salle Major

"Saturday 11 October"

Added to your list of favorites
Deleted from your list of favorites
C30
08:30 - 09:30

FT3 Oral - Increasing quality across modalities and organs

Chairpersons: Marta MAGGIONI (PhD) (Chairperson, Basel, Switzerland), Sebastian WEINGÄRTNER (Chairperson, Delft, The Netherlands)
08:30 - 08:40 #47883 - PG037 Contrasting the use of whole-body diffusion-weighted MRI and 18F-FDG PET/CT for the metastatic evaluation of paediatric malignancies: a systematic review and meta-analysis.
PG037 Contrasting the use of whole-body diffusion-weighted MRI and 18F-FDG PET/CT for the metastatic evaluation of paediatric malignancies: a systematic review and meta-analysis.

Paediatric cancers represent a small but significant spectrum of childhood and adolescent diseases with a substantial global disease burden. While Positron Emission Tomography/Computed Tomography (PET/CT) is one of the primary imaging modalities used for the staging and metastatic evaluation of paediatric malignancies, its reliance on ionising radiation poses significant risks for paediatric patients, who are highly radiosensitive. Whole-Body Magnetic Resonance Imaging (WB-MRI) is an emerging radiation-free modality that may offer a safer alternative for the detection of metastases in paediatric malignancies; however, its accuracy requires further validation. This systematic review aimed to synthesise the available evidence to comparatively evaluate the use of whole-body diffusion-weighted MRI (WB-DWI) as a radiation-free alternative to PET/CT for the metastatic evaluation of paediatric cancers.

A comprehensive literature search was conducted from September to December 2024 across PubMed, Embase and Web of Science. Inclusion criteria were: participants assessed by both WB-MRI and 18F-fluorodeoxyglucose PET/CT (18F-FDG PET/CT); histopathological confirmation of the primary malignancy was present; and participants aged ≤21. Exclusion criteria were: diffusion-weighted sequencing not used in the WB-MRI protocol; hybridised PET/MRI evaluated; or true positive (TP), false positive (FP), true negative (TN), and false negative (FN) data could not be extracted. Applicability and risk of bias were assessed using the Quality Assessment of Diagnostic Accuracy Studies (QUADAS)-2 tool. Pooled sensitivity, specificity and predictive values were calculated using a univariate weighted analysis.

9 studies met the criteria to be included in this review, and 8 were included in the meta-analysis. Figure 1 displays the PRISMA flow chart representing the selection of studies. The malignancies represented in the meta-analysis were all haematological in nature, primarily assessing Hodgkin lymphoma, with more limited data for Langerhans cell histiocytosis and non-Hodgkin lymphoma. The excluded study assessed patients with neuroblastoma and was analysed separately due to a high risk of bias and methodological incompatibilities. All studies were judged to be at a high or unclear risk of bias in at least one QUADAS-2 domain. Compared against PET/CT, the pooled per-patient and per-lesion sensitivity values of WB-MRI were 91.7% (95% CI: 77.5-97.3%) and 87.6% (95% CI: 78.0-94.2%), respectively. Using a per-region analysis, sensitivity was 94.9% (95% CI: 90.2-97.7%) and specificity was 98.7% (95% CI: 96.9-99.4%). The pooled sensitivity and specificity values are represented in Figure 2. While overall performance of the two modalities was comparable, some variability was observed, particularly in studies with smaller sample sizes. False negative WB-MRI results occasionally led to under-staging; however, not all discrepancies were clinically significant.

WB-MRI showed a high level of agreement with PET/CT for the identification of metastases, particularly for nodal disease. Diagnostic accuracy varied across anatomical locations; however, for overall staging, accuracy was high, with few patients incongruently staged by the two modalities such that there were implications for treatment. While PET/CT formed the reference standard for this review, it should be noted that PET/CT is not a perfect diagnostic test, and so discrepancies between the two modalities are not necessarily always indicative of a WB-MRI error. Without an objective, independent reference – such as histopathological confirmation of any identified lesions, or additional imaging – the true source of discordance between the two modalities cannot be conclusively established. Additionally, despite the substantial advantage that WB-MRI offers by eliminating radiation exposure, there are limitations to the implementation of WB-MRI. Limited availability of MRI scanners and longer scan durations compared to PET/CT increase the likelihood of sedation being required, introducing additional clinical risks. Quantifying the diagnostic value of specific MRI sequences is therefore essential for the development of evidence-based MRI protocols to minimise scanning times.

WB-DWI MRI demonstrated a high concordance with 18F-FDG PET/CT, however, rarer malignancies remain underrepresented in the literature and may rely on the generalisability of other results to guide clinical recommendations. Where serial imaging is required and cumulative radiation exposure is a concern, WB-MRI offers an advantage over PET/CT imaging. With further supporting evidence and appropriate protocol optimisation, WB-MRI may offer a viable, radiation-free alternative to PET/CT and may reshape staging practices in paediatric oncology by reducing radiation burden without compromising on diagnostic accuracy.
Leanne MAHER (Lincoln, United Kingdom), Daniel MCLAUGHLIN
08:40 - 08:50 #47739 - PG038 Diffusion MRI preprocessing impacts ADC estimation and automatic PI-RADS v2.1 classification in bi-parametric prostate MRI.
PG038 Diffusion MRI preprocessing impacts ADC estimation and automatic PI-RADS v2.1 classification in bi-parametric prostate MRI.

Prostate cancer (PCa) is the most common type of malignancy in the male population. Bi-parametric Magnetic Resonance Imaging (bp-MRI) combining T2-weighted (T2w) imaging with Diffusion MRI (dMRI), has been proven non-inferior to multi-parametric MRI (mp-MRI) for PCa detection [1]. DMRI-derived Apparent Diffusion Coefficient (ADC) maps are widely used to detect PCa, but dMRI suffers from artifacts that affect the quality of ADC maps. This study aimed to evaluate the impact of dMRI preprocessing on the estimation of ADC maps, with a goal to automatically determine PI-RADS [2],[3] scores based on bp-MRI sequences. As PI-RADS 3 lesions are radiologically further assessed using intravenous contrast, we aimed to automatically classify lesions as PI-RADS 3 or not, to facilitate workflow as the patient lies in the scanner.

Data: 268 cases from fastMRI prostate dataset were used [4], containing T2w and dMRI axial scans with individual-slice PI-RADS labels. Each case contained 48 dMRI images with two different b-values (b=50, 1000 s/mm²). Preprocessing: 5 pipelines were compared: 1) averaged unprocessed, 2) non-averaged unprocessed, 3) non-averaged denoised [5], 4) denoised and Gibbs-ringing corrected [5] and 5) denoised, Gibbs-ringing corrected and susceptibility distortion corrected by registration to the T2w along the phase encoding direction [5]. ADC estimation: for each pipeline iterative weighted linear least squares (IWLLS) [6] and LLS regression were performed, resulting in 10 differently processed ADC maps. Segmentation: axial T2w sequences were used as input for a pretrained, in-house finetuned UNet-based algorithm [7] to obtain segmentations of the prostate. PI-RADS classification: A DenseNet [8] architecture with 16 initial features and a block configuration of [6,12,24,16] was used for 3-class classification, comparing all pipelines with IWLLS estimation. PI-RADS scores 1,2 (class 1) and scores 4,5 (class 3) were grouped together. PI-RADS 3 patients represented class 2. Model input consisted of multi-channel 2D slices including: the T2w image, the IWLLS-estimated ADC map and either the averaged dMRI data for pipeline 1 or the non-averaged dMRI data for the rest. Adam optimizer [9] was used with a learning rate of 1e-5. Training was paused after 230 epochs when no significant improvement in per-class Area Under Receiver Operating Curve (AUROC) was observed. A validation set of [6/4/3] patients per class [1/2/3] was used to compare slicewise model performance, by comparing the average AUROC values per class for each pipeline. Optimal decision thresholds per class were calculated on the validation set for the best performing pipeline using Youden’s Index [10]. Model weights from the last training epoch of the best performing pipeline were applied per slice on a test set of 37 patients (17/11/9).

Although Wilcoxon signed-rank tests revealed statistically significant differences across mean slice-wise ADC estimates for all pipelines (p < 0.001), Pearson Correlation Coefficients (PCCs) were consistently high (0.975–1.000) within the prostate mask for all pipeline combinations. Figure 1 shows the differences in an axial IWLLS-estimated ADC slice across pipelines. Figure 2 displays a Bland-Altman plot of the two most different mean slicewise ADC distributions based on their lowest pcc value: pipeline 3 LLS and pipeline 5 IWLLS. Classification results are displayed in table 1. Pipeline 5 (fully processed data) was superior (AUROC values 0.685-0.827), yielding slicewise AUROC values of 0.852, 0.826 and 0.909 for classes 1,2 and 3 respectively on the independent test set. Sensitivity and specificity were reported 0.845/0.725, 0.667/0.841 and 0.316/0.993 for classes 1,2 and 3 respectively. Figure 3 shows the slicewise per-class ROCs.

dMRI preprocessing had a significant effect on ADC estimation and was associated with statistically significant differences in mean ADC values across slices. Nevertheless, the high PCC values indicate preserved contrast in dMRI images independently of the preprocessing method. Automatic PI-RADS classification performance, however, was more sensitive to preprocessing. Susceptibility distortion correction led to the largest performance gain, underscoring the importance of accurate dMRI-to-T2w alignment for AI-driven analysis. Additionally, the benefit of using raw dMRI data over scanner-averaged sequences for clinical use was demonstrated. These findings highlight how preprocessing choices critically influence downstream automatic tasks like PI-RADS classification.

Overall, results demonstrate that dMRI preprocessing has a dual impact: it alters mean ADC values significantly without disrupting diffusion patterns and, more critically, it enhances the reliability of dMRI data in supporting automated PI-RADS scoring and downstream clinical decision-making. This underscores the importance of selecting appropriate preprocessing strategies for robust AI-driven diagnostics in prostate MRI.
Christos KANAKIS (Utrecht, The Netherlands), Mathias PERSLEV, Tim SCHAKEL, Silvia INGALA, Michael Bachmann NIELSEN, Akshay PAI, Dennis W.j. KLOMP, Chantal M.w TAX
08:50 - 09:00 #47576 - PG039 Setting up a standardised Whole Body MRI clinical protocol for patients with myeloma across 10 UK hospitals.
PG039 Setting up a standardised Whole Body MRI clinical protocol for patients with myeloma across 10 UK hospitals.

Whole Body (WB) MRI is embedded in national [1] and international [2] guidance for myeloma imaging. However, a national survey data suggests that protocol optimisation and radiographer training are barriers to implementation of such a service [3]. This initiative aimed to deliver radiographer training and a standardised clinical WB-MRI protocol for early diagnosis of myeloma across 10 sites within the RM Partners West London Cancer alliance, UK.

Figure 1 summarises the project steps and participating scanners. All sites were visited during an eight-month period (October 2024 - May 2025). The standardised protocol derived from a 1.5T Sola Siemens scanner and was compliant with the MY-RADS core protocol guidelines [4]. The protocol includes multi-station axial acquisitions of Diffusion Weighted Imaging (DWI) and Dixon sequences; seven stations were utilised to cover an average adult from vertex to knees. The site visit (including a physicist and radiographer) supported protocol set up and provided practical training on healthy volunteer data acquisition and scanning of a DWI phantom. DWI acquisition of a single station from the WB-DWI protocol was performed using a calibrated phantom (Diffusion Phantom Model 128 [serial number 128-0230], Caliber MRI, Boulder, Co. USA, [5]). The same phantom was scanned in the same holder and orientation on each scanner. The Apparent Diffusion Coefficient (ADC) measurements were compared with the tabulated room-temperature-specific values available from the phantom manufacturer. Details of the MR protocol utilised for each vendor are presented in Figure 2. In order to support clinical sites with MRI capacity challenges, the WB-MRI protocol was optimised to accelerate the DWI acquisition (i.e. using a 2 b-value sequence and, where available, the artificial intelligence (AI)-based DWI reconstruction). The maximum DWI acquisition time across all seven stations was ~30 min. The site qualification process included review of the volunteer data and quantitative assessment of the DWI phantom.

The standardised WB-MRI protocol was successfully set up at 10 UK scanners/sites involving three vendor systems. The ADC measurements across all scanners (Figure 3) showed a relative ADC measurement error of < 10% across a wide clinical range of ADCs (e.g. 50-200 x 10-5 mm2/s). A relatively large room temperature range was observed across the 10 scanners (18 - 23 °C). Exemplar images from three healthy volunteers are presented in Figure 4, showing axial b900, ADC and fat-only Dixon images of the pelvis station, together with maximum intensity projection (MIP) of the coronal reconstruction of multi-station axial b900 images.

Various hardware and software limitations were observed. Two sites had lower specification gradients limiting the maximum gradient strength (e.g. 33 mT/m instead of 45 mT/m) and slew rate (125 T/m/s instead of 200 T/m/s) of the diffusion gradients, thus resulting in longer echo times and consequently slightly longer acquisition times. The GE and Philips scanners in this evaluation did not offer tools on the console/workstation for image arithmetic to calculate relative fat fraction [FF=F/(F+W)] from the T1w Dixon imaging. Across these 10 scanners, only the GE sites had access to AI-based DWI reconstruction for acceleration of DWI at the time of this study. Nevertheless, whilst accepting minimal site-specific modifications of the optimised MR sequence parameters, we were able to share the methodology and imaging protocols resulting in images which were suitable for qualitative and quantitative analysis, with accurate ADC estimates obtained in phantom measurements at all 10 sites. Patient data acquisition is ongoing and potential slight changes of the protocol may still occur.

Standardised WB-MRI protocols can be implemented and supported across the three main vendor systems allowing all hospital sites in the network to scan myeloma patients. With minimal modification, this protocol can also be applied to emerging WB-MRI applications in metastatic bone disease and screening high risk populations.
Mihaela RATA (London, United Kingdom), Alison MACDONALD, Georgina HOPKINSON, Richard NORCLIFFE, Lesley-Anne HAMMOND, Edith BENDANA, Rina KAPADIA, Pablo MARTINPOLANCO, Rosaleen O'KEEFFE, Aman JUTTLA, Jamal SALEH, Olga FADEEVA DA COSTA, Tara BARWICK, Jimaio UBALDO, Jessica WINFIELD, Christina MESSIOU
09:00 - 09:10 #45950 - PG040 Normative Diffusion MRI Metrics of the Cervical Spinal Cord Across Age Groups on a 3T Hybrid PET/MRI Scanner.
PG040 Normative Diffusion MRI Metrics of the Cervical Spinal Cord Across Age Groups on a 3T Hybrid PET/MRI Scanner.

Normative MRI datasets of the spinal cord are essential for detecting deviations linked to neurological disorders. However, age-specific reference values remain scarce, limiting their application in clinical settings. This study aims to characterize age-related microstructural changes in the cervical spinal cord using diffusion MRI. We focused on the gracilis, cuneatus, and lateral corticospinal tracts due to their known involvement in multiple sclerosis (MS) [1], to support future biomarker development. Notably, this is the first normative dataset acquired with a custom protocol developed for the Siemens Biograph mMR hybrid PET/MRI scanner, a system not previously optimized for spinal cord imaging.

Thirty-six healthy individuals were scanned on a 3T Siemens Biograph mMR hybrid PET/MRI system using a dedicated protocol including T2-weighted and DTI sequences. The cohort comprised 17 young (mean age = 30.4 ± 4.1 years, 13 female) and 19 elderly subjects (mean age = 60.8 ± 5.1 years, 13 female). T2-weighted images were acquired using a 3D turbo spin echo sequence (TR/TE = 1500/120 ms, flip angle =120°, voxel size = 0.8 × 0.8 × 0.8 mm³). DTI was performed according to international guidelines for quantitative MRI of the spinal cord, using a spin-echo EPI sequence (TR/TE = 670/76 ms, 30 directions, b = 800 s/mm², 5 b0 volumes, voxel size = 0.9 × 0.9 × 5 mm³) [2]. Images were processed using the Spinal Cord Toolbox (SCT) for segmentation and vertebral labeling (C1–C6) [3]. Diffusion metrics—FA, MD, AD, RD—were extracted from the gracilis, cuneatus, and lateral corticospinal tracts bilaterally. Statistical comparisons were performed using two-sample t-tests and Cohen’s d, with FDR correction. Results were visualized with bar and volcano plots.

FA and AD showed the most consistent age-related differences. The right gracilis tract at C2 exhibited the strongest effect (p = 0.0012, d = 1.17), remaining significant after FDR correction. Other features with large effect sizes (d > 0.8), although not surviving correction, were observed in the lateral corticospinal and gracilis tracts for MD, AD, and RD. Figure 1 shows mean ± SD of all metrics across tracts and vertebral levels (C1–C6). Elderly subjects had lower FA and higher RD values. The right lateral corticospinal tract at C2–C3 showed the highest inter-subject variability in diffusivity. Figure 2 presents line plots highlighting higher FA and lower RD in young participants, especially in posterior and lateral tracts. Figure 3 combines volcano plots for all four metrics. Only FA in the right gracilis at C2 remained significant after FDR correction. Several features fell in the large-effect zone (|d| > 0.8), especially in lateral corticospinal tracts for AD and MD (Figure 3).

This is the first normative diffusion MRI dataset of the cervical spinal cord acquired on a hybrid PET/MRI system. By combining tract-specific analysis with quantitative diffusion metrics, we identified robust and anatomically consistent age-related differences. Reductions in FA and increases in RD and MD, particularly in sensorimotor pathways, align with expected aging-related demyelination and axonal loss [4,5]. Methodologically, we provide standardized diffusion profiling across C1–C6, using a reproducible pipeline [3]. The integration of high-resolution anatomical and diffusion imaging within a PET/MRI platform enhances translational applicability. Identified features with high effect sizes and low variability offer a basis for biomarkers in MS and may aid in early diagnosis and monitoring [1]. This normative framework also enables future investigations into comorbidities and sex differences in spinal cord aging [6].

We present a tract- and level-specific normative dataset of cervical spinal cord diffusion metrics across age groups, acquired using a custom protocol on a hybrid PET/MRI system. Results confirm robust and anatomically localized microstructural changes with aging, particularly in MS-relevant tracts. This dataset provides a reference framework for precision MRI biomarkers in neurodegenerative and inflammatory disorders. This work was supported by the D³4Health initiative (Project PNC0000001), funded by the Italian Ministry of University and Research under the National Plan for Complementary Investments to the PNRR (PNC-PNRR).
Alessia SARICA (Catanzaro, Italy), Maria Eugenia CALIGIURI, Chiara CAMASTRA, Ilaria CHIMENTO, Paola VALENTINO, Stefania BARONE, Umberto SABATINI, Andrea QUATTRONE, Aldo QUATTRONE
09:10 - 09:20 #47845 - PG041 Breast tissue segmentation at 7T using Chemical Exchange Saturation Transfer (CEST).
PG041 Breast tissue segmentation at 7T using Chemical Exchange Saturation Transfer (CEST).

Breast tissue composes mostly of fibroglandular tissue (FGT) and fat, and the differentiation of these tissues is key for breast cancer diagnosis [1]. While CEST MRI is mainly used to probe metabolites, its frequency-selective saturation enables water-fat separation [2]. Beyond this, multidimensional CEST data may support more detailed breast tissue segmentation. We explore dimensionality reduction and clustering of Z-spectra for this purpose.

A CEST MRI sequence was implemented using 120 Gaussian-shaped saturation pulses (15.360 ms, 10 ms interpulse delay, B1 = 1 μT). Imaging readout used a snapshot acquisition (TR: 7.4 ms, TE: 1.46 ms, FA: 6°) [3]. 41 frequency offsets (0.25 ppm steps) were acquired from -5 to +5 ppm with 1 s recovery. All measurements were performed on a 7T MAGNETOM Terra.X scanner (Siemens Healthcare, Erlangen) using a local Rapid 4Tx/16Rx 1H breast coil, in three healthy female volunteers, with ethics approval and informed consent. Although a 4Tx system, the coil ran in fixed protected mode. For Volunteer 1, B1 was 1 μT; for Volunteers 2 and 3, reduced to 0.8 μT to meet SAR limits. Simulated CEST spectra were created with the BMCTool package [4]. For segmentation, dimensionality reduction (PCA, UMAP) [5,6] was applied to voxel-wise spectral data, followed by k-means and agglomerative clustering [7-8]. FGT segmentation was evaluated by computing the Dice Similarity Coefficient (DSC) against a reference manually segmented by a trained radiologist based on 1 CEST image and a DIXON acquisition.

Simulated Z-spectra of voxels containing only water, only fat, and a 50/50 mix show the influence of fat with a second dip at -3.5 ppm, the resonance frequency assumed in this work for the main fat peak (Figure 1a). Experimental spectra under matching conditions show similar features (Figure 1b). Figures 1(c-f) display CEST images at 4 saturation offsets, illustrating natural suppression of fat or water at different frequencies. In Figure 2a, the PCA component loading vectors are shown, with Figures 2(c-f) displaying the corresponding images. The second principal component (Fig. 2d) reveals a clear fat-water contrast, reflected in the loading vector through opposite weighting of fat and water frequencies. Figure 2b presents the PCA Cumulative Explained Variance, indicating 3 components explain 95% of the data and 6 explain 98%, with the curve stabilizing around 20 components. In different regions of interest (ROI), the cumulative explained variance does not hold. Figure 3 presents results from two clustering algorithms (k-means, agglomerative) using the full dataset, 3 and 21 PCA components, and 3- and 20-dimension UMAP reductions. Figures 3a and 3b show a raw CEST image and an FGT mask manually delineated by a radiologist on the image in 3a. In the “whole FOV” results, both raw and PCA data consistently subdivide FGT into two clusters: one at the periphery and one in the interior, likely due to partial volume effects. Only 20-dimension UMAP placed all FGT voxels into a single cluster, yielding the highest DSC for FGT. However, 3-dimension UMAP (Fig. 3(o-p)) resulted in good segmentation of the pectoral muscle, though not with complete efficacy as the muscle shares a cluster with some FGT voxels. Generally, both fat and FGT split into several clusters, leaving uncertainty whether these should be combined into a single mask or if subdivisions reflect meaningful variation. To explore CEST’s potential for differentiating FGT into ducts and glands, clustering was applied to a mask containing only FGT tissue (“Only fibroglandular tissue” column). Distinct localized clusters emerged, though no suitable reference is available to confirm anatomical correspondence. The most striking result appears in 3v, where 3 similar clusters (9, 10 and 11) are located near the nipple region, where higher duct density is expected. However other reasons (anatomical and technical) might be influencing this observation. Figure 4 further examines the results from the 20-dimension UMAP by showing the Z-spectra (4b, d) for ROIs of each cluster from the “Whole FOV” and “Only Fibroglandular Tissue” analyses. The clustering differentiates regions with higher noise, greater fat contribution, and stronger water peaks. In particular, Figure 4d highlights varying fat peak amplitudes, suggesting clustering reflects fat fraction variations.

This work demonstrates that CEST’s spectral data structure enables tissue clustering beyond fat-water separation. While fat and fibroglandular tissue often subdivide, this may reflect not only partial volume effects and field inhomogeneities but also additional contrast from CEST. Notably, UMAP-reduced data yielded the most coherent FGT segmentation. If the goal is purely fat-FGT separation, thresholding CEST images at -3.5 ppm or using the 2nd PCA component might suffice. However, the observed localized clusters suggest potential for meaningful tissue differentiation, warranting anatomical validation.
Magda DUARTE (Erlangen, Germany), Katharina BREININGER, Katharina TKOTZ, Sebastian BICKELHAUPT, Moritz ZAIß
09:20 - 09:30 #47665 - PG042 A novel deep learning pipeline for 17-segment myocardial scar segmentation and quantification in CMRI.
PG042 A novel deep learning pipeline for 17-segment myocardial scar segmentation and quantification in CMRI.

Accurate myocardial scar segmentation is vital for stratifying sudden cardiac death risk, ventricular arrhythmias, prognosis, and therapy planning [1]. Late gadolinium enhancement (LGE) CMR assesses left ventricular (LV) scar tissue, aiding arrhythmia risk evaluation [2]. However, automated segmentation is difficult due to subtle scars [3] and anatomical variability [4]. The AHA 17-segment model standardizes LV division across imaging modalities for consistent analysis [5]. Its coronary alignment enables precise ischemia localization, and automation may boost diagnostic accuracy [6]. Yet, current methods often need predefined LV contours and manual refinement [7], highlighting the need for a fully automated deep learning (DL) framework. We propose a тщмуд DL pipeline for automated LV scar segmentation using the 17-segment model. It includes: (1) DL-based slice classification and landmarks detection, (2) segmentation of healthy myocardium and scar, (3) algorithmic 17-segment partitioning. This approach accelerates processing, improves accuracy, reduces manual input, and supports clinical decision-making.

Pipeline overview. The DL-assisted pipeline (Figure 1) performs automated 17-segment myocardial scar segmentation and quantification. It starts with a ResNet50 model that classifies MRI slice levels, identifies the LV center of mass (C), and detects an anatomical reference point (P) (uppermost point of the attachment of the right ventricular wall to the left ventricle). LV center of mass guides image cropping. The cropped images are then processed by a U-Net model to segment healthy myocardium and scar. Outputs from both models feed into a mathematical algorithm that divides the LV into 17 segments following AHA guidelines. The multi-segment mask is combined with the scar mask to localize and quantify scar volume in each of the 17 segments. A bull’s-eye plot then visualizes scar distribution for intuitive interpretation. Dataset. The MRI dataset includes data of 150 post-infarction cases from ANMRC (130 for training/validation, 20 for testing) and 100 labeled cases from the EMIDEC dataset [8], both with delayed contrast-enhanced T1-weighted images for scar detection. ANMRC images were manually segmented in MedSeg by a medical physicist under radiologist supervision; EMIDEC provided annotated masks. Each slice was manually classified into four anatomical levels, anatomical reference points were identified, and 17-segment masks were generated semi-automatically following AHA standards [9]. Ground truth scar volume per segment was derived from these annotations. DL Models. Two DL models were used: ResNet50, with classification and regression output layers, for slice classification and anatomical landmarks prediction and U-Net (enhanced with attention mechanisms) for healthy myocardium and scar segmentation. To improve accuracy, images were cropped around the LV centroid and used as inputs for the U-Net model. Segmentation performance was evaluated using Dice Similarity Coefficient (DSC), anatomical landmarks (C and P ) prediction with mean absolute error (MAE), while scar volume estimation with both MAE and Pearson correlation.

The ResNet50 model achieved 86% slice classification accuracy, with MAE of 2.60 and 4.30 pixels for the LV centroid (C) and reference point (P), respectively. U-Net showed strong performance with median DSCs of 0.84 for healthy myocardium and 0.74 for scar segmentation (Figure 2a). The trained networks were integrated into the pipeline. A mathematical algorithm based on their outputs achieved a mean DSC of 0.85 ± 0.05 across the 17 segments (Figure 2b–c). Scar quantification showed a 7.63% MAE and a Pearson correlation of 0.86, indicating strong agreement with the ground truth.

Our deep learning-assisted pipeline for myocardial scar segmentation within the AHA 17-segment model demonstrates competitive performance compared to existing methods. While the scar quantification error (MAE 7.63%) is slightly higher than a previous semi-automatic approach (6.4%) [9], the proposed method is fully automated, enhancing processing speed. Additionally, the 17-segment myocardial segmentation achieved a higher mean DSC (0.85 ± 0.05) than a recent automated method (DSC 0.81) reported in [7], highlighting its strong potential for clinical application. The developed pipeline was implemented as a desktop application with a simple and user-friendly interface, as shown in Figure 3.

The proposed deep learning-assisted pipeline offers a fully automated and accurate solution for myocardial scar segmentation using the AHA 17-segment model. By integrating deep learning with mathematical modeling, it streamlines analysis, reduces manual effort, and supports standardized clinical interpretation. Future work will aim to improve performance in apical regions and validate the method across larger, diverse datasets. This study was supported by the Russian Science Foundation (RSF) grant No. 23-75-10045
Walid AL-HAIDRI (Saint Petersburg, Russia), Levchuk ANATOLIY, Kseniya BELOUSOVA, Vladimir FOKIN, David BENDAHAN, Ekaterina BRUI
Espace Vieux-Port

"Saturday 11 October"

Added to your list of favorites
Deleted from your list of favorites
D30
08:30 - 09:30

FT2-1 - Imaging early life

Chairpersons: Melanie BAUER (PhD) (Chairperson, Innsbruck, Austria), Moss ZHAO (Faculty) (Chairperson, Stanford, USA)
FT2: Cycle of Translation
08:30 - 09:30 Brain MRI on awake pediatric patients. Stefan SKARE (Keynote Speaker, Stockholm, Sweden)
08:30 - 09:30 MRI of fetal neurodevelopment. Daniela PRAYER (Keynote Speaker, Vienna, Austria)
Salle 120

"Saturday 11 October"

Added to your list of favorites
Deleted from your list of favorites
E30
08:30 - 09:30

EFRS
Putting the person first in MRI: an ESMRMB-EFRS working group session

Chairpersons: Allison MCGEE (PhD) (Chairperson, Dublin, Ireland), Claude PORTANIER MIFSUD (Masters) (Chairperson, Msida, Malta., Malta)
08:30 - 08:45 Gamification in MRI training: enhancing knowledge, skills, and safety, and care. Marie-Anaïs PETIT (Scientific Collaborator) (Keynote Speaker, Geneva, Switzerland)
08:45 - 09:00 Clinical simulation in MRI: providing access and supporting enhanced person-centred MRI. Frances GRAY (Health Profession Education Lead/Lecturer) (Keynote Speaker, Sydney, Australia)
09:00 - 09:15 Maintaining a person-centred approach for remote scanning: is this possible for patients and radiographers? Anton QUINSTEN (Keynote Speaker, Germany)
09:15 - 09:30 Panel Discussion (15'): Are we losing our skills in care and compassion?
Salle 76
09:30 TIME FOR A BREAK - Coffee and refreshments will be available at the cash bar.
09:50

"Saturday 11 October"

Added to your list of favorites
Deleted from your list of favorites
A31
09:50 - 10:50

FT1 Plenary
The renascence of gradients for high performance MRI

Chairpersons: Ileana JELESCU (Assistant Professor) (Chairperson, Lausanne, Switzerland), Hendrik MATTERN (Chairperson, Magdeburg, Germany)
FT1: Cycle of Technology
09:50 - 10:50 Diffusion imaging with ultra-strong gradients across the body. Chantal TAX (Associate Professor) (Keynote Speaker, Utrecht, The Netherlands)
09:50 - 10:50 Pushing the limits of high-performance gradients: design and applications. Markus WEIGER (PhD) (Keynote Speaker, Zurich, Switzerland)
Auditorium 900
10:50 TIME FOR A BREAK - Coffee and refreshments will be available at the cash bar.
11:00

"Saturday 11 October"

Added to your list of favorites
Deleted from your list of favorites
A32
11:00 - 12:30

FT1-2 - RF transmission and reception
Advanced techniques and applications

Chairpersons: Aurelien DESTRUEL (Research Fellow) (Chairperson, Marseille, France), Johanna  VANNESJÖ (PhD) (Chairperson, Trondheim, Norway)
FT1: Cycle of Technology
11:00 - 12:30 Metamaterials in MRI. Rita SCHMIDT (Senior Scientist) (Keynote Speaker, Rehovot, Israel)
11:00 - 12:30 pTx in practice. Christoph AIGNER (Research Scientist) (Keynote Speaker, Berlin, Germany)
11:00 - 12:30 SAR management in pTx. Andreas BITZ (Keynote Speaker, Aachen, Germany)
11:00 - 12:30 Tailor-made: Wearable RF coils (Flexible, wireless). Martijn CLOOS (PhD) (Keynote Speaker, Nijmegen, The Netherlands)
Auditorium 900

"Saturday 11 October"

Added to your list of favorites
Deleted from your list of favorites
B32
11:00 - 12:30

ET1-2 - Data visualization and figure creation

Chairpersons: Soetkin BEUN (PhD Researcher) (Chairperson, Ghent, Belgium), Patricia CLEMENT (Postdoctoral researcher) (Chairperson, Ghent, Belgium)
11:00 - 12:30 Interactive scatter plots. Saige RUTHERFORD (Keynote Speaker, Jena, DE, The Netherlands)
11:00 - 12:30 Coloring your MR maps. Miha FUDERER (Keynote Speaker, Utrecht, The Netherlands)
11:00 - 12:30 Interactive brain plots. Saige RUTHERFORD (Keynote Speaker, Jena, DE, The Netherlands)
Salle Major

"Saturday 11 October"

Added to your list of favorites
Deleted from your list of favorites
C32
11:00 - 12:30

FT3 LT - Increasing quality in AI applications

Chairpersons: Camilla CALOMINO (Chairperson, Catanzaro, Italy), Valentina VISANI (M.Sc. (Ph.D. Candidate)) (Chairperson, Padova - Basel, Italy)
11:00 - 11:02 #47923 - PG205 Enhancing Hippocampal Subfield Visibility from Repeated 3T MRI: High-SNR Image Generation for Deep Learning-Based Segmentation.
PG205 Enhancing Hippocampal Subfield Visibility from Repeated 3T MRI: High-SNR Image Generation for Deep Learning-Based Segmentation.

Accurate segmentation of the hippocampus and its subfields is critical for studying neurodegenerative diseases such as Alzheimer’s. These submillimeter structures require high-resolution MR images with strong signal- and contrast-to-noise ratios (SNR, CNR). These are difficult to achieve at 3T due to the hippocampus’s small size and deep brain location. A common approach for imaging the hippocampus is to use 2D T2-weighted (T2w) turbo-spin-echo (TSE) sequences, with very high in-plane resolutions and comparably thick slices. However, low SNRs and CNRs often compromise visibility of the fine internal hippocampal architecture. To address these limitations, within-subject averaging of multiple repeated acquisitions has been proposed to enhance image quality [1, 2]. When combined with robust preprocessing, such as N4 bias field correction and non-linear registration, this strategy can significantly boost anatomical fidelity. Here, we compare the generation of a high-SNR image using 25 repeated 3T T2w scans from two healthy subjects, aligned via a SyN-based ANTs pipeline. We compare simple averaging with a gradient-based method emphasizing structural boundaries, aiming to support improved visualization and ground truth annotation for deep learning-based hippocampal subfield segmentation.

Dataset. We acquired a unique dataset consisting of 25 repetitive T2w scans (3T Siemens Prismafit) of two healthy subjects. T2w scans were obtained using a 2D fast spin-echo with hyperechoes (48 slices, 0.47×0.47×1 mm³; 352×512×48 matrix) in an oblique coronal plane perpendicular to the long axes of the hippocampi. Image alignment. All T2-weighted volumes were aligned using a multi-stage registration pipeline implemented with the Advanced Normalization Tools (ANTs) software suite [3,4]. We applied symmetric normalization (SyN), a diffeomorphic model that generates smooth, invertible deformation fields suitable for high-resolution MRI registration [5]. To account for local intensity variations, common in T2-weighted imaging, the Mattes mutual information metric was used [6]. A four-level multi-resolution strategy (100, 70, 50, 20 iterations) with 32% voxel sampling per level was used to balance accuracy and efficiency [4,7]. The reference volume was selected based on the lowest Frobenius norm of intra-volume transformations between odd and even slices, indicating minimal inter-slice distortion and highest internal consistency. Prior to registration, all scans were N4 bias-corrected [8], padded by 20 mm in each spatial direction to reduce edge effects, and histogram-matched to the reference. Image Combination / Averaging. Following spatial alignment, which ensured a reliable basis for the subsequent voxel-wise high-SNR reconstruction, an average and gradient-based fusion approach was employed to synthesize a high-SNR T2-weighted volume from the aligned inputs. This method enhanced the representation of anatomical structures by prioritizing edges and tissue boundaries, which typically carry greater structural information. In particular, local gradient magnitudes were computed for each volume using the Gaussian gradient magnitude operator with a fixed standard deviation (σ = 1). Calculated gradients were then used to create weight maps. This process emphasizes smooth intensity transitions and edges while suppressing noise [9,10]. The final high-SNR volume was obtained by computing the weighted average voxel intensities. For comparison, also simple voxel-wise averaging of the aligned images was calculated.

To assess the quality of the resulting high-SNR images, SNR values were computed for the reference images and their corresponding batch-averaged reconstructions (N = 9, 16, 25). Quantitatively, the SNR of Subject 1 increased from 42.27 (original) to 59.99 using Gaussian-weighted averaging with a batch size of 25. For Subject 2, SNR improved from 35.56 to 54.44 under the same conditions. The complete set of SNR measurements across methods and batch sizes is summarized in Table 1. A qualitative comparison of the resulting images is shown in Figures 1 to 3.

Quantitative and qualitative assessments demonstrated consistent improvements in SNR across all reconstruction methods compared to the original T2-weighted MR images. Visual comparison (cp. Fig. 1 to Fig. 3) reveals enhanced anatomical detail and reduced noise in images reconstructed with Gaussian gradient weighting, particularly at higher batch sizes. Comparison of SNR values (Tab. 1) confirms that Gaussian weighting consistently outperforms simple averaging across all tested batch sizes.

This study demonstrates the benefit of generating high-SNR T2-weighted hippocampal images through averaging of repeated 3T acquisitions, with gradient-based Gaussian weighting consistently outperforming simple averaging. Resulting images offer improved anatomical fidelity, supporting more reliable downstream applications such as ground truth data for deep learning-based segmentation.
Maximilian SACKL (Graz, Austria), Marlene SCHICHL, Stefan ROPELE
11:02 - 11:04 #45793 - PG206 From Proof-of-Concept to Clinical Validation: Robust Automated Segmentation of Diffuse Lower-Grade Gliomas for Longitudinal Monitoring.
PG206 From Proof-of-Concept to Clinical Validation: Robust Automated Segmentation of Diffuse Lower-Grade Gliomas for Longitudinal Monitoring.

The monitoring diffuse lower-grade gliomas (DLGG) presents significant challenges due to the tumor's infiltrative nature and post-surgical brain remodeling, complicating MRI assessment. Traditionally, 2D tumor size measurements, as recommended by RANO criteria, have been used. Yet, they fail to capture subtle volumetric changes that are critical for tracking tumor progression. Volumetric assessment offers a more accurate estimation of tumor behavior but has so far been dependent on time consuming manual segmentation, rendering it impractical in routine clinical practice. Our previous proof-of-concept study demonstrated the feasibility of a nnU-Net model for DLGG segmentation, but clinical validation with larger, more heterogeneous datasets is essential. Indeed, existing literature reports encouraging results in low-grade glioma segmentation, but mainly on preoperative data, without incorporation longitudinal or post-surgical data.

This study was based on a cohort of 207 DLGG patients and 1971 MRI exams (Table 1) with longitudinal follow-up (9.55 exams ± 8.52). MRI imaging came from different MRI scanners (Siemens/GE/Philips) at different field strengths (1.5T/3T), including both 2D and 3D FLAIR acquisitions. The dataset, consisting of T1w and T2FLAIR (2D or 3D) data, was divided into a derivation set (N=1771) for model training and a validation set (N=200) for performance testing, while controlling for the 2D/3D FLAIR ratio in both sets (87.5%/12.5%). The nnU-Net model was trained using a 5-fold cross-validation approach. We evaluated the model's performance by comparing automated segmentations (AS) with manual segmentations (MS) performed by expert neuroradiologists. The primary evaluation metrics were the Dice Similarity Coefficient (DSC) and Intersection over Union (IoU), which measure segmentation overlap. Secondly, we derived tumor volume and mean tumor diameter (MTD) and compared AS with MS using Lin’s concordance correlation coefficient (CCC) and Bland-Altman tests. To further assess the model’s robustness, we analyzed its performance improvement across multiple training sets, gradually increasing the number of exams from 318 to 1971.

The nnU-Net model achieved a median DSC of 0.93 across both derivation and validation sets, with an IoU of 0.86. In the validation set, 64% of the cases showed a very good agreement (DSC ≥ 0.9) between AS and MS, and 31% had a good agreement (DSC between 0.7 and 0.9). Only 5% of cases showed unsatisfactory or poor results (Figure 1). Larger tumors were associated with higher DSC values (p<0.001). Tumor volume and MTD derived from AS showed near-perfect concordance with MS, with CCC values of 0.991 and 0.989, respectively for the validation cohort (Figure 2 and 3). Bland-Altman analysis showed a small underestimation by AS compared to MS, averaging 0.9 cm³ for tumor volume and 0.5 mm for MTD. The model’s performance improved as the number of training examples increased. With a smaller training set of 318 exams, the DSC was 0.82. Increasing the training data to 1009 exams improved the DSC to 0.89, and with 1771 exams, the DSC reached 0.93. However, adding more data beyond 1771 exams (up to 1971) did not yield further significant performance gains (p=0.84), indicating a plateau in the learning curve.

Our findings demonstrate that the nnU-Net model is a robust tool for automated DLGG segmentation, achieving a high level of accuracy that is comparable to manual expert segmentations. The model's performance, particularly in handling both 2D and 3D FLAIR images, shows its flexibility in real-world clinical settings. Importantly, the inclusion of longitudinal follow-up data and post-surgical cases with cavities makes this study more comprehensive compared to other studies, which focused solely on preoperative datasets. This broader scope allows for more accurate monitoring of DLGG progression over time and facilitates integration into clinical workflows. The minor underestimations observed in volume and MTD are unlikely to affect clinical decisions, suggesting that the model can be reliably used for patient follow-up. Furthermore, our analysis of the model’s performance across varying training set sizes confirms the importance of large, diverse datasets for improving deep learning model accuracy. The plateau observed in performance at 1771 exams suggests that the model has been sufficiently trained for this clinical context, although further external validation on datasets from different centers is recommended.

By significantly reducing the time required for segmentation while maintaining high accuracy, this model can enhance clinicians' ability to monitor tumor progression and assess treatment response in longitudinal follow-up. Future research should focus on external validation across diverse clinical environments to ensure generalizability and explore the model’s potential to provide more advanced clinical metrics, such as velocity of tumor expansion.
Jeremy DEVERDUN (Montpellier), Guillaume CLAIN, Margaux VERDIER, Hugues DUFFAU, Nicolas MENJOT DE CHAMPFLEUR, Justine MERIADEC, Mathilde CARRIERE, Amelie DARLIX, Emmanuelle LE BARS
11:04 - 11:06 #46663 - PG207 Implicit neural representations for white matter microstructure parameter estimation with gradient non-uniformity correction.
PG207 Implicit neural representations for white matter microstructure parameter estimation with gradient non-uniformity correction.

The Standard Model (SM) of white matter [1] describes the diffusion MRI (dMRI) signal as arising from the convolution of a fiber orientation distribution function (fODF) with a kernel comprising intra-axonal (sticks) and extra-axonal (zeppelin) water signal contributions. Fitting the SM to noisy dMRI data is challenging with its high-dimensional parameter space, potentially leading to low accuracy, precision, and degeneracy of estimates. Supervised deep learning has shown promise for fitting the SM to in vivo dMRI data [2-5], but it has potential drawbacks such as heavily relying on the choice of training data [6] and retraining for each acquisition scheme. Here, we implement Implicit Neural Representations (INRs) [7-9] for SM parameter estimation. INRs leverage spatial correlations across the brain to produce a continuous representation, in contrast to other methods that fit at voxel level. Furthermore, INRs are unsupervised, noise-robust, can be upsampled to higher resolutions, and can effectively include gradient non-uniformity correction in the fitting process. In this work, the INR method is compared against other machine learning methods and Nonlinear Least Squares (NLLS) fitting.

Ground Truth Generation: One MGH Connectome Dataset (subject 11) [10] was used for generating a ground truth. Acquisitions with Δ 19ms were selected. The SM was fitted with the SMI toolbox [2] to generate a set of realistic SM parameters for axon signal fraction f, intra-axonal diffusivity Di, extra-axonal parallel diffusivity De , extra-axonal perpendicular diffusivity Dp. An anisotropic diffusion filter was applied to generate spatially smooth ground truth maps. The Spherical Harmonics (SH) coefficients plm of the FOD were calculated using Multi-Shell Multi-Tissue Constrained Spherical Deconvolution (MSMT CSD) [11]. The simulated signals corresponding to these parameters were calculated from the SM signal equation with an optimized acquisition protocol [2]: b-values [0, 1000, 2000, 8000, 5000, 2000]mm/s2 , number of directions [6, 20, 40, 40, 35, 15] and B-tensor shape [1, 1, 1, 1, 0.8, 0]. A maximum SH order of lmax = 2 was used and Gaussian noise was added (SNR 50). A signal mask was applied based on white matter segmentation [12]. Fitting methods: The SM was implemented as INR (1) in Pytorch (Figure 1) and compared to three other SM fitting methods: 2) supervised machine learning using the SMI toolbox [2] with standard settings; 3) supervised deep learning as implemented in [3] trained on uniformly distributed parameters, 5e5 samples, 75%/25% training/validation split, Gaussian noise with SNR=50; 4) NLLS implemented in the MATLAB optimization toolbox using Levenberg-Marquardt algorithm . Method 1 was trained on a NVIDIA Titan X GPU for 150 epochs using a mean-squared-error loss. Pearson correlation coefficient ρ and Root-Mean-Squared-Error (RMSE) were used for evaluation. Gradient non-uniformity correction: One healthy volunteer was scanned on a 3T, 300 mT/m Connectom scanner (Siemens Healthineers) with b-values up to 4000 mm/s2 and B-tensor shape [1, 0.5, -0.5, 0]. SM parameter estimation was performed with the INR without and with correction for gradient-nonuniformities. In the second approach, spatially varying, scanner-specific gradient deviations were used to compute a B-tensor for every voxel [13]. This corrected B-tensor was then used in the forward signal prediction (Figure 1c).

Fig. 2a shows scatter density plots of the SM parameters for fitting approaches 1 to 4 . RMSE and ρ show superior performance of the INR model for all parameters, most significant for Di and De . Fig. 2b presents the resulting parameter maps across the brain, with INR representing the white matter structure smoothly, while the other methods show spatial irregularity. Fig. 3 highlights the impact of incorporating gradient non-uniformity correction on parameter estimation, with a notable reduction in De values observed when the correction is applied. Training on the simulated data took 308 seconds, whereas training with gradient non-uniformity correction required 534 seconds.

Validation on simulated data demonstrated that the INR method more effectively mitigates noise by leveraging spatial correlations compared to voxel-wise fitting methods. Gradient non-uniformity correction is cumbersome in supervised machine learning as training data would have to be generated capturing all B-tensor variations. INRs offer straightforward gradient-nonuniformity correction while being independent from training data. The INR method shows reasonable interference times, much faster than NLLS.

INR-based approach enables accurate and robust estimation of white matter microstructure, outperforming traditional methods by leveraging spatial continuity, incorporating gradient non-uniformity correction, and eliminating the need for training data.
Gerrit ARENDS (Utrecht, The Netherlands), Tom HENDRIKS, Dennis KLOMP, Edwin VERSTEEG, Anna VILANOVA, Maxime CHAMBERLAND, Chantal TAX
11:06 - 11:08 #47539 - PG208 TAsk-DRiven Experimental Design for Protocol Optimization of Ultra-high Gradient Strength Diffusion-weighted MRI Measurements.
PG208 TAsk-DRiven Experimental Design for Protocol Optimization of Ultra-high Gradient Strength Diffusion-weighted MRI Measurements.

Optimizing diffusion MRI (dMRI) acquisition protocols in clinical settings is essential for improving image quality, reducing scan times, and enhancing sensitivity to tissue microstructure. Traditional optimization methods have mainly focused on minimizing the Cramer-Rao Lower Bound (CRLB)[1], optimizing angular coverage of b-shells[2], or using data interpolation[3] to improve model parameter estimates during MR acquisition design. However, machine learning and deep learning methods, such as TADRED (Task-Driven Experimental Design)[4], or physics-informed networks[5] can generalize more flexibly to different dMRI models. TADRED is a deep learning framework that combines a subsampling network, which identifies the most informative measurements, with a task network that performs the task. This subsampling process efficiently identifies the most informative subsets of data while training a high-performing task-specific model. TADRED optimizes acquisition protocols by progressively reducing the sample set, enhancing overall efficiency. In this study, we demonstrate the TADRED-based subsampling approach against a naïve subsampling approach that aims to maximise angular coverage within each shell.

Data Acquisition, Processing and Fitting: Multi-shell dMRI data[6] were acquired on an ultra-strong gradient system (TE = 80 ms, TR = 5 s) with 1.8 mm slice thickness, 66 slices, and a 120 × 120 mm² FOV. The dataset included seven b-shells up to b = 6 ms/μm² and 266 directions (13 b=0). Gradient spacing (Δ) and duration (δ) were 24 ms and 7 ms. Direction counts scaled with b-values, with interleaved b=0 images to aid correction. Gradient spacing (Δ) and duration (δ) were 24 ms and 7 ms, respectively. Number of directions scaled with b-values, and the b=0 images were interleaved through the acquisition for improved correction. Data were denoised with MP-PCA[7], [8], [9], [10], corrected for drift, outliers (SOLID[11]), and distortions from susceptibility, motion, and eddy currents were corrected using FSL’s topup[12], [13] and eddy[14]. Gradient non-linearity was corrected using MATLAB, and Gibbs ringing was removed using MRtrix3[15]. For the TADRED, SANDI[16] model parameter maps were generated from the full dataset with a random forest regression as base parameter maps, using the SANDI MATLAB Toolbox[17]. Data Subsampling and Analysis: Two subsampling approaches were used to optimally subsample the dMRI data: uniform subsampling and TADRED framework[4]. In the first approach, data were reduced uniformly by 10%, 30% and 50% from each b-shell, ensuring that the remaining directions are still distributed uniformly on the unit sphere. For the latter approach, the dMRI data, the generated SANDI maps and acquisitions parameters were concatenated and provided as an input to TADRED framework. The TADRED subsampling and task networks were trained on these SANDI maps using 84% of the data for training and 8% each for validation and testing. Finally, TADRED generated desired subsampled datasets without any constraints from the fully sampled dMRI data. SANDI parameters maps were generated for uniformly and TADRED-subsampled datasets in the same way as the full dataset, which were compared to ‘gold-standard’ maps to evaluate the accuracy and effectiveness of each subsampling method.

Fig. 1 shows the subsampled diffusion directions across several b-shells for both uniform and TADRED approaches. Notably, TADRED removed more directions at the intermediate b-shell (b = 2.4 ms/μm²). Fig. 2 displays the TADRED-predicted SANDI maps alongside ‘ground-truth’ maps for subsampling rates of 10% (A) and 50% (B). Difference maps highlight parameter discrepancies between TADRED outputs and the ground truth. Fig. 3 compares SANDI model parameter maps derived from the uniform and TADRED-subsampled datasets, illustrating variations between the two approaches. Fig. 4 presents the mean squared error (MSE) and mean absolute error (MAE) of the SANDI parameters, averaged across all brain volumes.

TADRED test results show less than 20% error within brain tissue, with higher errors primarily observed in cerebrospinal fluid regions. In general, TADRED demonstrates lower errors in the difference maps of SANDI parameters across all subsampling rates compared to uniform subsampling (Fig. 3). However, at the 50% subsampling level, errors in fneurite and Rsoma are higher than those from uniform subsampling (Fig. 4); however, the higher error in the voxels originates in the CSF. In this study, we only utilised the TADRED subsampling network to focus on its protocol optimisation capabilities, applying the same model fitting method to both optimisation approaches. Future work will incorporate the TADRED task network to directly estimate the SANDI parameters.

TADRED outperformed uniform subsampling in estimating SANDI parameters, showing lower error rates and promising potential for efficient dMRI protocol optimization in future clinical and research applications.
Kadir ŞIMŞEK, Marco PALOMBO, Muhammed BARAKOVIC, Stefano MAGON, Jens WUERFEL, Derek K. JONES, Paddy SLATOR (Cardiff, United Kingdom)
11:08 - 11:10 #47583 - PG209 Automated Discovery of Pulsed Saturation Transfer Acquisition Protocols using an Autodifferentiable-Solver Fused with a Quantification Network (AutoPulST).
PG209 Automated Discovery of Pulsed Saturation Transfer Acquisition Protocols using an Autodifferentiable-Solver Fused with a Quantification Network (AutoPulST).

Saturation transfer (ST) MRI has shown promise in various molecular imaging tasks [1–5]. However, its traditional contrast-weighted form is affected by multiple confounding tissue and pulse-sequence parameters [2,6]. Quantitative ST techniques, such as QUESP, yield improved specificity, yet assume steady-state conditions that require a relatively long acquisition [6,7]. ST Magnetic resonance fingerprinting (MRF) overcomes these challenges by matching transient experimental signals to a precomputed dictionary [8–13], predominantly under preclinical settings or continuous wave (CW) acquisition. However, to render ST MRF a clinically viable method, the acquisition protocol must be shortened, optimized for clinical scanners, and accommodate rapid pulsed wave (PW) saturation [12]. Deep learning-based MRF pipelines [14, 15] can efficiently generate optimized acquisition protocols. Yet, to date, they were only compatible with CW acquisition, due to their inherent reliance on analytical solutions of the Bloch-McConnell (BM) equations. Here, we developed a fully differentiable framework for Automatic end-to-end discovery of Pulsed ST MRF sequences (AutoPulST).

A differentiable ST computational graph was implemented in JAX [16], unlocking the ability to rapidly extract the numerical solution of the BM equations. The solver was wrapped within an automatic acquisition protocol discovery framework [14], where a multi-layer perceptron quantification network is jointly trained (Fig. 1). The pipeline was implemented for discovering protocols composed of 4, 8, or 16 raw MRF images (representing a 1.9-7.5 fold acceleration). Before each optimization attempt, a baseline reference protocol was randomly generated. Imaging was performed at 7T (Terra, Siemens Healthineers) and 3T (Prisma, Siemens Healthineers). Pulsed ST-MRF sequences were automatically generated and implemented for two imaging scenarios: L-arginine phantom imaging (25-100 mM, pH 4–6, chemical shift = 3 ppm, room temperature, 7T) and semi-solid MT brain imaging of healthy volunteers (3T, following IRB approval and informed consent). The backbone pulse sequence used a spin lock saturation train (13x100 ms, 50% duty-cycle), which varied the saturation pulse power and frequency offset. A 3D centric reordered EPI (3T) or GRE (7T) readout module was used [17, 18]. For comparison, a previously established MRF protocol was implemented, which acquires 30 raw images within 143.4 s (3T) or 325.6 s (7T) [19].

In vitro imaging at 7T: the quantitative parameter maps obtained using AutoPulST demonstrated improved SNR compared to the random reference protocols and were visually similar to the gold standard (Fig. 2A). The absolute percent errors obtained by the full AutoPulST pipeline (namely, simultaneous optimization of the acquisition and quantification network) were more than 50% lower than those obtained by the reference random scan (p<0.001. Fig. 2B). Human brain imaging at 3T: A clear visual improvement was obtained using AutoPulST generated protocols (Fig. 3) compared to the random acquisition protocols. The AutoPulST optimized protocols provided statistically significant quantification improvement (p<0.001 across 12 optimization attempts, Fig. 4) compared to the random alternatives and were acquired within merely 19.1, 38.2, and 76.5 s.

In this study, only two acquisition parameters (B1 and Δωrf) were optimized. Nevertheless, we expect that incorporating additional parameters (e.g., saturation pulse time, recovery time, etc.) could further improve the quantification ability.

We demonstrate a differentiable, end-to-end optimization framework for rapid pulsed ST-MRF. We expect this approach to play a key part in the translation efforts of quantitative and rapid ST imaging.
Nikita VLADIMIROV (Tel-Aviv, Israel), Edna FURMAN-HARAN, Simon WEINMÜLLER, Moritz ZAISS, Hadar KOLB, Or PERLMAN
11:10 - 11:12 #47789 - PG210 Assessment of Uncertainty and Calibration of Voxel-Wise Supervised Modeling in IVIM.
PG210 Assessment of Uncertainty and Calibration of Voxel-Wise Supervised Modeling in IVIM.

Intravoxel Incoherent Motion (IVIM) is a diffusion-weighted (DW) MRI technique that models signal decay from tissue diffusion and capillary blood flows [1]. Deep Neural Networks (DNNs) have emerged as a powerful alternative to traditional fitting methods, offering fast and robust inference with respect to conventional non-linear least squares (LSQ) and Bayesian approaches [2], [3]. DNNs typically provide only point estimates without uncertainty, which can help in understanding the impact of noise and guiding experimental design [4]. This study, funded by a PRIN 2022 project [5], introduces a set of methods and metrics, based on the use of Mixture Density Networks (MDNs) [6] with Deep Ensembles (DEs) [7] enabling, in a supervised voxel-wise setting, the estimation of both aleatoric (AU) and epistemic uncertainty (EU) and model calibration in IVIM.

We trained our networks using simulated images based on the Shepp-Logan phantom in MATLAB, covering a wide range of IVIM parameters: D (0-0.003 mm²/s), f (0-0.4), and D* (0.003-0.2 mm²/s). The images were computed at the same b-values as those used in our in vivo acquisitions, employing the model equation: S(b) =S₀[f · e–b·D* + (1 – f) · e–b·D ] Rician noise was incorporated with SNRs of 25, 50 and 100, for a total number of 6000 phantoms. We used one in-vivo dataset for testing the networks in a real scenario: mouse brain data (n=6) acquired using a 7T Bruker Biospec using EPI-DWI with 14 b-values (0-1000 s/mm²). Acquisition parameters: TR = 3 s, TE = 61 ms, 2 segments, 2 repetitions, FOV =15 × 15 mm, MTX = 76 × 76, slice thickness = 0.5 mm, δ = 5.8 ms, ∆ = 50 ms. Architecture We implemented three voxel-wise models: an MLP, an MDN with either three or one Gaussian. All models used two hidden layers with ELU activations and a number of neurons equal to the number of b-values. Inputs were IVIM signals at each b-value, normalized by the signal at b = 15 (excluding b = 0 due to artifacts in-vivo). Sigmoid activations were applied to the output and scaled to the physiological ranges of the IVIM parameters. To capture overall uncertainty, we trained an ensemble (M=5) of MDNs with different random initializations. For each MDN in the ensemble, the predictive mean and variance were computed as a weighted average of its Gaussian components. Then, AU was computed as the average predictive variance across ensemble members, while EU was estimated as the variance of the predictive means of each MDN [7]. Experimental The dataset was split into 70% training, 20% validation, and 10% test sets, maintaining the SNR distribution across subsets. Adam optimizer (learning rate 0.0001, batch size 32) for up to 600 epochs, with early stopping (patience of 35) based on validation loss was used. The MLP used Mean Squared Error loss, while probabilistic models optimized the negative log-likelihood [8], [9]. For simulations, accuracy was assessed using the Median Absolute Error (MdAE), the Relative Median Bias (MdB) and Robust Coefficient of Variation (RCV) [10]. To quantitatively evaluate the quality of uncertainty estimates, we employed calibration reliability diagrams, and the Continuous Ranked Probability Score (CRPS) [11], with lower CRPS indicating better uncertainty estimates.

Tab.1 shows the accuracy metrics on the simulation test set across different SNR levels. MLP, MDN, and Gaussian models perform similarly and outperform the Bayesian fitting method. Fig.1 displays an MDN prediction on a Shepp-Logan phantom at SNR 50, where AU dominates due to noise (mean AU: 4.6×10⁻⁵ mm²/s for D, 0.02 for f and 0.02 for D*), while EU remains low (mean EU: 4.7×10⁻6 mm²/s for D, 0.001 for f and 0.001 for D*). The reliability diagrams of MDN and Gaussian models are reported in Fig.2, showing better calibration for MDN, as evidenced by a smaller miscalibration area. CRPS values also favor MDN, with slightly lower scores: D (5×10⁻⁵ vs 6×10⁻⁵ mm²/s), f (0.019 vs 0.021), and D* (0.021 vs 0.022 mm²/s). Fig.3 shows an MDN prediction on an in-vivo slice, where EU - especially for f - is notably higher (around 0.02) than in the simulated case (Fig.2), reflecting the model’s increased uncertainty on real data.

We adopt, for the first time in IVIM, probabilistic models like MDNs with DEs to estimate both AU and EU. EU, even though much lower than AU in our study, is often overlooked in quantitative MRI but is crucial for detecting out-of-distribution data. The elevated EPU for f in Fig. 3 may suggest a mismatch between the broad simulation range (0–0.4) and in-vivo values. Quantitative metrics for calibration and CRPS allowed to assess the better reliability of uncertainty estimation of MDN.

Our results demonstrate the value of probabilistic modeling for IVIM parameter estimation and uncertainty quantification. Future work will focus on incorporating spatial context via convolutional architectures (e.g., CNNs) and exploring alternative probabilistic approaches such as Normalizing Flows.
Nicola CASALI (Milan, Italy), Alessandro BRUSAFERRI, Giuseppe BASELLI, Stefano FUMAGALLI, Micotti EDOARDO, Gianluigi FORLONI, Riaz HUSSEIN, Giovanna RIZZO, Alfonso MASTROPIETRO
11:12 - 11:14 #47834 - PG211 Radiomics-Based Feature Extraction from DCE-MRI Analysis for Differentiating True Progression and Pseudoprogression in Glioblastoma.
PG211 Radiomics-Based Feature Extraction from DCE-MRI Analysis for Differentiating True Progression and Pseudoprogression in Glioblastoma.

Glioblastoma (GBM), which receives a grade IV classification from the World Health Organization (WHO), is the most prevalent malignant brain tumor in adults [1]. Differentiating between TrueProgression (TP) and Pseudoprogression (PsP) remains a diagnostic challenge, as both appear to be similar on structural MRI sequences like T1 post-contrast (T1pc) and T2 FLAIR. Misclassification of TP or PsP may result in unnecessary interventions or delayed treatment actions, which diminishes the overall patient outcome [2]. Dynamic contrast enhanced MRI (DCE-MRI) based pharmacokinetic (PK) modeling adds important information about tumor vascularity and perfusion. This study employs a parsimonious DCE-MRI model to derive biologically relevant vascular parameters (Ktrans, Ve, and Vp), which are further analyzed through radiomic feature extraction using PyRadiomics to enhance the detection of subtle patterns[3]. Machine learning models were assessed based on their capabilities to classify TP vs. PsP. Lasso, elastic net, and ridge regression were used for feature selection to enhance model performance.

The study featured a private DCE-MRI dataset from the University of Pennsylvania, USA and shared with TCG CREST (data sharing ID: RIS76150), containing 57 GBM cases with 38 TP and 19 PsP. Prior to image processing, a parsimonious modeling approach was used to fit DCE-MRI data and extract pharmacokinetic parameters. Tumors were segmented into enhancing, non-enhancing, and edema regions using the nnU-Net algorithm [4]. The dataset was split into 70% training and 30% testing sets, and SMOTE[5] was applied to correct the 2:1 class imbalance between TP and PsP. Five pharmacokinetic models (Non-linear Tofts, Extended Tofts, Shutter-Speed, 2CXM, and 3S2X) were voxel-wise fitted to generate R² and AIC maps[6].The model with the lowest AIC at each voxel was selected as the best fit. A parsimonious model was then derived by aggregating these voxel-wise best fits to estimate Ktrans (volume transfer constant), Ve (extravascular extracellular volume fraction), and Vp (plasma volume fraction) [7] as shown in Fig 1. Total of 280 radiomic features (140 for enhancing and 140 for non-enhancing regions) were extracted from the pharmacokinetic maps to quantify tumor heterogeneity. Four machine learning classifiers were trained on the selected features: Random Forest (RF), Support Vector Classifier (SVC), Logistic Regression, and XGBoost. Each model were trained and evaluated with and without feature selection to assess the impact of dimensionality reduction on classification performance. The classification performance was assessed using Accuracy and F1 Score. The pharmacokinetic parameters were analyzed separately to determine their predictive power. To improve classification performance, we applied three different feature selection techniques—LASSO, Ridge, and Elastic Net—to identify the most relevant features.

Fig. 2 presents the best-performing models for each feature selection method and pharmacokinetic parameter, along with their corresponding accuracy and F1-score. The highest-performing model in each category is highlighted in bold. ROC curve for all the models after feature selection using Elastic Net is shown in Fig 3 for the Ktrans parameter. For each estimated pharmacokinetic parameter, the important features after elastic net and gini importance (Fig 4) included: original shape - least axis length, GLSZM size zone percentage, original shape - sphericity, first order -variance, root mean squared, total energy, range.

Random Forest remained a strong performing model, consistently performing well due to its abilities to address underlying non-linearity and feature interactions. The ensemble approach of Random Forest also assisted in minimizing overfitting while working with a small dataset. In a similar manner, SVC (with RBF kernel) produced strong results, especially for Ve, likely due to the manner in which it can build non-linear decision boundaries in high dimensional feature spaces. Elastic Net addressed the challenges of overfitting with the balance of L1 and L2 regularization while selecting the most informative features. This study supports that the maximum classification performance occurred when Elastic Net, with Random Forest, was applied to Ktrans, achieving F1-score of 92.86% with accuracy of 88.89%.

The present study helps advance the use of machine learning applications in medical imaging by considering pharmacokinetic parameters during classification of the tumor type. An important limitation of this study is the small sample size which limited appropriate validation and increased the risk of overfitting. Future studies can explore multiparametric approach combining multiple features may further improve the robustness of tumor classification models. Additionally, as dataset sizes increase, deep learning architectures can increase the classification accuracy.
Sourav BASAK (Kolkata, India), Akashleena CHATTERJEE, Subhanon BERA, Gabriela W KOSTRZANOWSKA, Archith RAJAN, Harish POPTANI, Sanjeev CHAWLA, Sourav BHADURI
11:14 - 11:16 #47904 - PG212 Improving Cerebral Perfusion Estimation in ASL Using Physics-Informed Neural Networks: A Simulation Study.
PG212 Improving Cerebral Perfusion Estimation in ASL Using Physics-Informed Neural Networks: A Simulation Study.

Arterial Spin Labeling (ASL) is a non-invasive MRI method for quantifying cerebral perfusion via magnetically labeled blood water. Time-encoded pseudo-continuous ASL (te-pCASL) with Hadamard encoding enhances signal efficiency and enables simultaneous cerebral blood flow (CBF) and arterial transit time (ATT) estimation [1]. The Buxton model describes the ASL signal evolution and is widely used for perfusion quantification [2], though nonlinear least squares (NLLS) methods often yield unstable parameter maps under low signal-to-noise conditions due to sensitivity to noise and initialization. Physics-Informed Neural Networks (PINNs) offer a robust alternative by embedding governing physical models into the learning process, improving resilience to noise and data sparsity [3]. Their applications in biomedical imaging are expanding, including cardiovascular modeling [4], perfusion CT [5], and neonatal ASL [6]. Building on [6], we extend the PINN framework to te-pCASL and assess its performance in a synthetic simulation study.

We designed a two-stage PINN framework trained on synthetic te-pCASL data generated using spatially heterogeneous CBF, ATT, and equilibrium magnetization (M₀) derived from Boston ASL Template and Simulator [7]. A central slice was extracted and resampled to match the voxel size of real ASL datasets (3x3x7 mm3). The actual signals were simulated using a custom implementation of the Buxton model, accounting for sub-bolus-specific labeling durations (Figure 1). Gaussian noise was added to yield low temporal signal-to-noise ratio conditions (tSNR = 1.5 and 0.5), following methods from prior studies [8]. The model comprised two coupled SIREN-based Multi-Layer Perceptrons (MLPs): a data-fitting network (7 layers, 256 units) mapping spatial coordinates (x, y) and time to ASL signal, and a physics-based network (4 layers, 128 units) mapping (x, y) to CBF and ATT values (Figure 2). To consider the dependence of bolus duration on acquisition time in absence of an analytic expression, a fifth-order spline was used to model this relationship, and its derivative was included in the Buxton model derivative during training to better reflect time-encoding dynamics. Training minimized a hybrid loss combining mean squared error (MSE) between predicted and simulated signals, and MSE between time derivatives of the data-fitting network and those obtained from the Buxton model derivative using predicted parameters. Optimization used Adam (learning rate=0.0001) for 30,000 epochs with a batch size of 150. At inference, only the physics-based network was used for parameter estimation. As a baseline, we used a regularized NLLS estimator with soft-L1 loss, physiological constraints, and optimization via Dogbox. It minimized residuals between signals and Buxton model predictions, with mild regularization on ATT deviations from initialization. Performance was evaluated using Structural Similarity Index Measure (SSIM), Pearson Correlation Coefficient (r), and Percentage Relative Error (PRE), along with visual inspection for qualitative comparison.

At tSNR = 1.5, both methods performed similarly for CBF. However, PINN significantly outperformed NLLS in ATT estimation, a parameter more sensitive to noise (Table 1). At tSNR = 0.5, PINN’s advantage was even more pronounced, achieving higher SSIM and r values for both parameters. Qualitatively, PINN produced smooth, physiologically explainable maps (Figure 3). While ATT overestimation persisted, PINN better preserved spatial structure. Incorporating the spline correction reduced ATT bias, indicating better modeling of bolus-specific dynamics, though a residual bias remained. NLLS maps, in contrast, showed higher noise and voxel-wise variability, particularly for ATT.

Embedding the Buxton model in a PINN framework enhances robustness in perfusion quantification under noise. In particular, ATT estimation benefits significantly, addressing limitations of conventional methods. The spline-based correction partly mitigated ATT bias, supporting the hypothesis that bolus duration variability influences estimation accuracy. Nevertheless, the remaining bias suggests additional sources of mismatch, possibly due to simplifications in the kinetic model or training dynamics. Future work will explore further physical model refinements and apply the framework to real ASL datasets.

In conclusion, we propose a PINN-based framework for ASL quantification, integrating the Buxton model as a physical constraint. Compared to NLLS, our method improves ATT estimation and noise robustness, while maintaining physiologically plausible spatial patterns. This work lays the foundation for extension to 3D and clinical ASL studies.
Alessandro GIUPPONI (Padova, Italy), Chiara DA VILLA, Mattia VERONESE, Marco CASTELLARO
11:16 - 11:18 #46950 - PG213 Uncovering Alzheimer’s Disease Prediction Strategies of Convolutional Neural Network Classifiers using T1-weighted MRIs and Spectral Clustering.
PG213 Uncovering Alzheimer’s Disease Prediction Strategies of Convolutional Neural Network Classifiers using T1-weighted MRIs and Spectral Clustering.

Convolutional neural networks (CNNs) have shown strong performance in classifying Alzheimer’s disease (AD) from T1-weighted (T1w) MRI [1], yet their decision-making remains largely opaque [2]. Ensuring decisions are not driven by spurious features is critical for clinical applications. Prior work [3] indicated that CNNs favor skull-stripped over full images for T1-based AD classification. However, how learned features are spatially organized under different preprocessing pipelines remains unstudied. Spectral clustering (SC) [4] can group similar heatmaps and reveal dominant decision patterns beyond individual cases. This study applies Spectral Relevance Analysis (SpRAy) [5] to Layer-wise Relevance Propagation (LRP) [6] heatmaps in a CNN trained on T1w MRI. We assess whether relevance patterns vary across preprocessing methods and identify brain regions that consistently drive classification, allowing insights into model behavior and potential preprocessing biases.

Participants. From the ADNI database (https://adni.loni.usc.edu), we selected 1,042 AD and 2,227 normal control (NC) T1w MRIs acquired sagittally at 3T with consistent resolution. A balanced dataset was constructed with 990 images each from 159 AD and 201 NC participants (propensity-score matched by age and sex) [7]. Scans were split into training (70%), validation (15%), and test (15%) sets with subject-level separation. Preprocessing. Images were reoriented, bias-corrected [8], non-linearly registered to MNI space [9], and normalized to the white matter histogram peak. Skull-stripping was performed using FSL-SIENAX [10]. Binarization thresholds of 13.75%, 27.5%, and 41.25% of white matter peak intensity were applied to generate texture-masked images, resulting in eight preprocessing conditions (aligned/skull-stripped × 4 thresholds, see Fig. 1). CNN Architecture. We adapted a 3D CNN from [1] with reduced complexity to avoid overfitting. For a schematic overview see Fig. 2. Training. Each configuration was trained for 30 epochs (batch size 20) using Adam [11]. Ten random data samplings per configuration were used [12], with three models trained per sample (total: 30 per setup) [13]. The best validation-performing model per setup was used for further analysis. Heatmap Generation and Spectral Clustering. LRP (α=1.0, β=0.0) [6] generated voxel-wise relevance maps. Mean heatmaps were computed and thresholded to the top 40% of relevance for inspection. SpRAy involved: 1. Generating LRP heatmaps, 2. Downsampling to 2 mm resolution, 3. Spectral clustering of relevance maps, 4. Identifying meaningful eigenvalue gaps, 5. Visualizing clusters via t-distributed stochastic neighbor embedding (t-SNE) [14].

Skull-stripped data without binarization (A2) achieved the highest accuracy (81.6%). Other configurations, including 27.5% binarized skull-stripped images (C2) and 41.25% binarized aligned images (D1), performed comparably. For full statistics, refer to [3]. t-SNE visualization (Fig. 3) showed that only model D1 produced heatmap clusters aligning with subject groups (AD vs. NC). This suggests that omitting skull-stripping and using 41.25%-threshold binarization may lead to more positionally distinctive relevance distributions. Clustered mean heatmaps (Fig. 4) showed D1’s Group 2 highlighting the left insular cortex -a known AD-affected area- while Group 3 included skull regions, pointing to potential reliance on non-brain features. Models A2 and C2 showed less separation and less anatomically interpretable relevance.

This study extends prior findings on CNN reliance on volumetric cues [3] by showing how preprocessing impacts relevance patterns. SC enabled group-level analysis of LRP heatmaps, identifying systematic rather than instance-specific decision strategies. Only D1, the model trained on non-skull-stripped and 41.25% binarized images, revealed clustering aligned with AD vs. NC labels. Its mean heatmaps featured clearer anatomical relevance (e.g., left insular cortex), but also highlighted skull regions, suggesting possible biases. This reveals a trade-off: less aggressive preprocessing may preserve informative structure but also introduce non-brain artifacts. Importantly, similar classification performance across all configurations obscures these interpretability differences, underscoring the need for explainability techniques in model evaluation [15]. Preprocessing choices, even minor ones, can substantially alter feature attribution.

We applied SC to LRP heatmaps from CNNs trained on differently preprocessed T1w MRIs for AD classification. Despite similar accuracies, relevance patterns varied markedly, with the 41.25% binarized model without skull-stripping (D1) showing clearer separation between AD and NC. Our findings stress that preprocessing has a strong impact on interpretability, not just performance. Future work should explore the effects of preprocessing and the integration of quantitative MRI features to improve model transparency and clinical utility.
Christian TINAUER (Graz, Austria), Maximilian SACKL, Stefan ROPELE, Christian LANGKAMMER
11:18 - 11:20 #46479 - PG214 Preliminary Evaluation of Deep-learning Image Reconstruction in Clinical Setting at 7T.
PG214 Preliminary Evaluation of Deep-learning Image Reconstruction in Clinical Setting at 7T.

While deep learning (DL) methods in MR image reconstruction are becoming state-of-the-art, the possibility of DL models altering the appearance of pathology still raises concerns, especially when trained solely with healthy subjects and/or when employed on patients’ datasets acquired with higher undersampling factors [1]. This issue is particularly relevant and not sufficiently examined in the case of clinical acquisitions of the brain with submillimeter resolutions, where undersampling is highly desirable to reduce acquisition time. In this study, a DL-based reconstruction was investigated for the acceleration of patients’ clinical scans acquired with 0.6 mm isotropic resolution at 7T. Images were retrospectively undersampled to test different accelerations, and image quality and pathology conspicuity were compared against conventional compressed sensing (CS) reconstruction.

Study Population and MR Acquisition Six patients were enrolled in this preliminary analysis: three patients with different brain tumors and three patients with suspected multiple sclerosis (MS). All patients were scanned at 7T (MAGNETOM Terra, Siemens Healthineers, Forchheim, Germany) using an 1Tx/32Rx RF head coil (Nova Medical, Wilmington, USA). A 3D MP2RAGE research application sequence (resolution = 0.6×0.6×0.6 mm3, matrix size = 384x256x384, TR/TI1/TI2 = 6000/800/2700 ms, TE/echo-spacing = 2.06/6.2 ms, acquisition time = 7:40 min) with a 4x accelerated spiral phyllotaxis sampling was acquired [2–4]. The work was approved by the local ethics committee (Kantonale Ethikkommission für die Forschung Bern, Switzerland, 2020–02902, 2022–00720, 2024-00788). Prior to each examination, written informed consent was obtained. Image Reconstruction MP2RAGE acquisitions were also retrospectively undersampled to simulate acceleration factors of R=8 (3:50 min) and R=10 (3:04 min). All images were reconstructed using both a conventional CS reconstruction [5,6] and a 3D DL-based method [7]. The DL technique reconstructs images from undersampled k-space data and coil sensitivity maps using six iterations of data consistency updates and neural network evaluation. The network was initially trained with 5000 pairs from fully-sampled 3D datasets of healthy subjects scanned at 1.5 and 3T, followed by fine-tuning in a self-supervised manner using 1000 pairs of undersampled 3D datasets collected at 7T [8,9] (all MAGNETOM scanners, Siemens Healthineers, Forchheim, Germany). Image Analysis A visual inspection and a quantitative quality assessment of retrospectively reconstructed images was conducted by computing the structural similarity index measure (SSIM) and the peak signal-to-noise ratio (PSNR) considering the current clinical protocol (R=4, CS reconstruction) as reference.

Reconstructed images for patients with suspected dysembryoplastic neuroepithelial and epidermoid tumor are shown in Figure 1-2. Overall, DL reconstructions exhibit higher SNR than CS reconstructions while preserving tissue contrast. For the highest tested acceleration (R=10), better (Figure 1) or similar (Figure 2) conspicuity of tumor boundaries and higher SNR was observed in the DL reconstruction compared to CS. Images from two of the MS patients are reported in Figure 3-4. Lesions identified with acceleration R=4 could be visualized at higher acceleration rates. Lesion conspicuity was found to be similar or better in DL reconstructions in comparison to CS. None of the images reconstructed with the DL reconstruction exhibit hallucinations or misleading artifacts. For R=8, CS reconstruction achieved an SSIM of 0.99±0.01 and a PSNR of 37.3±0.3 dB, while DL reconstruction yielded an SSIM of 0.99±0.01 and a PSNR of 38.1±0.5 dB. At R=10, CS reached an SSIM of 0.98±0.01 and a PSNR of 35.6±0.2 dB, whereas DL reconstruction achieved an SSIM of 0.99±0.01 and a PSNR of 37±0.4 dB.

In this preliminary study, we evaluated the performance of a DL-based reconstruction method trained solely on healthy subjects to reconstruct images of patients with different brain abnormalities. No hallucinations or misleading artifacts resulting from the DL reconstructions were observed. Results were compared to a CS reconstruction, showing that the DL reconstruction exhibits higher SNR, PSNR and equivalent or improved conspicuity in the observed pathologies. These findings suggest robustness of the DL approach across different pathological presentations. The work conducted in this study is planned to be extended to a larger cohort of patients including radiologist rating of the reconstructed images, while being blind to the acceleration factor or the reconstruction technique, to establish the clinical value of DL reconstruction more comprehensively for 7T neuroimaging.

This preliminary study demonstrates the quality and reliability of DL-based MRI reconstruction in the presence of pathology, even at high acceleration rates. In the future, we will validate these results in a larger cohort of patients.
Jocelyn PHILIPPE (Lausanne, Switzerland), Gian Franco PIREDDA, Natalia PATO MONTEMAYOR, Dominik NICKEL, Patrick LIEBIG, Arsany HAKIM, Robin HEIDEMANN, Jean-Philippe THIRAN, Tom HILBERT, Gabriele BONANNO, Piotr RADOJEWSKI, Thomas YU
11:20 - 11:22 #46748 - PG215 Explainable Machine Learning Models for Radiomic-Based Assessment of Glioma Severity Using Multiparametric MRI.
PG215 Explainable Machine Learning Models for Radiomic-Based Assessment of Glioma Severity Using Multiparametric MRI.

Gliomas are primary brain tumors characterized by marked biological heterogeneity, affecting prognosis and treatment strategies [1,2]. Traditional histopathological grading, though informative, is invasive and limited by sampling bias [3,4]. Non-invasive radiomic analysis using MRI has shown promise in assessing tumor grade [5,6]. However, most machine learning (ML) studies frame glioma grading as a classification task, potentially overlooking subtle intra-class variability [7]. In this study, we propose a regression-based ML approach to predict glioma grade as a continuous variable using radiomic features extracted from T1-weighted and diffusion tensor imaging (DTI) to enhance diagnostic precision and interpretability [8,9].

We analyzed MRI data from 36 glioma patients (58.3% low-grade gliomas [LGG], 41.7% high-grade gliomas [HGG]) acquired on a 1.5T scanner. Radiomic features were extracted from normalized T1-weighted images and diffusion maps, including axial diffusivity (AD), radial diffusivity (RD), mean diffusivity (MD), and fractional anisotropy (FA) [10,11]. Feature extraction included intensity, shape, and multiple texture matrices (GLCM, GLRLM, GLSZM, NGTDM, GLDM) using PyRadiomics [12]. Dimensionality reduction was performed using Sequential Feature Selection (SFS) with a Random Forest regressor [13]. A total of 15 ML regression models, including XGBoost, CatBoost, SVM, and neural networks, were trained and optimized via stratified 5-fold cross-validation. Model performance was evaluated using MSE, MAE, and R² scores. SHAP analysis was applied to interpret the contribution of individual features [14], as showed in Figure 1.

Among all models, XGBoost achieved the best performance with an MSE of 0.0346 ± 0.0137, MAE of 0.1168 ± 0.0256, and R² of 0.5140 ± 0.3579 (Figure 2). Feature selection identified six key predictors, with texture features from T1-weighted images (e.g., GLRLM short run low gray level emphasis, GLCM contrast) being the most influential (Figure 3). Diffusion-derived features, particularly robust mean absolute deviation from AD maps, added complementary information. SHAP analysis highlighted how selected features differentially contributed to grade predictions across LGG and HGG samples, with interpretable patterns aligning with tumor microstructural complexity (Figure 4) [15,16].

Modeling glioma grade as a continuous variable allowed for finer granularity in characterizing tumor severity, capturing nuances missed by binary classification [17]. Texture features reflecting tumor heterogeneity and shape irregularity emerged as strong predictors. Diffusion metrics contributed additional microstructural information, reinforcing the importance of multimodal integration [18,19]. The regression approach provided accurate predictions and clinical insights, particularly when supported by explainability techniques like SHAP. Differences in hemispheric tumor location between LGG and HGG further support the biological underpinnings captured by the radiomic features [20].

Radiomic features from T1-weighted and DTI sequences, analyzed through ML regression models, enable accurate, interpretable, and non-invasive glioma grading. The XGBoost regressor demonstrated superior performance and SHAP-based analysis enhanced transparency. This continuous-scale grading strategy offers a refined perspective on tumor biology and supports its use in clinical decision-making. Future studies with larger and multi-site cohorts are encouraged to validate the model’s generalizability and explore its integration into routine radiological workflows. All radiomic processing scripts, ML models, and anonymized datasets used in this study are available from the corresponding author upon reasonable request. Feature extraction was conducted using PyRadiomics v3.0 in Python 3.8, and model development used open-source libraries, including Scikit-learn and XGBoost.
Pamela FRANCO, Cristian MONTALBA (Santiago, Chile), Raúl CAULIER-CISTERNA, Ignacio ESPINOZA, Carlos BENNET, Francisco TORRES, Steren CHABERT, Rodrigo SALAS
11:22 - 11:24 #46455 - PG216 Understanding predictive uncertainty of AI and expert confidence in multiple sclerosis cortical lesion segmentation on MP2RAGE.
PG216 Understanding predictive uncertainty of AI and expert confidence in multiple sclerosis cortical lesion segmentation on MP2RAGE.

Cortical lesion (CL) detection in magnetic resonance imaging (MRI) is a key biomarker for differential diagnosis and disability assessment in multiple sclerosis (MS) [1,2] (Figure 1). Recent deep learning (DL) methods have improved the standardization and accuracy of CL segmentation [3,4]. Trustworthy AI, particularly with uncertainty quantification (UQ), enhances model reliability and robustness, which are critical for clinical use [5]. While UQ is often used to estimate prediction errors, its clinical interpretation remains underexplored. Our prior studies [6,7] linked high lesion-level uncertainty with interpretable imaging features. This study examines how lesion-scale uncertainty relates to expert perception, including lesion type, diagnostic confidence, and segmentation quality.

The expert perception was assessed with the participation of an experienced neurologist (AC, 6 years of MRI experience). Figure 2 outlines the study workflow. We used our previous 3D nnU-Net model [7,8] trained on a clinical MP2RAGE dataset [9,10] with manual CL annotations by consensus between two experts (a medical doctor and the same neurologist; both had 5 years of MRI experience). The dataset included 163 MS patients (train:val:test = 109:13:41; CLs = 857:69:301). Test set lesion uncertainty was estimated using deep ensembles [11], and lesion structural uncertainty (LSU) [12] was computed (range: 0–1; higher - more uncertain). Lesions were grouped into five equidistant LSU bins; up to 23 per bin were randomly sampled, yielding 100 regions of interest (ROIs; Figure 2, Step 2). Due to the skewed LSU distribution, 68 ROIs had LSU > 0.19 (above 75th percentile); 34 of 100 were false positives. The neurologist reviewed each ROI overlaid on MP2RAGE using their preferred viewer, with detailed written instructions. For each ROI, they reported lesion type, confidence (5-point Likert), reasons for reduced confidence (from 13 predefined categories [7]), and segmentation quality (high/moderate/low) using a multiple-choice table-like form (Figure 2, Step 3). We analyzed categorical expert ratings and continuous variables not visible to the neurologist: LSU and lesion segmentation quality, measured by IoUadj between ROI and ground truth masks [13]. Distributions were visualized via violin plots, and group differences were tested using the Mann–Whitney U-test (n > 10). Inverse confidence scores weighted confidence-reducing factors to highlight dominant sources of uncertainty.

The average self-reported assessment time was 30 sec/ROI. Most ROIs were identified as leukocortical (n=36) or juxtacortical (n=50), with no significant LSU difference between groups (Figure 3-i). Notably, 9 of 34 false positives were reclassified as true lesions. Among the 66 lesions overlapping with the ground truth, 35 were labeled as non-CL (33 juxtacortical MS, 2 vascular MS lesions). Annotator confidence was most often "slightly" (n=42) or "moderately" confident (n=34) (Figures 3-ii, 4-ii). LSU has significantly different distributions across the perceived segmentation quality (Figure 3-iii) with p < 0.01. There was no statistical difference between evaluated segmentation quality (IoUadj) distributions for “high” vs “moderate” perceived quality (p=0.11), but a clear difference between “moderate” vs “low” (p<0.01). By far, the most influential factor lowering confidence was "unclear cortical involvement" (Figure 4-i).

We sampled lesions uniformly across LSU values to explore a possible one-to-one mapping with annotator confidence levels. However, the estimated annotator confidence distribution is also skewed, suggesting that this direct mapping is not viable. On the other hand, most of the sampled ROI had high LSU (above the 75th percentile) and were also deemed difficult by the neurologist, who was mostly “moderately confident” and changed his opinion about 44 of 100 ROIs. "Unclear cortical involvement" emerged as the primary reason for diagnostic uncertainty, consistent with the known challenges of CL detection in 3T MRI [14] and our prior uncertainty-focused work [7]. The observed association between LSU and perceived segmentation quality corroborates previous findings [12] and supports its utility in clinical settings.

This study advances the understanding of how predictive uncertainty aligns with expert confidence in MS cortical lesion segmentation. Our results demonstrate that lesion structural uncertainty from deep ensembles is a promising tool for identifying clinically ambiguous lesions and guiding expert review without ground truth, showing a potential for clinical decision support and targeted review. Future work should expand expert participation to validate these findings and enhance generalizability.
Nataliia MOLCHANOVA, Alessandro CAGOL, Delphine RIBES, Pedro M. GORDALIZA, Mario OCAMPO– PINEDA, Matthias WEIGEL, Xinjie CHEN, Adrien DEPEURSINGE, Granziera CRISTINA, Müller HENNING, Meritxell BACH CUADRA (Lausanne, Switzerland)
11:24 - 11:26 #47361 - PG217 Deep editable network for automatic and interactive segmentation of skeletal muscle MRI.
PG217 Deep editable network for automatic and interactive segmentation of skeletal muscle MRI.

Quantitative MRI provides increasingly relevant biomarkers for the characterization and monitoring of the musculoskeletal system. Such quantitative image analyses generally require delineating regions of interest (ROI) to separate the different muscles or muscle groups. Lately, AI models achieved excellent segmentation quality in a small fraction of the time taken by manual segmentation. Despite their efficiency, these automatic methods often generate partially erroneous segmentations, especially in the presence of important pathological involvements such as fatty replacements. In this case, the only way to correct errors is by manual segmentation, which can be very time-consuming depending on the size of the image and the number of errors. Based on the work of Diaz Pinto et al.[1], we propose a method for semi-automatic 3d muscle segmentation where users can correct errors by providing guidance to the network in the form of clicks or scribbles. On a database of MRI acquisitions or healthy and pathological legs, we trained and tested a modified nnU-net[2] model, including automatically generated clicks within the training loop, and compared its performance to that of the unmodified fully automatic nnU-net model. Initial results show that the proposed model provides a fully automatic segmentation comparable to the non-interactive nnU-net model and, in addition, allows efficient improvements through simple user interactions.

For this study, both training and test sets were composed of 20 MRI acquisitions of legs of consenting volunteers and neuromuscular disease patients, acquired at 3T (PrismaFit, Siemens Healthineers). Images were 3d Dixon acquisitions of 64 slices of 224 x 224 pixels, with TE = 3.95 ms. In both datasets, we selected equal numbers of cases with low and high degrees of fatty replacements. Ground truths were manually delineated for 9 labels : background, tibialis anterior (TA), extensor digitorum (ED), peroneus (PER), deep layer of posterior compartment (DLPC), popliteus (POP), soleus (SOL), lateral gastrocnemius (GAS_LAT), medial gastrocnemius (GAS_MED), by medical experts in 1 out of 4 slices. Using the nnU-Net framework, we modified the training pipeline to introduce simulated clicks using a method similar to that of Sakinis et al.[3]. In each training batch, clicks are progressively and randomly added into dedicated input channels with probabilities depending on the size of the mislabeled regions. Following Diaz-Pinto et al.[1], simulated clicks are added in only 80 % of the batches to maintain performance without click. We also used a modified loss (Figure 1) that forces the network to focus at first on the click-less segmentation and to prioritize click influence in later epochs. We trained our model on a Nvidia RTX A6000 using 5-folds cross validation, with each fold running for 800 epochs each. An example of the incremental correction with manual clicks of a test set image is given in Figure 2. For the testing part, we simulated 20 successive clicks based on the ground truth, computing relevant metrics for each prediction for all labels. The measured metrics were: the Dice similarity coefficient (mean, per label mean, mean of worst label), the maximum error distance (the distance to the border of the innermost pixel of the mislabeling error mask) and the click influence (the number of updated pixels). We also trained and tested an unmodified nnU-Net on the same dataset as benchmark (the “no-click” model). Comparison between models were assessed with paired t-tests.

Figures 3 and 4 show that the 0-click and no-click models have equivalent performance in terms of maximum error distance, Dice of worst label, mean Dice, and per-label Dice. As the number of clicks increase, the mean Dice and maximum error distance become significantly better than for the no-click model. The label frequency plot shows that the larger regions (background, DLPC, SOL) tend to be prioritized for the clicks, while smaller muscles are less often selected. The click influence plot indicates that initial clicks tend to have more influence than later clicks, the latter converging towards about 500 pixels.

These results show that adding corrective guidance to the nnU-net model does not penalize the fully automatic segmentation, while automatically added clicks significantly improve the segmentation quality. We used the nnU-Net framework for practical reasons, but this method can be used with any neural network architecture. Alternative architectures such as transformers could potentially improve segmentation performance. The above results were based on simulated clicks. Using actual user-guidance provided by medical experts is the logical next step to prove the relevance of the proposed method.

After further validation, this approach could be implemented into a simple user-interface to lighten the workload in research and clinical settings, making it possible to generate and correct a full 3D image segmentation in a few minutes.
Louis RIGLER (Paris), Jean-Marc BOISSERIE, Sophie JOUAN, Pierre-Yves BAUDIN
11:26 - 11:28 #47303 - PG218 Uncertainty in Deep Learning of DCE-MRI Parameter Estimation.
PG218 Uncertainty in Deep Learning of DCE-MRI Parameter Estimation.

Dynamic contrast-enhanced (DCE) MRI helps detect and characterize diseases, like cancer and neurodegenerative disorders, by quantifying tissue perfusion. However, conventional methods often yield noisy parameter estimates. Recently, deep learning has emerged as an alternative, offering more accurate and precise parameter estimates. However, even in regions of uncertainty, these deep-learnt parameter-maps are visually appealing , leading clinicians into a false sense of security. Incorporating uncertainty estimates in a deep learning framework can inform clinicians about trustworthiness. Moreover, understanding whether uncertainties stem from noise in the data (aleatoric) or model limitations (epistemic) can inform us whether we need better data or models. For example, in case of out-of-distribution (OOD) effects, epistemic uncertainty may be reduced by offering more varied training examples. Therefore, we propose an uncertainty-aware neural network, hypothesising it can detect aleatoric uncertainties (H1) and that a deep ensemble can capture epistemic uncertainties (H2). Finally, we demonstrate how this model’s uncertainties can be visualized in vivo.

We used the extended Tofts model to simulate 100,000 pharmacokinetic concentration-time curves with varying noise levels. This synthetic dataset was split into training, validation, and test subsets. To test H1, we extended a previously developed network (DCE-NET) by incorporating mean-variance estimation (MVE), enabling the model to output both pharmacokinetic parameters and associated uncertainty. We evaluated whether predicted uncertainties correlated with actual errors using quartile-based stratification and statistical comparisons of error distributions. To test H2, we trained an ensemble of ten independently initialized MVE-DCE-NET models. Each network’s output was treated as a sample from a posterior distribution, allowing us to compute both predictive mean and epistemic uncertainty. To simulate OOD effects, we intentionally excluded certain parameter ranges from the training and validation data while keeping them in the test set. This allowed us to observe whether the ensemble detected unfamiliar parameter regimes through increased uncertainty. Finally, we developed a visualization method for uncertainty-aware parameter maps. These maps display predicted parameter values and visually encode confidence by superimposing controlled noise that scales with predicted uncertainty. As a proof of concept, we applied our method to in vivo DCE-MRI data from two healthy volunteers.

The uncertainty-aware networks showed more accurate pharmacokinetic parameter predictions than the conventional network (Figure 1A). Larger aleatoric uncertainties predicted by MVE-DCE-NET correlated with a larger spread in parameter errors (Figure 1B). Paired Levene’s test indicated significant differences in error variances across uncertainty quartiles, confirming H1. Additionally, a positive correlation between median predicted uncertainty and error further supported this hypothesis (Figure 2). Evaluation of epistemic uncertainties revealed that the ensemble effectively identified unseen parameters in the test dataset (Figure 3), with lowest uncertainties for well-represented values and highest for unrepresented ones. Uncertainty was also high for low ke and ve. As curves with little tissue uptake can be explained both with a low ke (and arbitrary ve) or low ve (and arbitrary ke), there is a large uncertainty on ke and ve in those situations. With no noise, in vivo parameter maps look smooth and trustworthy (Figure 4). However, as the noise scaling parameter increased, the uncertainty-informed maps displayed more noise in uncertain regions, making it clear to the viewer which regions are less trustworthy.

This study presents MVE-DCE-NET, an uncertainty-aware neural network designed to predict pharmacokinetic parameters along with their aleatoric and epistemic uncertainties. Our findings demonstrate that MVE-DCE-NET effectively highlights high aleatoric uncertainties when estimation errors are large and shows low uncertainty when errors are low, making results interpretable. Additionally, deep ensembles identified underrepresented data with high uncertainties, which could support create balanced datasets with equal representations of healthy and diseased tissues. If certain tissues exhibit parameters not present in the training data, our approach can flag these tissues, encouraging further examination and reducing reliance on uncertain predictions.

This work introduces MVE-DCE-NET, an uncertainty-aware model that enhanced DCE-MRI parameter reliability, distinguishing between inherent data noise and model limitations. This approach can support clinicians in making informed decisions by highlightening prediction confidence and potential outliers.
Natalia KOROBOVA (Amsterdam, The Netherlands), Jonas VAN ELBURG, Mohammad ISLAM, Marian TROELSTRA, Oliver GURNEY-CHAMPION
11:28 - 11:30 #47669 - PG219 Deep Learning based acceleration of Prostate DWI on a 1.5T MR-Linac and assessment of ADC bias and repeatability.
PG219 Deep Learning based acceleration of Prostate DWI on a 1.5T MR-Linac and assessment of ADC bias and repeatability.

Magnetic resonance-guided radiotherapy (MRgRT) enables superior soft-tissue visualisation and daily adaptive treatment planning. Online adaptation can extend treatment sessions by 20–30 minutes, with high-resolution imaging potentially further contributing to this delay [1, 2]. Apparent diffusion coefficient (ADC) maps derived from diffusion-weighted imaging (DWI) show promise as a reliable biomarker for dose escalation based on tumour response [3]. Strategies to accelerate acquisition while preserving image quality are key for improving workflow efficiency for MRgRT where imaging enables online treatment adaptation, such as identifying targets for dose escalation. Although current workflows may accommodate longer scans, future optimizations in radiotherapy delivery will require that imaging speed also keep pace. This study aims to accelerate diffusion imaging for MRgRT using deep learning to generate high-quality DWI and assess the bias and repeatability of the resulting quantitative ADC maps.

This study analysed DWI from 11 prostate cancer patients enrolled in the HERMES clinical trial (REC 20/LO/1162) [4], treated on a 1.5T Unity MR-Linac (Elekta AB, Stockholm, Sweden). The cohort included patients from both the two-fraction (2#) (P1 – P6) and five-fraction (5#) (P7 – P11) arms, with a median age of 72 years (range: 53–77). All patients received neoadjuvant and concurrent androgen deprivation therapy. DW images were acquired using single-shot echo planar imaging with b-values(averages) of 0(6), 30(6), 150(6), and 500(14) s/mm² based on an MR-Linac consortium recommended consensus protocol [5]. A deep learning model [6] based on a U-Net architecture was trained to produce high-quality DWI from noisy input data [Fig. 1]. Training was performed over 70 epochs using the Adam optimizer (learning rate 1e−4), with mean absolute error (MAE) as the loss function and a batch size of 20. Each training scan consisted of 15 transverse slices, with 30 training samples per slice assembled from different diffusion averages, resulting in 450 training samples per scan. Each sample was represented as a [224 × 224 × 12] volume, where the 12 input channels comprised the current slice, preceding and following slices, and images from the four b-values. For the models, the input at each b-value was a directionally averaged trace image. The specific acquisition or means of any two or three acquisitions was/were randomly selected per sample. In total, 25 scans (11,250 samples) were used for training and 5 scans (2,250 samples) for validation. A five-fold cross-validation was used for the best model. For Fold 1, patient P1 was used for testing, P6 and P10 for validation, and the remaining patients (P2–P5, P7–P9, and P11) for training. For the subsequent training folds, the other 2# patient data were rotated to be test data. Three model configurations were evaluated, differing in diffusion input averaging: all-direction input using single, two and three averages respectively: 1. AD_avg1 2. AD_avg2 3. AD_avg3 Quantitative evaluation included voxel-wise fit of ADC of whole prostate (WP) and comparison between model outputs and ground truth (GT). The ADC repeatability coefficients (RC) of WP and gross-tumour volume (GTV) were calculated.

Fig. 2 shows a representative transverse slice for visual comparison of GT, inputs and the predicted images. MAE and RMSE between predicted and GT ADC are reported in Table 1. AD_avg3 had the lowest error, followed by AD_avg2. Box plots of WP ADC distributions showed good agreement between model predictions and GT, with the models showing a narrower distribution [Fig. 3]. AD_avg2 had a negative bias for the tested patient. RC Calculation: Absolute ADC RCs in 10-6 mm2/s (relative RC) for the full acquisition were 483 (28.0%), and 234 (12.8%) for GTV and whole prostate respectively. In the predicted ADC maps of AD_avg1 model, these were improved to 181.83 (10.4%) and 180.48 (9.5%).

We demonstrate that deep learning can generate high-quality DWI from subsampled data on the MR-Linac. Specifically, model trained with only one average from all-direction data (AD_avg1) produced results visually comparable to full averaging, reducing acquisition time to 36 seconds from the current 4:12 minutes. This model achieved superior ADC repeatability compared to the full acquisition ground truth for this dataset. There is a clear trade-off between denoising performance and acquisition time. While AD_avg3 achieves the lowest error, AD_avg1 offers substantial scan time reduction with only a marginal increase in error, suggesting it may be preferable in a time-constrained clinical setting.

Deep-learning accelerated DWI makes feasible shorter scan times, improved patient comfort, and better workflow compatibility for diffusion imaging in MRgRT without compromising image quality.
Prashant NAIR (London, United Kingdom), Yu XIAO, Bastien LECOEUR, Joan CHICK, Sian COOPER, Alison TREE, Petra J VAN HOUDT, Uwe OELFKE, Matthew D BLACKLEDGE, Andreas WETSCHEREK
11:30 - 11:32 #46906 - PG220 Influence of T1-weighted MRI data on convolutional neural network performance on neurodegenerative disease classification.
PG220 Influence of T1-weighted MRI data on convolutional neural network performance on neurodegenerative disease classification.

The use of deep learning has increased significantly in recent years in the field of neuroscience. Various methods are being developed as aid-to-diagnosis tools from imaging data with successful results. Our objective is to study how different parametric maps, all calculated from T1-weighted (T1w) magnetic resonance imaging (MRI), influence the learning process of a 3D convolutional neural network (3D CNN) to classify healthy controls (HC) from patients suffering from multiple system atrophy (MSA), a rare neurodegenerative disease [1].

The dataset comprised T1w MRI acquisitions gathered from three MSA reference centres in France [1-5], including 126 HC and 92 MSA patients. Images were processed using SPM12 on MATLAB R2019b with the following steps: (i) spatial normalization of T1w volumes in the Montreal National Institute (MNI) space (ii) resampling to a 2×2×2 mm3 resolution; (iii) skull stripping; (iv) segmentation of brain substances from the normalized T1w, obtaining grey matter density (GD), white matter density (WD) and cerebrospinal fluid (CSF) maps. We considered a 3D CNN architecture [4] to perform a binary classification task between HC and MSA patients, using a single image type (monomodal) and different combinations from the maps (bimodal, trimodal, and quadrimodal). The CNN was trained for 30 epochs with a ten-time repeated five-folds cross-validation with two different dataset splits. The database was divided into 80%/20% for training/testing our model. We considered accuracy, specificity and sensibility on the hold-out sets to evaluate CNN performance according to the different inputs.

In the monomodal study, we obtained the best mean accuracy with GD and WD maps (0.92 ± 0.06 and 0.94 ± 0.06 respectively), followed by T1 and CSF (0.87 ± 0.05 and 0.88 ± 0.04). However, the parametric maps showed a greater difference between sensitivity (0.50-1.00) and specificity (0.89-1.00), compared to the model based on T1 images (T1-CNN). The multimodal study showed an overall improvement in performance, with a mean accuracy of 0.90 ± 0.06 for the T1-GD-CNN and particularly for the T1-GD-WD-CNN, with a mean accuracy of 0.93 ± 0.06. The T1-GD-WD-CSF-CNN yielded results comparable to those of the previously mentioned models with a 0.92 ± 0.06 accuracy.

Firstly, the monomodal study enabled us to demonstrate the good classification capabilities of our 3D CNN to distinguish MSA patients from HC. Second, the multimodal study allowed us to observe a general improvement in performance depending on the type of map used with the T1 images. In our bimodal study, we found that adding as input a single parametric map improves the classification capabilities of the 3D CNN, but also can inform about the interpretability of the model from the monomodal performance. For example, considering the T1-GD-CNN, we can suppose that performances will benefit from the better classification found with GD maps alone. In the trimodal approach, we observe an increase in classification capabilities but interpreting these models becomes more challenging as we cannot know to which extent each map contributes to the multimodal performance. Finally, our quadrimodal study yielded classification capabilities comparable to the trimodal study, while increasing computational complexity. It is also important to note that there is a trade-off between the classification capabilities of our model and the computational cost. Indeed, the addition of a modality greatly increases the computational time of the algorithm. Although our sample size is limited by the rarity of the disease, these results are encouraging and show that multimodality can play a role in enhancing diagnostic accuracy. Lastly, to our knowledge, no study has yet exploited the unique contribution of parametric maps derived from the same MRI sequence targeting different aspects of brain structure compared to the sequence itself. This approach could pave the way for a better understanding of the “black box” nature of 3D CNNs thanks to the analysis of input data. However, the use of visualization techniques and the study of misclassified patients could help us to shed light on the impact of parametric maps on the 3D CNN performance.

Using different T1-derived maps as input to a 3D CNN increased classification performance to distinguish HC from MSA patients. However, the monomodal study based on the parametric maps calculated from the T1-weighted sequence showed the contribution of each cerebral substance by providing more precise information. To validate our approach, we plan to apply it to other pathologies, such as Alzheimer's disease, and to extend it to the differential diagnosis of parkinsonian syndromes.
Pierre TODESCHINI (Toulouse), Giulia Maria MATTIA, Lydia CHOUGAR, Alexandra FOUBERT-SAMIER, Wassilios G. MEISSNER, Margherita FABBRI, Anne PAVY-LE TRAON, Olivier RASCOL, David GRABLI, Bertrand DEGOS, Nadya PYATIGORSKAYA, Marie VIDAILHET, Jean-Christophe CORVOL, Stéphane LEHÉRICY, Patrice PÉRAN
11:32 - 11:34 #47314 - PG221 Automatic Spinal Cord Gray Matter Segmentation Across Multiple Contrasts, Magnetic Fields, Regions and Pathologies.
PG221 Automatic Spinal Cord Gray Matter Segmentation Across Multiple Contrasts, Magnetic Fields, Regions and Pathologies.

Magnetic resonance imaging (MRI) of the human spinal cord (SC) has seen significant technical advances, enabling the visualization of white matter (WM) and gray matter (GM) across various sequences such as MGE-T2starw, PSIR [1], TSE-T1w, MTR, rAMIRA [2], MP2RAGE [3], and SWI [4], at different field strengths (1.5T, 3T, 7T). GM segmentation is a key step for extracting biomarkers such as cross-sectional area (CSA) [5,6], which are essential for monitoring neurodegenerative and traumatic pathologies including MS [7,8], ALS [2,9,10], SCI [11], SMA [12], PPS [13], and DCM [14]. It also facilitates enhanced image registration, inter-subject alignment within the lumbosacral SC [15], tensor-based morphometry [16], ROI-based qMRI analyses [17], new templates construction [18] and fMRI processing [19–21]. Manual segmentation is time-consuming and subject to inter- and intra-rater variability [15,22,23], prompting the development of automated approaches [5,16,22,24–26]. Among these, the deep learning-based model sct_deepseg_gm [27], integrated into the Spinal Cord Toolbox (SCT) [28], has demonstrated strong performance particularly on MGE-T2starw images and similar contrasts and was the winner of the SC GM Segmentation Challenge [22]. However, the growing diversity of MRI contrasts, acquisition protocols, and use cases, including pediatric and thoraco-lumbar imaging, presents ongoing challenges for model generalization. This study aims to develop an automatic GM segmentation method that is robust across contrasts, field strengths, SC regions, and pathologies.

Data This study relies on multicentric data from 16 sites (Figure 1a), including 3 magnetic field strengths and 12 MRI contrasts grouped into 9 categories (Figure 1b). The dataset includes pediatrics controls, adult healthy controls (HC) as well as patients with ALS, MS, SMA, PPS, DCM, SCI, and stroke, for a total of 1,367 volumes (Figure 1c). Preprocessing All images were reoriented to RPI orientation and resampled in the axial plane to 0.3x0.3 mm2 using SCT v6.5 [28]. GM Ground Truth Manual GM segmentations, provided as binary masks, were available from 10 sites. For the remaining 6 sites, GM segmentation was first obtained using a preliminary version of our method (r20250204), followed by manual correction to ensure accuracy. Automated Segmentation Benchmark: Contrast-specific models were used as benchmarks (Table 1). For contrasts without existing segmentation methods (PSIR, 3T-TSE-T1w, 7T-MP2RAGE-T1map, and thoraco-lumbar images), single-contrast models were trained using the nnU-Net v2 framework [29]. Our approach: The nnUNetv2 framework was used to train on 1000 epochs in 5 folds with cross-validation on a 2D model. The training dataset consisted of 1,141 volumes (15,535 axial slices). The testing dataset comprised 20% of the images from sites with GTs (Figure 1a). Evaluation of Segmentation Segmentation performance was assessed using the Dice Similarity Coefficient [30] and the Hausdorff Distance (HD) in mm [31], calculated for each 2D axial slice. Statistics Wilcoxon test for paired samples, comparing benchmark and our approach.

Figure 2 summarizes the Dice scores and HD, showing that our approach significantly outperforms the benchmark methods in multiple sclerosis (MS) cases (p < 0.05). This demonstrates the model’s superior performance in segmenting gray matter in the presence of MS lesions (Figure 3). A Dice score above 0.85 (Figure 2d) indicates high segmentation fidelity, comparable to that of benchmark #1 [27] reported in the SC GM Segmentation Challenge. However, benchmark #1 shows reduced performance in the lower cervical and thoracic regions (Figure 2a,b). For the 7T datasets, both the benchmarks (#3, #6) and our method performs well.

While our method and the benchmarks perform adequately overall, segmentation in patients with SMA and DCM is less accurate (Figure 2a), likely due to SC compression that alters GM shape and contrast. This highlights the need for more training data from varied pathological cases. In the thoraco-lumbar region (Figure 2b), our model maintains good performance, although segmentation accuracy decreases at the L2 level due to the small size of the spinal cord at this point (~10 pixels; Figure 3). Dice scores are impacted by the limited number of GM voxels in this region across all methods. Our model achieves an average HD below 0.6 mm across most contrasts, indicating that the predicted GM contours typically deviate by only one pixel from the ground truth. This robustness holds across diverse GM morphologies and pathological conditions (Figure 3)

We present a robust approach for automatic GM segmentation, demonstrating consistent performance across multiple MRI contrasts, SC regions, and pathological conditions. Our approach is publicly available in the SCT v7.0. To further enhance generalizability, especially in challenging pathological cases, future work should incorporate more diverse and pathology-rich datasets during training
Nilser LAINES-MEDINA (Marseille), Jan VALOSEK, Samira MCHINDA, Katerina KREJCI, Josef BEDNARIK, Tomas HORAK, Petr KUDLICKA, Nico PAPINUTTO, Roland G HENRY, Deborah PARETO, Jaume SASTRE-GARRIGA, Alex ROVIRA, Mindy LEVIN, Feroze MOHAMED, Seth SMITH, Tobias GRANBERG, Christopher HEMOND, Charidimos TSAGKAS, Cristina GRANZIERA, Regina SCHLAEGER, Claudia WHEELER-KINGSHOTT, Kristin P. O'GRADY, Gergely DAVID, Virginie CALLOT, Julien COHEN-ADAD
11:34 - 11:36 #45719 - PG222 Performance monitoring of AI-based MR reconstructions via image quality metrics: a two-year study.
PG222 Performance monitoring of AI-based MR reconstructions via image quality metrics: a two-year study.

AI-based MR reconstructions can accelerate scanning and/or improve image quality. Guidelines for deploying AI tools in radiology[1–4] recommend post-deployment monitoring, as performance may vary due to scanner software updates[5], yet lack specific methods for monitoring that follow established quality control (QC) frameworks: defining performance metrics, baseline values, monitoring frequency, and feedback mechanisms[6–8]. Radiologist assessments are resource-intensive; while phantom-based methods have not been developed for AI-based reconstructions, making both unsuitable for QC. Image quality metrics (IQMs), used to evaluate performance of AI-based images and reconstructions[9–14], offer a more efficient alternative for monitoring. Our institution introduced an AI-based reconstruction for rectal MRI, evaluated using radiologist scoring[15]. We developed a QC programme using IQMs proven to be sensitive to known perturbations in the AI-based reconstruction[16]. The aim of this study was to evaluate 24 months of QC data, during which the MR systems underwent software upgrades with known modifications to the reconstruction pipeline.

90 patients (47M/43F, 33-89y, median 64y) undergoing routine anorectal MRI (Apr 2023-Apr 2025) were scanned on a 1.5T or 3T system (1.5T-A: n=19, 1.5T-B: n=18, 3T-A: n=36 and 3T-B: n=17, MAGNETOM Sola/Vida, Siemens Healthineers, Forchheim, Germany) using a 30-ch body array and 32-ch spine array. The study was approved by a research ethics committee; patients gave verbal consent for additional imaging as part of routine clinical MRI examinations. Axial T2-weighted small field-of-view turbo spin-echo sequences were acquired with and without AI-based reconstruction[15, 16] at matched positions. Raw data were also saved. Patients were numbered chronologically, the first 50 patients formed the reference dataset; the rest formed the constancy dataset. During the study, the 1.5T-A, 3T-A and 3T-B systems underwent software upgrades. A radiologist qualitatively reviewed 3 prospective post-upgrade datasets per upgraded system. Post-upgrade reconstructions and difference images were generated for 3 datasets per 3T system (Fig.1). Paired IQMs – mean squared error (MSE), peak signal-to-noise ratio (pSNR), structural similarity index (SSIM), and visual information fidelity (VIF)[17–19] – and unpaired IQMs – image entropy, and Tenengrad[17, 20] – were evaluated in a 214×214-pixel central region-of-interest for all slices. IQM values for all datasets were evaluated using Shewhart control charts, comparing each exam's mean IQM against the reference mean and standard deviation (SD). Control chart test rules (Fig.2) were applied[21]. Radiologist scoring was performed for the reference dataset[15]. IQMs were evaluated using MATLAB (R2024b, Natick, MA).

Additional QC data acquisition took an average of 6 minutes per exam. Difference images (Fig.1B) showed changes in accelerated acquisitions with a mean pixel intensity of 0.4 ± 0.6 whereas standard acquisitions showed minimal change, with a mean pixel intensity of 0.0007 ± 0.04. Mean IQM values for patients 56 (SSIM, VIF), 60 (SSIM) and 85 (MSE, pSNR, SSIM, VIF) exceeded 2 SDs, triggering control chart rule 1 (Figs.2&3). Rules 2-4 were not triggered. Mean IQM values for post-upgrade retrospective reconstructions did not trigger any control chart rules. Only rule 1 was triggered for patients 56 (SSIM, 1.5T-A); 60 (MSE, pSNR, SSIM 3T-A) and 85 (MSE, pSNR, SSIM, VIF, 1.5T-A) when evaluating the IQMs per scanner (Fig.4).

This study evaluated IQMs for QC of AI-based MR reconstructions over 2 years during which there were system software upgrades. Longitudinal IQM trends indicated stable performance since clinical deployment as no results triggered additional inspection of data or re-evaluation of the imaging. Examinations with outlier IQM values were traced to gross motion. Motion was generally minimised through patient setup and use of antispasmodics. No IQM values indicated changes outside of expected variation for examinations conducted post software upgrade, suggesting image quality is consistent with reference data for which radiologist scoring indicated good image quality. Differences images showed that software upgrades altered the reconstruction pipeline - specifically, a change in the phase correction method for the AI-based reconstruction. Despite this, neither IQMs nor radiologist review indicated changes in image quality. The IQMs provide a resource-efficient QC method, with automated, quantitative analysis with minimal added acquisition time and no extra radiologist burden.

IQMs offer a resource-efficient alternative to routine radiological evaluation for ongoing monitoring of AI-based MR reconstructions. No clinically significant performance changes were detected by IQMs or radiologists after software upgrades. Future work will include radiologist scoring of post-upgrade data and expansion of this QC framework to other MR sequences.
Ciara HARRISON (London, United Kingdom), Owen WHITE, Joshua SHUR, Francesca CASTAGNOLI, Geoff CHARLES-EDWARDS, Brandon WHITCHER, David COLLINS, Matthew CASHMORE, Matt HALL, Spencer THOMAS, Andrew THOMPSON, Georgina HOPKINSON, Dow-Mu KOH, Jessica WINFIELD
Espace Vieux-Port

"Saturday 11 October"

Added to your list of favorites
Deleted from your list of favorites
D32
11:00 - 12:30

FT2-3 - Brain Banks

Chairpersons: Maxime GUYE (Professor) (Chairperson, Marseille, France), Dominique NEUHAUS (Postdoc) (Chairperson, Basel, Switzerland)
FT2: Cycle of Translation
11:00 - 12:30 Advancing the diagnosis and treatment of neurological diseases with the help of brain banks. Helena RADBRUCH (Keynote Speaker, Berlin, Germany)
11:00 - 12:30 Challenges and pitfalls of setting up MRI protocols for brain banks. Liana GUERRA SANCHES (Postdoctoral Fellow) (Keynote Speaker, Montreal, Canada)
11:00 - 12:30 The digital brain bank. Benjamin TENDLER (Keynote Speaker, Oxford, United Kingdom)
Salle 120

"Saturday 11 October"

Added to your list of favorites
Deleted from your list of favorites
E32
11:00 - 12:30

MS2 - Self-learning MRI

Keynote Speakers: Shaihan MALIK (Keynote Speaker, London, United Kingdom), Or PERLMAN (Keynote Speaker, Tel Aviv, Israel), Tony STÖCKER (Keynote Speaker, Germany), Moritz ZAISS (Professor) (Keynote Speaker, Erlangen, Germany)
Chairpersons: Shaihan MALIK (Chairperson, London, United Kingdom), Moritz ZAISS (Professor) (Chairperson, Erlangen, Germany)
Salle 76

"Saturday 11 October"

Added to your list of favorites
Deleted from your list of favorites
G32
11:00 - 12:30

Poster 6
FT2 - Diffusion | FT1 - Acquisition methods | FT1 - Spectroscopy and X-Nuclei | FT2 - Functional and metabolic MRI | FT1 - New technologies for new application

11:00 - 12:30 #47419 - PG465 Comparison of diffusion-weighted imaging for detection of spontaneous muscular activities to clinically established methods: Preliminary results.
PG465 Comparison of diffusion-weighted imaging for detection of spontaneous muscular activities to clinically established methods: Preliminary results.

Diffusion-weighted magnetic resonance imaging (DW-MRI) is able to visualize focal spontaneous muscular activity (SMAM) [1]. This technique is based on the signal reduction induced by the three-dimensional incoherent motion pattern of muscular contraction and has shown a strong correlation to surface electromyographic measurements [2,3]. Furthermore, an increased rate of visible spontaneous activities was found in patients suffering from amyotrophic lateral sclerosis. [3-7] However, a systematic comparison with clinically established methods, e.g., muscle ultrasound and needle electromyography, for the detection of spontaneous activity is still missing. In this work, the first attempt to compare the results of DW-MRI with two clinically established measurement methods in a cohort of five healthy volunteers is presented.

DW-MRI: Time-series of diffusion-weighted imaging were acquired from five healthy subjects (age: 29.4±4.6 years) on a 3T MR system (MAGNETOM Prismafit, Siemens Healthineers AG, Forchheim, Germany) using a diffusion-weighted stimulated-echo (DW-STE) EPI research sequence. Following muscle groups were examined: tibialis anterior (TA) and gastrocnemius medialis (GM) of the left and right lower leg, paraspinal muscles at the position of the vertebra Th10 (PM), deltoid muscles (DM) and tongue muscles (TM). Protocol parameters of the DW-STE-EPI were chosen according to Schwartz et al. [4] and are given in Table 1. 500 repetitions were chosen leading to a total scan-time of 250 s for each muscle group. Muscle ultrasound (US): For comparison, muscle ultrasound images were acquired at all aforementioned muscular regions with an examination time of 120 s per muscle using a Canon Aplio i800 ultrasound system. Needle electromyography (nEMG): Due to the invasiveness of this measurement technique, examination was restricted to the TA and GM of the two lower legs. In each case, 3 needle positions were examined along the muscle with an overall acquisition time of 90 s (30 s per needle position). A Sierra Summit (Cadwell, USA) system was used for recording the myoelectric signals. The study protocol was approved by the local ethics review board of the medical faculty of the Eberhard Karls University and the University Hospital of Tübingen in 830/2020BO2. Evaluation: DW images were intra-subject registered before applying a neural network approach [5] for detection and segmentation of spontaneous muscular activities. All segmentation results were manually revised to ensure proper classification and were visualized as percentage Event Count Maps (pECM), i.e., the summation of events in time direction normalized by the number of repetitions, using custom-built tools in MATLAB® (The MathWorks, Natick, MA, USA). Spontaneous activities in muscle ultrasound images were visually detected by an experienced specialist during the examination. Results of the nEMG measurements were also manually counted. All results were reported as rate of activity per minute. Relation between nEMG vs. DW-MRI and US vs. DW-MRI was examined with a Spearman correlation.

Exemplary pECMs of Subject #4 (highest mean rate) for each individual muscle group is depicted in Figure 1. It can be seen that an overall high rate of activity is detectable in the GM of the right and left lower leg. This is in good accordance to the detected activity rate of nEMG and US. The rate of activity for each modality and muscle group is given in Table 2. A significant correlation for nEMG (ρ = 0.64, p = 0.003) and US (ρ = 0.49, p = 0.0008) was found. In two subjects, the tongue muscle could not be analyzed due to non-resting musculature and enhanced imaging artifacts caused by a dental retainer.

There is a significant agreement between the various muscle groups and modalities. However, it must be noted that in contrast to US and nEMG, DW-MRI was evaluated on the entire cross-sectional area of the muscle instead of a more localized area. Depending on the parameterization, there is a certain probability of missing a spontaneous activity in DW-MRI, e.g., start of muscle contraction after image readout [8]. These two influencing factors must be investigated further. Recording and evaluating the tongue muscles appears to be more difficult, since this muscle region is not always in a resting posture, depending on the subject.

The detection results of DW-MRI show good agreement with clinically established methods (US and nEMG) in a small cohort of healthy volunteers. Further studies are needed to investigate the correlations between all three modalities in a patient cohort.
Martin SCHWARTZ (Tuebingen, Germany), Petros MARTIROSIAN, Julia WITTLINGER, Thorsten FEIWEIER, Guenter STEIDLE, Bin YANG, Ludger SCHÖLS, Fritz SCHICK
11:00 - 12:30 #47560 - PG466 Frequency-dependent diffusion tensor distribution imaging in the evaluation of ischemic stroke.
PG466 Frequency-dependent diffusion tensor distribution imaging in the evaluation of ischemic stroke.

Ischemic stroke is a global health and economic burden, with up to 7.6 million incident cases annually [1]. The imaging techniques used in clinics effectively discern large-scale structural damage in the core, however, they often fail to detect subtle changes and estimate tissue viability in the lesion, penumbra and distal regions. [2-4]. Brain imaging urgently requires solutions. Frequency-dependent diffusion tensor distribution imaging (ωDTD) is an emerging method that exploits frequency-dependent tensor-valued diffusion encoding for sub-voxel parameter estimation [5,6]. To extract within the voxel information on signal-fractions specific to certain tissue characteristics we exploit gaussian mixture-model based clustering of tensor-valued distributions as in [7] as opposed to traditional, manual bin-segmentation [6]. Here we have combined ωDTD, clustering of the per-voxel parameter distributions and multivariate statistical modeling to capture the relationship between MRI and histology following an ischemic stroke.

Eleven 4-month-old male Wistar Han rats 250-450 g, were used in this study. A transient ischemic injury was induced in the left hemisphere using the intraluminal middle cerebral artery occlusion model described in [8,9]. The animals were transcardially perfused at 24-hours post-reperfusion. Ex vivo MRI was acquired in a 11.7-T Bruker Avance-III HD spectrometer in a 10-mm volumetric coil using a multi-slice multi-echo 2D sequence customized for tensor-valued diffusion encoding. The sequence included variable b-values (700 - 8000 s/mm^2), normalized anisotropy b∆ (-0.5, 0, 0.5 and 1), TR = 800 ms, TE = 30 ms, orientation (θ, ϕ), centroid frequency ω_cent/2π = 34 - 115 Hz, and an in-plane voxel resolution of 80 x 80 μm^2. After, the brain sections were prepared for Nissl staining. The clustering of diffusion tensor distributions was performed as in [7]. For the regression analysis (Fig.1.), quantitative histological parameters were extracted from the Nissl micrographs using QuPath. These parameter maps were downsampled and registered with MRI. Both MRI and histological parameter maps were preprocessed and entered into the random forest (RF) model. The performance of the RF [10] was evaluated with cross-validation leave-one-animal-out (CV LOO) and common metrics such as R^2, R, Q^2, MSE and MAE. Additionally, we investigated how the prediction accuracy depends on the input MRI parameters, by training a separate RF model with both conventional diffusion tensor imaging (DTI) and three different ωDTD parameter sets (per-voxel means, bin-resolved and cluster-resolved fraction maps).

Fig.2. shows how the RF predictions depend on the input MRI parameters. The predicted number of cells based on conventional MRI (Fig.2. D) shows a scenario where the regression model has failed to capture the more nuanced tissue changes. However, the predicted number of cells based on bin-resolved ωDTD (Fig.2. E) resembles more closely the original histological parameter map both in lesion details and values. The original histological parameters and their counterpart predictions based on ωDTD cluster-resolved fractions are shown in Fig.3. The predicted maps replicated the distinct lesion boundaries and characteristics of each histological parameter (white arrows), such as the layer of increased number of cells in the cortex. The performance metrics for evaluating the RF are shown in Table.1.

We found that the ωDTD parameters were highly predictive of changes in cellularity and morphology of cells, including alterations in nucleus size and shape. This indicates that the ωDTD parameters are more descriptive of the histological changes, i.e. more strongly related to the target variable. The R^2 values showed our models explained between 35% - 70% of the variance present in the data. The correlation R was also consistently positive for the CV, showing that our models repeatedly captured a relationship between the input MRI parameters and the target histological parameters. The variability observed in both MSE and MAE across CV folds suggests inter-subject differences. In the future, additional histological stains and expansion to fully 3D analyses incorporating deep learning algorithms could open new perspectives in predicting tissue changes.

In conclusion, ωDTD can open new avenues in the evaluation of ischemic stroke by capturing subtle cellular-level alterations in tissue viability, composition, and microstructure.
Sara GRÖHN (Kuopio, Finland), Angela NARANJO, Omar NARVAEZ, Maxime YON, Buse BUZ-YALUG, Santos BLANCO, Daniel TOPGAARD, Esther MARTINEZ-LARA, Ma Angeles PEINADO, Jussi TOHKA, Alejandra SIERRA
11:00 - 12:30 #47606 - PG467 Reaching the Tail: Validating MRI Axon Radius Mapping with MRI-Scale Histology.
PG467 Reaching the Tail: Validating MRI Axon Radius Mapping with MRI-Scale Histology.

The axon radius is a promising clinical biomarker for neurological disorders and may be accessible via non-invasive diffusion-weighted MRI (dMRI). One candidate dMRI model estimates the effective axon radius r_eff = (⟨r^6⟩ / ⟨r^2⟩)^(1/4), which emphasizes the tail of the axon radius distribution [1-2]. However, r_eff remains insufficiently validated against ex vivo histology. While qualitative comparisons hint at common spatial patterns in the corpus callosum [3-9], there is no quantitative proof that r_eff reflects tissue microstructure. This gap is due to limited variation [2] or sparse sampling [3,8,10-16] in existing histology. Additionally, the small ROI sizes likely yield imprecise r_eff - due to its tail-weighting [2,11]. Here, we quantitatively validate r_eff via spatial correlations between in vivo and ex vivo dMRI and corresponding histology, using 35 in vivo dMRI voxel-sized ROIs from two human corpora callosa.

We acquired light microscopy (LM) images for 35 ROIs of two human corpus callosum samples (Fig. 1a–b). We segmented axons [17] per ROI and estimated r_eff. For in vivo dMRI, we acquired magnitude data of five healthy adults (age: 31 ± 3 years; sex: 2 male, 3 female) on a Siemens Connectom 3T scanner at MPI-CBS, Leipzig, Germany, following the protocol in [4]. Briefly, we applied b = [0.5 1, 2.5, 6, 30.45] ms/µm^2 for [30, 30, 30, 60, 120] gradient directions with variable gradient amplitude and 2.5 mm isotropic resolution. We also acquired T1-weighted MPRAGE and non-diffusion-weighted images for geometric susceptibility correction. We corrected for Gibbs ringing artifacts [18-19], geometric susceptibility, eddy currents, motion [19-21] and gradient distortions [22-23]. For b ≥ 6 ms/μm^2, we estimated powder-averaged signals per b using a Rician maximum likelihood (ML) estimator [24] relying on a noise level estimate [19], [25], [26]; subsequently, we estimated r_eff [5]. For b ≤ 2.5 ms/μm^2, we mapped DKI-based fractional anisotropy (FA) [19,27-28]. For ex vivo dMRI, we acquired magnitude data using a Bruker Biospin 9.4T scanner at the Berlin Ultrahigh Field Facility in Berlin, Germany, using a protocol akin to [2]. Briefly, we used a segmented EPI sequence with b = [20, 30, 40, 50, 60, 70, 80, 90, 100] ms/µm^2 for 65 gradient directions per b with variable gradient amplitude and 0.35 mm isotropic resolution. To enhance SNR, we averaged up to 8 images for high b. We corrected for Gibbs ringing artifacts using MRtrix3 [18], [19]. We estimated the powder-average per b using a Rician maximum likelihood (ML) estimator [24]. We subtracted the immobile water compartment signal [29], estimated from signals at b = 100 ms/µm^2 with strong alignment to the main fiber direction. Finally, we estimated r_eff [30]. For qualitative dMRI-histology comparison, we assessed spatial r_eff patterns for all modalities in the mid-sagittal slice of MNI space (see Fig. 2 for registration). For quantitative comparison, we assessed absolute agreement across ROIs evaluated in their native spaces using the normalized root-mean-square error (NRMSE), normalized by the mean of histological r_eff (Fig. 2). We assessed sensitivity via Pearson’s R and its two-sided p-value using Monte Carlo permutation with K = 10⁶ permutations (null hypothesis: R = 0).

Fig. 3 compares group-level in vivo dMRI-based r_eff with histology. The spatial patterns (Fig. 3a) appear slightly overestimated and show reduced dynamic range, suggesting limited microstructural sensitivity. Still, dMRI captures a coarse histological trend, with alternating low–high r_eff across anterior midbody, midbody, posterior midbody, and splenium. The quantitative analysis (Fig. 3b) confirms this agreement via significant correlation (R = 0.41, p = 0.019). Fig. 4 show the ex vivo counterpart to Fig. 3 based on a single sample (CC-01). The spatial pattern (Fig. 4a) shows low dynamic range and no clear structure, resulting in the absence of significant correlation (Fig. 4b, R = 0.23, p = 0.41). While the strong dynamic range reduction may be inherent to ex vivo dMRI and tissue, it may also reflect the added model complexity introduced by the immobile water compartment.

We provide the first quantitative evidence that r_eff, and axon morphology more broadly, are detectable in human brain in vivo dMRI. This is despite recent 3D histology revealing complex axonal morphology [12,14,16,31-32] which challenges the perfect cylinder assumption of r_eff. Consequently, 2D histology emerges as a scalable method for experimental validation, complementing simulations based on sparse 3D axonal reconstructions. The low ex-vivo sensitivity suggests that using ex-vivo dMRI as an intermediate validation step to bypass inter-individual differences may be inherently difficult.

Our demonstration of dMRI’s sensitivity to axon morphology motivates advances to address the observed dynamic range reduction, better model realistic axonal morphology, and support clinical translation.
Laurin MORDHORST (Lübeck, Germany), Luke J. EDWARDS, Maria MOROZOVA, Mohammad ASHTARAYEH, Tobias STREUBEL, Björn FRICKE, Francisco J. FRITZ, Henriette RUSCH, Carsten JÄGER, Starke LUDGER, Thomas GLADYTZ, Ehsan TASBIHI, Joao S. PERIQUITO, Andreas POHLMANN, Thoralf NIENDORF, Nikolaus WEISKOPF, Markus MORAWSKI, Siawoosh MOHAMMADI
11:00 - 12:30 #47708 - PG468 Using Mahalanobis Distance to Detect Along-Tract DTI Abnormalities Predictive of Long-Term Outcome After Traumatic Brain Injury.
PG468 Using Mahalanobis Distance to Detect Along-Tract DTI Abnormalities Predictive of Long-Term Outcome After Traumatic Brain Injury.

Traumatic brain injury (TBI) is a leading cause of morbidity and mortality in individuals under 45 years of age [1-3]. Despite this, our ability to predict functional outcomes following injury remains limited. Accumulating studies have highlighted the utility of diffusion tensor imaging (DTI) in aiding outcome predictions through its sensitivity to traumatic axonal injury, a hallmark histopathological feature of TBI [4,5]. However, a common limitation of such studies is the reliance on whole-tract averages, which may obscure small but still clinically relevant injuries. Alternatively, these studies rely on voxel-wise group comparisons, which assume consistent injury patterns across the patient cohort. Given the substantial heterogeneity of mechanisms in which TBI can be sustained, this assumption may not be warranted. Hence, analysis methods that can capture subtle abnormalities across white matter tracts, without requiring spatial overlap of injuries across individuals are needed. One such approach is using Mahalanobis distance, a multivariate outlier detection method that quantifies the extent to which there are regions along the tract that deviate significantly from the reference group. By applying this method to DTI metrics sampled from multiple points along a given tract, it becomes possible to identify subject-level abnormalities that might otherwise be overlooked.

Here, we adapted a previous approach [6] by applying a robust version of Mahalanobis distance, using the minimum covariance determinant [9,10], to quantify abnormalities in axial diffusivity (AD) and radial diffusivity (RD) along several white matter tracts. The study cohort consisted of 18 adult TBI patients (mild to severe) and 18 healthy controls from a previous study [7]. Diffusion-weighted images were acquired on a 3T Siemens Magnetom Verio scanner at the Oxford Acute Vascular Imaging Centre, along 64 directions (b=1500s/mm²) with 5 b=0 images (2×2×2mm voxels, TR=2153ms, TE=85ms, MB=2). Two datasets with opposing phase-encoding directions (A-P, P-A) were collected for distortion correction. Patients were scanned within 24 hours post-injury, and 17 re-scanned at 7–15 days, whilst controls were scanned once. An automated tractography pipeline (pyAFQ [8]) was used to reconstruct 28 white matter tracts per subject, sampling 100 equidistant nodes along each tract to generate tract profiles. To ensure tract reliability and data completeness, only tracts with >10 streamlines in all participants were retained, resulting in 25 tracts for analysis. For each tract, mean AD and RD values were extracted at all 100 nodes. Robust Mahalanobis distance was calculated for each subject by individually comparing their entire AD and RD tract profiles to the healthy control group, with larger distances indicating a greater deviation from normal. For each tract, correlations between AD and RD Mahalanobis distances and functional outcome, measured by the Glasgow Outcome Scale–Extended (GOSE) [11] at 6 months post-injury (range: 1 = dead to 8 = upper good recovery), were assessed using Spearman’s rank correlation, with p-values adjusted for a 5% false discovery rate.

Within 24-hours post-injury, greater AD Mahalanobis distance in the right anterior thalamic radiation was significantly associated with a lower GOSE score at 6 months (Spearman ρ= –0.82, p=0.0015). However, at 7–15 days post-injury, only increased AD Mahalanobis distance in the right inferior longitudinal fasciculus (ρ= –0.75, p=0.013) and in callosal fibres projecting to the superior parietal lobule (ρ= –0.82, p=0.0031) were significantly correlated with poorer outcome. No other significant associations were identified.

Our findings demonstrate that robust Mahalanobis distance applied to along-tract DTI profiles may be able to identify clinically meaningful abnormalities that predict long-term functional outcome in TBI patients. Unlike the typical approaches that rely on tract-averaged metrics or voxel-wise group comparisons, Mahalanobis distance provides a subject-specific, multivariate assessment of the magnitude of abnormality across the whole tract. Interestingly, the predictive tracts differed between the first and second timepoints, potentially reflecting the evolving nature of TBIs. In a mixed-severity cohort, patients may recover or deteriorate at varying rates, which in a small sample may have reduced the stability of group-level effects. Our findings also suggest that AD may be more sensitive to outcome-relevant axonal abnormalities in the early post-injury stage, compared to RD. Nevertheless, this study is limited by the lack of covariate adjustment (e.g., for age, sex, or lesion burden).

Mahalanobis distance may be a promising approach for detecting along-tract abnormalities and aiding outcome predictions following TBI. Future work should implement multivariate outlier detection methods in larger, covariate-controlled cohorts to further assess their utility.
Izabelle LÖVGREN (Oxford, United Kingdom), Michiel COTTAAR, Natalie VOETS, Tim LAWRENCE
11:00 - 12:30 #47800 - PG469 Cerebral Magnetic Resonance Imaging Insights into Bariatric Surgery-induced Changes in Obese Mice.
PG469 Cerebral Magnetic Resonance Imaging Insights into Bariatric Surgery-induced Changes in Obese Mice.

Obesity is a chronic disease associated with several pathologies such as type 2 diabetes, cardiovascular risk or neurodegeneration. Bariatric surgery (BS), initially a high-risk weight-loss procedure, is still the most successful approach at restoring non-obese body mass indexes (BMI) in an increasing range of population [1]. Beyond weight reduction, BS alters metabolism, gut microbiota, and brain function. [2,3]. Among available techniques, vertical Sleeve Gastrectomy (VSG) is one of the most common, removing 70%–80% of the stomach. This study aims to investigate VSG's effects in the brain on a rodent diet-induced obesity model using diffusion tensor imaging (DTI) and magnetization transfer imaging (MTI).

26 C57BL/6 mice (male and female) were fed with a high-fat high-sugar (HFHS, 45kcal% fat, 30 kcal% sucrose) diet (Research Diets Inc., D08112601i). After 20 weeks, obese mice were assigned to either a sham-operated or BS group. Post-surgery, animals were maintained on a liquid diet for 1 week, followed by a chow diet for 6 weeks. Body weight (BW) was followed daily. Brain diffusion tensor images (DTI, 30 directions, TR/TE= 3000/37.56 ms, δ/Δ= 4/25ms, Mtx= 128×128, slice thickness= 1.25 mm, b-values= 800µm2 /s & 2500µm2 /s) and magnetization transfer images (MTI, MTON/OFF, TR=2500ms, TE=9.8ms, and Av=1) were acquired pre-surgery and at 3- and 6-weeks post-surgery using a Bruker Biospec 7T system (Bruker Biospin, Ettlingen, DE). Image pre- and processing was performed using a software based on Dipy [4]. Parametric maps of mean, axial and radial diffusivities (MD, AD, RD), anisotropic fraction (FA) and MT ratio (MTR) were obtained, and regions of interest (ROI) from the hypothalamus (Hyp), hippocampus (Hipp), nucleus accumbens (NAc), and infralimbic area (ILA) selected. Statistical analyses were performed using R [5], and MR parameters were fitted to a variety of LME regression models using the “lme” function of “nlme” [6] package to evaluate the differences of the MR parameters between sham and BS groups over time. Correction for multiple comparisons accross the tests on MRI parameters was achieved by the hierarchical Benjamini-Hochberg procedure [8] using the structSSI package [9]. Briefly, such approach levels groups of hypotheses hierarchically, and only if superior null hypothesis are rejected, the subsequent are tested.

BS was associated with a significant reduction in body weight, with mean values of 43.11 ± 6.12 g at pre-surgery, 31.54 ± 3.40 g at 3-weeks post-surgery, and 32.98 ± 3.31 g at 6-weeks post-surgery. The LME analysis of MRI parameters in Hyp revealed significant interactions between “Type” (Sham vs. BS) and “State” (Pre, Post3w, or Post6w) for RD, MD, and FA values (p < 0.001, p < 0.001, and p < 0.05, respectively). Post-hoc tests indicated a significant increase in RD values in the BS group from both Pre (p<0.01) and Post3w (p<0.05) to Post6w, while the Sham group showed a significantly decrease in RD from Post3w to Post6w (p<0.01) (Figure A). Similarly, MD values in the BS group increased significantly from Pre to Post6w (p<0.05) (Figure B). Additionally, group comparisons at each time point confirmed that by week 6, the BS group exhibited significantly lower FA values (Figure C) and higher MD and RD values compared to the sham group (p<0.05 for all metrics).

Our results suggest that BS induces a reduction in body weight and distinct and time-dependent changes in MRI parameters. By week 6, the BS group exhibited higher RD and MD values, along with lower FA values compared to the sham group. These findings are consistent with a successful reversal of the obesity-induced inflammatory state, as the observed increases in RD and MD may reflect an expansion of the extracellular space or alterations in cellularity. [7].

We found longitudinal changes in DTI parameters following bariatric surgery, with a reduction in body weight, demonstrating that the effects of bariatric surgery on the brain can be detected in vivo using MRI. Currently, our dataset comprises only n = 13 with the three time points. Future research will increase the sample size and extend the analysis to additional brain regions.
Adriana FERREIRO (Madrid, Spain), Maya HOLGADO, Raquel GONZÁLEZ-ALDAY, Pilar LÓPEZ-LARRUBIA, Blanca LIZARBE
11:00 - 12:30 #47355 - PG470 Adaptive prescan calibration routines and connection to the gammaSTAR framework for accurate sample probing in tabletop MRI system.
PG470 Adaptive prescan calibration routines and connection to the gammaSTAR framework for accurate sample probing in tabletop MRI system.

The rising interest in low field MRI (<1.5T) is uniting a community that has the potential to make a meaningful impact in this niche area of MRI. We here investigate the use of the commercially available Open-Source Console for Realtime Acquisition (OCRA) tabletop system[1] to expand the range of application of portable low-field systems by allowing a connection with gammaSTAR[2], a scanner-agnostic MRI pulse sequence development framework. Previous work [3] has presented a wrapper software that resolves differences between OCRA machine code and the open-source pulse sequence programming environment PulSeq, using MAgnetic Resonance COntrol System (MaRCoS[5,6]) server. In this work, we developed a driver that translates gammaSTAR sequences into the input data format for the MaRCoS server. The connection to the gammaSTAR backend is direct, enabling on-the-fly generation of MRI sequences and flexible changes of sequence protocols. The entire pipeline encompasses a dynamic system calibration workflow, acquisition data storage in the ISMRM Raw Data format [7], and image reconstruction performed using gammaSTAR reconstruction server.

The original Red Pitaya 125-14 in the OCRA console was substituted with Red Pitaya 122-16[8]. A gammaSTAR software driver was implemented to convert gammaSTAR sequence raw data format from the interpreter to MaRCoS numpy arrays input data. The wrapper rearranges the gammaSTAR sequence information into numpy arrays of times and amplitudes for each hardware output and control (radiofrequency pulses, gradient pulses, along with adc data) to be fed as input to the MaRCoS server. Prior to data acquisition, calibration measurements were carried out through the implementation of a calibration routine [1] utilizing a gammaSTAR 1D spin echo sequence for the Larmor frequency sweeping and a 1D spin echo with slice selection sequence for the gradient shimming. Tests were performed using 3D printed shaped cylindrical phantoms (8 mm diameter and 30 mm length) with tap water mixed with copper sulfate (phantom A), and only water (phantom B), along with a plant stem (9 mm diameter and 28 mm length of pseudobulbs of noble dendrobium). The execution of customized pulse sequences was performed by using an acquisition pipeline in python for sending, receiving, and reconstruction. Acquired data were streamed to the gammaSTAR reconstruction server which returns final images in DICOM format. Different 2D and 3D sequences were tested: rapid acquisition with refocused echoes (RARE), balanced steady-state free precession (bSSFP), single shot spin echo echo-planar imaging (SE EPI) and fast low-angle shot (FLASH).

Calibration measurements enabled the acquisition of images with a 30 parts-per-million (ppm) B0 inhomogeneity at a Larmor frequency of 11.278 MHz. Figure 1 illustrates the workflow of the connection between gammaSTAR frontend and MaRCoS server for executing user-defined sequences, incorporating both a dynamic calibration pipeline using an iterative method to determine the centered Larmor frequency, gradient shimming offsets, and a data acquisition pipeline. Table 1 summarizes the sequences imaging parameters employed across different phantoms/materials. Figure 3(a-d) illustrates different 2D sequences with very high signal-to-noise (SNR) ratio, including more challenging sequence such as SE-EPI with phase correction. Figure 3e shows a 3D FLASH sequence of a pseudobulb of noble dendrobium specimen with a short echo time, enabling the imaging of materials with low water content, primarily consisting of alkaline substances.

We have developed a driver that links the gammaSTAR platform to the OCRA tabletop system through the MaRCoS server, allowing for the design of sequences with various features. We anticipate that this approach will enable efficient validation of MRI sequences on tabletop systems, with direct transfer to full-scale scanners without modification, facilitated by the translational compatibility of gammaSTAR. This would facilitate a quicker and more efficient development of customized sequences. Furthermore, a range of pulse sequences implemented on a clinical MRI scanner have demonstrated robust performance across diverse sample probes on a low-field system, supporting their potential for broader implementation in advanced applications, such as materials science. Additionally, for fast sequences such EPI, further validation of distortion and phase correction techniques may be required for optimal performance.

We established a technically functional workflow for OCRA low-field MRI scanner, demonstrating the deployment of optimized custom sequences executed using gammaSTAR and the MaRCoS server. Furthermore we presented illustrative use cases that highlight the versatility of different sequence types moving beyond the hardcoded sequences used in previous work. This establishes a foundation for developing new sequences and exploring innovative applications in scientific research.
Juela CUFE (Bremen, Germany), Daniel Christopher HOINKISS, Simon KONSTANDIN, Jörn HUBER, Matthias GÜNTHER
11:00 - 12:30 #47609 - PG471 Detection and parsing of MRI sequences using an autonomous field camera.
PG471 Detection and parsing of MRI sequences using an autonomous field camera.

Measuring and characterizing gradient fields in MR sequences using NMR field probes is a frequently recurring aspect to for example modern image reconstruction, sequence development and sequence evaluation. In particular, the evaluation and testing of sequences can be a powerful tool in debugging erroneous gradient pulses or in understanding the fundamental composition of a sequence. Such measurements can however normally only be made if the user has special access rights to the scanner platform and if they can incorporate trigger pulses and probe position calibration sequences onto the scanner. In this abstract, we show how ‘true’ sequence diagrams can be characterized, including their imperfections, for unknown sequences using a scanner independent field camera.

Our proposed system employs a clock that is fully separated from the scanner and uses software-driven triggering for probe measurements, illustrated in Fig. 1 [1]. By relying on the periodic nature of MR sequences, the system timing can be aligned with that of the sequence by determining the repetition rate. Once the repetition rate is found, pseudo-continuous measurements of the TR can be provided which can serve as a basis for position calibration, Fig. 2. To turn field measurement into measurement of gradients, the probe positions need to be calibrated. To do this, the probes are set up in pairs with known distances, where the method presented in Fig. 3 is applied to find the probe positions in the imaging coordinate system. This method is compatible with a large set of different sequences and does not rely on knowing the exact gradients beforehand. To produce the final gradient waveforms illustrated in Fig. 3 we however need to overcome two obstacles: First, they have some unknown individual offsets O, and are in the intermediate step in Fig. 3 also rotated by some unknown 3D rotation matrix. The offsets occur due to individual probe off-resonances, illustrated in the top right of Fig. 3, caused by local field inhomogeneities across each probe. The determination of these offsets can be done in a few different ways: The simplest is to directly measure them while the scanner is inactive and use these values for all subsequent measurements. The disadvantage with this approach is that if the scanner applies shimming gradients, or if the probes are displaced, these values may become obsolete. A different method that accounts for this is to ensure that the sequence used for calibration features some gradient ‘silence’ and use those windows for explicit measurement of the offsets in real time. The missing rotation stems from the step in the calibration method that employs the known calibrated rigid body constraints: These will generally have been determined in some arbitrary orientation which does not match the present one. Correcting for this rotation can be done by identifying some isolated and mutually orthogonal gradient segments, such as readout and slice select, both of which are generally found in cartesian imaging sequences. Going through the steps above, a set of sequence diagram-style waveforms can be produced, without the probes ever needing any scanner input. For the sake of creating an undistorted sequence diagram, the imaging RF was disabled during measurements.

A set of calculated sequence diagram waveforms together with their corresponding reference waveforms are illustrated in Fig. 4. The full calibration procedure has been applied for each of these three sequences, which means that they are all compatible with our method and can be used to calculate the probe position. Because the phase encoding waveforms change throughout the sequence, the measurements have been scaled to match the reference waveforms. The agreement between measurement and reference suggests that the position calibration method has successfully determined the probe positions, which in turn translates into precise measurements of gradient strengths.

In this work we show how to parse sequence diagrams of unknown sequences using an autonomous field camera. Our method does expect some basic features in the sequence being measured, such as it having gradient silence or it using cartesian imaging. This does rule out a subset of sequences from direct use for calibration, but still leaves the possibility of using any compatible sequence for initial position calibration and later reusing that same calibration for fully arbitrary sequences. Producing sequence diagram results as we have done in this abstract has potential in sequence development, hardware diagnostics and in understanding the exact physical implementation of sequences, and can further be used on scanners that do not have the appropriate hardware and software integrated for regular field camera measurements. This could also be useful for MR sites that do not have research agreements with their vendors, or for mobile field camera systems that could be readily moved between different scanners and scanner platforms.
Oskar BJORKQVIST (ZURICH, Switzerland), Klaas P. PRUESSMANN
11:00 - 12:30 #47595 - PG472 The benefits of magnetic resonance simulation for emerging technologies: an emblematic application to magnetic-resonance-guided gamma imaging.
PG472 The benefits of magnetic resonance simulation for emerging technologies: an emblematic application to magnetic-resonance-guided gamma imaging.

Magnetic resonance (MR) simulation is a key enabler in exploring unconventional imaging approaches where no physical device yet exists. Magnetic-resonance-guided gamma imaging (MRG-γ)—based on the anisotropic γ-emission of hyperpolarized metastable nuclei controlled by MR manipulation of spin—is a promising but experimentally inaccessible modality [1–3]. Therefore, realistic simulation is crucial for validating physical models, characterizing parameters, and informing the design of acquisition strategies and hardware architecture. Although recent MR simulators have expanded their support for quantitative imaging, artificial intelligence, and sequence prototyping, they are not suited to model spin behavior at the γ-event level or to simulate γ image formation [4–9]. Our simulator, MRGS, addresses this gap by integrating spin dynamics, anisotropic γ-emission modeling, γ-detection, and γ-image reconstruction, enabling in-silico MRG-γ. This work illustrates the broader value of MR simulation in the development of emerging MR techniques.

We developed a modular MRG-γ simulator (see Figure 1) composed of MR and γ simulation parts. The simulation begins with user-defined inputs specifying the MR and γ physical parameters, phantom geometry, and the MR sequence. The simulator first computes magnetization evolution by solving the Bloch equations voxel-wise with high temporal resolution. These spin evolutions are used to stochastically model anisotropic γ-emission based on spin orientation, followed by γ-detection, and then γ-image reconstruction using list-mode maximum likelihood expectation maximization (MLEM) [10–13]. The outputs include magnetization evolutions, detected γ-events, and reconstructed γ images. The design emphasizes temporal fidelity and physical accuracy over spatial resolution and speed, making it uniquely suited for event-scale MRG-γ. MRGS considers MR and γ parameters, as well as phantom geometries and any MR sequence defined using PyPulseq [14] (see Table 1 for detailed MRG-γ parameters). The MR part numerically solves the Bloch equations using a fifth-order Runge-Kutta method [15, 16] with a time step ranging from 1 to 200 µs, chosen to approach the γ-event scale. The γ-emission and detection are modeled using a probabilistic approach based on Poisson-distributed decay events and voxel-wise angular probabilities defined by P(θ)=a0+a2cos(2θ), where a0 is the isotropic baseline, a2 modulates the emission anisotropy relative to the spin orientation, and θ is the angle between the spin and the detector (see Figure 1 γ-detection) [2, 3]. Detector sensitivity is incorporated through precomputed voxel-to-detector visibility maps, which account for geometric coverage and solid angles (see Figure 1 γ-reconstruction). These maps modulate the emission probability to yield physically consistent detection events.

MRGS was evaluated on 2D phantoms under multiple configurations (see last column of Table 1 for tested values). The γ-simulation reproduced expected angular distributions consistent with P(θ)=a0+a2cos(2θ), validating the physical emission model (see Figure 1 γ-emission and γ signal). It also enabled the reconstruction of MR parameters from the γ signal (see Figure 2a). Using a “border” gradient trajectory, we achieved high phase dispersion across voxels (see Figure 2b). This sequence maximized angular discrimination for γ-emission. Simulations confirmed the importance of T₁ and T₂*: shorter T₁ reduced signal amplitude over time, while shorter T₂* increased phase dispersion within voxels, degrading emission directionality and increasing uncertainty in γ-origin. We used isochromats per voxel to assess this effect [17, 18] (see Figure 2c). MLEM reconstruction yielded γ-images that qualitatively matched the underlying source distribution (see Figure 1 γ image).

MRGS enabled the design of MR sequences optimized for MRG-γ and the reconstruction of physical parameters (T₁, T₂, a₂) from simulated γ-detection. It achieved high temporal precision, allowing realistic modelling of anisotropic γ-emission. While spatial resolution is limited and full Monte Carlo simulation is avoided, this tradeoff ensures computational efficiency and physical consistency. Simulations highlight the critical impact of T₂* on localization uncertainty. Excess dephasing reduces angular precision, increasing the required number of detected events. Achieving usable SNR thus depends on longer T₁, T₂, higher polarization, or higher activity. Despite current limitations, the simulator offers valuable insights to guide future MRG-γ designs and acquisition strategies.

We presented MRGS, a dedicated MRG-γ simulation framework. By combining spin dynamics with anisotropic γ-emission modeling and image reconstruction, our simulator enables exploration of this novel modality. It supports sequence design, parameter validation, and performance estimation. This work highlights the pivotal role of simulation in the development of emerging MR techniques.
Christophe CHÊNES (Geneva, Switzerland), Pablo GALVE, Marie-Anaïs PETIT, Joaquín LOPEZ HERRAIZ
11:00 - 12:30 #47378 - PG473 MR Spectroscopy without water suppression using the Gradient Impulse Response Function.
PG473 MR Spectroscopy without water suppression using the Gradient Impulse Response Function.

Water suppression in MRS is considered essential due to artefactual sidebands on the water peak, which obscure the metabolite signals. These sidebands arise from field perturbations caused by gradient induced eddy currents in the MRI hardware. However, MRS without water suppression is desirable, as the high signal water can aid in data correction, concentration referencing, and lowering SAR load. Additionally, downfield labile peaks will remain visible without water suppression. Previous attempts[1,2] to achieve MRS without water suppression have fallen short due to hardware limitations and a lack of generalisation. In this study, the effect of system imperfections (eddy currents) are removed by accurately characterising them using the Gradient Impulse Response Function (GIRF) [3]. We implement a post-processing method using the GIRF to correct the artefactual sidebands on the water peak, achieving a generalisable method for non-water suppressed single-voxel spectroscopy (SVS) without requiring additional hardware.

SVS was performed in a 3T Siemens Prisma scanner using the vendor harmonised SEMI-LASER sequence from the CMRR spectroscopy package[4] (20 mm isotropic voxel, TE: 36 ms, bandwidth: 6000 Hz, GOIA-WURST pulses). Non-water suppressed spectra were acquired by disabling the VAPOR water suppression. Water suppressed spectra were acquired as a reference. The study was performed using a SPECTRE phantom (Gold Standard Phantoms, Sheffield, UK), with voxel locations at isocenter and 20 mm offsets; and in one healthy participant with voxel locations at isocenter and the primary motor cortex. The GIRF was measured in the same scanner following the optimised protocol established by Wu[5]. Additional 5x5 2D phase encoding[6] was used to minimise T2* decay, improving spectral resolution. The GIRF was constructed using 100 ms readouts. Both the self and B0 cross-terms of the GIRF were considered[7]; linear cross-terms were not included in this work. Figure 1a shows the magnitude of the measured ‘x’ gradient response functions. All code relating to the GIRF sequence creation (via PyPulseq[8]), processing, and calculation is available at https://github.com/jbbacon/GIRF_PE_Python. Field perturbations occurring during the SVS readout, arising from gradient-induced eddy currents were predicted (Figure 1b-d). This was achieved by: 1) Multiplying the frequency domain representation of the gradient waveforms by the GIRF to estimate the actual gradient fields during the sequence, including during the readout. 2) Time-integrating the estimated gradient fields during the readout to compute the accumulated phase error from system imperfections. The correction was performed by subtracting the accumulated phase from the measured phase of the non-water suppressed spectrum. The correction process was performed retrospectively, offline, in Python.

Figure 2 displays the spectrum measured at a 20 mm ‘x’-offset the phantom. The water peak signal remains ~1e4 times stronger than the metabolite signals, and the GIRF correction considerably reduces sidebands, yielding a spectrum comparable to that with water suppression. Similar results were found at isocenter and for offsets in the ‘y’ and ‘z’ directions. Figure 3 displays the in vivo spectra at isocenter and in the primary motor cortex. Although the correction at isocenter performs better, sideband reduction is evident in both cases. FSL_MRS[9] was used to fit the metabolite concentrations in the GIRF corrected and the water suppressed spectra from the primary motor cortex. The results are displayed in Figure 4. Outside of a larger baseline and an over prediction of the metabolite concentrations between 3.5-4 ppm, the GIRF corrected spectrum performs comparably to the water suppressed spectrum.

Our proposed method substantially reduces the impact of eddy current artefacts in non-water suppressed SVS, resulting in metabolite spectra that are comparable in quality to those obtained using water suppression. The in vivo results at isocenter suggest that the correction using the B0 cross terms of the GIRF works particularly well, whilst the reduced performance in the primary motor cortex suggest the correction using linear terms needs further correction, such as consideration of the linear cross terms This method requires no additional hardware, and is generalizable to any SVS pulse sequence. The GIRF is acquired in a one-time calibration measurement, independently of the spectra, and can be used to predict the accumulated phase errors for any sequence with known input gradients. This method may potentially be extended to achieve non-water suppressed MRSI.

This study introduces a new post-processing method for achieving non-water suppressed SVS. The method uses the GIRF to correct artefactual sidebands on the water peak by characterising the system imperfections from which they originate. This method does not require additional hardware and is generalisable to any SVS sequence.
James B BACON (Oxford, United Kingdom), Peter JEZZARD, William T CLARKE
11:00 - 12:30 #47726 - PG474 CRYO-CEST: Non-invasive imaging of cryoprotectants using chemical exchange saturation transfer.
PG474 CRYO-CEST: Non-invasive imaging of cryoprotectants using chemical exchange saturation transfer.

Cryopreservation holds promise for transplantation medicine via improved utilization and immunological matching of organs [1]. Successful organ cryopreservation and transplantation has recently been achieved in rodents, using vitrification [2-5]. Vitrification enables ice-free cryopreservation by replacing high proportions of tissue water with polar solvents (cryoprotective agents, CPA) to avoid water crystallization at cryogenic temperatures [6]. CPA introduction into organs via perfusion of the vasculature has to be precisely controlled: The minimal CPA concentration needed to vitrify must be exceeded in all parts of the organs to preclude damage from ice-formation during cooling and rewarming. At the same time, CPA toxicity correlates with increasing CPA concentration, exposure temperature, and time [7]. Therefore, techniques for precisely determining the moment of sufficient, but not excessive cryoprotectant equilibration in all parts of an organ before cryopreservation for transplantation would be of great utility. Typically employed CPAs for vitrification include ethylene glycol (EG), dimethyl sulfoxide (DMSO), and formamide (FA) [8]. While non-invasive x-ray computed tomography imaging of DMSO is possible due to the radiodensity of its sulfur atom [9, 10], FA and EG are only composed of CHON elements.

All three CPAs were analyzed individually. For this purpose, different amounts of concentrations (2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22 %w/v) were combined in 15ml phantom tubes with distilled water. Image acquisition was performed on a 7T system, by using a 3D snapshot CEST sequence with three different B1 levels (0.4, 0.6, 0.9 muT). CEST data were acquired from -4 to 4 ppm with 0.1 ppm sampling. To correct for B₀ and B₁ field inhomogeneities, WASABI [11] was employed to simultaneously obtain B₀ and relative B₁ maps. In order to calculate the MTRasym, an equidistant sampling was used for the Z-spectrum acquisition. An omega-plot [12] was calculated to determine the different concentrations in each tube retrospectively according to 1/MTRasym vs. 1/ω12. Since the slope of each line in the omega plot is inversely proportional to the concentration of the exchanging proton pool, the concentration can be directly inferred from the slope.

Figure 1 shows for FA and EG that the peaks in both the Z-spectrum and the MTRasym appear to correlate with the respective concentration. While FA has the advantage to be very sensitive with concentration changes, EG has the advantage to resonate near resonance frequency of water and thus have less contributors through the NOE, ranging from -1 to -5 ppm. However, in the case of DMSO, additional NOE appear to occur which interfere with an adequate evaluation by the MTRasym. Figure 2 shows the relative concentration using FA as an example, calculated from the slope of the omega plots at 2.6 ppm. Based on the known concentration of phantom tube 11 (22 % w/v), all other values were calculated relative to this reference concentration.

The in vitro experiment shows that CPAs can be detected by CEST imaging. Assuming that no further MT effects occur in the Z-spectrum, the relative concentration can be calculated from the MTRasym. It has been demonstrated that EG oscillates in close proximity to the resonance frequency of water. Consequently, it is less susceptible to interference from NOE factors. However, EG shows a slight drift of the amplitude in MTRasym. FA reacts even more sensitively to changes in concentration and could therefore be a promising CPA marker. Further studies on in vivo tissues such as porcine organs are planned to verify the effect by including further MT effects and performing CEST imaging before and after CPA loading.

In conclusion, cryoprotectants can be detected using CEST imaging. This seems to be a promising approach to control the amount of CPA and to test it further, for example in animal models.
Jan SCHÜRE (Nürnberg, Germany), Moritz ZAISS, Arnd DÖRFLER, Alexander GERMAN
11:00 - 12:30 #45929 - PG475 Development and Validation of an Open-Source Pulseq-Based MRE Sequence Using Experimental and Finite Element Phantom Data.
PG475 Development and Validation of an Open-Source Pulseq-Based MRE Sequence Using Experimental and Finite Element Phantom Data.

Magnetic Resonance Elastography (MRE) is a noninvasive imaging technique used to assess the mechanical properties of soft tissues by visualizing the propagation of externally induced shear waves through the tissue [1]. MRE enables the estimation of viscoelastic parameters such as stiffness, which are valuable for diagnosing and monitoring a variety of pathological conditions, including liver fibrosis[2], tumors[3], and neurodegenerative diseases [4]. The reliability of MRE depends heavily on the accuracy of both the pulse sequence used to acquire motion-sensitive images and the inversion algorithms that convert the wave image into Stiffness maps [5]. To support the development and validation of novel MRE pulse sequences and inversion techniques, phantom studies offer a controlled environment with well-characterized mechanical properties. In this work, we developed an open-source MRE pulse sequence based on the Pulseq framework. The sequence was tested experimentally on a homogeneous MRE phantom over a frequency range of 50–120 Hz using a 3T MRI scanner. In parallel, a finite element (FE) model of the phantom was created in FEBio[6] to simulate the wave propagation under identical boundary conditions and excitation frequencies. This dual experimental and simulation approach enabled a comprehensive comparison of the measured and simulated displacement fields, providing a robust framework for validating the custom Pulseq-based sequence.

A homogeneous cylindrical phantom (diameter 150 mm, height 130 mm; CIRS Inc., VA, USA) was imaged on a 3T MRI scanner using a custom MRE sequence developed with the Pulseq within MATLAB. The sequence employed a gradient-echo echo-planar imaging (GE-EPI) readout and incorporated motion-encoding gradients (MEGs) synchronized with externally applied mechanical vibrations. MEGs were applied in the through-plane (Z) direction with an amplitude of 10 mT/m. Mechanical excitation was delivered using a pneumatic active driver system (Resoundant Inc., USA) connected to a passive driver placed on the phantom’s top surface (Fig. 1). The phantom was positioned within a 32-channel head coil, and sinusoidal shear waves at 50, 60, 70, and 120 Hz were induced and synchronized with the MRE acquisition. For all frequencies, the driver amplitude was fixed at 30%. Image acquisition was performed using a single coronal slice positioned at the isocenter of the phantom. Displacement fields were encoded over a single vibration cycle to capture transient shear wave propagation, and motion-induced phase shifts were reconstructed into phase-difference maps. For finite element (FE) simulation, the phantom geometry was meshed using the GIBBON toolbox within MATLAB and imported into FEBio (Fig. 2). The phantom was modeled with a Young’s modulus of 9 kPa, Poisson’s ratio of 0.49, and density of 1000 kg/m³. To match the experimental boundary conditions, nodes on the lateral cylindrical surface were constrained in the X and Y directions, while a single-cycle sinusoidal displacement (amplitude 150 µm) was applied in the Z direction at the same four frequencies. Transient time-domain simulations were conducted.

Phase images from the experimental and simulated datasets were compared (Fig. 3) at selected time points for each frequency (50, 60, 70, and 120 Hz). Overall, there was good qualitative agreement in wavefront shape and propagation direction. At 50–70 Hz, both datasets showed coherent wave patterns with similar wavelengths. At 120 Hz, increased attenuation and shorter wavelengths were observed, with the experimental data showing more noise and edge artifacts. These results indicate reasonable alignment, though some differences were evident, particularly at higher frequencies.

The agreement between experimental and simulated phase images indicates that the Pulseq-based MRE sequence and FE simulation can capture key features of shear wave propagation in the phantom. Similar wave behavior was observed across all frequencies; however, discrepancies in amplitude and edge effects, especially at higher frequencies, suggest limitations in the current setup. These may result from unmodeled factors such as imperfect driver-phantom coupling, material property mismatches, or oversimplified boundary conditions. Overall, the results are promising but highlight the need for further refinement of both the sequence and simulation for improved accuracy.

This study demonstrates the feasibility of using an open-source Pulseq-based MRE sequence in combination with finite element simulations for phantom validation. While qualitative agreement in shear wave propagation was observed across frequencies, discrepancies in wave amplitude and boundary effects indicate that further refinement of both the sequence and simulation setup is needed. This framework provides a solid starting point, but additional work is required to improve accuracy and robustness for broader application.
Mehmet Nebi YILDIRIM (Cardiff, United Kingdom), Samuel EVANS, Daniel GALLICHAN
11:00 - 12:30 #46902 - PG476 3D golden-means PROPELLER: Towards high spatio-temporal volumetric MRI.
PG476 3D golden-means PROPELLER: Towards high spatio-temporal volumetric MRI.

PROPELLER MRI [1] is a prominent MRI acquisition technique, which samples k-space in rotating blades. Because of the repetitive acquisition of k-space center, this method enables estimation of translational and rotational in-plane motion from the oversampled region in k-space. Moreover, combined with a golden-angle sampling scheme, this leads to a high spatio-temporal resolution because of the uniform angular distribution of PROPELLER blades. There exist 3D implementations of the PROPELLER MRI scheme, e.g., 3D GRASE PROPELLER [2], which acquires a stack of PROPELLER blades (so called bricks) along the partition direction. The major drawback of these methods is that oversampling of k-space center is still restricted to the in-plane direction. Particularly, these techniques do not allow an extension of the in-plane motion correction scheme to through-plane motion correction and suffer from a low spatial resolution along the partition direction for large imaging volumes. In this work, we verify the feasibility of a 3D golden-means PROPELLER acquisition scheme, which naturally extends the original 2D PROPELLER to three dimensions and enables high-spatio temporal resolution in all directions. Particularly, we extend golden-angle 3D GRASE PROPELLER to rotate about all three physical axes and apply our method to in-vivo cranial MRI.

Following [3], we generalize the 3D golden-means radial scheme to a 3D golden-means PROPELLER sampling scheme, i.e., the azimuth and polar brick angles are derived from the eigenvalues of the Fibonacci matrix (see Figure 1). The pulse sequence is adapted from a custom 3D GRASE PROPELLER sequence implemented in gammaSTAR [4]. We generalize the phase correction scheme in [1] to compensate for non-uniform brick centers arising from eddy currents and defective gradients in all three dimensions. To this end, we extend the originally defined 2D rhomboid-shaped low-pass filter to a 3D rhomboid-shaped filter, which suppresses low-frequency phase variations in image space, i.e., centering the DC component of each brick. For reconstruction, we apply direct Fourier inversion using density compensation. Here, the forward operator is defined as the non-uniform discrete Fourier transform, which encodes the transformation from a uniformly resolved 3D imaging volume to the corresponding 3D golden-means PROPELLER k-space. Individual coil images are combined using the sum-of-squares approach. Our experiments were performed on a healthy subject (male, 27 years old) using a Siemens Magnetom Vida Fit 3T system. We chose 4 s TR and 26.9 ms TE with a brick size of 96x32x32 and an FOV of 256 mm x 256 mm x 256 mm. Slice thickness was chosen as 8 mm to achieve a uniform k-space sampling in all directions per brick. A total of 30 bricks were acquired within 2 minutes total acquisition time and the final image matrix has size 96x96x96.

Figures 2, 3, and 4 depict different reconstructed imaging slices along the sagittal, coronal and axial plane respectively.

Our results suggest that 3D golden-means PROPELLER is a feasible 3D acquisition method for high spatio-temporal imaging in cranial MRI (see Figures 2-4). The straightforward extension of the phase correction to 3D is a promising result for future extensions of other PROPELLER-related methods. In future work, specifically the PROPELLER in-plane motion correction scheme must be extended to allow motion correction along all physical axes in 3D golden-means PROPELLER to enable robust distortion-free imaging. 3D golden-means PROPELLER enables comparatively high-resolution imaging in all dimensions for large imaging volumes compared to the standard 3D GRASE PROPELLER, because in the latter the repeated refocusing leads to low signal in outer partitions. Our reconstruction algorithm is basic in the sense that the forward operator does not incorporate imperfect measurement conditions. A 3D off-resonance correction scheme must be developed to compensate for extra phase accumulation along the phase encoding directions to improve image quality. Furthermore, the oversampling of k-space center can further be exploited to severely reduce acquisition time by applying parallel imaging techniques. Lastly, our method is a promising candidate for SNR- and motion-sensitive applications such as Arterial Spin Labelling, since it can acquire a large imaging volume within a low number of shots and should be tested on other organs of interest which move substantially during acquisition, e.g., liver.

In summary, our results verify the feasibility of 3D golden-means PROPELLER in cranial MRI. It is a promising candidate for motion- and SNR-sensitive tasks which require high spatio-temporal resolution.
Tom LÜTJEN (Bremen, Germany), Jörn HUBER, Matthias GÜNTHER, Daniel HOINKISS
11:00 - 12:30 #46944 - PG477 Prospective undersampling compensation in motion-resolved abdominal PROPELLER MRI.
PG477 Prospective undersampling compensation in motion-resolved abdominal PROPELLER MRI.

Axial MRI of abdominal organs under free-breathing is a highly desirable imaging technique for patients who cannot suspend respiration. However, the patient’s respiration leads to severe motion during acquisition. A prominent motion-robust MRI acquisition technique is PROPELLER [1], which samples k-space in rotating blades. Particularly, oversampling of k-space center allows to estimate in-plane rotational and translational motion for each blade [1]. However, in axial imaging, respiration primarily induces through-plane motion, which cannot be corrected. To compensate for through-plane motion, one can resolve imaging data in an extra motion dimension, i.e., partition blades into different respiratory phases and reconstruct an image for each state separately. But this partitioning, especially considering the scarcity of shots in PROPELLER MRI, leads to severe undersampling per motion state, which cannot be sufficiently compensated for using already existing reconstruction frameworks, e.g., XD-GRASP [2]. In this work, we propose to adapt the rotation angle of each blade based on the current motion state to achieve a golden-angle sampling scheme per motion state, mitigating undersampling in motion-resolved PROPELLER MRI without relying on specialized retrospective reconstruction schemes.

The custom 3D GRASE PROPELLER [3] sequence and real-time feedback are implemented in gammaSTAR [4] and experiments were performed on a Siemens Magnetom Vida Fit 3T system. Before each blade excitation, a global fat FID navigator is used to identify the current respiratory phase. Particularly, we use the center of mass (COM) of the FID signal along the coil dimension as a surrogate for the current respiratory phase. Based on the current respiratory phase and the desired motion-resolution, we prospectively sort the next blade into the appropriate motion state. Specifically, we implement an online k-means algorithm with an experimentally determined threshold, which controls the maximal diameter of clusters (see Figure 1). A blade is sorted into a new motion state, if the desired motion-resolution is not achieved yet and the COM of its' corresponding FID lies outside of the maximal diameter of all existing motion states. Otherwise, the blade is sorted into the motion state, whose mean COM is closest to the COM of its' corresponding FID. After clustering, the next blade angle is adapted during sequence runtime to the next golden-angle with respect to the current motion state. The resulting clustered PROPELLER data is reconstructed by means of direct Fourier inversion using gridding [1] and the least squares method, i.e., XD-GRASP without regularization. Our method was verified in-vivo on a healthy subject (male, 25 years old) with a TR of 4 s and TE of 24.5 ms. The blade matrix size was 96 x 32 and 15 blades were acquired in total.

Figure 1 shows the COM of FID navigators and the corresponding clustering. Figure 2 depicts the COM of a train of FID navigators and the simultaneously acquired respiration signal detected by the systems’ Physiological Monitoring Unit (PMU). Figure 3 shows the (non-) adapted PROPELLER trajectories. Figure 4 shows different motion-resolved PROPELLER-based reconstructions.

Our work verifies the effectiveness of the proposed prospective undersampling compensation in motion-resolved PROPELLER MRI. The global fat FID navigator is a sufficient surrogate for true respiration, which does not require external hardware or a vendor-specific respiration tracking system (see Figure 2). However, in future work, the influence of preparation modules on the accuracy of the respiration estimation must be investigated. The online k-means algorithm with thresholding yields a good separation between motion states and compensates for lack of reference data during early FID acquisitions but the threshold must be refined to sharpen the separation between motion states (see Figure 1). Even low motion resolution can lead to severe undersampling in motion-resolved PROPELLER MRI, but our prospective blade angle adaptation effectively compensates for poor blade angle distribution (see Figure 3). Acquisition time can be reduced in the future by stopping the sequence automatically, when sufficient k-space coverage is achieved. Prospective undersampling compensation allows us to reconstruct motion-resolved PROPELLER data without severe undersampling artifacts (see Figure 4). However, images still suffer from residual distortions arising from imperfect binning. Our method must be tested with higher motion resolution to minimize intra-bin motion, which can be further reduced by means of the PROPELLER in-plane motion correction. Lastly, our method must be verified in motion- and SNR-sensitive applications such as free-breathing liver Arterial Spin Labelling perfusion MRI.

In summary, our proposed method compensates undersampling in motion-resolved PROPELLER MRI effectively and allows a fair spatio-temporal resolution in free-breathing abdominal MRI.
Tom LÜTJEN (Bremen, Germany), Jörn HUBER, Matthias GÜNTHER, Daniel HOINKISS
11:00 - 12:30 #47718 - PG478 Comparison between diffusion-tensor and diffusion-weighted images along perivascular spaces index and influence of ROI size.
PG478 Comparison between diffusion-tensor and diffusion-weighted images along perivascular spaces index and influence of ROI size.

The glymphatic system (GS)[1,2] hypothesis aims to explain the waste clearance mechanism in the brain, which could be noninvasively evaluated using diffusion-tensor imaging (DTI) along perivascular spaces (ALPS) index[3]. A low index may suggest impaired GS function, as observed in neurodegenerative diseases[4]. Diffusion-weighted imaging (DWI) ALPS index could also be calculated when planning the imaging plane following the anterior commissure to posterior commissure line[5]. DWI is easier, faster, and more widely used in clinical routine than DTI, and it has shown its potential in the indirect evaluation of the GS in healthy volunteers[5] and for whole-brain radiotherapy[6]. Here, we assess how variations in the size of the region of interest (ROI) affect ALPS index calculation in DTI and DWI ALPS index.

Thirteen healthy volunteers (8 women; aged 22.8 ± 1.4 years) provided written consent before the examination. The study was approved by the local ethical commission. We used a 3T MRI scanner (MAGNETOM Vida, Siemens Healthineers, Germany), with the following parameters for DTI and DWI: TE/TR = 92/4400 ms; FOV = 200 x 200 mm^2; voxel size = 2 x 2 x 2 mm^3; and b-values = 0 and 1000 s/mm^2. For DTI, 64 directions were used, and for DWI three orthogonal directions in the readout, phase-encoding, and slice-selection direction, with a total duration of 5:30 and 1:30 min for DTI and DWI, respectively. The DTI ALPS index is calculated by using a ratio between diagonal elements of the diffusion tensor matrix (Dxx, Dyy, and Dzz) in two ROIs on the projection (proj) and association (assoc) fibers in the area of the periventricular veins as: mean(DxxProj,DxxAssoc)/mean(DyyProj,DzzAssoc)[3]. For DWI, the diffusivities along the x-, y-, and z axes were obtained directly from the scan and the ALPS index was calculated using the same formula[5]. The DTI and DWI were analyzed using DSI Studio[7] and ImageJ[8], respectively. For DTI ALPS, the ROIs (single voxel and 4-voxel isotropic) were positioned on a single slice according to a color-coded fractional anisotropy map by referring to susceptibility-weighted images. For DWI ALPS, In ImageJ, an image composite was generated with three channels: red, green, and blue for diffusivity along x-, y- and z- directions[5]. Statistical analysis was performed using Matlab R2022a (The MathWorks, Natick, MA) with α = 0.05. We investigated interhemispheric differences in the DTI and DWI ALPS indices and between 2 ROIs (Wilcoxon signed-rank). Intraclass correlation coefficient (ICC) was used to study the inter-method agreement and Bland-Altman plots to analyze the differences between methods and ROI configurations.

No interhemispheric differences in DTI and DWI ALPS were found for 1- and 4-voxel ROI (p >> 0.05). Additionally, we did not observe any significant differences between DTI and DWI for both ROI sizes (p >> 0.05). However, inter-method agreement for 1-voxel ROI was poor (ICC = 0.3). The 4-voxel ROI showed moderate agreement between methods (ICC = 0.52). Bland-Altman plots (Fig. 2) suggest that while there is low bias between techniques, some variability does exist.

We did not find significant interhemispheric differences in DTI and DWI and ROIs in healthy volunteers. However, larger ROIs should be preferred as they can cancel out the spatial inhomogeneities in the brain parenchyma[5,9]. Contrary to Taoka et al.[5], we did not find significant inter-method differences, and only poor-to-moderate inter-method reliability. The fact that we did not average the two hemispheric indices, which provided a higher ICC than a unilateral calculation[5], might explain this finding. The interhemispheric ALPS index average could be appropriate for research performed on healthy volunteers. However, several studies[10–12] have reported interhemispheric differences in the ALPS index. Therefore, when the area of the periventricular veins is intact, it is better to analyze the two hemispheres separately and to report possible asymmetries. Additionally, inter-method variability should be considered in clinical or research settings to ensure consistent and reliable measurements

Our findings highlight the importance of standardizing ROI configurations, thereby improving the reliability of DTI and DWI measurements. If researchers need to compare their findings with other published results, then it is better to use a 4-voxel ROI, which shows the best agreement between methods. Although recent developments have called the validity of the ALPS index into question, indicating that it should not be directly related to GS function, it might still represent a potential biomarker for diffusion in the perivascular space[13]. Indeed, various methods should be used in combination to study GS function.
Janina KREMER (Lübeck, Germany), Justus Christian RUDOLF, Aileen SCHMIDT, Peter SCHRAMM, Patricia ULLOA
11:00 - 12:30 #47832 - PG479 Comparison of deep learning predicted and universal pTx pulses for a 3D turbo spin echo sequence at 7T.
PG479 Comparison of deep learning predicted and universal pTx pulses for a 3D turbo spin echo sequence at 7T.

To counteract the problem of B1+ inhomogeneities arising at higher magnetic field strengths such as 7T, the concept of parallel transmission (pTx) was introduced. However, pTx pulses come with increased SAR exposure and require time-consuming calculation. To address the latter, pre-computed universal pTx pulses (UPs) [1] have been proposed to improve the excitation homogeneity in the human head without requiring online calibration. In order to enable tailored pTx pulse design in clinical routines at 7T, optimization times must be further reduced. Recently, deep learning (DL) approaches have been shown to be feasible for 2D single-slice excitations and either dynamic one-channel RF pulse design [2] or static pTx [3], providing negligible calculation time. To extend the potential of DL to multi-channel, dynamic pulse design, this study aims to investigate the use of a supervised trained neural network (NN) for scalable 3D dynamic pTx pulses for a turbo spin echo sequence. The resulting predicted pTx pulses are compared to UPs, representing the current state of the art without requiring additional calibration time.

A convolutional NN was trained using pre-acquired B1+ and B0 maps of the human brain to predict optimized RF and gradient waveforms. A total of 132 B1+ and B0 maps [4] were acquired with an 8Tx/32Rx head coil (Nova Medical, Wilmington, USA) at 7T (Magnetom Terra, Siemens Healthineers AG, Erlangen, Germany) and augmented retrospectively using affine transformations and elastic deformations [5], resulting in a total input library size of 5500. Corresponding target pulses, pulsestarget (Tpulse = 1.2ms, α = 10°), were optimized using a vendor-provided MATLAB toolbox with an interior-point based optimization algorithm [6]. The DL workflow is schematically illustrated in Figure 1. The NN was trained to minimize the mean squared error (MSE) between the predicted pulses ("pulsesDL ") and the corresponding pulsestarget. Subsequently, the model was used to predict pulses for 72 unseen test datasets. For comparison, two UPs (UPlowSAR designed to initialize individual pulse calculation and UPhighSAR designed for direct application without further calibration) were evaluated on the same test datasets. All pulses were designed using symmetric RF and anti-symmetric gradient shapes for scalability. For validation, an in vivo measurement of an unseen subject was performed. 3D T2-weighted SPACE images were acquired with the circularly polarized (CP) mode, DL predicted pulse and both UPs, each applied as both excitation and refocusing pulse (Δx3=0.4×0.4×0.5mm3, TE=299ms, TR=8000ms, TA=5:54min).

Figure 2 compares the performance of the DL predicted pulses with the CP mode and the UPs evaluated for the 72 unseen data sets. The boxplots illustrate that the CP shim yields the highest median coefficient of variation (CV) with 25.9%. UPlowSAR reduces the median CV to 15.0%, while the pulsesDL further improve it to 14.1%. UPhighSAR achieves the lowest median CV of 12.1%. However, this comes at the cost of a higher specific energy dose (SED) of 9.1 mJ/kg, which is over 40% more than the median SED value of the pulsesDL (6.4 mJ/kg). UPlowSAR yields a SED value of 4.9 mJ/kg. Figure 3 shows the 3D T2-weighted SPACE images of a DL-wise “unseen” volunteer to validate the performance of the aforementioned pulses. While the CP mode and UPlowSAR fail to produce a uniform signal distribution across the whole brain, the pulsesDL and UPhighSAR accomplish a homogenous excitation without visible signal voids.

While UPhighSAR slightly outperforms the DL-predicted pulses with a reduced median CV, it requires substantially more RF energy. In contrast, using an UP with reduced SED shows unacceptable performance compared to the pulsesDL in both simulation and measurement. With an average prediction time of a few milliseconds, DL-predicted pulses offer a fast solution for subject-specific pTx pulse design at 7T and can be beneficial in cases with anatomical anomalies. Nonetheless, there is room for improvement in terms of excitation uniformity. One reason for that might be insufficient generalization of the NN. Therefore, future work will focus on expanding the training dataset library and the implementation of a physics-informed loss function based on Bloch simulations [7]. In addition, combining the DL approach with a regular optimization for enhanced performance as in the FOCUS method [4] is conceivable, too.

This study demonstrates the feasibility of using a DL approach for dynamic pTx pulse design, showing that DL-predicted pulses achieve comparable performance to state-of-the-art UPs. The results were verified both in simulation and in vivo measurement at 7T.
Sophia NAGELSTRAßER (Erlangen, Germany), Jürgen HERRLER, Mads Sloth VINDING, Nico EGGER, Patrick LIEBIG, Michael UDER, Moritz ZAISS, Armin NAGEL
11:00 - 12:30 #47608 - PG480 MRI-guided laser interstitial thermal therapy thalamotomy for patients with pharmacoresistant tremor: a single-center MR Imaging and MR Spectroscopy follow-up.
PG480 MRI-guided laser interstitial thermal therapy thalamotomy for patients with pharmacoresistant tremor: a single-center MR Imaging and MR Spectroscopy follow-up.

Pharmacoresistant tremors can significantly impair functional abilities. Thalamotomy using Laser Interstitial Thermal Therapy (LITT), guided and monitored by Magnetic Resonance Imaging (MRI), is among the recent therapeutic alternatives designed to enhance the quality of life for these patients [1-2]. Although practiced in the USA and Europe since 2019, there are currently no published studies examining spectroscopic and metabolic changes following LITT thalamotomy. Therefore, the primary objective of this study was to combine MRI and proton Magnetic Resonance Spectroscopy (MRS) to monitor morphological, spectroscopic, and metabolic characteristics within the treated ventral intermediate nucleus (VIM) region of the thalamus following LITT thalamotomy.

A total of 29 patients treated with LITT at the University Hospital of Amiens (from March 2019 to date) were prospectively followed. Imaging and spectroscopic data were acquired preoperatively, immediately postoperatively, at postoperative days 2–7, at 6 months, 12 months, and beyond 12 months for some patients. MRI data included T1-weighted, T2 FLAIR, T2*, diffusion-weighted imaging, perfusion imaging, and 3D T1-weighted sequences. Proton single Voxel Magnetic Resonance Spectroscopy (MRS) was performed using a Point RESolved Spectroscopy (PRESS) sequence at three echo times (TE: 35 ms, 144 ms, and 288 ms). MRI analyses included volumetric quantification of T2-FLAIR hyperintensities and diffusion-weighted hyperintensities within the VIM region. MRS spectra were analyzed using LCModel software to quantify metabolite ratios, specifically Choline (Cho), N-Acetyl-Aspartate (NAA), Myo-Inositol (mI), Glutamine-Glutamate complex (Glx), lactate, and CH2 and CH3 phospholipids, normalized relative to Creatine (Cr).

MRI analysis (Figure 1.C) revealed the presence of small hyperintense volumes immediately postoperatively on T2-FLAIR (mean: 0.104 ± 0.062 cm³) and diffusion-weighted sequences (mean: 0.225 ± 0.118 cm³). These hyperintensities increased in 100% of patients at postoperative days 2 to 7 on both T2-FLAIR (mean: 3.302 ± 1.712 cm³) and diffusion-weighted imaging (mean: 1.455 ± 0.806 cm³). Subsequently, these hyperintense regions markedly decreased by approximately 98% at the 6- to 12-month follow-up period on T2-FLAIR (mean at 6 months: 0.061 ± 0.042 cm³; mean at 12 months: 0.026 ± 0.029 cm³) and diffusion-weighted images (mean at 6 months: 0.020 ± 0.036 cm³; mean at 12 months: 0.016 ± 0.032 cm³). MRS results demonstrated spectroscopic and metabolic changes based on metabolite ratio calculations [Creatine (Cr), N-acetyl-aspartate (NAA), Choline (Cho), Myo-inositol (mI), and Lactate (Lac)]. Specifically, the mI/Cr ratio was increased in 100% of patients immediately postoperatively and subsequently decreased by 12 months. The Lac/Cr ratio was elevated in 85% of patients either immediately postoperatively or at postoperative days 2–7, and although it subsequently decreased, a residual lactate signal persisted long-term in 71% of patients (Figure 1.D).

The present results provide a comprehensive overview of the MRI-based morphological and spectroscopic-metabolic evolution within the VIM thalamic region treated by LITT. These findings demonstrate an initial marked fluctuation in imaging and metabolic biomarkers, followed by progressive stabilization over the long term after short-duration and low-intensity LITT thalamotomy. The combined MRI-MRS approach presented here appears more promising than conventional MRI alone for refining the procedural planning, monitoring, analysis, and clinical interpretation of this innovative minimally invasive neurosurgical technique.

To our knowledge, this study is the first to offer detailed insights into the morphological and metabolic dynamics of the VIM region following LITT, providing crucial data for evaluating the efficacy and impact of this minimally invasive neurosurgical approach. Future studies, involving larger patient cohorts and longer-term follow-ups, are necessary to validate these findings. Additional research exploring the functional impact of LITT thalamotomy on distant motor regions will also be conducted.
Salem BOUSSIDA, David LAYANI, Mickael AUBIGNAT, Aurélien LAMBERT, Adrien PANERO, Romain DRAILY, Amandine OSAER, Simon BERNARD, Melissa TIR, Michel LEFRANC, Jean-Marc CONSTANS (AMIENS)
11:00 - 12:30 #47614 - PG481 MR Spectroscopy evidence of brain alterations in Long Covid patients with persistent neurological complications.
PG481 MR Spectroscopy evidence of brain alterations in Long Covid patients with persistent neurological complications.

A considerable number of COVID-19 patients exhibit persistent neurological symptoms, such as anosmia, ageusia, fatigue, impaired attention and concentration, language disturbances, and reduced working memory. However, the underlying pathogenesis remains incompletely understood, particularly concerning brain metabolic alterations associated with these persistent neurological complications. To investigate this, combined proton Magnetic Resonance Spectroscopy (MRS) and Magnetic Resonance Imaging (MRI) data were obtained from a cohort of patients with Long COVID and compared with healthy controls, focusing on identifying potential spectroscopic and metabolic abnormalities linked to COVID-19 persistent neurological disorders [1].

Proton Magnetic Resonance Spectroscopy (MRS) and Magnetic Resonance Imaging (MRI) data were acquired from 20 patients diagnosed with Long COVID and compared with 5 healthy control subjects. MRI acquisitions consisted of 3D T1-weighted spin-echo sequences with and without gadolinium contrast enhancement, gradient-echo T2* (or SWI), diffusion-weighted imaging (DWI), T2-Fluid Attenuated Inversion Recovery (T2-FLAIR), coronal T2-weighted imaging, and Time-of-Flight Magnetic Resonance Angiography (TOF-MRA). Single voxel MRS was performed using the Point RESolved Spectroscopy (PRESS) sequence with three different echo times (TE: 35 ms, 144 ms, and 288 ms). Spectroscopic measurements were performed on three brain regions: medial frontal cortex, hippocampus, and pons. MRS spectra were analyzed using LCModel software to quantify metabolite ratios, including Choline (Cho), N-Acetyl-Aspartate (NAA), Myo-Inositol (mI), Glutamine-Glutamate complex (Glx), lactate, and CH2 and CH3 phospholipids, relative to Creatine (Cr).

This study demonstrates the potential of proton MRS to detect spectroscopic and metabolic brain abnormalities in patients experiencing persistent neurological symptoms following COVID-19 infection. Compared to conventional MRI, MRS exhibited greater sensitivity in identifying and delineating COVID-19-associated cerebral alterations. Significant spectroscopic abnormalities were observed in Long COVID patients compared to healthy controls, varying according to brain region. These abnormalities suggest the involvement of multiple pathophysiological processes, including: (1) neuroinflammation (Figure 1), (2) glutamatergic dysfunction, (3) energy metabolism dysfunction, and (4) early neuronal dysfunction.

The findings of this study provide evidence of spectroscopic, tissue-specific, and metabolic brain abnormalities that are measurable by Magnetic Resonance Spectroscopy (MRS) but not detectable on conventional MRI alone. These abnormalities indicate that SARS-CoV-2 infection can cause persistent metabolic alterations in specific brain regions, lasting several months after the acute phase of COVID-19. These data enhance our understanding of the complex pathophysiological mechanisms underlying persistent neurological symptoms observed in patients with Long COVID [2].

This study demonstrates that SARS-CoV-2 infection is associated with long-term cerebral metabolic disturbances that persist beyond the acute COVID-19 phase and are detectable and quantifiable by MRS, though undetectable by conventional MRI. These findings emphasize the clinical relevance and potential utility of incorporating MRS into routine clinical assessments and follow-up care for COVID-19 patients presenting persistent neurological symptoms.
Salem BOUSSIDA, Antoine GALMICHE, Yousef EL SAMAD, Amine ZEMANI, Nicolas DELEVAL, Julien MAIZEL, Serge METANBOU, Daniela ANDRIUTA, Olivier GODEFROY, Valery SALLE, Ahed ZEDAN, Catherine LE BRAS, Claire ANDREJAK, Jean-Marc CONSTANS (AMIENS)
11:00 - 12:30 #47846 - PG482 Fat/Water Spectroscopic Imaging for Improved Detection of Cribriform Prostate Cancer.
PG482 Fat/Water Spectroscopic Imaging for Improved Detection of Cribriform Prostate Cancer.

Cribriform prostate cancer is an aggressive subtype associated with higher risks of tumour metastasis, recurrence post-treatment and disease-specific mortality[1]. Identifying these highly heterogeneous tumours with sufficient sensitivity is challenging using established clinical diagnostic methods such as multiparametric MRI-targeted biopsy[2,3]. Fatty acid biosynthesis has been proposed as an important metabolic pathway for distinguishing cribriform lesions from other subtypes. However, invasive measurement of these fatty acids is impractical as tumours are typically small and difficult to identify using MRI. We assessed the potential for 2D 1H magnetic resonance spectroscopic imaging (1H-MRSI) to non-invasively differentiate cribriform from non-cribriform tumours in vivo. It is hoped that earlier and more reliable detection of cribriform prostate cancer may aid in identifying appropriate treatment and improve clinical outcomes for patients[4,5].

12 patients underwent prostate MRI (3 T Premier, GE HealthCare, Waukesha WI) using the in-built 60-channel posterior spine coil and a 30-channel anterior flexible array coil (GE HealthCare). Written informed consent was obtained from all patients as part of a prospective study approved by NRES East of England, Cambridge South (16/EE/0346). Tumour localisation was achieved with a high resolution axial T2-weighted sequence over the prostate (FOV 18 cm) and diffusion-weighted imaging (FOV 28 cm, b = 1400/750/100 s/mm^2). Fat/water content was assessed with 2D axial MRSI through the tumour (Hamming-filtered density weighted trajectory over 3231 points of k-space, FOV 32 cm, matrix 64x64 interpolated to 128x128, 30° flip, TR 88.7 ms, TE 2.1 ms, 5 kHz full-receiver bandwidth). Images were co-registered to the high-resolution axial T2 series. The fat fraction of the total signal was calculated from MRSI by integrating baseline-corrected magnitude spectra using Matlab R2024b (Mathworks, Natick MA) between 3.0 – 6.1 ppm (water) and -0.2 – 2.9 ppm (fat). ROIs were drawn on axial T2-weighted images by a radiologist with 13 years of experience in clinical prostate MRI reporting. Statistical significance was assessed by comparing: 1) the ratio of tissue ADC values to that of urine and 2) fat fraction measurements between cribriform lesions, non-cribriform lesions and contralateral healthy prostate tissue using a Mann-Whitney U test.

Single axial slices from T2- and diffusion-weighted imaging series in a single patient are shown in Figure 1A-B, highlighting a left-sided peripheral zone tumour at the mid-point of the prostate. Lesions presented with low signal on T2-weighted images and high signal in diffusion-weighted images, both due to higher cellularity. Example images showing fat fraction of total signal from 2D MRSI within the prostate are shown in Figure 1C-D, with regions of adipose, muscle, healthy prostate and tumour highlighted for reference. Corresponding fat and water spectra from these regions are shown in Figure 1E-H. The relative ADC value from diffusion-weighted imaging and the mean fat fraction as determined from 2D MRSI for cribriform and non-cribriform lesions and healthy prostate tissue across the patient cohort are shown in Figure 2.

Fat and water peaks were clearly distinguishable in 2D MRSI magnitude spectra, with an elevated fat signal observed in cribriform lesions relative to non-cribriform disease. Reliable characterisation of cribriform lesions from other tissue types was possible (p < 0.05). No statistically significant difference was observed between non-cribriform lesions and healthy tissue using MRSI, and diffusion-weighted imaging was unable to reliably distinguish cribriform and non-cribriform lesions. These results broadly agree with a recent study correlating prostate cancer risk with fat fraction derived from a multi-echo imaging method[6]. The high spatial resolution of 2D MRSI employed in this work necessitated a comparatively long scan duration of 4:47 min for a single slice. However, the combination of high-resolution T2- and diffusion-weighted imaging facilitated reliable tumour slice identification, reducing the need to cover the entire prostate prospectively using MRSI. An increase in scan duration of approximately 5 minutes was considered clinically tolerable, suggesting that the incorporation of fat/water spectroscopic imaging into clinical protocol for active surveillance is feasible. Quantitative comparison of 2D MRSI with established fat/water imaging methods in the prostate in future patients may be of interest.

We have demonstrated the feasibility of using elevated fat fraction as a non-invasive biomarker for cribriform prostate cancer with MRSI. Multi-centre validation of this approach may facilitate integration into routine clinical practice to improve the reliability of cribriform prostate cancer detection and associated clinical outcomes.
Jonathan BIRCHALL (Cambridge, United Kingdom), Nikita SUSHENTSEV, Mary MCLEAN, Anne WARREN, Tristan BARRETT, Ferdia GALLAGHER
11:00 - 12:30 #45947 - PG483 Normalization-free Quantitative Analysis of Xe-129 HyperCEST Image Series.
PG483 Normalization-free Quantitative Analysis of Xe-129 HyperCEST Image Series.

The combination of hyperpolarized Xe-129 and chemical exchange saturation transfer as HyperCEST MRI offers unprecedented sensitivity to detect molecular targets with xenon biosensors at nanomolar concentrations.[1] Despite the 10000-fold higher spin polarization of Xe-129 after spin exchange optical pumping (SEOP), the signal-to-noise ratio (SNR) of dissolved Xe is still low compared to proton MRI of aqueous samples because of a low spin density ([Xe-129] < 100 µM) in most experimental settings. Moreover, the non-self-renewing character of hyperpolarized magnetization requires re-delivery of fresh Xe for each data point in a z-spectrum that is derived from HyperCEST MR image series. This imposes challenges because the quantitative evaluation usually requires a defined and stable baseline for normalization. SEOP setups may deliver a variable starting magnetization from shot to shot, particularly during warm-up, that is not immediately seen in the MRI scans. Here, we present a method that circumvents normalization and delivers reliable quantitative information even for rather unstable baselines.

Experiments were performed at 9.4 T on a Bruker Avance III HD console, using a gas mixture of 5% natural abundance Xenon, 10% N2 and 85% He dispersed into a concentric two-compartment phantom at an operating pressure of 4.5 bar (abs.). MDA-MB-231 cells were labelled with cryptophane cages that were functionalized with a peptide sequence for addressing the LHRH receptor and served as targeted HyperCEST agent for reversibly bound Xe. The phantom’s inner compartment (IC) contained 300 µL with 500'000 labelled cells/mL, the outer compartment (OC) served as a control with 500 µL of unlabeled cell suspension (same cell density). The Xe gas mixture exists the SEOP setup with a continuous flow of 300 mL/min and was dispersed into the phantom for 15 s prior to a 5 s wait period and subsequent HyperCEST acquisition with a RARE sequence. The saturation offset was incremented stepwise to cover the range of the expected HyperCEST response. Signals for z-spectra were obtained by evaluating ROIs with the scanner's image sequence analysis tool. The signal baseline is particularly unstable at the beginning of SEOP operation (Fig. 1). However, the reference signal from the OC can be approximated by a polynomial behavior that is fed into the fitting of the HyperCEST response in the IC with the full HyperCEST (FHC) model.[2,3] Fit results were compared to another z-spectrum that was taken later with a stable baseline (Fig. 2).

The signal of ROIs from the two compartments exhibits a standard deviation (SD) of ca. 20%. However, changes outside the HyperCEST response are strongly correlated between both compartments. The OC reference signal can be approximated by a 3rd or 5th order polynomial (P3/P5). Using P5 with a scaling factor as the baseline for the IC signal yields fit results that are extremely consistent with a data set that exposes only a weak linear change in the baseline (Fig. 2). In particular, depolarization rates and line widths are in perfect agreement between these measurements and the HyperCEST intensity is highly consistent for different saturation times.

The polynomial approximation of the baseline should be done carefully and may not be used outside the acquired data range. Nevertheless, P5 for the reference signal is a suitable input to approximate the baseline in the target volume and achieve a HyperCEST quantification with a standard deviation that is ca. 10-fold smaller than the SD of the ROI signals. The correlated signal change throughout the z-spectrum would thus allow to identify HyperCEST responses as small as ca. 2-3%.

Distorted baselines are not necessarily a limitation for reliable quantification of HyperCEST data. Given the availability of a reference ROI, this approach should be valuable for future biomedical applications with low SNR where a reference signal can be used as input to compensate for variable baselines. It also allows to quantify less ideal datasets that were previously discarded due to inappropriate normalization.
Leif SCHRÖDER (Heidelberg, Germany), Jabadurai JAYAPAUL
11:00 - 12:30 #47721 - PG484 Fast Mapping of Intramyocellular Lipids Using Spiral MRSI and novel Apparent IntraMyocellular Lipids Content Indicator (AIMLI): Development, validation and Application for Longitudinal Metabolic Monitoring.
PG484 Fast Mapping of Intramyocellular Lipids Using Spiral MRSI and novel Apparent IntraMyocellular Lipids Content Indicator (AIMLI): Development, validation and Application for Longitudinal Metabolic Monitoring.

The quantification of intramyocellular lipids (IMCL) is of major interest in metabolic studies. Still, it remains constrained by long acquisition times, complex post-processing, and a lack of spatial resolution when using conventional spectroscopy [1], [2], [3]. This study introduces a rapid and straightforward method using proton spiral MRSI and a novel Apparent IntraMyocellular Lipid Indicator (AIMLI) to effectively map lipid distributions in muscle tissue. AIMLI was evaluated through numerical simulations accounting for susceptibility effects, validated in healthy volunteers against standard quantification techniques [4], and applied in a longitudinal study to monitor metabolic changes due to prolonged fasting.

Spiral MRSI data were acquired using a 3T clinical scanner (MAGNETOM Prisma, Siemens Healthineers) using a custom sequence with spatially selective excitation followed by a spiral readout gradient (FOV=200×200×25mm³, spatial resolution=64×64, voxel size=3.1×3.1×25mm³, TR/TE=2000/2ms, 1024 points, temporal resolution=500ms, spatial/temporal interleaving=22/5). Total acquisition time was 3min48s per slice. A 1H/31P transmit/receive surface coil (Rapid Biomedical) was positioned under the calf muscle of healthy volunteers. Post-processing involved regridding to a Cartesian grid with 2× oversampling, Hamming apodization, and inverse 2D Fourier transform. Given the considerable spatial variations in phase and frequency, we put in place a robust spectral correction method, following the approach of Le Fur et al. [5], that utilized the strong water peak for phase alignment and frequency registration. The AIMLI was calculated from the cumulative amplitude curves of the modulus spectrum in the lipid region (1.1–1.7 ppm). Three chemical shift values (1.23, 1.31, 1.38 ppm) were used to generate maps reflecting apparent IMCL and EMCL contributions. These maps were used to assess repeatability, spatial distribution, and inter-subject variability. Full quantitative validation was performed in selected voxels using LCModel analysis [6] (figure 1). We applied AIMLI for the monitoring of changes along a nutritional intervention [7] on 21 subjects, with MRSI scans acquired at baseline (D–1), post-fasting (D+12), and follow-up (D+30). Reference IMCL quantification was also performed using SVS-STEAM (TR/TE/TM = 3000/10/10 ms) and LCModel analysis [8]. Spatially averaged AIMLI values were extracted over muscle ROIs and compared across time points using non-parametric Friedman tests, with Wilcoxon signed-rank tests and Bonferroni correction for post-hoc analysis.

Group-level AIMLI values demonstrated significant differences across the three time points (p<0.05). Post-hoc comparisons revealed a significant increase in mean AIMLI after fasting (D+12), followed by a return to baseline at D+30. These trends were consistent with those observed with SVS-LCModel data [8], supporting the physiological relevance of AIMLI (table 1 and figure 2). The AIMLI maps of two individual cases of special interest are presented in figure 3. In the first subject, AIMLI increased post-fasting and returned to baseline later, with spatial heterogeneity across different muscle heads (e.g., soleus, gastrocnemius). In a the second case with fat infiltration (incidental discovery in ours volunteers confirmed by Dixon imaging), AIMLI decreased progressively from D–1 to D+30. Notably, AIMLI revealed focal lipid changes in the medial soleus region that were not detected by fat fraction maps, likely due to Dixon’s sensitivity to EMCL over IMCL.

Our findings demonstrate that AIMLI derived from spiral MRSI enables fast and reproducible mapping of apparent IMCL content with high spatial resolution. The modulus-based frequency registration ensures robust automated post-processing, reducing user intervention. Compared to SVS, AIMLI provides complementary spatial insights (modified ICML/(EMCL+IMCL) ratio of crucial interest at constant PDFF) and is more sensitive to subtle regional metabolic shifts. These advantages make it particularly suitable for longitudinal or interventional metabolic studies, and for detecting localized pathological alterations.

The proposed ALCI method offers a fast, spatially resolved, and semi-quantitative alternative to traditional MRSI quantification approaches. Its clinical feasibility, low acquisition time, and resilience to spectral distortions position it a promising tool for metabolic imaging and follow-up in diverse physiological and pathological contexts.
Antoine NAËGEL, Antoine NAËGEL (Lille), Magalie VIALLON, Benjamin LEPORQ, Kevin MOULIN, Pierre CROISILLE, Hélène RATINEY
11:00 - 12:30 #47714 - PG485 Mapping of mobile macromolecules using metabolite-nulled sLASER with adiabatic water suppression and inversion and correlation with Macromolecular Proton Fraction: a 3T feasibility study.
PG485 Mapping of mobile macromolecules using metabolite-nulled sLASER with adiabatic water suppression and inversion and correlation with Macromolecular Proton Fraction: a 3T feasibility study.

Metabolite-nulled proton magnetic resonance spectroscopy (¹H MRS) reveals broad signals from mobile macromolecules (MM). While their exact molecular sources remain unknown, these signals show regional variation and are altered in pathology such as brain tumors (BT), and their growth disrupt the myelin structure [1]. Myelin breakdown products may become mobile and contribute to the MM spectrum. Another potential quantitative marker of myelin disruption could be the magnetization-transfer based macromolecular proton fraction (MPF) method [2], MPF shows a strong association with local myelin density in various neurological conditions [3]. Combining MM profiling from MRS with myelin mapping may provide complementary information, improve the characterization of BT-related damage, and allow for a better delineation of BT margins, which could improve treatment planning. This study is taking a step back from ultra-high-field MRSI applications for mapping brain MMs [4] and moving towards a potential clinical application at 3T. Its aim is to create a robust protocol to measure BT-associated demyelination by exploring correlations between MM signal intensities and myelin content quantified via MPF.

Data were acquired from two healthy volunteers using a 3T MRI (MR7700, Philips, The Netherlands) with a 16-channel head coil. The protocol included 3D T1w, 2D T2w and 3D FLAIR (12 min). For both single voxel (SV) and MRSI acquisitions, the sLASER sequence was applied, with an adiabatic inversion prepulse (hypsec, 750°, 7 ms, center at 2.5 ppm) introduced prior to VAPOR water suppression (WS). Due to low T1 of the MM, reducing TR improves the SNR of MM [3]. A minimum TR = 1.4 s was achieved by shortening WS delays and pulse durations by ~30%, yielding 145 Hz WS bandwidth and 520 ms WS duration. The sLASER parameters were TE = 31 ms, bandwidth = 2000 Hz, 1024 points. Assuming a metabolite T1 of 1.4 s [5], the inversion time (TI) was pre-estimated as 530 ms. For the first volunteer, single-voxel MRS in the posterior cingular cortex (PCC) with VOI = 45×25×25 mm³, was acquired to determine the optimal TI, checking TI = 520, 530, and 540 ms (NSA = 192, 4.5 min each). Except for -Ch2 of Creatine, no metabolites were visible at 530 ms (Figure 1A). For the second volunteer, 2D MRSI was acquired at the PCC level using TI = 530 ms (NSA = 4, SENSE = 1.5×1.5, FOV = 240×240 mm², matrix size = 15x15, slice thickness = 20 mm, scan time = 12 min). The reconstructed voxel size was 7.5×7.5×20 mm³. MPF mapping [2] was acquired alongside MRSI with an EPI sequence (FOV = 230×230×182 mm³, voxel size = 0.7 mm³). MT settings: TR = 45 ms, TE = 4.6 ms, FA = 8°, MT offset = 1200 Hz, scan time = 3 min. Variable FA: TR = 20 ms, TE = 4.6 ms, FA = 20° and 4° (3 min). Surrogate B₁ mapping [6] was applied. MRS(I) data were processed in jMRUI using AMARES, with Lorentzian peaks and prior knowledge adapted from [7]. MPF maps were generated using an open-access tool [8]. MPF values for each voxel were obtained with an in-house MATLAB code. MM amplitudes were then correlated with MPF values in the corresponding voxels.

The metabolite-nulled SV spectrum from volunteer 1 is shown in Figure 1A. The AMARES fit demonstrates good fitting quality with low residual. Spectral fitting of an MRSI voxel from volunteer 2 is shown in Figure 1B. The MM and MPF maps obtained from Volunteer 2 are presented in Figure 2, illustrating spatial variations in MM signal intensities across the brain. Notably, regions with high MPF values (bright areas) correspond to low MM signal intensities (green and blue areas). Negative MM–MPF correlations were observed (examples in figure 3).

In this pilot study, we demonstrate that the sLASER sequence, combined with both an adiabatic inversion prepulse and water suppression, is a method feasible for acquiring metabolite-nulled spectra and for mapping individual macromolecular (MM) components. At 3T, a spatial resolution suitable for tumor studies can be obtained within 12 min. The spatial patterns observed in our data, such as elevated MM signals in grey matter, are consistent with previous ultra-high-field findings. Although myelin is composed of lipids and specific proteins, these components are largely structurally bound and thus not highly mobile under physiological conditions [9]. The negative correlations between MM signal intensities and MPF values support this interpretation. The proposed acquisition protocol offers a unique opportunity to correlate the myelin breakdown measured by MPF with the increase in breakdown products measured by MM-MRSI in tumors. Further investigation will show whether the increased specificity will improve the diagnostic value of MPF in tumor tissue.

Our findings support the feasibility of MM mapping using sLASER at 3T and open the opportunity to explore its role in tumor-related myelin disruption.
Andrei MANZHURTSEV (Frankfurt/Main, Germany), Nouha TEGHLET, Seyma ALCICEK, Dennis C. THOMAS, Ulrich PILATUS, Vasily L. YARNYKH, Elke HATTINGEN, Katharina J. WENGER
11:00 - 12:30 #47858 - PG486 Feasibility of the Detection of Human Hepatocellular Content of Lipids using Deuterium Metabolic Imaging.
PG486 Feasibility of the Detection of Human Hepatocellular Content of Lipids using Deuterium Metabolic Imaging.

To study hepatic disorders, assessment of hepatocellular content of lipids (HCL) using well-established single voxel ¹H-MRS [1] is of high interest. ²H(deuterium)-MR spectra contain analogous metabolic information but exhibit a relatively low natural abundance of ²H (0.012%), which potentially hampers the detection of HCL using deuterium metabolic imaging (DMI) [2]. Despite that, DMI offers good MR sensitivity due to short T1 relaxation times, and is less susceptible to magnetic field inhomogeneities [3]. One major advantage over ¹H-MRS is the ability to orally administer in low doses harmless ²H-labeled substrates, e.g. glucose or water to dynamically assess changes in ²H spectra, which could offer novel non-invasive insight into lipid metabolism during different interventions [4]. This study aimed at a DMI-based HCL estimation.

Four volunteers (sex: 1f/3m, age: 26-64y, BMI: 30.1±3.7kg/m²) with presumed high HCL were measured in a 7T MR system (Siemens Healthineers, Erlangen, DE) using a dual-tuned ¹H/²H surface coil (2 ²H-channels (~27x27cm), STARK CONTRAST MRI Coils Research, Erlangen, DE). The subjects were situated in a right lateral position with the liver centered on top of the RF coil. Standard ¹H MRS-based HCL measurement was performed according to Gajdošík et al. [1] using a ¹H-GUSTEAU sequence at three different voxel positions (á 8 measurements, VOI: 3x3x3cm³) within the liver. Additionally, the ¹H methylene content (MC) was calculated analogously with solely its own resonance (1.3ppm) instead of all lipids. For DMI an FID MRSI sequence with 3D density-weighted concentric ring trajectory readout (CRT) was used (2ms block pulse, 2ms acquisition delay, TR: 290ms, 47 circles, FOV: 27x27x26cm³, matrix: 22x22x21, total time: 8:21min) [5]. Anatomical images were acquired with a 3D gradient-echo sequence (scan time: 1:10min) for segmentation. 3D Slicer [6] was used to mask the liver and a smaller region within the hepatic tissue to calculate the ²H MC. Both volumes were down-sampled to the MRSI matrix size. The spectra from the liver voxels were further processed with an in-house programmed pipeline (MATLAB R2012b, LCModel v6.3, Python 3.12) for image reconstruction and spectral fitting. The used basis set for LCModel was generated previously, containing water (4.7ppm) and a single lipid methylene line (1.3ppm). Spectra from voxels within the smaller mask were averaged after phasing and frequency alignment using FSL-MRS [7] within the pipeline. Unlike for ¹H no T1 corrections were applied. The ²H MC was calculated as mentioned above and an extrapolated ²H HCL value was derived by applying the HCL/MC ratio from ¹H.

Figure 1 shows the DMI-MRSI grid and the GUSTEAU-voxel location superimposed on anatomical images and depicts an averaged spectrum of the ¹H-MRS, the metabolic map of ²H-labeled water and (fitted) spectra of chosen voxels. The mask for spectral averaging of the DMI voxels and the averaged spectrum are depicted in Figure 2, including a comparison with the ¹H acquisition. With a nominal voxel size of 1.86ml, the accumulated volumes used to derive the lipid content ranged from 367 to 565cm³ (197–303 voxels). MC values of 6.23%/4.94%, 5.44%/3.81%, 4.01%/3.70%, and 9.45%/6.18% were calculated for ¹H/²H, respectively. These correspond to the (extrapolated) HCLs of 8.54%/6.77%, 7.45%/5.22%, 5.32%/4.91%, and 12.9%/8.40% (Fig. 3). At this stage, no significant difference (p=0.079), but high correlation (Pearson correlation: 0.961) was detected between the two methods.

Low natural abundance of 2H limits the detectability of low HCL levels solely based on 2H signals [8]. The results show that the DMI-based assessment underestimated MC for all volunteers systematically by up to 35%. This deviation could result from the missing correction for incomplete relaxation, as there were no ²H T1 values of water and methylene available. Furthermore, errors could be introduced by the voxel selection process (masking), the pre-processing for averaging and by the fitting procedure (basis set), and partial volume errors. Therefore, DMI should not be used independently for static HCL assessment, but instead to assess complementary data on metabolic dynamics, e.g., after oral tracer administration and accompanied by other well-established 1H-based techniques [1], at best, in an multinuclear interleaved matter [9]. At this stage, the study is limited by the small number of subjects.

The study demonstrates the feasibility of HCL assessment with DMI if a certain minimum lipid content is present in the liver. Exact level of sensitivity will be determined in further measurements. Nevertheless, offers the possibility to perform dynamic studies by 2H enrichment during different tracer intervention, e.g., administration with oral intake of heavy water to study hepatic de novo lipogenesis. Further optimization in hardware, acquisition and post-processing, could result in higher precision in relation to the ¹H HCL estimation.
Lorenz PFLEGER (Vienna, Austria), Viola BADER, Fabian NIESS, Bernhard STRASSER, Thomas SCHERER, Wolfgang BOGNER, Siegfried TRATTNIG, Peter WOLF, Martin KRSSAK
11:00 - 12:30 #47938 - PG487 New trajectories for functional MRSI.
PG487 New trajectories for functional MRSI.

Density weighted (DW) k-space sampling is often used in magnetic resonance spectroscopic imaging (MRSI) to reduce bleeding of the strong lipid signals present in the scalp into brain voxels. To achieve this, trajectories are typically designed for a point spread function (PSF) which minimises contributions from distant regions (minimise stopband ripple). This, in turn, can be achieved by having a sampling density close to the Hann window. DW concentric ring trajectories have proven effective for spectroscopic imaging [1, 2]. However, they are suboptimal for functional MRSI (fMRSI), as they require many repetition times (TRs) to form a single image, with sparse ring coverage leading to large gaps in k-t space. From fMRI BOLD imaging, we can assume any functional response diminishes over time as participants habituate to a given stimulus [3] (and references within). It is therefore desirable to implement trajectories that retain a Hann window density whilst comprehensively sampling k-t space in short time blocks. To address these challenges, we propose two novel 2D DW k-space sampling patterns inspired by rosette and spiral imaging trajectories (Fig. 1) [4]. An additional motivation for this work is the emergence of non-water-suppressed MRSI techniques [5-7], where each TR could yield a B0 map to facilitate motion and shim correction [8]. Compared to conventional functional MRS (fMRS), fMRSI promises advantages including lower partial volume, improved spatial specificity, and reduced motion sensitivity.

Rosette trajectories were generated using the general formula used in [9], with the addition of a slowly varying rotation matrix. Spiral trajectories were constructed using the Spiral Gen support routine [10], and were extended to include analytical solutions for the time optimal return to the k-space centre. Three temporal interleaves were applied. Trajectories were rotated by the golden angle (137.5 degrees) between each TR. Both trajectories were optimised via least squares regression, comparing their k-space densities with the Hann window. Density weighted concentric rings were also implemented for comparison. All trajectories were designed to reconstruct to a 32x32 image (FoV 240mm, in-plane voxel size 7.5mm, slice thickness 15mm). Phantom (4 minutes, TR 1.5 s) and in-vivo (5 minutes TR 1.5s) studies were conducted at 7T (Siemens MAGNETOM 7T Plus, 8Tx32Rx Nova coil, 70mT/m, max slew 200 mT/m/ms). Identical 2π-CSAP magnetisation preparation (as implemented in [11]) was used. All sequences were generated using pypulseq [12]. For the in-vivo study, a slice which covers both motor and visual cortex was selected. These areas are commonly used in fMRS experiments [13]. Reconstruction was performed using BART [14] (coil sensitivity estimates and nufft adjoint with density correction [15] to Hann filter).

The density of the optimised trajectories and their point spread functions are presented in Fig. 2, with the more flexible, variable density spiral achieving a closer match to the Hann window than the rosette. The concentric rings have the smoothest, and broadest central lobe. After density reweighting, each trajectory’s PSF is visible in its respective phantom reconstruction (Fig. 3B). The bright spot in each plot is unsuppressed water due to B0 distortion around a filling cap, acts as a high signal point source and so reflects the point spread function. Far from this water contaminant, in phantom the spectra obtained by all three trajectories was clean. Fig 3A shows the spectra from the phantom with normalised baseline noise standard deviation. Imaging rosettes and spirals approach the SNR of concentric rings despite the reweighting. Figure 4 shows results from in vivo acquisitions.

Preprocessing and fitting of the in-vivo spectra are left as future work. In Figs. 3 & 4, density compensation is shown to smoothen and broaden the resulting image. All trajectories show similar PSF after this reweighting. Because spirals and rosette densities approach the desired Hann function weighting the loss of SNR is limited. While density compensation was shown reduces the lipid contamination toward the centre of the brain, it increases contamination at the edges, in the cortex where functional activation occurs (Fig 4.B). It therefore might be better to use un compensated or an inverse iterative reconstruction which will result in lower apparent SNR (due to smaller voxels), but less lipid bleeding. Future work and comparisons will determine the optimal route for fMRSI.

Two novel trajectories for time-resolved MRSI are presented, a rosette and a variable density spiral. Both trajectory densities were optimised on the Hann window using L2 regression. Phantom and in-vivo studies were conducted to compare both trajectories to density-weighted concentric rings. This work lays the foundation of a sequence for (motion and shim) corrected time-resolved MRSI targeting functional metabolism.
Simon FINNEY (Oxford, United Kingdom), William CLARKE
11:00 - 12:30 #47940 - PG488 Role of peri-tumoural lipid composition for aggressive breast tumour using chemical shift-encoded imaging at ultra-high field of 9.4 T.
PG488 Role of peri-tumoural lipid composition for aggressive breast tumour using chemical shift-encoded imaging at ultra-high field of 9.4 T.

Breast cancer is the most common female cancer in the UK and globally, and the deregulation of lipid composition in the breast has been suggested as a risk factor [1,2]. Chemical shift-encoded imaging (CSEI) allows rapid lipid composition mapping, utilising the known resonant frequencies of lipids with a theoretical model for the quantification of monounsaturated, polyunsaturated and saturated fatty acids (MUFA, PUFA, SFA) [3,4]. However, the resolution is limited in clinical MRI due to a low signal to noise ratio (SNR) at a typical field strength of 1.5 – 3 T and the scan time tolerable by the patients. Ultra-high field preclinical MRI offers elevated SNR with typical ex vivo deployment, facilitating the acquisition of submillimetre lipid composition maps. We therefore hypothesise that deregulation in peri-tumoural lipid composition show a difference between tumour grade, an indicator for cellular differentiation and tumour aggressiveness, in breast tumour specimens.

We hence conducted high resolution imaging on specimens excised from patients with invasive ductal carcinoma using a 9.4 T preclinical MRI scanner. The study was approved by the North West – Greater Manchester East Research Ethics Committee (Identifier: 16/NW/0221), and signed written informed consents were obtained from all the participants (Figure 1). Specimen Preparation: Twenty-one breast tumour tissue blocks, 12 Grade 2 and 9 Grade 3, were dissected into size of approximately 50 × 50 × 10 mm after routine histological examination. The tissue blocks were fixed in 10% formalin solution and stored in screwed-top plastic containers at 4˚C. Each tissue block was placed in a custom-made, standard size cassette holder layered with gauze and filled with a susceptibility-matched perfluorocarbon liquid (FluorinertTM, 3M, St. Paul, MN, USA), before the whole set up was sealed with a tightly fitted lid prior to MRI. Lipid Composition Mapping: All images were acquired on a 9.4 T preclinical MRI scanner with a 20 cm diameter inner bore (Bruker, BioSpec, Ettlingen, Germany). The cassette holder set up was snug-fit inside the middle of a 12 cm quadrature coil (Rapid Biomedical, Rimpar, Germany), and inserted into the centre of the magnetic field. Lipid composition images were acquired using a 3D CSEI sequence [5,6] with 24 echoes, initial echo time of 2.14 ms, echo spacing of 1.03 ms, repetition time of 50 ms, reconstruction matrix of 256 × 256, and an isotropic resolution of 0.25 mm. Image Analysis: Image analysis was conducted in MATLAB (R2023b, MathWorks Inc., Natick, MA, USA). A simplified triglyceride model was used to map the number of double bonds from the complex data on a pixel-by-pixel basis, and quantitative maps of MUFA, PUFA and SFA were subsequently derived as a fraction of the total amount of lipids [3,4]. The tumour boundary was delineated on the first echo of CSEI magnitude images, and the peri-tumoural region was defined as a 2 mm (8 voxels) annular ring surrounding the tumour boundary. The mean lipid composition from the region-of-interest was subsequently computed for each lipid constituent. Statistical Analysis: All statistical analysis was performed in the R software (v4.3.2, R Foundation for Statistical Computing, Vienna, Austria). Wilcoxon rank sum tests were performed to compare the difference in lipid constituents between Grade 2 and 3 tumours. The correspondence between lipid constituents against tumour diameter was examined using Spearman’s rank correlation test. A p value < 0.05 was considered statistically significant.

There was a significantly higher PUFA (p=0.028) of Grade 3 breast tumours (0.22, interquartile range (IQR): 0.21 – 0.22) in comparison to Grade 2 (0.20 (0.20 – 0.21)) (Figure 2b, Table 1). There was no significant difference in MUFA (p=0.095) between Grade 2 and Grade 3 (Figure 2a, Table 1). There was no significant difference in SFA (p=0.069) between Grade 2 and Grade 3 (Figure 2c, Table 1). There was no significant correlation in PUFA (rs = 0.09, p=0.710), MUFA (rs = 0.14, p=0.552) and SFA (rs = -0.14, p=0.542) against tumour diameter (Figure 3).

Deregulation of peri-tumoural lipid composition was associated with tumour aggressiveness. PUFA is depleted in higher grade tumour [7], and may induce an increased concentration of PUFA in the peri-tumoural region to support elevated membrane synthesis during cancer progression [8]. However, an elevated mechanistic action in PUFA may not relate to morphological tumour size.

There was an association between peri-tumoural PUFA and tumour grade. Lipid composition imaging at ultra-high field might have potential to probe cellular mechanistic actions in the tumour microenvironment.
Sai Man CHEUNG (Newcastle upon Tyne, United Kingdom), Kwok-Shing CHAN, Kangwa NKONDE, Yazan AYOUB, Nicholas SENN, Bernard SIOW, Jiabao HE
11:00 - 12:30 #46849 - PG489 Quantitative 7Li MRI in patients with bipolar disorder initiating lithium treatment: a first look at the European R-LiNK multicentric dataset using a region-based approach.
PG489 Quantitative 7Li MRI in patients with bipolar disorder initiating lithium treatment: a first look at the European R-LiNK multicentric dataset using a region-based approach.

Bipolar disorder (BD) is a debilitating psychiatric disease marked by extreme mood swings with a large societal burden. For decades, lithium salts have been prescribed to stabilize BD patients’ moods [1]. Although their effectiveness in preventing both manic and depressive phases has been demonstrated [2], the precise mechanism of action is still only partially understood. Moreover, only a third of BD patients fully respond to lithium treatment. It is in this context that the R-LiNK project [3-4] was initiated, gathering expertise across multiple domains including Psychiatry, Neuroimaging, “Omics”, Data Sciences in research centers throughout Europe to develop lithium (7Li) MRI [5-6] to characterize brain lithium distribution and optimize the early prediction of lithium treatment response of newly diagnosed BD patients.

BD patients (37 ± 12 years; 15F/15M) were recruited from across Europe. 3D 7Li MRI were acquired from 3T Siemens or Philips MR scanners equipped with dual-resonance 1H/7Li radiofrequency coils (Rapid Biomedical, Germany) three months after the beginning of their lithium treatment using a bSSFP sequence [6-7] optimized for 7Li signal detection (TE/TR=2.5/5ms, FA 34°, 25mm isotropic resolution). 3D T1-weighted anatomical reference images were obtained using a MPRAGE sequence (1mm isotropic resolution). Comparable data was also acquired at 7T in one centre (not presented here). Our brain [Li] quantification pipeline is schematized in Figure 1. 7Li MRI were interpolated and co-registered to anatomical reference images. To better estimate [Li] in the brain parenchyma and CSF(+eyes) compartments, 7Li MR data were acquired from identical Li reference phantoms (LiCl 2 mmol·L⁻¹ in water/glycerol mixture) for each site and its T1 and T2 relaxation times were estimated. For each center, 7Li signal was calibrated using these identical, batch-produced external references. A partial volume correction (PVC) was applied using the “iterative Yang” method [8] to lessen the substantial signal bleeding from CSF due to the limited spatial resolution of 7Li images. Homogeneous ⁷Li distribution regions were segmented semi-automatically [9] to enable PVC. A correction for the differential T2/T1 weightings was then applied using the bSSFP signal equation [10], the flip angles and reported relaxation times for CSF and brain tissue [6]. 7Li MRI were projected into the MNI-152 space [11-12] to allow region-based analysis. Eight regions of interest (ROIs) were then extracted from the Harvard-Oxford [13-14] and MNI-152 [12] atlases to investigate brain lithium distribution across our cohort.

Regional Li concentrations are summarized in Table 1. To account for some of the inter-individual variability (attributable in part to the varying delay between the MRI examination and the last lithium intake), each [Li] map was normalized relative to the average [Li] value in the eyes as a proxy of plasma Li concentration. Response to lithium was evaluated by a panel of experts applying the Alda scale to clinical ratings acquired prospectively over data 24 months after treatment initiation. This yielded a classification of the BD patients as either good responders (GR, n=11), partial responders (PaR, n=12) or non-responders (NR, n=7). Figure 2 shows the mean brain Li distributions for each “lithium treatment response” group. One can appreciate the apparently higher brain [Li] levels in PaR and NR groups compared to the GR group, in particular for the “relative” Li maps. Figure 3 presents the “relative” Li concentrations averaged across each ROI for each lithium treatment response groups. An Ordinary Least Squares (OLS) linear regression model was applied to those data with each BD patient’s sex, age and lithium treatment response as regressors. Lithium treatment response was significantly associated with “relative” Li concentrations in most regions (p < 0.05), indicating a consistent influence. In contrast, age and sex showed no significant associations, suggesting the observed effect is independent of demographic factors.

Our quantification pipeline incorporated external signal referencing, PVC and differential T2/T1 weighting correction steps to yield coherent [Li] values despite the multicentric nature of our database. Lower apparent brain Li content seems to be predictive of a positive response to lithium treatment. This could be related to differences in Li cellular compartmentation between groups. Indeed, one could expect shorter relaxation times for intracellular or “bound” 7Li. If a larger fraction of 7Li+ were “bound” in GR compared to PaR and NR, it would lead to an underestimation of [Li] levels. Additional 7Li relaxometry or Multiple Quantum Filtering experiments could help ascertain this hypothesis.

7Li MRI remains the only method to investigate brain lithium distribution non-invasively. Additional analysis is ongoing to investigate the relationship between Li brain distribution and clinical, anatomic or metabolic outcomes.
Mariam EL BALQ (Paris-Saclay), Gerard HALL, Antoine GRIGIS, Karthik CHARY, Franck MAUCONDUIT, Pete E THELWALL, Aymeric GAUDIN, Marie CHUPIN, Dimitri O PAPADOPOULOS, Letizia SQUARCINA, Thomas SCHULZE, Lars V KESSING, Michael BAUER, Paolo BRAMBILLA, Daniel KEESER, Maj VINBERG, Bruno ETAIN, Philipp RITTER, Edouard DUCHESNAY, Frank BELLIVIER, David A COUSINS, Fawzi BOUMEZBEUR
11:00 - 12:30 #47829 - PG490 Diffusion-weighted MR spectroscopy of the pathological prostate.
PG490 Diffusion-weighted MR spectroscopy of the pathological prostate.

The micro-structure and -environment of tissues can be probed by Diffusion-Weighted MR Spectroscopy (DW-MRS) by simultaneously quantifying apparent diffusion coefficients (ADCs) of metabolites and water [1,2,3]. In a recent study we established DW-MRS of the prostate, providing reference metabolite ADC values for healthy tissue [4]. Prostate pathologies are anticipated to induce microstructural changes detectable by DW-MRS. This work presents the first investigation of metabolic ADCs measured simultaneous with concentration variations across prostate pathologies, including prostate cancer (PCa), prostatitis, and benign prostatic hyperplasia (BPH).

Twenty-five patients with elevated PSA (≥9 ng/mL) underwent a 3T multi-parametric MRI examination. Single-voxel DW-MRS extended the exam by 15 minutes, using a metabolite-cycled STEAM sequence (TE/TM/TR 33/35/2500 ms) and b-values of 124, 776, 1988 s/mm². Voxels targeted low-intensity lesions identified on T2W and ADC images. The voxels were of varying dimensions (3 – 22 cm3) because of differences in lesion size. Clinically suspicious lesions were biopsied under ultrasound or MR guidance, with histopathological analysis. The MRS signals of citrate (Cit), total choline (tCho), spermine (Spe), total creatine (tCr) and water were analyzed. Post-processing involved motion correction, 2D spectral fitting for ADC extraction, and absolute quantification of metabolite concentrations using water signals, with T1/T2 corrections. Quality control involved blinded evaluation by seven spectroscopists. In healthy controls and a number of patients 3 additional b-values were measured allowing to fit the water signal decay with a slow and fast diffusion component.

Among the 25 subjects, 11 were diagnosed with PCa, 7 with prostatitis, and 5 with BPH. Two had both prostatitis and BPH (included in the prostatitis group). Diagnoses were based on biopsy results or radiological reports. Distinct metabolic patterns were observed across pathologies (Fig.1). The ADCs of the luminal space metabolites Cit and Spe increased in pathological prostates (Table 1), and for PCa also that of mI. In contrast the ADC of intracellular metabolite tCho decreased. The tCho concentration increased in pathology (p= 0.03–0.08), but Cit concentration did not change. We found moderate to strong correlations between the concentrations of Cit, Spe and mI (left column Fig.2A,B,C), There were also strong correlations between their ADCs (right column Fig 2, A,B,C). In contrast, we found no correlation between the concentrations of tCho and tCr,. However, a strong correlation occured for their ADCs (Fig 2 D). Contrary to the ADC of luminal metabolites, the ADCs of water tended to decrease in PCa, prostatitis and BPH (Table 1). No correlations were found between the slow or fast ADC components of water and that of the cellular or luminal metabolites.

The increased ADCs of luminal metabolites in the pathological prostate indicate environmental changes: e.g.lumen fluid viscosity and/or ion, protein content. The decreased tCho ADC indicate higher cellular density in PCa, prostatitus and BPH (Table 1), corresponding to traditional DWI. Our findings align with glandular component alterations and support tCho as a stronger PCa marker than Cit. The concentration correlations between luminal metabolites are in agreement with the correlation of their levels in expressed prostatic fluid [5] and the correlations between their ADC is anticipated because of their luminal origin. We previously provided evidence that Cit and Spe are associated in prostatic fluid [4,6], which may also contribute to their correlation. The absence of correlations between the concentrations of tCho and tCr is understandable because of their different biochemical origin, while the correlation of their ADCs most likely is due to a similar cellular environment. The findings on the ADC of water indicates that it is affected by factors other than that of the metabolites and supports the notion that the slow and fast water ADC components not simply represent cellular and luminal spaces.

This study demonstrates that DW-MRS can identify diffusivity properties of metabolites, simultaneous with their tissue concentrations and with the diffusivity of water in the prostate associated with their micro-environment and pathological changes thereof.
Arend HEERSCHAP (Plasmolen, The Netherlands), Angeliki STAMATELATOU, Rudy RIZZO, Kadir SIMSEK, Sjaak VAN ASTEN, Roland KREIS, Tom SCHEENEN
11:00 - 12:30 #46635 - PG491 Dynamic of total Glutamate and Glutamine in response to a short heat pain stimulus.
PG491 Dynamic of total Glutamate and Glutamine in response to a short heat pain stimulus.

Proton magnetic resonance spectroscopy (MRS) allows noninvasive study of metabolism in vivo. Spectra are acquired usually for at least 2-3 minutes to obtain a sufficient signal. Results acquired from these studies are interpreted from metabolic and neuromodulation points. But if one uses short (a few seconds) stimuli metabolic changes should not be presented. In this case, the reason for an increase in neurotransmitter levels may be the transition of neurotransmitters from a vesicle into free space [1, 2]. It was shown that both major neurotransmitter levels increase in a short period after start of presentation of visual stimulation (1-3s) with consequtive decrease to initial values. Mechanism of neurotransmitter vesicular cycling should be same across different brain regions, therefore the aim of this work is to study the kinetics of excitatory neurotransmitter levels after a short-term heat pain stimulus.

All fMRI images and MR spectra were acquired on a Philips Achieva dStream 3 T MR scanner. Twenty-six healthy subjects took part in the study. Before the study, the subjects reported that they had no major medical, neurological, or chronic pain disorders, and did not take painkillers. The subjects were familiarized with all procedures that were applied to them during the study, as well as the MRI protocol. They signed a written informed consent. Thermal stimulation was performed using a MEDOC TSA-2 with a TSA 16x16 mm thermopad, which was attached to the subject's right arm close to the elbow. Before the MRI scan, the subject was presented with stimuli of varying temperatures and fixed duration (5s), which he orally had to rate on a scale from 0 to 10. For stimulation during the MRI scan, a temperature was selected that the subject considered painful, but could tolerate. Stimulation was carried out using a heat pain stimulus of selected temperature for three seconds, repeated after a current period (between the stimuli, the subject was presented to a baseline temperature of 35 degrees for 9-11s). Spectra were obtained using the PRESS pulse sequence and was placed inside an insular cortex of the left hemisphere (40 × 15 × 28 mm3, 16.8 ml, TR/TE = 2000/35 ms, NSA = 315). We analyzed the dynamics of metabolite concentrations with a time development of 2 seconds, as well as the BOLD effect, depending on the determination of the width and height of the NAA and Cr resonance lines.

After excluding subjects that had bad MRS data (5 subj.) and no activation in the region (5 subj.), analisys of data was conducted on a 16 subjects (26,6±4.5 years, m – 6, f – 10). Average stimulus temperature was 46.9±1.4 degrees Celsius. The average ratio of activation regressors to the constant level over the spectroscopic voxel volume was 0.50±0.16%. Based on the concentration measurement results, a trend towards an increase in Glx is observed at 4s after heat pain explosion (∆Glx = 0.49±0.19, +5±2%; p = 0.02, p adj. = 0.08) comparing with values at 0s. The Glx/Cr value normalized to creatine does not increase statistically significantly (∆Glx/Cr = 0.07±0.03, +3.7±1.6%; p = 0.06, p adj. = 0.08. The widths of the Cr and NAA lines do not change upon activation (minimum p-value non-adj. = 0.15).

It is assumed that changes in the levels of neurotransmitters caused by short stimulation probably caused their release from vesicles, and the subsequent decrease is associated with their return to vesicles. Thus, in this study, excitation and inhibition processes in the visual nucleus of the brain were assessed for the first time using a flickering chessboard, by directly measuring the amount of neurotransmitters released from vesicles. The study was carried out with the financial support of the Russian Science Foundation (agreement number 23-13-00011).
Alexey YAKOVLEV (Moscow, Russia), Elena VORONKOVA, Maxim UBLINSKII, Ilya MELNIKOV, Olga BOZHKO, Tolib AKHADOV
11:00 - 12:30 #47360 - PG492 Somatotopic reorganization is induced by targeted proprioceptive training : fMRI surface analysis.
PG492 Somatotopic reorganization is induced by targeted proprioceptive training : fMRI surface analysis.

Motor training, frequently used in medicine or sport, induces functional reorganization in the sensorimotor network. However, the distinct contributions of sensory (proprioception) and motor components in these remodeling processes remain uncertain. This study examined functional remodeling and somatotopic changes in primary sensorimotor areas after targeted proprioceptive training of the leg.

Twenty healthy volunteers underwent daily training for a fortnight, with two MRI sessions conducted before and after the training period. The training involved mechanical vibrations applied to the tendons of knee muscles to activate proprioceptive afferents and to induce illusions of movement in only the non-dominant leg, while the participant remained motionless. During MRI, we mapped somatotopic organization by vibrating six different muscles at the hip, knee, and ankle levels of both the trained and non-trained legs, using an MR-compatible pneumatic vibration device. As the somatotopic representation of the leg spans the interhemispheric and central sulci of the cortex, we used surface-based analysis to enhance the accuracy of cortical localization by reducing signal contamination between the two sides of the same sulcus [1]. Univariate analysis identified brain regions activated during movement illusions and allowed us to quantify overlaps between representations of different leg segments in the somatosensory cortex. We further applied multivariate representational similarity analysis (RSA) to assess changes in the similarity of fMRI response patterns pre- and post-training.

Movement illusions evoked by the six vibration conditions elicited activation across a large sensorimotor network [2,3]. Following proprioceptive training, we observed specific somatotopic reorganisation in the contralateral primary sensorimotor cortex: reduced overlap between the knee and ankle representations of the trained leg, and enhanced lateralization of activations. By contrast, the overlap between knee and ankle representations increased in the contralateral primary motor cortex of the untrained leg. These univariate findings were corroborated by RSA, which showed a significant dissimilarity increase between the trained knee and ankle in the contralateral primary sensorimotor cortex after training, while no significant difference was found between the knee and the hip.

In only two weeks, proprioceptive training alone was sufficient to refine the somatotopic organization of the sensorimotor cortices, enhancing the distinction between the trained segment and its adjacent segments. This contrasts with active motor training, which typically increases representational overlap.

This study underlies the impact of proprioceptive component in brain remodeling supporting the relevance of a pure sensory training for sensorimotor rehabiitation. A clinical extension of this work is currently underway in amputees, aiming to reduce maladaptive brain reorganization and phantom limb pain.
Aurore LAPUYADE-AUFOO (Marseille), Lilia PONSELLE, Raphaëlle SCHLIENGER, Laurent THÉFENNE, Bruno NAZARIAN, Julien SEIN, Jean-Luc ANTON, Anne KAVOUNOUDIAS
11:00 - 12:30 #46937 - PG493 Subcortical Dysregulation in Post-COVID Breathlessness using 7T MRI.
PG493 Subcortical Dysregulation in Post-COVID Breathlessness using 7T MRI.

An estimated 10% to 50% of post-COVID individuals experience breathlessness despite a fraction of severe hospitalised ones showing measurable pulmonary injury. COVID-19 is known to affect the central nervous system (CNS), potentially leading to functional alterations in the processing and perception of respiratory signals.

To investigate these neural changes, we acquired 7 Tesla resting-state functional MRI (rs-fMRI) data from 53 post-COVID patients with varying infection severity and breathlessness levels, despite minimal evidence of pulmonary dysfunction. Using univariate robust regression models followed by FDR correction, we evaluated the predictive value of 153 resting-state functional connectivity (rs-FC) measures across 18 brain regions implicated in the hierarchical inference of respiratory interoception and allostasis.

We found that decreased rs-FC between the dorsal periaqueductal gray and posterior insula (dPAG-PoI1), along with increased rs-FC between the basolateral amygdala and dorsal anterior cingulate cortex (BLA-dACC), were significantly associated with higher breathlessness catastrophizing scores. Post-COVID breathlessness was characterised by a broader pattern of increased connectivity within visceromotor structures (beyond BLA-dACC) and decreased connectivity in primary interoceptive regions (beyond dPAG-PoI1), despite not surviving FDR correction. The contribution of dPAG-PoI1 rs-FC to breathlessness remained significant after adjusting for general anxiety, whereas BLA--dACC did not. A significant interaction effect was identified between ventilator use and dPAG-PoI1 rs-FC, but not with BLA-dACC, such that individuals who had undergone mechanical ventilation exhibited a stronger association between decreased dPAG-PoI1 connectivity and greater breathlessness, whereas this relationship was weaker in non-ventilated individuals.

The hypo-connected dPAG-PoI1 rs-FC may represent a pathway of reduced integration of afferent visceral signals within primary interoceptive structures, possibly relating to brainstem damage in severely affected individuals, and that it impairs safety signal learning after recovery. The hyper-connected BLA-dACC rs-FC may represents an exaggerated efferent anticipatory bias toward adverse respiratory experiences within visceromotor structures, contributing the general anxiety, yet possibly not related to the acute-phase severity. Both pathways may prevent the generative model of gas-exchange in the brain from updating when recovered from the acute-infection.

Our findings support a dual-pathway model for post-COVID maladaptive breathlessness: hypoconnectivity within the interoceptive dPAG–PoI1 pathway that prevents safety signal learning and hyperconnectivity within the visceromotor BLA–dACC pathway that prime threat actions in face of normal gas-exchange after recovery.
Lin QIU (Oxford, United Kingdom)
11:00 - 12:30 #47653 - PG494 Acute response of hepatic fat content to consuming fructose or glucose alongside fat in obese and non-obese subjects.
PG494 Acute response of hepatic fat content to consuming fructose or glucose alongside fat in obese and non-obese subjects.

Metabolic dysfunction-associated steatotic liver disease (MASLD) is a growing global health concern characterized by excessive fat accumulation in the liver (hepatic steatosis) in individuals without excessive alcohol consumption. While the exact mechanisms are complex and multifactorial, dietary factors, particularly the consumption of fructose, have been implicated in its development and progression. In previous study[1], we demonstrated that fructose if provided together with high fat load led to accumulation of fat in the liver in non-obese subjects. On the contrary the coadministration of glucose with high fat load did not affect hepatic fat content (HFC). In this study we tested whether such a negative effect of fructose is preserved in obese subjects.

Fourteen non-steatotic, non-obese subjects (HFC < 5.56 %, BMI < 30 kg/m2), and eight obese subjects (BMI ˃ 30 kg/m2) were enrolled in this study. The exclusion criteria were diabetes, excessive alcohol consumption, use of drugs affecting lipid metabolism and triacylglycerols ˃ 4.0 mmol/l, and other serious illnesses. Each subject underwent two almost identical interventions. In each of these interventions the HFC (HFC-0) was measured by 1H MR spectroscopy (MRS) after overnight fasting. Then, subjects consumed 473 ml of high fat cream (150 g of fat) and fruit tea sweetened with 50 g of glucose. Same sugar was given to them again after 2 and 4 hours. Second MRS for HFC determination was measured six hours after the first dose of sugar (HFC-6). Blood was collected before the first consumption and then at 0.5, 1, 2, 2.5, 3, 4, 4.5, 5, and 6 hours after, and stored at -80 °C for later analysis. In the second intervention, the fructose was consumed instead of glucose. The order of interventions was randomized. The MRS examination was performed in the supine position during held exhalation at 3T MR system (Siemens, Germany) equipped with 8- or 30-channel surface coil and 32-channel spine coil, with use of single voxel spectroscopy sequence (TR = 4500 ms, TEs = 20-33-50-68-80-100-135-150-180-270 ms, 2 acquisitions, water suppression). The position of VOI (40×30×25 mm) was placed in the liver segment V/VIII in the area without visible big vessels. Automatic and manual shimming were combined to reach a linewidth <50 Hz. MR spectra were evaluated by LCModel[2] and the concentrations were corrected for T2 relaxation times in each subject using MATLAB software. HFC was calculated from fat fraction using Longo correction[3]. Relative content of saturated fat fraction in the VOI was estimated from fractions of hydrogen atoms of functional groups[4].

Basic characteristic of both groups is stated in Table 1. Compared to the non-obese group, obese subjects showed increased HFC and higher insulin resistance evaluated as HOMA-IR, and decreased relative lipid saturation. The relative HFC change (HFC-6/HFC-0 (%)) after fat with fructose was higher in non-obese than in obese subjects. Moreover, in non-obese group, the relative HFC was higher after fat administration with fructose than after fat with glucose (Table 2) contrary to obese subjects, where no statistically significant difference between the glucose or fructose experiments was detected. Insulin level was increased after high fat load with glucose than with fructose (Figure 1) in both groups. No significant changes were found in FFA nor TG in either group or between the two interventions.

In this study we observed that HFC in non-obese subjects increased after high fat load with fructose, but not after high fat with glucose. On the contrary, we were unable to detect any change in HFC in the same experiments in obese individuals. The negative impact of fructose coadministration in non-obese subjects can be explained by differences in metabolism of both sugars. Fructose is completely metabolized in the liver and there is no feedback inhibition of fructolysis leading to overproduction of substrate for de novo lipogenesis (DNL). On the other hand, only 20% of glucose is metabolized in the liver and metabolism of glucose is under strict control. The lack of significant changes in circulating FFA and TG between interventions in both groups suggests that the observed HFC changes might be driven by rapid intrahepatic DNL rather than increased peripheral lipid delivery. No observed changes in HFC after fructose consumption in obese subjects might be explained by already increased DNL. It remains to be determined whether insulin resistance typical for obesity plays any role in observed effects. The role of fructose in MASLD pathogenesis is currently under comprehensive discussion and our data may contribute to understanding its role in accumulation of liver fat.

Contrary to non-obese subjects, no differences could be detected in the response of HFC to glucose and fructose coadministration with high fat load in obese individuals.
Petr KORDAC (Prague, Czech Republic), Dita PAJUELO, Milan HAJEK, Petr SEDIVY, Monika DEZORTOVA, Petra STASTNA, Jan KOVAR
11:00 - 12:30 #47734 - PG495 COVID-19: Investigation of BC007 for the treatment of patients with Post-COVID syndrome (PCS) using comprehensive CEST imaging.
PG495 COVID-19: Investigation of BC007 for the treatment of patients with Post-COVID syndrome (PCS) using comprehensive CEST imaging.

Patients suffering from Post-COVID Syndrome (PCS), present a wide range of symptoms that are not entirely specific to PCS. To the state of this abstract, no treatment has emerged beyond the status of a clinical study. Initial findings from an internal study (discover 1.0) [1] indicate the need of further subclassification of PCS patients into (i) virus-induced autoimmune reactions, (ii) prolonged recovery due to organ damage with functional impairment, and (iii) sustained immune activation caused by persistent viral components [2]. However, these categories may not fully capture the complex heterogeneity of PCS, highlighting the urgent need for deeper phenotyping and mechanistic insights, especially in the diagnostics Recent data [3] suggest that a subgroup of patients with PCS has functional autoantibodies directed against a G-protein-coupled receptor (GPCR-fAAb). The neutralization of fAAb by a new drug called Rovunaptabin (BC007) has been demonstrated [4] to ameliorate the symptoms of PCS in a clinical trial. In this randomized controlled study, PCS patients received BC007 and placebo in a cross over design. We monitored the influence of this drug on the intracellular metabolics using 7T CEST MRI in an unprecedented and unique clinical study setup.

29 patients with PCS were scanned on a MAGNETOM Terra.X 7 Tesla scanner with an 32ch Rx and 8ch Tx head coil. Each patient was scanned three times: Subjects underwent comprehensive Chemical Exchange Saturation Transfer (cCEST) imaging [5] with 3D snapshot readout [6] at B1=1, 2 and 4µT to detect slow, intermediate and fast exchanging protons groups from -NH, -NH2 and -OH compounds. PCS patients received up to three measurements with a 2-week interval. While the first measurement can be interpreted as metabolic reference scan before treatment, the patients received in the subsequent scans either a drug treatment with BC007 or a placebo. For post-processing, cCEST data were B0 and B1. Lorentz amplitude maps from data acquired with B1= 1µT were predicted by a deepCEST network [7] to generate aliphatic NOE, semi-solid MT, amide and guanidine maps. MTRasym maps from the amine and hydroxyl groups were calculated separately (Fig.1). In a first experiment, white matter (WM), grey matter (GM) and cerebrospinal fluid (CSF) were segmented for each patient and the timepoint of the first measurement was compared with age-matched healthy control datasets from our cCEST database. The data were unblinded and analyzed longitudinally in order to investigate if molecular changes appear in cCEST imaging through drug treatment.

The segmented white and gray matter revealed a significantly increased amine and hydroxyl signal in the PCS cohort. In contrast, the other CEST markers, as well as T1, did not show significant differences compared to the healthy control cohort (Fig. 2). When observing PCS patients after the intake of placebo or BC007 (Verum), no significant reductions were observed within the WM and GM for the NH2 and OH groups (Fig.3)

These data show clearly increased CEST signals of the NH2 and OH groups of patients with PCS compared to age-matched healthy subjects. The intake of BC007 seems to reduce these CEST signals, but cannot be significantly confirmed. This may be related to the small number of participants, as only 19 of the initial 29 PCS patients participated in all 3 measurements.

cCEST reveals metabolic changes of PCS patients compared to age-matched healthy controls.While a global evaluation shows differences, especially in amines, more detailed analyses of the WM/GM are necessary in future.
Jan SCHÜRE (Nürnberg, Germany), Moritz FABIAN, Bettina HOHBERGER, Anja-Maria LADEK, Marion GANSLMAYER, Thomas HARRER, Friedrich KRUSE, Stefanie MAAS, Tobias BORST, Ralph HEIMKE-BRINCK, Andreas STOG, Thomas KNAUER, Eva RÜHL, Victoria ZEISBERG, Adam SKORNIA, Armin STRÖBEL, Monika WYTOPIL, Caroline MERKE, Sophia Hofmann SOPHIA HOFMANN, Katja G. SCHMIDT, Petra LAKATOS, Julia SCHOTTENHAMM, Martin HERRMANN, Christian MARDIN, Andy HESS, Jürgen RECH, Armin NAGEL, Arnd DÖRFLER, Moritz ZAISS
11:00 - 12:30 #47762 - PG496 ¹H-MRS Study of Glutamate–Glutamine Dynamics in the Insular Cortex Following Short-Term Heat Pain.
PG496 ¹H-MRS Study of Glutamate–Glutamine Dynamics in the Insular Cortex Following Short-Term Heat Pain.

Functional magnetic resonance spectroscopy (fMRS) is used to investigate task-related changes in brain metabolism and neurotransmitter activity in vivo. Typically, fMRS requires at least 30 seconds of spectral acquisition to achieve sufficient signal-to-noise ratio. Changes observed over these time frames are generally interpreted from metabolic and neurochemical perspectives. However, at shorter time scales, metabolic processes are unlikely to produce MRS-detectable changes[1, 2]. In such cases, transient increases in neurotransmitter levels may instead reflect the rapid release of neurotransmitters from synaptic vesicles into the extracellular space[3]. Previous studies have shown that levels of major neurotransmitters can rise within 1–3 seconds of visual stimulation onset, followed by a return to baseline[4, 5]. Given that the mechanism of vesicular cycling is conserved across brain regions, the aim of this study was to investigate the kinetics of excitatory neurotransmitter levels in the insular cortex following a brief heat pain stimulus.

All fMRI and MRS data were acquired using a Philips Achieva dStream 3T MR scanner. Twenty-six healthy volunteers participated in the study. Prior to participation, all subjects confirmed they had no major medical, neurological, or chronic pain conditions and were not taking pain medications. Participants were fully briefed on all procedures and the MRI protocol and provided written informed consent. Thermal stimulation was presented using a MEDOC TSA-2 system with a 16×16 mm thermopad attached to the right forearm near the elbow. Before scanning, heat stimuli of varying temperatures (5-second duration) was presented to each subject. They rated the pain intensity orally on a scale from 0 to 10. For in-scanner stimulation, a temperature that was rated as painful but tolerable was selected individually for each subject. During the scan, thermal stimulation consisted of a 3-second heat pulse followed by a rest period with baseline temperature (35°C) lasting 7–9 seconds. Stimulus was presented 60 times during MRS and 30 times during fMRI. Spectra were acquired using a PRESS pulse sequence (TR/TE = 2000/35 ms, NSA = 315) with the voxel placed in the left insular cortex (40 × 15 × 28 mm³; volume: 16.8 mL). Spectra were acquired twice: without stimulation (‘sham’ condition) and with (‘act’ condition). In addition, we assessed potential BOLD-related effects by monitoring changes in the width and amplitude of the N-acetylaspartate (NAA) and creatine (Cr) resonance lines. Spectra were preprocessed using FID-A, including phase and frequency alignment, signal averaging, and water suppression. Quantification of metabolite concentrations was performed using LCModel. Metabolite dynamics were analyzed across five time points with a temporal resolution of 2 seconds; the sixth time point was excluded due to a low number of signal averages (NSA).

After excluding subjects with poor-quality MRS data (n = 5) and those without significant fMRI-measured activation in the target region (n = 5), data analysis was conducted on 16 participants (age: 26.6 ± 4.5 years; 6 males, 10 females). The average temperature of the pain stimulus was 46.9 ± 1.4 °C. The mean activation regressor (according to fMRI) ratio relative to the constant level within the spectroscopic voxel was 0.50 ± 0.16%. A trend toward increased Glx concentration was observed at 4 seconds after the onset of the heat pain stimulus compared to baseline (∆Glx = 0.49 ± 0.19, +5 ± 2%; p = 0.02, p_adj = 0.08) and the Glx/Cr ratio showed a nonsignificant increase (∆Glx/Cr = 0.07 ± 0.03, +3.7 ± 1.6%; p = 0.06, p_adj = 0.08) in act condition. No changes Glx and Glx/Cr observed during sham condition. No significant changes were observed in the linewidths of the Cr and NAA resonance peaks (minimum uncorrected p = 0.15).

fMRI results confirmed activation in the insular cortex, where Glx dynamics were measured. However, compared to visual stimulation paradigms, the average BOLD signal change following the heat pain stimulus was smaller. This reduced BOLD response may explain the more modest increase in Glx levels observed in this study. A lower concentration of Glu release from vesicles likely reflects weaker neuronal activation, which corresponds to the smaller BOLD signal in the region. Additionally, a lower BOLD response may limit the detectability of MRS-BOLD–related spectral changes.

The mechanism of vesicular neurotransmitter release may account for a transient increase in Glx following a brief stimulus. However, reliable detection of such changes using fMRS appears to require sufficiently strong neuronal activation.
Alexey YAKOVLEV (Moscow, Russia), Elena VORONKOVA, Maxim UBLINSKIY, Olga BOZHKO, Tolibjon AKHADOV
11:00 - 12:30 #47776 - PG497 Measuring Renal Reabsorption Dynamics with Dynamic Glucose Enhanced (DGE) MRI.
PG497 Measuring Renal Reabsorption Dynamics with Dynamic Glucose Enhanced (DGE) MRI.

Dynamic glucose-enhanced (DGE) MRI utilizes chemical exchange saturation transfer (CEST) [1] or direct water saturation [2] to measure glucose uptake in vivo. In kidneys, this potentially allows for observing glucose reabsorption dynamics, unlike DCE MRI, which can only measure the filtration of the respective contrast agent. DGE MRI protocols usually require high temporal resolution. To achieve this, often no full Z-spectrum is acquired. Additionally, traditional CEST quantification methods are confounded by magnetization transfer (MT), relaxation effects, and field inhomogeneities. To overcome these limitations, we aim to utilize model-based analysis techniques to achieve sufficient temporal resolution, while correcting for confounding factors. Model-based approaches have demonstrated to be able to quantify MT and CEST effects in preclinical research [3,4]. We adapted these approaches and developed them further to reliably quantify glucose under dynamic conditions.

All measurements were performed with a 35 mm resonator on a 9.4 T small animal Bruker Biospec MR system. A glucose bolus of 6 μmol/g body weight was injected intravenously into one representative wild-type mouse after 0, 30, and 60 minutes. During the infusion protocol, 20 consecutive CEST measurements were conducted: one axial slice of the left kidney, RARE sequence, 32x32 matrix, 0.2x0.2 mm^2 resolution, 27 offsets, B_1=1.6 μT, 2s saturation, at least 2s recovery, with respiration trigger applied. The total acquisition time per spectrum was approximately 4 min. All data were denoised with a total-variation denoising algorithm [5]. For the model-based analysis of CEST MRI data, we simplified the steady-state solution for Z-spectra by Zaiss et al. [3] assuming that glucose exchange rates are much larger than the nutation frequency ω_1 and that for Δω≲ω_1, the MT relaxation effects are dominated by the direct water saturation: Z_ss (Δω)=(R_(1,obs)⋅Δω^2)/((R_(1,obs)+f_MT/(1+f_MT )⋅R_rf^MT (Δω))⋅Δω^2+(A⋅Δω+B)⋅ω_1^2 ), where R_rf^MT (Δω) is the MT absorption line-shape function. Here, we assume a Lorentzian line-shape: R_rf^MT (Δω)=(ω_1^2⋅R_(2,MT))/(R_(2,MT)^2+(Δω-δω_MT )^2). R_(1,obs) was provided from an additionally measured T_1-map. B_0- and B_1-maps were obtained using WASABI [6] and used for explicit correction of Δω and ω_1. Fitting was performed in two steps: all parameters were fitted to the mean spectrum of one kidney compartment (pelvis, medulla, cortex). The obtained δω_MT was then fixed and A,B,f_MT,R_(2,MT) were fitted to the pixelwise spectra with initial values set to results of the first fitting step.

Figure 1 shows mean Z-spectra, MTRasym and AREX curves for different kidney compartments, as well as fit results for each region before the first glucose infusion (baseline). Residuals of the fits oscillate closely around zero, indicating most of the spectral asymmetry was captured by the model. Baseline maps of MTRasym, AREX, and asymmetry parameter A (Figure 2) revealed substantial differences in the calculated CEST contrasts. For MTRasym the values in the pelvis were relatively larger compared to other compartments, while AREX showed a mostly homogeneous distribution across the whole kidney and model-based analysis showed higher asymmetry in the cortex. Figure 3 depicts snapshots of the difference between MTRasym, AREX, A and their corresponding baseline values throughout DGE MRI. Compared to the two metrics, the model parameter map shows a much smoother, less fractured pattern and clear glucose accumulation in the cortex. Mean time courses of ΔMTRasym, ΔAREX, and ΔA for different kidney compartments revealed glucose signal peaks following each infusion time point (Figure 4). AREX and A showed higher signal difference in the cortex compared to medulla and pelvis. However, this effect was much more pronounced for the model-derived contrast.

The calculated DGE contrast strongly varied with the chosen analysis method. MTRasym does not account for T1- or T2-relaxation effects, which lead to an over-estimation of the asymmetry in the pelvis. AREX considers T1 effects but offers no explicit B_0- and B_1-correction and does not account for T2 related water saturation broadening and asymmetric MT effects. Only the model-based approach considers all these effects, which lead to much high glucose signal observed in the cortex, where the reabsorbed glucose should remain. This indicates that model-based analysis offers better access to the true underlying glucose dynamics in healthy kidneys. The presented simplified model for steady-state Z-spectra remained stable to fit even at pixelwise noise levels. Following up on this research, the temporal resolution might be improved using shorter saturation (Spin-Lock) and Gradient-Echo snapshot acquisition.

In this study, DGE MRI in combination with model-based analysis was demonstrated to detect glucose reabsorption dynamics in the kidney. In future studies, this might offer novel insights into renal pathologies.
Chris LIPPE (Münster, Germany), Verena HOERR
11:00 - 12:30 #47783 - PG498 Resting-state fMRI signals associated with EEG-detected eye blinks during multimodal acquisitions.
PG498 Resting-state fMRI signals associated with EEG-detected eye blinks during multimodal acquisitions.

There is a growing interest in spontaneous fluctuations of functional brain networks during rest measured using fMRI, EEG, or their combination [1]. Eye blinks, linked to vigilance and arousal processes that contribute to these fluctuations [2], have been associated with activity surges within the ascending arousal network [3], indicating their potential as markers of arousal events. Such events have been further linked to large-scale cortical BOLD signal fluctuations and pulsatile cerebrospinal fluid (CSF) flow [4,5]. Importantly, arousal events can vary in intensity and duration, with higher-intensity arousals often eliciting stronger physiological responses [6]. Eye blinks during rest also vary in frequency, resulting in differing pre-blink intervals that may reflect distinct types of arousal events. They are typically detected using eye tracking; however, in the absence of such recordings, they can also be extracted from the EEG signals. In this study, for the first time, we detect eye blinks based on the EEG signals recorded simultaneously with fMRI, and use the EEG-detected blinks as arousal event markers, investigating their fMRI correlates, including cortical and subcortical brain regions as well as global and CSF signals.

Simultaneous EEG-fMRI was acquired from 45 participants (9 M, 36 F; age 29.8 ± 7.6 years) during 7min (n=29) or 10min (n=16) eyes-open resting state sessions. EEG data were recorded with a 32-channel MR-compatible system (Brain Products) at a 5 kHz sampling rate. EEG signals were corrected for gradient and pulse artefacts and bandpass filtered. Eye blinks were detected using the BLINKER pipeline applied to frontal EEG channels [7], with those occurring within one 1 TR (1.26 s) merged. Blinks were then categorised into two groups based on the pre-blink interval: (i) clustered blinks with at least one prior blink within the preceding 5 seconds and (ii) isolated blinks with no prior blink activity for at least 10 seconds. The EEG data were then further preprocessed and used to extract a scan-level vigilance index given by the ratio of the averages of the alpha to delta and theta powers. Subjects were divided into low- and high-vigilance groups based on the 40% and 60% percentiles of the vigilance index distribution. fMRI data were collected on a 3T MRI system (Siemens) using a 64-channel head coil. T2*-weighted multi-slice GRE-EPI sequences were employed (TR/TE = 1260/30 ms, GRAPPA = 2, SMS = 3, 2.2mm isotropic resolution). The data were analysed using FSL tools, and pre-processing included motion and distortion correction, high-pass temporal filtering and spatial smoothing. Voxel-wise general linear model analyses were performed using two blink time series, corresponding to the clustered and isolated blink groups, as regressors of interest. Analyses were conducted across a range of time lags (-10 to +10 TR, with a 1 TR step) to capture temporal dynamics. Motion parameters and outliers were included as nuisance regressors. A group-level mixed-effects voxelwise analysis determined the main effects of blinks on the fMRI signal across the brain in each group using cluster statistical inference. A region-of-interest (ROI) analysis was performed by averaging the resulting voxelwise Z-scores, including whole brain and CSF (lateral and 4th ventricles) as well as cortical and subcortical regions.

Fig. 1 shows the distribution of the normalised blink counts for clustered and isolated blinks for low and high vigilance subjects. Voxel-wise fMRI analyses (Fig. 2–3) revealed pre-blink activations in subcortical and visual cortical regions, more pronounced during low vigilance scans, followed by widespread cortical deactivation, particularly evident in high vigilance. These patterns are consistent with previous findings based on eye tracking. Isolated blinks were associated with a delayed reduction in cortical BOLD signal when compared to clustered blinks. ROI-based analyses (Fig. 4) corroborated these results. Additionally, blink-related signal modulations were observed in the fourth ventricle, more prominent following isolated blinks, suggesting a potential link to arousal-related CSF dynamics.

These findings support the use of EEG-detected eye blinks as markers of arousal events during resting state fMRI, in line with prior eye tracking research [3]. Crucially, the distinction between clustered and isolated blinks leads to differences in both the timing and amplitude of associated BOLD signal changes, indicating heterogeneity among arousal-related events. The observed modulation in the fourth ventricle signal adds to the emerging body of evidence linking neural activity to CSF flow dynamics in awake humans [4,5].

The study shows that EEG-detected blinks may be effective arousal markers in resting-state fMRI. Differences between clustered and isolated blinks reflect distinct BOLD responses, highlighting arousal-related variability and linking blink timing to neural and CSF dynamics.
Frederico SANTIAGO (Lisbon, Portugal), Inês ESTEVES, Ana FOUTO, Amparo RUIZ-TAGLE, Gina CAETANO, Patrícia FIGUEIREDO
11:00 - 12:30 #47843 - PG499 Olfactory functional MRI: Application to evaluate brain activation patterns in women with sexual interest-arousal disorders.
PG499 Olfactory functional MRI: Application to evaluate brain activation patterns in women with sexual interest-arousal disorders.

Olfactory functions such as odor detection or response to olfactory stimuli can be assessed by functional MRI and contribute to the understanding of brain and behavior under different conditions. However, in comparison to other sensory domains, fMRI under olfactory stimulation has been less explored, in part due to the need for specific olfactory delivery systems. We performed olfactory-based fMRI using a custom-built system and applied it to evaluate the response to pheromone in female sexual dysfunction (FSD) subjects before and after treatment. FSD significantly impacts quality of life, with the most common subtype being hypoactive sexual desire disorder (FSIAD), characterized by a persistent lack of sexual desire or fantasies. Its causes are not fully understood but likely involve neuroendocrine, psychiatric, and behavioral factors (1,2). Only two studies have directly compared brain activity in women with and without FSIAD (3, 4). This study hypothesizes that FSD and the improvement in sexual dysfunction observed with ospemifene treatment is associated to changes in the response to pheromone, that can be measurable through olfactory stimulus-based fMRI (5).

We conducted fMRI analyses to study brain activation patterns before and after ospemifene treatment, in a cohort of 15 women with FSD (9 with ospemifene treatment, 6 with placebo). Participants were exposed to alternating scents—pheromones, clean air, and Phenyl Ethyl Alcohol (PEA) —using an open-source, low-cost, custom-built olfactory delivery system compatible with the fMRI setting. The fMRI protocol followed a standard block design with 12 one-minute alternating scent exposures. Head movement was minimized using individually molded foam supports. Prior to functional imaging, a high-resolution T1-weighted structural scan was acquired to exclude anatomical abnormalities and enable accurate localization of brain activity. Functional images were preprocessed with motion correction, EPI correction with T1 and a registration to the MNI152 atlas (6). First level analysis was performed afterwards, to obtain each subject activation in response to each odor in comparison with clean air, followed by a dual regression and randomization. The activation before and after treatment in each treatment group (ospemifene and placebo) was compared using voxel-wise randomize with TFCE correction. Significance was defined as p<0.005.

Fig 1.A shows the mean activation map in response to pheromone and PEA, showing a similar pattern of activation in areas related to olfaction, but with some differences in more occipital regions. Regarding the treatment effect, in women who received ospemifene, decreased brain activation was observed after treatment in response to both pheromone (fig.1B) and PEA odors (Fig 1C). Specifically, changes were noted in the frontal pole and medial frontal cortex for the pheromone, and in the insula, parietal operculum, and planum temporal for PEA. In the placebo group, changes between pre- and post-treatment were smaller. Reduced activation to pheromone was seen in the frontal pole (compared to no stimulus) and in both the frontal pole and cingulate gyrus (compared to PEA).

This study demonstrates that olfactory-based fMRI can detect changes in brain activation associated with sexual dysfunction and its treatment. Specifically, we observed a significant reduction in neural response to both pheromone and PEA stimuli following ospemifene treatment, particularly in brain areas involved in emotional processing, attention, and sensory integration, such as the frontal pole, medial frontal cortex, and insula. These changes were not as prominent in the placebo group, suggesting a potential effect of ospemifene on olfactory-related brain processing. Although previous studies on FSIAD have been limited, our findings support the hypothesis that olfactory responses, and possibly underlying limbic and cognitive pathways, are modulated by pharmacological intervention in women with FSD. This supports a broader neurobiological involvement in sexual desire disorders, beyond hormonal or psychological explanations.

In conclusion, our results suggest that fMRI combined with olfactory stimulation is a promising tool to investigate the neural mechanisms underlying female sexual dysfunction and its treatment. The use of a low-cost, open-source olfactory delivery system demonstrates the feasibility of incorporating such approaches in clinical research. Ospemifene treatment was associated with measurable changes in brain activation, supporting its potential to modulate neural circuits involved in sexual function. Further studies with larger cohorts and longitudinal designs are warranted to validate these findings and explore their clinical significance
Iñigo HERRERO VIDAURRE (Barcelona, Spain), Ribera-Torres LAURA, Jorge OTERO, Ramon FARRÉ, Camil CASTELO-BRANCO, Emma MUÑOZ-MORENO
11:00 - 12:30 #47839 - PG500 Optimization of glutamate quantification using CEST-MRI for neuronal compartment imaging.
PG500 Optimization of glutamate quantification using CEST-MRI for neuronal compartment imaging.

GluCEST imaging has been proposed to image brain glutamate distribution with a better resolution than spectroscopic methods and has many potential applications for the study of neurodegenerative diseases [1]. In this study, we pushed further the limits of gluCEST imaging by combining high magnetic field and high performance cryoprobe to acquire gluCEST images with the best resolution so far. To demonstrate the potential of quantitative gluCEST mapping, we focused on mouse hippocampus, a highly organized structure composed by several neuron-rich layers with high concentrations of glutamatergic synapses. Whereas gluCEST enables in vivo mapping of glutamate distribution, quantification remains challenging [2,3]. To overcome this obstacle, we developed a signal-optimization pipeline to improve the quantification of glutamate in vivo at 11.7T based on our 6-pools model [4].

CEST images were acquired in 2 anesthetized mice at 11.7T (Bruker) using a cryoprobe and a RARE sequence (B1 = 5 μT, Tsat = 1 s, saturation offsets = [-5:0.2:5] ppm, 0.15 x 0.15 x 0.3 mm3 resolution). A WASSR map was acquired for B0 correction. A B1 map was acquired using the double-angle method to correct for field inhomogeneities. Raw data were denoised using multilinear singular value decomposition (MLSVD) [5] and then fitted using our 6-pools model [4] (creatine (Cr), glutamate (Glu), amide (APT), nuclear overhauser effect (NOE), magnetization transfer (MT) and myo-inositol (MI)). Hippocampal correlation maps, mutual-information maps, and homogeneous-parameter maps were generated to identify the most interdependent parameter pairs to be fixed. Fit quality was assessed by RMSE, the coefficient of determination (R2), the Akaike Information Criterion (AIC), its corrected analogue for small sample sizes (cAIC), and the Bayesian Information Criterion (BIC) calculated as follows: BIC=nlog(σ^2 )+klog(n), AIC= nlog(σ^2 )+2k, cAIC=AIC+ (2k(k+1))/(n-k-1), Where n is the number of offsets and k the number of degrees of freedom.

MLSVD preprocessing increased AIC, BIC and cAIC of the hippocampal Z-spectra by 10.8 %, 7.6 % and 11.1 % respectively (Fig.1). Strong interdependence (r>0.4) among [Cr], [APT], and [MT] was revealed by the correlation maps (Fig.2a) and mutual-information maps (Fig.2b), and confirmed on homogeneous-parameter histograms (Fig.2c), including water-shift: voxel histograms displayed Gaussian distributions. [MT], [APT], [Cr] and water-shift were fixed at 8633 mM, 1998 mM, 86 mM and 0, respectively. At the same selected hippocampal voxel as Fig.1, statistical criteria were estimated to compare fitting performance based-on on raw data (Fig.3c), MLSVD-denoised data (Fig.3d), and MLSVD-denoised data and B1 correction (Fig.3f). MLSVD denoised improved AIC, BIC and cAIC by 12 %, 10 % and 12.1 %, respectively; with both MLSVD and B1 correction, fit criteria were improved by 12.9 %, 10 % and 12.9 %, respectively. In both cases, RMSE decreased from 0.008 to 0.005 and R2 increased from 0.979 to 0.992. The quality of quantitative gluCEST map was significantly improved compared to standard MTRasym map (Fig.4). The solid line (gluCEST, σ = 0.08) is markedly narrower than the dashed line (MTRasym, σ = 0.17), quantitatively confirming its reduced relative dispersion.

Enhanced fit quality was observed in the hippocampus, with all statistical criteria showing improvement (Fig.4). The selection of fixed parameters guided by correlation and mutual-information maps ensured the coherence of homogeneous-parameter maps, as reflected by their gaussian voxel-value distributions. Furthermore, signal quality in ventral regions was significantly improved in spite of high B1-heterogeneity inherent to the transmission-reception cryoprobe (Fig.3c).

The signal-optimization pipeline associated Z-spectrum fitting based on our 6-pools model significantly enhanced the quality of in vivo gluCEST parametric maps in the mouse brain at 11.7T, and particularly in the hippocampus. We observed higher glutamate concentrations in the CA1 and dentate gyrus regions of the hippocampus which is consistent with higher concentration of glutamatergic neurons in these particular substructures [6]. This quantification tool, when integrated with ultra-high-resolution imaging, holds the potential to enable highly specific visualization of the neuronal compartment. Such an approach could significantly enhance our understanding of the pathological mechanisms underlying neurodegenerative diseases, particularly Alzheimer’s disease, which is known to selectively affect neuronal structures.
Pierre LEMOIS (Paris), Julien FLAMENT
11:00 - 12:30 #46460 - PG501 Role of intramuscular inorganic phosphate in liver transplant candidates.
PG501 Role of intramuscular inorganic phosphate in liver transplant candidates.

Sarcopenia is well recognized in elderly individuals but is also highly prevalent among patients with chronic diseases, including end-stage liver disease, where the prevalence is approximately 40%. It negatively affects patient status before transplantation and significantly influences post-transplant recovery and survival. This study aims to describe the physical condition and metabolic status of calf muscles of patients before liver transplantation and wants to check these hypotheses: 1) there exists a significant difference in 31P MRS profiles of patients and controls; 2) MRS parameters correlate with simple clinical and kinesiological parameters as are e.g. liver frailty index (LFI) [1], 6-minute walk test (6MWT), etc.

In total, 51 patients (f/m=16/35, mean age 57.4±8.8 y/o, mean MELD score = 18.04) with liver cirrhosis of alcohol etiology were examined at the time of their inclusion on the liver transplant waiting list. The results were compared to those of 22 healthy volunteers (f/m=10/12, mean age 56.3±8.7 y/o). Patients, as well as volunteers, underwent kinesiological tests used for LFI calculation, 6MWT, and MRI and 31P MRS examination of the calf muscles. All subjects gave their written informed consent before participating in the study. 31P MR spectroscopy was performed at 3T MR system VIDA (Siemens Healthineers, Germany) using flexi 31P/1H surface coil (Rapid Biomedical, Germany) underneath calf muscle. Two FID sequences were applied (TR=15 s, TE*=0.4 ms, 16 acq at rest; dynamic part: TR=2 s, 1 acq, 420 measurements, 1 minute rest - 4 minutes plantar flexion at 25% maximum voluntary force - 9 minutes recovery). Signal intensities of PCr, Pi, ßATP, PDE and PME arising predominantly from the m. gastrocnemius and soleus were evaluated using the AMARES fitting routine in the jMRUI v5.0 software. 23 parameters from clinical tests, MRIs, and MRS examinations were used to compare both groups. The comparison of control and patient groups was done using t and U tests in PRISM and JMP software. Significant differences were described by False Discovery Rate (FDR, Benjamini-Hochberg), and significant difference between groups was considered for p<0.05.

Results of functional and MRS tests are summarized in Table 1 for 21 parameters, and the difference between groups of subjects and patients was found for 8 variables. These results can be summarized as follows: a) Patients consistently have lower functional measures (e.g., 6MWT, LFI, power output, area of gastrocnemius), confirming reduced strength and mobility in patients. b) Metabolic and phosphate-related markers (e.g. Pi/sum) show clear differences between groups, confirming altered muscle metabolism. On the contrary, dynamic MRS parameters did not reveal any significant changes. The most significant changes were visible in kinesiological tests, especially in 6MWT, where patients walked less than half the distance of the controls (see Table 1). The correlation matrix of above mentioned 21 parameters shows a strong correlation between 6MWT and LFI but a moderate correlation between clinical/kinesiological tests and MRS parameters (see Figure 1).

A key consideration in this sarcopenia study is the quality of the MR spectra. While the signal-to-noise ratio (SNR) was sufficient for reliable quantification of PCr, Pi, and ATP, the signal intensities of PME and PDE should be interpreted with caution, as their lower SNR renders them less suitable for detailed analysis. Expected changes in the decreasing PCr/Pi signal intensity ratio were observed in all patients, confirming their muscle impairment. However, a more detailed analysis revealed that the observed alterations are not primarily due to changes in PCr levels, but rather to an accumulation of Pi. This Pi accumulation supports the hypothesis of calcium phosphate precipitation, as originally proposed by Allen et al. [2]. According to this mechanism, elevated Pi enters the sarcoplasmic reticulum (SR), where it binds to Ca²⁺, forming insoluble calcium phosphate complexes. This leads to a reduction in the free Ca²⁺ concentration within the SR, thereby limiting Ca²⁺ release and contributing to impaired excitation–contraction coupling during muscle fatigue. Recent studies have provided strong experimental and theoretical support for this hypothesis, demonstrating that Pi-induced reductions in SR Ca²⁺ availability are a significant contributor to fatigue-related muscle dysfunction.

In conclusion, simple kinesiological tests may be sufficient for characterizing the current physical condition of liver transplant candidates in routine clinical practice. However, MR spectroscopy provides complementary metabolic information about skeletal muscle, with the inorganic phosphate signal emerging as a particularly promising marker for investigating the pathophysiological background of sarcopenia.
Monika DEZORTOVA (Prague, Czech Republic), Petr SEDIVY, Petr KORDAC, Dita PAJUELO, Robert CHARVAT, Pavel TAIMR, Milan HAJEK
11:00 - 12:30 #47664 - PG502 Automated whole liver segmentation to enable efficient hepatic function assessment with constrast-enhanced mri following selective internal radiation therapy for liver cancer patients.
PG502 Automated whole liver segmentation to enable efficient hepatic function assessment with constrast-enhanced mri following selective internal radiation therapy for liver cancer patients.

Hepatic function (HF) evaluation is essential for monitoring chronic liver diseases and liver cancers like hepatocellular carcinoma (HCC) [1]. Clinically, methods such as hepatic scintigraphy, indocyanine green (ICG) clearance test, ALBI grade [2], and MELD score are utilized, though these offer limited insights about anatomy. Hepato-specific MR contrast agents [3,4] provide a less invasive way to visualize liver tissue properties while delivering anatomical information without ionizing radiation. This study introduces an MRI-based approach to assess HF changes in patients with liver cancer undergoing selective internal radiation therapy (SIRT) and compares it to clinically validated methods.

This prospective single-center study was approved by the ethics committee. Sixteen patients with either HCC or liver metastases from other primary cancers treated by SIRT and with an ICG clearance test, dynamic hepatobiliary scintigraphy, lab tests, and a gadoxetic acid–enhanced liver MRI (3T or 1.5T, Siemens or Philips) before and two months after SIRT were included. Detailed information is in Fig. 1. HF change was quantified by assessing the evolution in healthy liver volume from gadoxetic acid–enhanced MRI, relying on an automatic liver segmentation and a volume of interest (VOI) of size between 0.75–1 cm³ manually placed in the liver parenchyma as illustrated in Fig. 2. Liver segmentations were performed automatically [5] and manually refined by a radiologist. VOI quality was checked via variation coefficient control, by ensuring that <30% of voxels deviated by > one standard deviation from the VOI mean intensity. For each patient, we ensured that the VOI was selected at the same location between the baseline and the post-op scans. MRI intensity was normalized using the VOI median intensity value for consistency across scans, scanner manufacturer, and timing differences between contrast injection and image acquisition. The VOI also served for the HF evaluation. A thresholding operation was performed to define the healthy liver volume, according to the formula: S_(liver voxels) ≥ μ_NVOI-n∙std_NVOI (1) S_(liver voxels) represents normalized signal intensity in liver voxels [6], μ_NVOI and std_NVOI are the median and the standard deviation of the VOI normalized signal intensity, respectively. The tuneable parameter n sets the intensity threshold to distinguish healthy from abnormal tissue (e.g., tumor areas, regions affected by SIRT, cysts). Eventually, the relative change in healthy tissue volume between baseline and the post SIRT MR scans was computed to classify the HF evolution. A Receiver Operating Characteristic (ROC) analysis was used to find the optimal threshold. ALBI grade was calculated using albumin and bilirubin levels from lab tests [2] and used as ground truth. A threshold for absolute change was set: an ALBI grade increase >0.1 indicates HF decreases. The ICG value obtained at 15 min post injection (ICG15) was used in the analysis.

Liver uptake rate obtained by scintigraphy, ICG15 values, and our MRI-based approach were compared to ALBI grade calling upon ROC curves. Since liver uptake rate and ICG15 are already relative values, solely their absolute change was considered to classify HF evolution. We determined the parameter n based on the largest area under the curve (AUC) shown in Fig. 3(a, b) and selected n = 9. Our MR-based approach showed an improved accuracy compared to scintigraphy in classifying patients with decreased HF from those with an increased or unchanged HF following SIRT (AUC of 0.78 versus 0.6), although still below ICG15 (AUC = 0.82), as shown in Fig. 3(c). The F1 score of our method reached 0.84, close to ICG15's 0.86, and superior to scintigraphy’s 0.63. Accuracy was slightly lower for HCC patients for all the methods as shown in Fig. 4(a). ROC curves could not be computed for metastatic liver disease as a decrease in HF was systematically observed for these patients. However, 80% of patients (4/5) were correctly classified by our method and ICG15, compared to 60% by scintigraphy. We also evaluated the effect of treatment selectivity on the different methods. As shown in Fig. 4(b, c), we observed an increased accuracy for the ICG15 and MR-based methods while scintigraphy exhibits a decrease in accuracy in terms of AUC when the treatment becomes more selective. ROC curves could not be computed for whole liver treatment as a decrease in HF was systematically observed.

Gadoxetic acid–enhanced MRI scans offer a robust mean of assessing HF evolution, surpassing scintigraphy in both F1 score and AUC, and nearing the accuracy of ICG15. These prospectively determined findings highlight the potential of this non-ionizing method to monitor HF changes following SIRT while providing additional relevant anatomic information. Our method also demonstrated its effectiveness across different MRI field strengths. Further larger prospective trials are needed to validate our data.
Mathieu RUCH (Bulle, Switzerland), Chloé AUDIGIER, Flavian TABOTTA, Bénédicte MARÉCHAL, Rafael DURAN
11:00 - 12:30 #46220 - PG503 Detection of Aggressive Mesenchymal Glioblastoma by Mannose-Weighted CEST MRI.
PG503 Detection of Aggressive Mesenchymal Glioblastoma by Mannose-Weighted CEST MRI.

Glioblastoma is one of the most aggressive cancers known to men. Non-invasive assessment of aggressiveness is crucial for treatment planning, but current MRI protocols lack specificity. Amide proton transfer CEST MRI can grade diffuse gliomas, but not GBM aggression levels. GBM invasiveness arises from a shift from a pro-neural to mesenchymal phenotype. Based on a report that mannose-weighted (MANw) CEST MRI can detect unlabeled mesenchymal stem cells (MSCs) overexpressing mannose [1], we investigated if mesenchymal cancer stem cells can be detected “label-free” in a similar fashion.

Mannose expression was assessed using fluorescein-labeled galanthus nivalis lectin (GNL-FITC, specific for mannose) staining, and the mesenchymal cellular phenotype by anti-CD44 immunostaining. A tissue microarray, containing 35 cases of glioblastoma and 5 cases of normal cerebral tissue was obtained from Tissuearray.Com. CD44 expression and mannose levels were calculated by measuring mean fluorescence intensity (MFI) from fluorescence images, with values normalized on a 0–100% scale for comparison across samples. For pre-clinical studies, low aggressive GBM1a and highly aggressive M1123 cells were used throughout. MANw CEST MRI was conducted using a Bruker 11.7T vertical bore spectrometer. For in vivo tumor models, 2E5 M1123 and GBM1a spheres were injected into the striatum of NSG mouse brain. In vivo T2-w and MANw CEST MRI was performed 1, 8 and 16 days after injection. Tumor and brain ROIs were manually drawn based on T2-w images. For M1123 cells, the mannose-binding lectins LMAN1 and LMAN2 were knocked down using liposomal transfection with LMAN 1/2 siRNA, and LMAN1/2 expression was quantified with qRT-PCR.

For the tissue microarray, analysis of CD44 expression and mannose levels demonstrated a positive correlation (r=0.65, p=0.0003)(Fig. 2C), indicating a connection between elevated mannose levels and mesenchymal phenotypic transitions in GBM, with the two markers absent in normal brain. Low mannose expression was seen for both 2D cell cultures, but 3D M1123 spheres contained more mannose compared to GBM1a (Fig. 1A). In vitro MANw CEST MRI showed the highest CEST signal for the M1123 3D spheres (Fig. 1B). T2-w MRI showed M1123 cells growing much faster than GBM1a invading across the entire hemisphere on day 16 (Fig. 1C). On day 1, a distinct MANw CEST MRI signal was observed for M1123, but not for GBM1a. Eight and 16-day post-injection follow-up revealed a continuous pronounced MANw CEST signal only for M1123 (Fig. 1D), which correlated with anti-mannose staining (Fig. 1E). The MANw CEST signal of M1123 was significantly higher (>1.8-fold) than GBM1a and host brain for all time points (Fig. 1F). Anti-CD44 immunostaining revealed an abundance of MSCs in M1123, but none in GBM1a. Silencing LMAN1/2 in M1223 cells (Fig. 2A) resulted in a 4-fold reduction of LMAN1/2 and mannose expression (Fig. 2B), which was accompanied by a 10% reduction in MANw CEST MRI signal (Fig. 2C).

Changes in glycosylation profiles are an important feature of mesenchymal transitions and offer a potential biomarker for classifying tumor subtypes and monitoring transitions to more aggressive treatment resistant tumors. We showed that mesenchymal GBM cells express higher levels of genes involved in mannose regulation and display significantly higher mannose levels and higher MANw CEST signal than their proneural counterparts. Importantly, these correlations were maintained in patient derived glioma cells and tissues and tumor xenografts. While conventional T2-weighted and Gd-based contrast-enhanced MRI enable visualizing brain tumors, they lack specificity in differentiating tumor subtypes and assessing microenvironmental changes. Integrating MANw CEST MRI with the currently available MRI portfolio, including APTw MRI, could enable a more comprehensive evaluation of GBM. We envision this approach will improve detection of aggressive mesenchymal tumors and their recurrence, refine treatment stratification, enhance the monitoring of therapeutic responses, and aid in optimizing surgical planning.

We have developed MANw CEST MRI as a novel method to assess GBM aggressiveness without the need of injecting imaging agents. Once translated, this advancement may decrease the time interval between diagnosis and treatment, increasing patient survival. Since brain tumor patients already undergo routine MRI, our approach can be added to existing MRI protocols without further regulatory approval. Clinical studies are currently in progress.
Behnaz GHAEMI, Hernando LOPEZ-BERTONI, Shreyas KUDDANNAYA, Sophie SALL, John LATERRA, Guanshu LIU, Jeff BULTE (Baltimore, USA)
11:00 - 12:30 #47364 - PG504 Optimal control pulses and MIMOSA for CEST preparation at 7 T.
PG504 Optimal control pulses and MIMOSA for CEST preparation at 7 T.

In UHF systems at 7T, highly inhomogeneous B1 fields pose a major challenge for RF pulses. The MIMOSA approach [2], using alternating circular and elliptical polarization, improves saturation homogeneity for conventional Chemical Exchange Saturation Transfer (CEST) pulses. The newly introduced approach of Optimal Control (OC) pulses for the preparation of CEST effects shows advantages over classical pulse shapes [1,4]. This work investigates whether OC pulses retain their properties and benefit similarly from MIMOSA. This investigation was motivated by the complex superposition of electromagnetic phenomena and the special properties of OC pulses.

In contrast to optimized pulse trains in 1Tx systems, pTx using MIMOSA requires to repeat the same pulse with different modes. Thus, it requires a single efficient OC Pulse, which is B1 independent has been optimized for this purpose. This pulse is then concatenated to a pulse train of arbitrary B1rms, duty cycle (DC) and duration and played out using Pulseq pTx and the hybrid Pulseq-Gradient Echo Sequence [8]. The Pulseq pTx extension [7] now allows us to modulate each pulse individually in different RF modes and thus represent the MIMOSA principle. The resulting OC CEST preparation pulse is shown in Fig 1. The High B1 preparation method of the comprehensive CEST approach [3] was optimized with OC pulses. The B1 maps used for the B1 correction were generated using a DREAM [5] mapping method (Fig 2.). For the B0 correction, a B0 map was created with a WASABI [6] measurement. The evaluation of the CEST maps was carried out with the CEST pipeline of the cCEST [3] approach shortened to the High B1 level, 4µT Hydroxy. All experiments were performed on a 7T Terra.X VA60 (Siemens Healthineers) scanner and an 8Tx/32Rx head coil (Nova Medical) and under approval of a local ethics committee. The measured subject was a male healthy subject.

It can be shown that the use of OC pulses with MIMOSA preparation can improve homogeneity [Fig 3]. The strong signal of the CP mode is only homogeneous in the center [Fig 2]. The areas outside the center have fewer and a less stable signal. The MIMOSA mode, which combines the CP and EP modes, ensures that a homogeneous contrast is achieved across a wider area.

OC pulse for CEST preparation provides visible improvements for CEST imaging. This has also already been demonstrated at 7 Tesla [4]. MIMOSA preparation has already been shown to improve B1 inhomogeneities in UHF imaging [2]. The combination of the two technologies improves the homogeneity of the CEST maps . The Pulseq Hybrid approach allows new optimized pulse shapes to be easily tested. This allows OC Pulse to be applied flexibly to different B1rms levels, duty cycles and number of pulses. It is also possible to permanently integrate optimized pulse shapes into CEST sequences.

The combination of OC pulses and MIMOSA preparation can visibly improve homogeneity of CEST imaging even further Acknowledgements: Thanks to Moritz S. Fabian for providing the cCEST evaluation pipeline. Funded by IDL@7T, BMBF.
Martin FREUDENSPRUNG (Erlangen, Germany), Clemens STILIANU, Simon WEINMÜLLER, Rudolf STOLLBERGER, Moritz ZAISS
11:00 - 12:30 #46239 - PG505 Deviant loading-induced deformation pattern as a potential marker of discogenic pain: A distinct phenotype of nonspecific low back pain?
PG505 Deviant loading-induced deformation pattern as a potential marker of discogenic pain: A distinct phenotype of nonspecific low back pain?

The diagnosis of nonspecific low back pain (LBP) faces several challenges due to the lack of precise biomarkers [1]. MRI often fails to reveal a clear cause, leading to potential misinterpretation of findings [2]. Increased stress on the intervertebral discs may cause fissures and lead to structural weaknesses of the annulus fibrosus [3]. This weakening may alter the biomechanical properties and introduce micro-instabilities in the motion segment [4]. The deformation of such discs may be elevated and cause pain-signaling from nerve endings in the outer part of the annulus fibrosus. This study aimed to determine whether disc deformation is linked to annular fissuring and if it has the potential to phenotype/target the pain in patients with nonspecific LBP. The aim was investigated using a novel MRI method to assess disc deformation (Fig 1) [5] with CT and low-pressure discography as references of annular fissuring and pain provocation.

76 intervertebral discs in 28 LBP patients [45±9 years, 16 women] were examined with MRI in supine position with and without spinal loading, followed by low-pressure discography and CT during the same day. To determine the disc deformation, MR images with and without loading were registered to a common spatial volume using the Elastix software. Disc compression or expansion was then calculated as the Jacobian determinant of the registration deformation field in five midsagittal slices (Fig 1). A senior radiologist classified the discs on post-CT-discograms into no fissures, posterior fissures, anterior and posterior fissures, and severe fissuring (<50% continuously intact outer third annulus fibrosus). The operational criteria for pain provocation during discography [6] were applied to classify discs into discogenic pain/no pain. Wilcoxon rank-sum and Levene’s test were used with p<0.05 to determine group differences and equality of variances. A binary logistic regression model was used to explore possible associations between deformation and fissure extent or pain, where the strength of the model was displayed using receiver operating characteristics (ROC).

In general, the intravertebral discs displayed compression of the annulus fibrosus posteriorly and expansion anteriorly (Fig 2) and only small differences within groups and between groups, were seen. However, discs with fissures both anteriorly and posteriorly and those with severe fissuring displayed larger deformation and significantly larger within-group variance (p=0.001-0.04). Discs with high anterior and low posterior deformation were more likely pain-signaling, whereas those with high posterior and low anterior deformation were more likely non-pain-signaling (Fig 3). These specific deformation patterns could predict pain and no pain in the discs with high certainty (Fig 4). Probability thresholds <0.38 were all correctly classified as no pain (n = 9), whereas those with probabilities >0.65 correctly classified pain in 12 out of 14 discs (Fig 3).

Building on a novel MRI method for non-invasive quantification of disc deformation [5], this study showed that disc deformation has the potential to phenotype/target discogenic pain in patients with nonspecific LBP. Such a biomarker could potentially guide surgeons in decision-making regarding therapy. The study also moves the current research front forward by providing in vivo evidence of a close relationship between disc deformation and annular fissuring. While most discs with posterior fissures only displayed similar deformation as non-fissured discs, with compression posteriorly and expansion anteriorly, discs with fissures both anteriorly and posteriorly, and those with severe fissuring displayed large anterior deformation under load. While this deviant deformation pattern was clearly able to distinguish identify pain signaling discs, the results require further validation.

This study supports the hypothesis that disc deformation, quantified with loading-based MRI, may be an image biomarker linked to disc-specific pain-signaling. Especially elevated anterior deformation associated with extensive fissuring, seems to be of value in identifying the pain-signaling discs. Such a precise biomarker of nonspecific LBP can lead to improved diagnostics, and potentially also better treatment outcomes for this large patient group.
Kerstin LAGERSTRAND (Västra Frölunda, Sweden), Hanna HEBELKA, Helena BRISBY, Christian WALDENBERG
11:00 - 12:30 #47790 - PG506 Low-cost, open-source, MRI-compatible grip force sensor for NMES-synchronised dynamic muscle MRI.
PG506 Low-cost, open-source, MRI-compatible grip force sensor for NMES-synchronised dynamic muscle MRI.

Synchronising dynamic MRI acquisitions with physical force measurements and neuromuscular electrical stimulation (NMES) enables standardised and normalised assessment of muscle activity [1] but requires an MR-compatible, e.g., safe and artefact-free setup with force sensors and NMES. While the NMES setup is generalised to dynamic MRI, the force sensor needs to be tailored to the respective muscle group under investigation. Building on a custom foot pedal sensor previously used for leg muscles [2], this study presents a further developed open-source, low-cost, MR-compatible grip force sensor for dynamic forearm muscle MRI.

Sensor design and setup: A handheld device was designed in FreeCAD (v0.21.2) and 3D printed (A1, Bambu Lab, Shenzhen, China) to house the force measurement components. The grip force measurement is implemented with two 50 kg (490 N) aluminium beam load cells in a parallel Wheatstone bridge configuration. An Ethernet cable connects the load cells to the electronics outside the scanner room. Furthermore, the subject is in head-first (superman) position so that the cable length within the scanner bore is minimised. A custom low-pass filter protects the microcontroller (Arduino Uno [3]) from MRI interference. The microcontroller, placed outside the scanner room, streams force data to a PC via USB. A custom Python program (v3.13.0) logs the data. The setup is extended by placing an (optional) NMES device (EM 49, Beurer GmbH) outside the scanner room. Detailed building instructions are available at [4], [5]. Fig. 1 shows a schematic of the electronics and assembly. Testing the potential interaction between the grip force sensor and the MR scanner: The sensor was calibrated and tested for accuracy both inside and outside the MRI by systematic placement of known weights ranging from 0.1 to 100 kg outside the scanner room and up to 10 kg MRI-compatible weights inside the MRI while a GRE sequence was running. To evaluate the MR compatibility of the force sensor, water phantom measurements and in-vivo measurements were conducted with a 3 T whole-body MRI scanner (MAGNETOM Prisma, Siemens Healthineers) and a 18-channel flex coil for signal acquisition. For the phantom-based measurements, a dual echo, gradient-recalled echo (GRE) sequence was used to calculate B0 maps and SNR with and without the setup active. For both scenarios, a Siemens RF noise service sequence was used to acquire RF noise spectra. Following NEMA [6] standards, the SNR was calculated from ten separate acquisitions of signal and pure noise, which were subsequently used for a t-test. To assess the functionality of the whole setup, a conventional 2D phase contrast sequence was acquired sagittally while triggering with NMES in five healthy subjects.

The force sensor demonstrated good linearity with an R² value of 0.998 / 0.999 inside and outside of the MRI (Fig. 2). Minor B0 inhomogeneities were observed with the installed setup and active sensor compared to the baseline. SNR decreased by 3.7% (p < 10⁻⁴) from 232 ± 5 to 223 ± 10 with the sensor active. Mean and max RF noise remained similar with and without the device (Fig. 3). The setup reliably recorded the force profile of each voluntary contraction during dynamic MRI. The magnitude of the measured force varied intersubjectively. Furthermore, in subjects one, three and five, a gradual decrease in contraction force is observed (Fig. 4).

With consistent linearity and accuracy, the sensor suits dynamic MRI tasks requiring a broad range from 20% of normal grip force ranges of 11 kg/ 110 N evoked by NMES to a maximum voluntary grip force of up to 83 kg/ 814 N [7], [8]. The low-pass RF filter is essential for a reliable force recording. Without the filter installed, the microcontroller experienced random resets. Furthermore, uncontrolled motion and poor cable management introduced falsely recorded force values, including negative force values and RF-induced offsets. This can be addressed by proper wrist stabilisation with vacuum paddings and minimising the length of the Ethernet cable within the scanner bore (direct RF field). The utilisation of the grip force sensor caused a 3.7% drop in SNR, which is acceptable for grip force measurements but may be problematic for lower SNR applications like non-proton imaging or spectroscopy. The associated B0 variations were minor compared to B0 inhomogeneities induced by differences in susceptibility of anatomical structures in various regions of the body [9], [10].

In this paper, we presented an open-source implementation of a grip force sensor using commercially available components not specifically designed for the application in an MRI environment. The device demonstrated robust functionality and a minimal penalty in terms of output image quality. Therefore, it is feasible to utilise the grip force sensor with optional NMES in dynamic muscle MRI to characterise forearm muscle activity in subjects.
Sabine Melanie RÄUBER (Basel, Switzerland), Marta Brigid MAGGIONI, Francesco SANTINI
11:00 - 12:30 #47821 - PG507 Low-field knee MRI in the clinical setting: a comparative study of a 72 mT with a 3 T scanner.
PG507 Low-field knee MRI in the clinical setting: a comparative study of a 72 mT with a 3 T scanner.

Low-field magnetic resonance imaging (LF-MRI) systems stand out for their portability and cost-effectiveness, albeit at the expense of reduced signal-to-noise ratio (SNR), or resolution, when compared to high-field systems. Despite growing interest in LF-MRI development, its diagnostic utility remains largely unexplored. In this study, we present an on-going investigation of the clinical potential of LF-MRI for musculoskeletal imaging of patients with knee lesions. To this end, we are employing a 72 mT system called Physio I [1]. All patients are also being scanned in a Philips ACHIEVA 3T clinical scanner [2]. The comparison between the paired images will allow us to determine the diagnostic potential of our Point of Care(PoC) system. The study is performed at La Fe Hospital in Valencia.

A cohort of at least 80 patients with undiagnosed knee injuries is presently undergoing MRI scans on both systems. These images will be compared to evaluate the diagnostic capacity of our LF system. Our LF protocol for Physio I is optimized for clinical diagnosis, aligning with the sequences of the 3T system in La Fe while ensuring sufficient resolution, SNR, and total duration. It includes four sequences: a T1-weighted Rapid Acquisition with Relaxation Enhancement (RARE) sagittal scan, a T2-weighted RARE sagittal scan, and both sagittal and coronal Short Tau Inversion Recovery (STIR) sequences, for a total duration of approximately 40 minutes (Fig.1). These sequences will be evaluated by at least one radiologist without prior knowledge of the injuries present, and compared with the diagnosis from the 3 T acquisitions. Technically, several key improvements have been implemented in our LF system since a prior study on healthy volunteers [3]: the x-gradient coil was extended to increase the axial field-of-view (FOV), the RF coil elements were lengthened, and sequence parameters optimized for better contrast and SNR. An in-depth eddy-current analysis led to mechanical redesigns, reducing aluminium parts and suppressing related artefacts. For improved patient comfort, we added bed-positioning rails and a screen for a better overall experience.

At the time of writing this abstract, we have successfully installed our system, Physio I, in La Fe Hospital (Fig.2a). Once there, we optimized the positioning and configuration of our system to minimize electromagnetic noise, and trained the radiology technicians in patient handling for Physio I. So far, we have scanned 6 out of the intended 80.

These initial images show promise in distinguishing anatomical structures and musculoskeletal pathologies (Fig.2). We observe certain distortions and artifacts due to the inhomogeneity of B0 and non-linearities of the gradient fields. However, these can be corrected using both Single-Point Double-Shot methods (SPDS, [4]), and geometrical co-registration algorithms based on Elastix [5]. As we are still in the data acquisition phase, no post-processing has been applied, and diagnostic evaluations are pending. At the moment, we are building the database by storing the acquired knee paired images, following a common folder convention between our data and the data acquired in Philips ACHIEVA. This paired 72 mT and 3 T dataset will then be used as training data for machine learning applications, including domain translation networks, among others, aiming to improve the perceived resolution and diagnostic value of low-field images. Additionally, it will be used to evaluate the diagnostic capability of our LF images with respect to the high-field images, following an evaluation performed by radiologists from La Fe hospital.

This is the first comparative clinical study evaluating the diagnostic performance of a low-field scanner for musculoskeletal knee applications with patients presenting real injuries. Although the project is still in the data-acquisition phase, the preliminary results obtained with our 72 mT Physio I scanner show potential to distinguish important anatomical features of the knee, as well as different injuries. As we scan patients, we are building the first muskuloskeletal knee database of paired images from low to high field strength. After the data acquisition phase, we will use said database to provide insight into the clinical viability of LF systems, as well as the potential of AI-based methods to enhance the contrast and increase the quality of LF images.
Marina FERNÁNDEZ-GARCÍA, Teresa GUALLART-NAVAL, Amadeo TEN ESTEVE, Sonia GINÉS CÁRDENAS, Jose BORREGUERO PLAZA, Lorena VEGA CID, Luiz GUILHERME DE CASTRO SANTOS, Lucas SWISTUNOW, Eduardo PALLÁS LODEIRO, Jesús CONEJERO RODRIGUEZ, Jose M. ALGARÍN, Fernando GALVE CONDE, Luis MARTÍ-BONMATÍ, Joseba ALONSO OTAMENDI, Elisa CASTANON GARCIA-ROVES (Valencia, Spain)
11:00 - 12:30 #46625 - PG508 Fast Field-Cycling as a Tool for Investigating Fibrin Clot Microstructure.
PG508 Fast Field-Cycling as a Tool for Investigating Fibrin Clot Microstructure.

Fast-field cycling NMR relaxometry (FFC-NMR) measures T1 over a wide range of low magnetic field strengths (Figure 1), typically between 25 µT - 200 mT, to produce R1 (1/T1) NMR dispersion profiles (NMRD) that graphically show T1 relaxation changes with the magnetic field strength. While nuclear magnetic resonance dispersion (NMRD) profiles acquired using FFC-NMR reflect molecular dynamics of water occurring on different timescales (ms to µs), the biological meaning and physiological importance is unclear. We investigated whether and to what extent biologically relevant characteristics of protein gels could be quantified from NMRD profiles. We used a fibrin clot as a model as it is a widely studied protein system. In fibrin clots, water molecules demonstrate a spectrum of molecular dynamics, inclusive of adsorption and desorption motion [1,2]. Relaxation of such motion is thought to be mediated via reorientation mediated by translational displacements (RMTD) [1,2], an expression that characterises relaxation of adsorption and desorption motion using the diffusion constant of water molecules interacting with proteins, fractal dimension (integer characterising geometric complexity), and resonance frequency. It remains uncertain if interactions between water molecules and the fibrin fibres can be detected using FFC-NMR, and whether such adsorption and desorption motion can be reliably described by RMTD. Moreover, the dominant timescale where water molecules continuously transfer between bulk and fibrin fibre surfaces is unknown. Therefore, this study aimed to model NMRD profiles of fibrin clots using the RMTD expression to retrieve the fractal dimension and quantify the microstructure of fibrin network.

To determine if RMTD was dominant in the NMRD profiles of fibrin clots, we compared the fractal dimension obtained using the RMTD expression with the one obtained from confocal microscopy images. Fibrin clots comprised of various concentrations of thrombin (0.01–1U/mL) and fibrinogen (1–3mg/mL) were measured using FFC-NMR relaxometry at 25 – 40°C across 15 different magnetic fields. Measurements were acquired using both pre- and non-polarised multi-exponential sequences with a change at 4 MHz succeeding polarisation (Figure 1). Confocal microscopy of fibrin clot with fluorescent-labelled fibrinogen were then generated in chamber slides and imaged to validate information from RMTD expression. Gold standard image analysis algorithms were used to obtain reference fibrin clot fractal dimensions.

Confocal images (Figure 2) validated structural changes of fibrin clots in accordance with the concentration of fibrinogen or thrombin used for clot formation. High concentrations of thrombin and fibrinogen produced dense clots composed of highly branched and thin fibres, whereas lower concentrations produce course networks of unbranched and thick fibres. The differing fractal dimensions between all fibrin clots retrieved using confocal microscopy image algorithms (Figure 3) further quantitatively validated the structural difference. Moreover, the microstructural differences between fibrin clots were measurable using FFC-NMR, as distinct differences in NMRD profiles were evident (inclusive of inflection points, gradients, and offsets). We identified three different molecular motions dominating (inflection points of NMRD profiles) between 25 µT – 200 mT: regime 1 (200 mT and 10 mT), regime 2 (10 mT and 100 µT), and regime 3 (100 µT and 25 µT). Structural information of fibrin clots from FFC-NMR between 10 mT – 100 µT was equivalent to confocal microscopy (p > 0.05). The fractal dimensions for all fibrin clots found using RMTD expression compared to confocal microscopy between these magnetic fields were 1.70 (±0.1) and 1.68 (±0.09), respectively (Figure 3).

This work shows the relaxation of fibrin clots between 10 mT – 100 µT is likely dominated by rapid adsorption and desorption of water molecules between the bulk and surface of fibrin fibres, RMTD. The general structure of fibrin clots can be characterised in this region by modelling NMRD profiles with RMTD expression. Outside this field range, other molecular motions dominate and may be better studied with alternative models.

Determination of fibrin clot microstructure is crucial in predicting the likelihood of rupture, embolization or response to antithrombotic management. Correctly identifying the motional water regimes over the frequency spectrum will ultimately contribute to assessing the potential future use of low-field imaging of blood clots, as well as other pathological protein networks.
Madeleine RHODES (Aberdeen, United Kingdom), Nicola MUTCH, Lionel BROCHE
11:00 - 12:30 #46975 - PG509 MR-based characterization of Giant Unilamellar Vesicles as synthetic cell phantoms.
PG509 MR-based characterization of Giant Unilamellar Vesicles as synthetic cell phantoms.

The assessment of cell size and cell packing via diffusion-weighted MRI (dMRI) have proven useful to monitor tumor progression and anti-tumor treatment efficacy.[1,2] The development and refinement of dMRI techniques and biophysical diffusion-signal models has thus far mainly been performed on aqueous suspensions of (yeast) cells or polystyrene latex beads.[3,4] While cell suspensions best replicate cellular structures, their biophysical and chemical properties are difficult to control over time and between batches. Furthermore, preparations of individual samples can take several days to weeks. Bead-filled phantoms are faster to produce with controlled diffusion dimensions but the bead material does not replicate biological membranes in elasticity and permeability. To address these issues, we propose giant unilamellar vesicles (GUVs) as synthetic cell phantoms.

GUVs were prepared in an aqueous solution via the hydration method. Their membranes were composed of 10 mg/mL phosphatidylcholine (POPC) and 1 mol% biotin. Different size classes were achieved after gravity-filtration through a 10 µm mesh. GUV samples were condensed into visible patches by adding 5-10 µg/mL streptavidin to the suspension and brief centrifugation. The supernatant of a subset of unfiltered, H2O-filled GUVs was replaced with >99%, 50% or 25% D2O to determine the impact of the extravesicular compartment on dMRI measurements. Patches in suspension were imaged in a Bruker BioSpec 94/20 MR scanner using a 2-element cryoprobe with pulsed and oscillating gradient spin echo sequences with segmented EPI readout (PGSE and OGSE, respectively, fmax = 200 Hz, bmax = 2000 mm²/s). GUV radii and packing were calculated using the IMPULSED model.[5] IMPULSED-derived radii were compared to radii obtained from fluorescence microscopy of the same samples. Since larger GUVs contribute more to the MR-derived radii, microscopy radii were volume-weighted to allow for meaningful comparisons (effective radii reff).[6] To confirm the samples’ chemical composition, we determined relaxation times T1 and T2 in the GUV patches and recorded localized 1H NMR spectra (STEAM; 3×1×3 mm³ voxel, 512 averages, TE/TR = 3/4000 ms, VAPOR water suppression).

Aggregated GUV patches were always visible in dMRI as hyperintense areas, characterized by reduced T2 and unchanged T1, compared to the standard medium (fig. 1). IMPULSED-derived radii and microscopy radii for filtered samples were smaller than for unfiltered samples (fig. 2A, B). With respect to IMPULSED radii, this difference was significantly larger for scans using sine-modulated OGSE dMRI sequences compared to scans using cosine-modulated OGSE. IMPULSED radii did not differ significantly from microscopy radii. While the slope of the linear regression between microscopy radii and sine radii across filtered and unfiltered samples was only 0.47, the regression slope was 0.90 for cosine radii, albeit at a wider confidence interval (fig. 2C, D). Localized 1H NMR spectra revealed three peaks upfield of the water resonance frequency (fig. 3). H2O-filled GUVs suspended in >99% D2O were hyperintense even in T2-weighted spin echo sequences. Despite very low overall signal in the >99% D2O samples, GUVs were still visible in high b-value and high frequency dMRI. T2 was reduced by 40% at >99% D2O but ADC was slightly elevated, compared to 50% and 25 % D2O suspensions. Low signal intensities corresponded to a larger spread of IMPULSED radii in the GUV patch at >99% D2O (fig. 4). In all cases, radii outside of the patch converged on the fit limits (0 µm and 30 µm; fig. 1 & 4).

Using multiple MR modalities, we have characterized key physicochemical parameters of the GUV system. Compared to conventional phantoms for diffusion-based cell size measurements in MRI, GUVs can be synthesized within hours. Streptavidin-biotin-assisted packing is sufficient to form macroscopic patches with reduced diffusivities and T2. Here, we confirmed that the IMPULSED model is suitable to detect size differences of GUVs following gravity-driven filtration and that IMPULSED radii are in good agreement with radii determined from microscopy. 1H spectra of cross-linked GUVs in suspensions show peaks for the three main constituents of POPC, however, peaks are relatively broad.[7] Replacing the extravesicular medium with D2O reduces overall signal, however, IMPULSED can still be successfully applied after sufficient averaging. Doping the intravesicular or extravesicular medium with signal suppressing D2O presents a relatively straight-forward route to disentangle contributions of different compartments to diffusion signals. This may open the possibility for calibrating signal models under well-defined in situ conditions.

GUVs are a promising multicompartment tool for dMRI-based cell size measurements that can be produced within hours at desired size ranges, packing and chemical composition.
Bastian MAUS (Münster, Germany), Daniele DI IORIO, Robert VORNHUSEN, Seraphine V. WEGNER, Cornelius FABER
Poster hall
12:30 LUNCH BREAK
13:30

"Saturday 11 October"

Added to your list of favorites
Deleted from your list of favorites
B34
13:30 - 15:30

CAMERA

Chairpersons: Udunna ANAZODO, Marina FERNANDEZ GARCIA (PhD Candidate, CAMERA Consortium Manager) (Chairperson, Valencia, Spain)
13:30 - 13:40 Welcome remark. Udunna ANAZODO
13:40 - 14:00 Real-world implementation of open source MRI designs. Guillermo SAHONERO ALVAREZ (Keynote Speaker, Santiago de Chile, Chile)
14:00 - 14:20 Multisite construction of open source preclinical scanners. Maureen NAYEBARE (Keynote Speaker, Canada), Sipan HOVSEPYAN (Undergraduate research assistant at Brain Imaging lab) (Keynote Speaker, Abu Dhabi, United Arab Emirates)
14:20 - 14:40 Engineering low-field MRI for resource constrained settings. Zhiyong ZHANG (Keynote Speaker, Shanghai, China)
14:40 - 14:50 Two years experience scaning on a wholebody 0,55T MRI. Cristian MONTALBA (Keynote Speaker, Santiago, Chile)
14:50 - 15:00 Perfusion MRI in resource constrained settings. Danny Jj WANG (Keynote Speaker, Los Angeles, USA)
15:00 - 15:30 Interactive discussion : implementation of open source MRI in RCS. Marina FERNANDEZ GARCIA (PhD Candidate, CAMERA Consortium Manager) (Keynote Speaker, Valencia, Spain)
Salle Major

"Saturday 11 October"

Added to your list of favorites
Deleted from your list of favorites
D34
13:30 - 15:00

ET2-3 - Low Field MRI

Chairpersons: Allison MCGEE (PhD) (Chairperson, Dublin, Ireland), Najat SALAMEH (Chairperson, Aberdeen, United Kingdom)
13:30 - 15:00 Cardiac at low field. Anmol KAUSHAL (Keynote Speaker, London, United Kingdom)
13:30 - 15:00 Low field MRI - How? - Radiographer's perspective on sequence optimisation at LF. Anastassia KOROLENKO
13:30 - 15:00 Low field MRI - Why? - Reasons forand against low field MRI. Joan C (Kai) VILANOVA (Chief) (Keynote Speaker, Girona/ES, Spain)
13:30 - 15:00 MSK at low field. Christian BREIT (Keynote Speaker, Basel, Switzerland)
13:30 - 15:00 Neonatal at low field.
13:30 - 15:00 Neuro at low field. Edmond KNOPP (Chief Medical Officer) (Keynote Speaker, White Plains, USA)
Salle 120

"Saturday 11 October"

Added to your list of favorites
Deleted from your list of favorites
G34
13:30 - 15:00

Poster 7
FT2 - Aging Across the Lifespan | FT2 - Neurodegenerative Diseases | FT2 - Multiple Sclerosis | FT1 - Spine and body | FT1 - Brain and neuroscience

13:30 - 15:00 #47575 - PG510 Evaluation of the therapeutic effect of stem cells on an animal model of neonatal brain injury by advanced diffusion MRI.
PG510 Evaluation of the therapeutic effect of stem cells on an animal model of neonatal brain injury by advanced diffusion MRI.

Preterm infants represent the largest patient cohort in pediatrics. Despite increased survival rates due to advances in neonatal intensive care, the risk of long-term complications such as encephalopathy of prematurity (EoP) remains high. Inflammation as well as high oxygen concentrations (hyperoxia) are major risk factors for premature birth and preterm birth related brain injury. Hyperoxia and inflammation induce perinatal brain injury, affecting white and gray matter structures differently. Currently, there is no causal therapy available. Mesenchymal stem cells have shown promising neuroregenerative potential in preclinical models. The aim of this work was twofold, 1st, to evaluate brain alterations in our model of neonatal brain injury and 2nd, to assess the potential neuroprotective effect of human umbilical cord-derived mesenchymal stem cells (HMSCs) on it.

Pregnant rats received an intraperitoneal (i.p.) injection of lipopolysaccharide (LPS, 100 µg/kg) or sodium chloride (NaCl) at embryonic day 20. Newborn pups were then exposed to either normoxia (21% O₂) or hyperoxia (80% O₂) from postnatal day 3 (P3) to P5. Human MSCs (50 × 10⁶ cells/kg) were administered intranasally at P5.3 groups were finally assessed: Sham (NaCl+normoxia), LPS (LPS+Hyperoxia) and HMSC (LPS+Hyperoxia+MSCs therapy). Corresponding to term-equivalent age in humans, rat brains were collected at P11. Myelination and neuroinflammatory responses were assessed using immunohistochemistry and western blot. To evaluate long-term effects, motor-cognitive behavioural tests were performed during adolescence and adulthood (P40). Following completion of behavioural testing, brains were examined ex-vivo using advanced diffusion MRI to detect microstructural alterations. Ex-vivo MRI experiments were performed with a 2.5 cm diameter birdcage coil, on an 9.4T/31cm actively shielded horizontal-bore magnet (Magnex Scientific, Yarnton, UK), B-GA12S HP shielded gradient set (114mm ID, 660 mT/m peak strength and 4570 T/m/s slew rate, Bruker BioSpin, Ettlingen, Germany) interfaced to a Bruker BioSpec console with AVANCE NEO electronics running ParaVision 360 v3.5. A multi-b-value shell protocol was acquired using a spin-echo sequence (FOV = 23 × 18 mm2, matrix size = 128 × 92, 18 slices of 0.6 mm, 3 averages with TE/TR = 22/1800ms). 82 DWI were acquired, 6 b0 images and 76 separated in 3 shells (noncollinear and uniformly distributed in each shell) with number of directions/b-value in s/mm2: 16/1500, 30/3000 and 30/6000. DTI metrics including Axial diffusivity (AD), Radial diffusivity (RD), and Fractional anisotropy (FA) were derived from the tensor. We also calculated neurite orientation dispersion and density imaging (NODDI) metrics using AMICO, including Neurite density index (NDI), Orientation dispersion index (ODI), and Free water fraction (FWF). These parameters were calculated for 5 Ipsilateral ROIs for each animal (Figure): corpus callosum (CC), cingulum (Cg), external capsule (EC), junction form corpus callosum to external capsule (CC_EC), primary motor cortex (M1Cx) and primary somatosensory cortex (S1Cx). Data were averaged for the coronal planes and statistically tested between groups using one-way ANOVA tests with Tukey’s post-hoc.

Double-hit model showed decreased fibre length and reduced branching points of myelin basic protein (MBP)-positive fibres reversed by MSC treatment Indeed, an increased microglial activation was observed in the LPS group, indicated by increased Iba1 and CD68 double-positive cells, which was markedly reduced after MSC application. Adolescent and young adult animals exposed to the double-hit showed memory impairments, associated with altered white matter microstructure as detected by DTI (Figure). Mainly, in the CG and CC_EC regions, increased RD and ODI as well as decreased FA and NDI were observed in the LPS group compared to both Sham and HMSC groups.

We demonstrated that the combination of prenatal inflammation and postnatal hyperoxia (double-hit) significantly reduces brain volume, likely due to impaired myelination. Both behavioural and structural alterations were alleviated by neonatal MSC treatment as suggested also by MRI results.

Our findings suggest that intranasal MSC therapy mitigates both early and long-term structural and functional brain impairments in a rat model of EoP. These findings support the translational potential of MSC therapy for neonatal brain injury in preterm infants. This project has received funding from the European Union’s Horizon 2020 Research and Innovation programme under Grant Agreement No 874721.
Yohan VAN DE LOOIJ (Geneva, Switzerland), Meray SERDAR, Ursula FELDERHOFF-MÜSER, Ivo BENDIX
13:30 - 15:00 #47748 - PG511 ¹H MRS at 3T reveals impact of childhood adversity on age-related neurometabolic changes in the hippocampus and posterior cingulate cortex.
PG511 ¹H MRS at 3T reveals impact of childhood adversity on age-related neurometabolic changes in the hippocampus and posterior cingulate cortex.

Maintaining metabolic balance in the human brain is vital for cognitive and neurological function, yet this equilibrium shifts with advancing age [1], altered neurotransmission, and the onset of neuroinflammatory processes [2]. These metabolic alterations may also be affected by early environmental influences, such as early-life stress (ELS) that includes experiences of neglect or abuse. ELS is recognized for its detrimental effects on development and long-term brain health [3] and can also alter both, cognition and emotional processing [4]. Understanding the interplay between ELS and age-related neurometabolic changes could offer new insights into individual trajectories of brain health across the lifespan. 1H MR spectroscopy (MRS) provides a non-invasive means to assess neurochemical processes in vivo [5] and is well-suited to identifying biomarkers associated with ELS. The hippocampus (HC) and posterior cingulate cortex (PCC) were selected – two regions central to cognition and emotion, and known to be sensitive to early adversity. The PCC, a metabolically active hub of the default mode network [6], is associated with cognitive impairment [7], while the HC is susceptible to stress-induced dysregulation and structural damage [8]. Despite the suggested link between age, brain metabolism changes, and neuropathology progression in later life, the role of ELS in this context remains underexplored. Thus, this study examined whether ELS interacts with age to influence neurometabolic profiles in adulthood, as measured by 1H MRS. Preliminary results from the female cohort have been recently reported [9].

135 adults (79f, aged 30–60 yrs), with varying severity of ELS exposure, were recruited for structured interviews and questionnaires and MRS acquisitions. ELS Assessment: Exposure to ELS (occurring prior to the onset of puberty) was ascertained using the Childhood Trauma Questionnaire (CTQ) [10].The total CTQ score that assesses five different categories of childhood maltreatment was used, since with its high granularity subtle variations in trauma severity can be captured. MRS: Scans were performed on a 3T PrismaFit system (Siemens Healthineers, Erlangen, Germany) using a 64 channel radiofrequency (RF) coil. High-resolution T1-weighted MPRAGE images were used for voxel placement. For 1H MRS, localized RF calibration was performed, and first- and second-order shims were adjusted using FAST(EST)MAP [11]. Single volume spectra were acquired from the HC and PCC using the semi-LASER technique [12] (TR/TE = 3000/23 ms, spectral width = 2000 Hz, VOIHC = 10x12x35 mm3, number of averages (NA)HC = 256, VOIPCC = 20x20x20 mm3, NAPCC = 128). MRS data were pre-processed utilizing the FID-A toolkit [13]. Metabolites of resulting spectra were quantified using LCModel [14] with a simulated basis set. Statistics: Generalized Additive Models (GAMs) [15] were applied for statistical analyses. Using tensor product smoothing, GAMs were fitted to the metabolite data to model the interaction between age and CTQ scores – both as continuous predictors – using the Restricted Maximum Likelihood method. All statistical analyses were run in R Project for Statistical Computing (R Core Team) with the significance level set at p<0.05.

Shimming resulted in water linewidths of 8.1 ± 0.8 Hz (HC) and 6.0 ± 0.4 Hz (PCC), respectively. Cases with poor shim in the HC (LWH2O ≥ 10 Hz) or strong artifacts were excluded, such that NHC = 117 and NPCC = 133. The overall high spectral quality (Fig. 1) allowed quantification of neurochemical profiles in both regions including several metabolites (Fig. 2). Using GAMs, highly non-linear interactions between CTQ score, age, and metabolite levels were observed. Significant effects were found for glutamate (Glu) (p = 0.02), N-acetylaspartate (NAA) (p = 0.01), and myo-inositol (Ins) (p < 0.001) in the HC (Fig. 3), and for total choline (tCho) (p = 0.004), and Ins (p < 0.001) in the PCC (Fig. 4).

This study examined whether age interacts with ELS severity to affect neurometabolic profiles in adulthood. Key findings revealed that GluHC, NAAHC, and tChoPCC levels were highest in younger adults with high maltreatment severity. Notably, choline—a marker of membrane turnover—was elevated, potentially reflecting myelination breakdown [16]. Ins showed a bimodal pattern across regions, echoing prior evidence of non-linear glial responses in neuroinflammation and degeneration [17,18]. NAA levels, while typically reduced in neurodegeneration, showed compensatory increases, possibly reflecting early adaptive responses to stress [19]. Altered Glu in the HC suggests early astrocytic engagement in managing excitotoxic stress [20]. Together, these patterns indicate subtle, early metabolic shifts linked to ELS, particularly in the context of aging, which may precede structural or cognitive decline.

Exposure to ELS can be linked to age-related alterations in specific brain metabolite concentrations in adults.
Ralf MEKLE (Berlin, Germany), Lara FLECK, Martin BAUER, Dinesh K. DEELCHAND, Claudia BUSS, Sonja ENTRINGER, Jochen B. FIEBACH, Matthias ENDRES, Christine HEIM
13:30 - 15:00 #46034 - PG512 Exercise-induced changes in resting state functional brain activity in children with concussion.
PG512 Exercise-induced changes in resting state functional brain activity in children with concussion.

Over the past decade, the approach to managing concussion has evolved. Rest was traditionally considered the most effective treatment. However, recent research suggests that exercise may be a key component of effective concussion management1,2. Sub-maximal aerobic exercise has been shown to reduce symptoms and improve outcomes1, but there remains limited understanding of how this impacts functional brain activity in pediatric patients. Resting-state functional MRI (rsfMRI) is a valuable tool for assessing these changes, as it provides insight into brain connectivity patterns post-injury3. Data in adults suggests that there is a differential rsfMRI response to exercise in those with concussion compared to healthy controls4. Our study aims to explore the effects of sub-maximal aerobic exercise on resting-state functional brain activity in children with concussion.

A prospective cohort study was conducted with children experiencing their first concussion within four weeks of injury. Participants were age- and sex-matched with healthy controls and it was verified that all were without any prior neurological conditions. Two study visits were completed. In the first visit, sub-maximal aerobic exercise was performed using the Buffalo Concussion Treadmill Test5, to determine each individual subject’s symptom-limited exercise threshold. During the second visit, imaging was conducted using a 3-Tesla GE Discovery MR750 scanner with a 32-channel phased array head coil (General Electric Healthcare, Milwaukee, WI). A 3D T1-weighted anatomical MRI (1mm isotropic IR-prepped fSPGR,TE/TR/TI/flip angle = 7.5ms/2.1ms/450ms/12o, 1mm slice thickness, 256x256, 25.6cm FOV) and resting-state fMRI (gradient echo EPI, TE/TR/flip angle = 35ms/2000ms/90degrees, 64x64matrix, 4mm thick, 24cm FOV, 5 discarded volumes, 240 volumes= 8:10min) scans were acquired, with preprocessing in CONN, involving registration and normalization, slice-timing correction, outlier and artifact detection, and spatial smoothing (8mm FWHM). More specifically, during this secondvisit, a baseline resting-state fMRI was obtained, followed by 10 minutes of treadmill exercise and (within 2-minutes of completing exercise and transit to the MR room) a post-exerciseresting-state fMRI to allow for an understanding of within-subject and between-group pre-post exercise changes in rsfMRI. The study was approved by our local research ethics board.

Preliminary data from 9 participants included five children with concussion (3 males, average age 14.8±2.1, with an average symptom score of ) and four healthy controls (2males, average age 14.2±2.3). Seed-based analysis in the posterior cingulate cortex (PCC) revealed no significant pre-post exercise changes in connectivity for healthy controls. Children with concussion, however, exhibited hypoconnectivity in regions including the inferior parietal lobule and post-central gyrus after exercise. Group-level analyses indicated more pronounced hypoconnectivity in the concussion group compared to controls. Discussion: Based on these findings we suggest a differential response in rsfMRI following exercise between children with concussion and healthy controls. Children with concussion demonstrated notable hypoconnectivity post-exercise, whereas healthy participants did not show similar changes. These results are consistent with studies in adults with mild traumatic brain injury3, suggesting lasting impacts of concussion on brain connectivity. Understanding these exercise-induced changes may inform targeted interventions aimed at both symptom management and enhancing brain health during concussion recovery.

Our results are preliminary with further data analyses pending. Initially, these results converge with prior data on adults, with the concussion group demonstrating pre-post exercise hypoconnectivity not observed in controls. The impact of these changes on other clinical outcomes remains to be explored.

Our preliminary findings may significantly impact rehabilitation strategies for pediatric concussion. If confirmed in a larger sample (recruitment is ongoing), we suggest that while sub-maximal aerobic exercise aids in symptom reduction, it may also alter brain connectivity in ways that need further investigation. These insights could support the development of personalized exercise prescriptions to optimize brain health and functional recovery in children post-concussion.
Bhanu SHARMA (Hamilton, Canada), Eric KOELINK, Carol DEMATTEO, Brian TIMMONS, Michael NOSEWORTHY
13:30 - 15:00 #47874 - PG513 White Matter Alterations in Interhemispheric Tracts Predict Age-Related Decline in Proprioception.
PG513 White Matter Alterations in Interhemispheric Tracts Predict Age-Related Decline in Proprioception.

Proprioceptive deficits have been reported to emerge in normal aging after the age of 65, with a specific impairment in the ability to discriminate movement velocity [1]. A previous fMRI study showed reduced lateralization of primary sensorimotor activations in older adults during unilateral proprioceptive stimulation when compared to young adults [2]. Moreover, this reduction in lateralized activity patterns in older adults was found to correlate with proprioceptive decline [1,2]. Although numerous studies have described microstructural alterations in the brain associated with aging [3], the potential link between these structural changes and proprioceptive decline remains to be established. In the present study, we explored the extent to which alterations in interhemispheric structural connectivity between the two sensorimotor cortices might account for the loss of functional hemispheric laterality observed in normal aging. To this end, we examined the relationship between age-related White Matter (WM) alterations and proprioceptive decline by combining diffusion-weighted imaging (DWI), task-related fMRI activity, and psychophysical measures obtained during proprioceptively induced hand illusions. The analysis specifically focused on the integrity of the Corpus Callosum (CC), which has been previously associated with inefficient interhemispheric communication [3], and on the interhemispheric fiber bundles connecting the primary somatosensory and motor areas.

Twenty young (20-28 years) and twenty older (65-75 years) healthy right-handed adults participated in the study. Psychophysical performance was assessed using the just noticeable difference (JND) in hand movement illusions, while functional lateralization was evaluated through the interhemispheric difference (IHD) index [2]. WM microstructure was analyzed using diffusion tensor imaging (DTI) and constrained spherical deconvolution (CSD), with a specific focus on the corpus callosum. In particular, a tractography analysis was conducted on the motor (CC4) and somatosensory (CC5) interhemispheric tracts. Quantification of FA values along the reconstructed tracts was performed using TractSeg [4], which segmented each bundle into 100 segments. To further investigate the relationship between WM integrity and functional outcomes, an unsupervised machine learning approach was applied using K-means clustering. Prior to clustering, dimensionality reduction was carried out using a backward Sequential Feature Selection (SFS) method, enabling the identification of the five most informative structural features across the 100 tract segments for each callosal tract (CC4 and CC5).

Whole-brain voxel-wise analyses (TBSS) [5] and region-of-interest (ROI) tractography confirmed that aging is associated with reduced fractional anisotropy (FA) and axial diffusivity (AD), alongside increased mean diffusivity (MD) and radial diffusivity (RD) within sensorimotor callosal tracts. Cluster-based analysis performed on the five selected features for each fiber bundle revealed that the somatosensory tract (CC5) enabled a more robust and functionally meaningful classification of participants compared to the motor tract (CC4). Specifically, CC5-based clusters showed strong alignment with participants’ chronological age groups and demonstrated higher predictive accuracy for proprioceptive impairments (JND) and reductions in interhemispheric lateralization (IHD). These predictions were further validated through cross-validation procedures, supporting the reliability of the clustering approach.

The present results confirm structural brain alterations associated with aging, characterized by reduced FA overlapping with increased RD, a pattern typically linked to myelin degradation [6]. This suggests that the reduced integrity of the corpus callosum and associated interhemispheric fibers in older adults may predominantly result from demyelination processes. Age-related microstructural alterations within the CC5 somatosensory tract may explain the observed reduction in functional laterality, reflecting less specific neural recruitment during proprioceptive processing. Critically, alterations in the CC5 somatosensory tract, rather than in the CC4 motor tract, more strongly predicted age-related declines in proprioceptive acuity (JND) and reductions in sensorimotor lateralization (IHD). Unsupervised clustering based on DTI features from CC5 successfully discriminated between age groups and accurately predicted functional impairments, highlighting the critical role of somatosensory callosal fibers in maintaining proprioceptive function with aging.

These findings support the hypothesis that age-related microstructural degeneration of somatosensory callosal fibers contributes to a decrease in the specificity of neural recruitment during proprioceptive processing, aligning with the dedifferentiation theory of aging [3].
Daniela PINZON (MARSEILLE), Nicolas CATZ, Caroline LANDELLE, Raphaëlle SCHLIENGER, Julien SEIN, Jean-Luc ANTON, Olivier FELICIAN, Anne KAVOUNOUDIAS
13:30 - 15:00 #47572 - PG514 Neuroprotection via stem cell therapy mitigates structural brain injury in preterm lambs: evaluation by advanced diffusion MRI.
PG514 Neuroprotection via stem cell therapy mitigates structural brain injury in preterm lambs: evaluation by advanced diffusion MRI.

Preterm birth is the leading cause of neonatal morbidity and mortality. Advances in perinatal medicine increased survival rate, consequently increasing the number of preterm infants at risk for life-long neurocognitive disabilities. The pathogenesis of preterm brain injury is multi-factorial, with chorioamnionitis and mechanical ventilation as important contributors. To increase mechanistic understanding and develop therapeutic strategies, we developed a long-term translational triple-hit ovine model for preterm brain injury. Sheep brains display similar gyrification patterns to human brains. Therefore, utilizing sheep models for studying perinatal brain injuries offers the advantage of lesions being closer in proximity to those found in human neonates. Stem cells are interesting candidate that could mediate neuroprotection / recovery following perinatal brain injury. The aim of this work was twofold, 1st, to evaluate early (6 weeks) and late (1 year) brain alterations in our model and 2nd, to assess the potential neuroprotective effect of human umbilical cord-derived mesenchymal stem cells (hMSCs) on it.

Preterm lambs were exposed to triple perinatal hits including intra-uterine lipopolysaccharides (LPS), preterm birth and mechanical ventilation (3HIT group, n=7). Animals were either sacrificed directly after preterm birth, after 72h of mechanical ventilation, or followed-up for 12 months. hMSCs were administered intravenously directly after preterm birth and/or intranasal after 6 weeks (3HIT+SC, n=10). A sham group in the same conditions as 3HIT with saline injection was also assessed (SHAM, n=10). During long-term follow-up MRI, gait analysis and behavioral tests were conducted and combined with post-mortem histology for microglia, myelin and oligodendrocytes. MRI experiments were performed in-vivo at 6 weeks and 1 year old on a clinical 3.0T Philips scanner with a 32 channels human adult head 1H radiofrequency coil. A multi-b-value shell protocol was acquired using a SE-EPI sequence (FOV = 120 × 120 × 57 mm3, matrix size = 80 × 80 × 38, 2 averages with TE/TR = 132/3439 ms). 131 diffusion weighted images were acquired, 3 b0 images and 128 separated in 2 shells with number of directions/b-value in s/mm2: 64/1000, 64/2000. Acquired data were fitted using DTI-TK [1] for the conventional DTI derived parameters as well as the spherical mean technique (SMT) model [2] for advanced diffusion. Several white matter tracts were assessed including internal capsule (IC), external capsule (EC) and cortico-spinal tract (CST). DTI derived parameters (Axial diffusivity (AD), Radial diffusivity (RD), Mean diffusivity (AD) and Fractional anisotropy (FA)) and SMT derived metrics (intra-axonal volume fraction (intra), intra-axonal diffusivity (diff), extra-axonal mean diffusivity (extramd) as well as extra-axonal transverse diffusivity (extratrans)) were averaged in the different regions assessed for all animals. A Mann-whitney test was used for significance between the groups (p<0.05).

Diffusion maps are presented on figure 1. At 6 weeks (figure 2 – upper panel), among the significant changes between SHAM and 3HIT we found an increase in AD and RD, and a decrease in intra and diff, depending on the white matter region assessed. These changes were not observed between Sham and 3HIT+SC groups. At 1 year old, only few metrics were significantly changed between SHAM and 3HIT (figure 2 – lower panel). Microglial numbers were elevated following preterm birth and mechanical ventilation. Moderate histological alterations were observed. Structural brain injury correlated with aberrant behavior, assessed around adulthood.

At 6 weeks, myelin impairments were evident in the evaluated white matter tracts, indicated by elevated diffusivity values (AD and/or RD) and reduced intra (neuronal density) and diff (intra-axonal diffusivity) in the injured group. Interestingly most of these changes were restored in the stem cells treated group. By the age of 1 year, these injuries appeared less severe, likely owing to defense mechanisms and well-established brain plasticity mechanisms characteristic of brain development.

In this study we were able to show the phenotype of mild 3HIT induced lesion characterized by advanced diffusion MRI as well as the potential neuroprotective effect of hMSCs. Early intervention with hMSCs showed promising effects on white matter structure and neurocognitive functioning on the long-term, which is of potential clinical interest to improve quality of life for children born preterm. This project has received funding from the European Union’s Horizon 2020 Research and Innovation programme under Grant Agreement No 874721.
Yohan VAN DE LOOIJ (Geneva, Switzerland), Valery VAN BRUGGEN, Rob WESTERLAKEN, Reint JELLEMA, Daan OPHELDERS, Tim WOLFS
13:30 - 15:00 #47144 - PG515 Age-related changes in structural and functional organization of the human spinal cord.
PG515 Age-related changes in structural and functional organization of the human spinal cord.

Aging is associated with changes in sensorimotor function1,2 and its neural correlates2,3,4, but most studies to date have focused on brain sensorimotor networks, often overlooking the spinal cord. In addition, age-related changes in spinal cord function have mainly been explored through electrophysiological approaches, which reveal reduced reflex loop responses5,6. However, this approach focuses on local circuitry, hence missing large-scale interactions between spinal segments. In the present study, we used spinal MRI7,8 in humans to investigate on a large-scale the age-related functional and structural changes at the cervical spinal cord level.

Sixty-seven healthy adults (36 females, 46.5 ± 16.8 yrs old) were included in this study. The experiment was approved by the local ethics committee and written informed consent was obtained. The acquisition protocol (Fig. 1) included spinal cord T2*w, magnetization transfer (MT) and multi-shell diffusion MRI sequences (DWI), as well as simultaneous brain/spinal cord T1w and functional imaging (3T Siemens Prisma scanner). Preprocessing was performed using the Spinal Cord Toolbox (SCT)9 and included spinal cord segmentation, vertebral labeling of the T1w image, motion correction for functional and DWI data, co-registration for MT on/off images, and non-linear registration of the T1w image on the PAM50 template. Functional images were also denoised and filtered using a custom pipeline. Diffusion metrics including fractional anisotropy (FA) and radial diffusivity (RD) were computed from the DWI images. Using the PAM50 spinal segmental atlas10 we extracted the average T2*w gray/white matter ratio, MT ratio, and diffusion metrics from each spinal level from C2 to C7 (Fig. 2a) and regressed them against age. Spinal functional levels (C1–C7) were identified in a data-driven manner using the iCAPs framework8,11. A seed-based approach examined the age-related changes in functional connectivity (FC) between ventro-ventral (V-V), dorso-dorsal (D-D), ventro-dorsal ipsilateral horns (within) and ventro-dorsal contralateral horns networks (cross) across 28 seeds (4 horns x 7 levels). For each participant, mean denoised, deconvolved signal was extracted from the seeds, and Fisher-transformed correlation coefficients were used to generate individual FC matrices. The top 50% strongest correlations were retained for graph analysis with community structure identified via Louvain community algorithm12 (gamma = 1.8, 1000 partitions), followed by a consensus partitioning at the individual level.

Linear regression analyses showed age-related decreases in all microstructural metrics (Fig. 2b, upper panel), including the GM/WM ratio, MT ratio, and changes in diffusivity measures such as decrease in FA and increase in RD (t=-3.07, p=0.003). Notably, these age-related changes were found significant across most spinal levels (Fig 2b, lower panel). The seven spinal cord levels were successfully identified using the iCAPs framework (Fig. 3a). The FC matrices revealed stronger intra-segment connectivity (within the same spinal level) compared to inter-segment connectivity (between different levels), with age-related increases in inter-segmental FC (Fig. 3b). To better interpret these FC changes, we applied graph theory analysis. Although modularity was not affected by aging (t=0.93, p=0.35), both local efficiency and centrality—reflecting the effectiveness and quantity of community connections—significantly decreased with aging (Fig. 2c). In addition, an increase in inter-communities connection strength was accompanied by a decrease in the ratio of intra- to inter-communities connection strength.

This study provides first evidence of spinal microstructural changes13,14 using multimodal acquisition at different cervical spinal cord levels. Importantly, it also reveals age-related reorganization of functional connectivity. The relative increase in dorso-ventral FC, alongside inter-segmental FC likely reflects a reorganization of spinal networks with aging. While this may suggest compensatory mechanisms, graph-based analysis reveals a decrease in network segregation and FC specificity (reduced in weights ratio, local efficiency and centrality), alongside an increase in connectivity between the different spinal networks. These findings point to reduced synaptic efficiency and neural specificity, potentially driven by impaired inhibitory processes15,16. Further analyses that integrate structural and functional similarities, as well as brain-spinal cord functional connectivity, will be essential for a more comprehensive interpretation of these findings.

This study provides the first opportunity to investigate age-related changes in the sensorimotor system, including the spinal cord. It offers valuable insights into sensorimotor integration across the lifespan and emphasizes the importance of distinguishing between healthy aging and disease effects in clinical research.
Caroline LANDELLE (Montreal, Canada), Nawal KINANY, Samuelle ST-ONGE, Ovidiu LUNGU, Benjamin DE LEENER, Véronique MARCHAND-PAUVERT, Julien DOYON
13:30 - 15:00 #47920 - PG516 NR2F1-associated neurodevelopmental disorder: computational neuroanatomy and cortical gyration.
PG516 NR2F1-associated neurodevelopmental disorder: computational neuroanatomy and cortical gyration.

The Bosch-Boonstra-Schaaf optic atrophy syndrome (BBSOAS) is a rare neurodevelopmental disease (< 1/1000000 birth resp.). It is classically characterized by developmental delay, intellectual deficiency and significant visual impairment due to optic nerve atrophy and hypoplasia or cerebral visual dysfunction. The spectrum of neurodevelopmental disorder is actually broader including autism spectrum disorder, learning disability without intellectual development disorder or epilepsy [1]. This syndrome is caused by loss-of-function variant of the NR2F1 gene, encoding a key factor in brain development. A French collaborative translational study of the BBSOAS has been initiated that already enabled to clarify the role of NR2F1 in cortical development and highlighted the existence of recurrent anomalies in the brain anatomy including abnormal cortical gyration such as dysgyria (excess and atypical organization of folds) [2]. However, these anomalies are still poorly described and understood. In this context, the present study proposes a first neuroanatomical insight in global and local cortical volumes and surfaces in the context of NR2F1 variant.

10 patients aged between 14 and 23 (mean age 18 y/o, sex ratio: 1) were imaged at NeuroSpin, CEA Paris-Saclay. 3D T1-weighted MRI were performed at 3T (Magnetom Prisma Fit, Siemens Healthcare) to obtain 0,9 mm isometric images. The dataset was completed with 3T 3D T1-weighted MRI of 77 typically developing controls from previous studies (12-18 y/o, mean age 16 y/o, sex ratio: 0,97), 40 of them with same site and sequence than the patients. The data were segmented using a pipeline combining Morphologist (BrainVISA [3]) and volBrain-AssemblyNet [4][5] into 6 cortical regions (Frontal, Central, Temporal, Parietal, Occipital and Insula). Automated sulci recognition was performed on Morphologist sulci models. Global and regional cortical surfaces and volumes were extracted, and values were harmonized for site and sex using pyComBat. Statistical analysis included t-test (mean volumes comparison), and normative scaling analysis based on a power law modeling between either cortical surfaces or cortical volumes and the Total Brain Volume (TBV, corresponding to the Cerebrum, the Cerebellum and the brainstem) in controls, providing 10th and 90th percentile curves. We ensured homocedasticity of residuals. We tested whether there was a signicant mean deviation of the patient group to the typical scaling using a shuffle-and-split procedure [6] and corrected for False Discovery Rate (FDR, Benjamini-Yekutieli). Effect size was measured as the mean of patients’ z-scores.

An atypical sulcal pattern in the parieto-occipital region was observed in all 10 patients. Especially, major anomalies of the parieto-occipital sulcus led to its misidentification by Morphologist and to an incorrect segmentation of parietal and occipital lobes in 9 out of 10 patients. Central sulcus atypia was also observed in 8 out of 10 patients, but without misidentification (fig.1). As a result, we chose to group the parietal and the occipital lobes as one region for analysis, while segmentations of other regions appeared correct in comparison to controls. There was no difference in TBV between patients and controls (fig.2). Normative scaling analyses revealed a significant excess of global cortical surface in relation to TBV in patients (p-value < 10e-7, mean-z: 1.1) (fig.3). At a regional scale, a significant excess of surface in relation to TBV was observed in the temporal lobe (p-value < 10e-7, mean-z: 2.5) ) (fig.3), associated with a significant excess of volume (p-value < 10e-7, mean-z: 2.6) (fig.4). In addition to this result, qualitative observations showed major atypia in the shape of primary sulci on the outer surface of the temporal lobe, especially of the superior temporal sulcus, in all 10 patients (fig.1). An excess of volume in the parieto-occipital region was also found but with a lesser size effect (p-value=0.03, mean-z: 0.9) (fig.4).

Theses preliminary results revealed an overall excess of cortical surface in BBSOAS patients, not explained by a normal TBV. This global increase seemed to be mainly related to an excess of cortical surface in the temporal lobe, associated to an oversizing (over-scaling) of its volume. This disproportionate scaling came with important modification in the folding pattern of large primary folds, in the temporal region but also the central and internal parieto-occipital ones, limiting our ability to separate between occipital and parietal lobes. Our results also highlight the potential of normative scaling analysis to study cortical development even in rare diseases.

Work is still in progress to further characterize theses hemispheric anomalies in terms of surface and volume regional distribution (scaling), sulcal pattern, and to study their link with corpus callosum posterior thinning also described in BBSOAS patients [2].
Emma SOUCANE (Paris), Jérémy SADOINE, Ombline DELASSUS, Lucie HERTZ-PANNIER, Liubinka MIRAKOVSKA, Raphaelle MOTTOLESE, Laurence FAIVRE-DOURE, Michèle STUDER, Jean-François MANGIN, David GERMANAUD
13:30 - 15:00 #47574 - PG517 Effects of a Long-Term Exercise Intervention on Skeletal Muscle Metabolism in Aging Adults Assessed by Proton and Phosphorus Magnetic Resonance Spectroscopy Radka Klepochová1,2,3,4, Ivica, Just 3,4, Lucia Slobodová1,5, Petra Dubajová1,5, Miriam Dojčárová1.
PG517 Effects of a Long-Term Exercise Intervention on Skeletal Muscle Metabolism in Aging Adults Assessed by Proton and Phosphorus Magnetic Resonance Spectroscopy Radka Klepochová1,2,3,4, Ivica, Just 3,4, Lucia Slobodová1,5, Petra Dubajová1,5, Miriam Dojčárová1.

Healthy aging is increasingly recognized as a public health priority, with skeletal muscle health playing a central role in maintaining mobility, metabolic function, and overall quality of life in older adults (Tieland et al., 2017). Aging is associated with declining muscle mass, mitochondrial function, and metabolic flexibility, contributing to frailty and metabolic diseases. Regular physical activity, especially combining aerobic and resistance training, has been shown to counteract these changes by improving muscle functional capacity(Slobodová et al., 2022), mitochondrial efficiency and muscle bioenergetics (Hughes et al., 2018). Non-invasive magnetic resonance spectroscopy (MRS) enables in vivo quantification of skeletal muscle metabolites and mitochondrial function (Krššák et al., 2020; Meyerspeer et al., 2021). This study aimed to evaluate the metabolic effects of a long-term aerobic-strength exercise intervention in aging adults using both proton (1H) and phosphorus (31P) MRS.

Sixteen older adults (age 67 ± 8 years, BMI 28 ± 5 kg/m²) were randomly assigned into an aerobic-strength exercise group (n=10) and an active (stretching) control group (n=6). All participants underwent magnetic resonance (MR) measurements before and after the 9-month intervention. The exercise group participated in a supervised aerobic and strength training program three times 1 hour per week, complemented by dietary counselling (group educational sessions on monthly basis), while the active control group performed only light stretching exercises during the same 9-month period. All MR measurements were performed in the morning following overnight fasting. Individuals were positioned supine with the right calf placed on a RF coil mounted on an ergometer dedicated for plantar flexion exercise inside of the 7T whole body MR system. Static 1H MRS of the gastrocnemius muscle was used to quantify acetylcarnitine, carnosine, and intramyocellular lipids (IMCL). Static 31P MRS assessed levels of phosphocreatine (PCr), phosphodiesters (PDE) (glycerophosphocholine (GPC) and glycerophosphoethanolamine (GPE)), inorganic phosphate (Pi), and phosphomonoesters (PME). A dynamic 31P-MRS protocol was used during and after a 6-minute submaximal plantar flexion exercise to evaluate phosphocreatine depletion (VPCr), phosphocreatine recovery (τPCr), maximum oxidative capacity (Qmax), and pH.

There were no significant differences between the groups in any of the investigated metabolites at baseline. Following the intervention, the exercise group exhibited a trend toward increased acetylcarnitine (p=0.06), significantly lower GPC (p=0.02) and PDE (p=0.01), and elevated PME levels (p=0.04). Improvements in mitochondrial function were indicated from faster τPCr (p=0.05) and higher Qmax (p=0.05). Exercise performance, including delta PCr and end-exercise pH, was similar between the groups at both time points. No significant changes were observed in the control group.

Our pilot results demonstrate that in aging individuals, exercise induces favorable changes in skeletal muscle metabolism detectable by advanced 1H and 31P MRS at 7T and dynamic exercise protocol in a rather small study population. Trend to increased acetylcarnitine levels although not statistically significant (p = 0.06), may suggest improved mitochondrial substrate availability and possibly enhanced β-oxidation capacity(Bruls et al., 2019). The observed reductions in GPC and PDE are indicative of improved membrane turnover or reduced degradation, potentially reflecting healthier muscle cell membrane status, consistent with findings in trained older adults(Cikes et al., 2024). An increase in PME (p = 0.04) may indicate not only enhanced anabolic remodeling or regeneration of membrane structures but also altered metabolic activity. PME includes phosphorylated sugars involved in glucose transport and phosphorylation, as well as intermediates of glycolysis, suggesting broader changes in cellular metabolism. This supports the hypothesis that exercise promotes not only the preservation but also the renewal of muscle cellular architecture in aging tissue(Ziaaldini et al., 2017). The faster phosphocreatine recovery time (τPCr) and increased maximal oxidative capacity (Qmax) reflect enhanced mitochondrial efficiency and ATP resynthesis, which are critical for muscle endurance and recovery. These improvements suggest that mitochondrial function is plastic even in later life, responding positively to regular training stimuli(Kemp et al., 1993).

Exercise intervention in aging adults results in measurable improvements in skeletal muscle metabolism and mitochondrial capacity, as assessed by advanced 1H and 31P MRS at 7T. These findings underscore the importance of physical activity in promoting metabolic health and functional capacity in older populations.
Radka KLEPOCHOVÁ (Bratislava, Slovakia), Ivica JUST, Lucia SLOBODOVÁ, Petra DUBAJOVÁ, Miriam DOJČÁROVÁ, Pavol SZOMOLÁNYI, Viera LITVÁKOVÁ, Raynald BERGERON, Jozef UKROPEC, Barbara UKROPCOVÁ, Martin KRŠŠÁK
13:30 - 15:00 #47712 - PG518 REGIONAL T1 and T2 TRAJECTORIES in PEDIATRIC BRAIN DEVELOPMENT: DIFFERENTIAL MATURATION of LIMBIC and EXECUTIVE REGIONS.
PG518 REGIONAL T1 and T2 TRAJECTORIES in PEDIATRIC BRAIN DEVELOPMENT: DIFFERENTIAL MATURATION of LIMBIC and EXECUTIVE REGIONS.

Brain development from the fetal stage to adulthood involves dramatic and region-specific changes. These changes are most rapid in the first few years of life[8]. The limbic system has a vital role in emotional regulation and social communication. On the other hand, executive functions are cognitive processes essential for controlling behavior in everyday tasks[4-10-19]. The study aims to investigate regional developmental trajectories by T1/T2 mapping across childhood and adolescence.

The study analyzed the publicly available “Developmental Relaxometry Dataset” (80 healty participants, 3-17 yr) hosted on OpenNeuro website. 36 subjects (17 toddlers, age 3–5 years; 19 adolescents, age 12–17 years) were randomly selected to form two age groups. Subjects underwent whole-brain MP2RAGE scanning at 3T (MAGNETOM Prisma Fit, Siemens Healthcare, Germany). T₁ maps were generated in MATLAB, fitting each voxel’s inversion recovery signal (TI = 700, 2500 ms; TR = 5000 ms) via nonlinear least squares. We also analyzed the T2 maps, provided in the dataset. Both maps were coregistered to the MNI template in SPM12. The AAL atlas was used to define 11 regions of interest (ROIs): amygdala, hippocampus, insula, parahippocampus, anterior cingulate cortex (ACC), ventromedial prefrontal cortex (vmPFC),orbitofrontal cortex (OFC), fusiform, dorsolateral prefrontal cortex (DLPFC), and composite limbic/executive regions. Mean T₁ and T2 values were extracted within each ROI for all scans. Age trajectories were modeled by ordinary least-squares linear regression of T₁ versus age. Unpaired two-sample t-tests compared children versus adolescents per ROI, and paired t-tests compared limbic versus executive within each group. False- discovery rate correction controlled for multiple ROI comparisons.

Linear regressions revealed highly significant age-related decreases in T1 for the amygdala (p<0.001), hippocampus (p<0.001), parahippocampus (p<0.001), ACC (p<0.001), composite limbic (p<0.001), fusiform (p<0.001). The OFC showed significant increase (p<0.001). Slopes in the insula, vmPFC, DLPFC, and the composite executive regions were non‐significant (all p>0.05). Between-group t-tests confirmed lower adolescent T₁ in the limbic composite (p<0.01), amygdala (p<0.001), hippocampus (p=0.001), parahippocampus (p<0.001), ACC (p<0.001), fusiform (p<0.001), higher OFC p<0.05), all survived FDR correction. Within-group paired t- tests showed limbic network T₁ was significantly lower than executive T₁ in both children (p<0.001) and adolescents (p<0.001). In T2 regressions, significant age-related decreases observed in amygdala (p<0.001), parahippocampus (p<0.001), and fusiform (p<0.001), but increase in th hippocampus (p<0.05). All composite regions showed no change. Between t-test results were consistent with the regression results, and no within group differences showed significance.

This study mapped relaxation in limbic and executive networks from early childhood through adolescence, revealing a heterogeneous maturation profile. Our findings align with previous literature reporting rapid T₁ and T₂ relaxation changes in the first year of life, followed by slower,region-specific maturation after age three[23-24-28]. In our study, all limbic regions except the insula and fusiform demonstrated significant T1 decreases, whereas the amygdala, parahippocampus, and fusiform showed T2 declines. Such early limbic lead is consistent with the timeline of social-emotional development: children first develop parental bonding, recognize and interpret others’ intentions[25], and acquire facial decoding via fusiform[20].This early interaction lays the foundation for developing adaptive social behavior. In contrast, T1 values in the OFC increased in adolescence, which seems like protraction, but OFC and prefrontal cortex develop slowly[26]. We observed significant T2 increase in hippocampus, likely arising from methodological differences in ROI detection: we applied fully automated atlas while previous studies performed manual delineation. Myelination is a dynamic process, it fluctuates asynchronously across regions[24].This asynchronous maturation, limbic circuits maturing earlier than executive networks[22] may explain typical adolescent behaviors: risk comprehension is intact, their elevated emotional responsiveness can dominate decision‐making [18-19-21-22]. These observations align with normative patterns of myelination. Although absolute relaxation times can vary with mapping protocols and MRI field strength, our analyses provide a robust normative reference[22, 23].

Our relaxometry data establish clear, region specific measure: limbic circuits mature rapidly in early childhood, while prefrontal networks continue myelinating through adolescence. These quantitative T₁/T₂ metrics can be integrated into normative developmental models to enable precise detection of atypical maturation trajectories in pediatric population.
Selin OZCAN (Istanbul, Turkey), Pinar S. OZBAY
13:30 - 15:00 #45431 - PG519 Functional connectivity breakdown between the Default mode and attentional networks as a ubiquitous mechanism of cognitive vulnerability during neurodevelopment and aging.
PG519 Functional connectivity breakdown between the Default mode and attentional networks as a ubiquitous mechanism of cognitive vulnerability during neurodevelopment and aging.

New computational approaches suggest that functional imbalance between key fMRI resting networks is critical for normal cognition and behavior, which would drive cognitive decline in neurodegenerative diseases. Specifically, the connectivity between the Default mode network (DMN) and the Attentional Networks such as the Dorsal (DAN) and Ventral attention networks (VAN), was identified as crucial for mental health.

We quantified the fMRI anti-correlation between DMN and DAN as a potential proxy for risk of neuropsychiatric disease in two studies A) In 2707 adolescents from the ABCB cohort https://nda.nih.gov/study.html?id=2248 , cognitive tests measuring intelligence were quantified along with demographic variables assessing risk for mental and neurologic diseases such as education level B) In another study fMRI and PET data from 183 elderly subjects with preclinical Alzheimer’s disease was analysed. We quantified the fMRI anti-correlation between the DMN and attentional networks using group ICA and dural regression in high-quality data from ADNI3. The between-network connectivity of the network of interest was quantified as the correlation between the time course of the ICA components of interest coming from dual regression analysis. The anti-correlation measures between the DMN and DAN were analysed along with PET tau, and PET Amyloid. Cognitive evaluation measures assessing general cognitive capabilities were the outcome variable

I showed that an attenuated fMRI DMN-DAN anti-correlation is tightly correlated with general cognitive decline independently of p-tau pathology in elderly subjects and with general cognitive capabilities in adolescents. Together, these studies propose that DMN-DAN connectivity attenuation may represent a ubiquitous mechanism of cognitive vulnerability across the lifespan, from adolescence to aging and neurodegeneration

One possibility is that the attenuation of the fMRI DMN-DAN anticorrelation would lead to brain network imbalance promoting spatial and temporal spreading of molecular changes. In this line, future studies should focus on understanding using multimodal neuroimaging and environmental factors such as childhood trauma, socioeconomic stress, and social isolation whether they could drive maladaptive connectivity between the DMN and attentional networks. This approach aims to understand the mechanism for neuropsychiatric diseases broadly, rather than only focusing on single genetic-molecular features as a source of cognitive decline and mental disease which hold as the mainstream proposed mechanism for neuropsychiatric diseases. As a possible future direction, one approach would be to attempt to build causality by focusing on longitudinal synergic interactions on large-scale studies between risk environmental and neuroimaging factors such as the fMRI DMN-attentional network imbalance as a possible feature

Together these two studies shown that the DMN-DAN anticorrelation may represent an ubiquitous mechanism of cognitive vulnerability across the lifespan, from adolescence to aging and neurodegeneration
Diego Martin LOMBARDO VERA (Lac du Bourget)
13:30 - 15:00 #47660 - PG520 Characterizing normative trajectories of choroid plexus volume across the adult lifespan in healthy and diseased conditions.
PG520 Characterizing normative trajectories of choroid plexus volume across the adult lifespan in healthy and diseased conditions.

The Choroid Plexus (ChP) is a vascular structure within the brain's ventricular system that supports several physiological processes [1]. While prior studies have primarily investigated ChP volume (ChPV) in clinical populations—postulating a relationship between ChPV enlargement and neuroinflammatory mechanisms [2,3]—the contribution of normative biological variables (e.g., age, sex) and brain anthropometric measures (i.e. Total Intracranial Volume (TIV), Lateral Ventricle Volume (LVV)) to ChPV variability remains insufficiently characterized, partly due to limited healthy control (HC) sample sizes [4–6]. To address this gap, we introduce a normative modeling (NM) framework to delineate age-related trajectories of ChPV across the adult lifespan, aiming to advance its utility as a quantitative neuroimaging biomarker [7,8]. The NM was tested on two pathological cohorts of Multiple Sclerosis (MS) and Depression (DEP) subjects.

Data details are available in Table 1. The NM training dataset consisted of 3D T1-weighted MRI images from 1,036 HC sourced from the Cam-CAN [9] and HCP-A [10] datasets, restricted to a common age range (36–88 years). MRI quality was assessed using MRIQC v24.1.0 [11], and the ChP was automatically segmented using the fine-tuned ASCHOPLEX approach [12]. The validation dataset included 18 MS [12] and 26 DEP [13] subjects within the same age range, with ChPV also extracted with ASCHOPLEX. Lesion filling was applied to MS scans [14,15]. LVV and TIV were computed using FreeSurfer v7.1.1 [16]. Before building the Bayesian hierarchical NM, a preliminary statistical analysis on age, sex, dataset, ChPV, TIV, LVV, ChPV/LVV, and ChPV/TIV was performed on HCs using Python v3.12 and JASP [17] to identify which independent regressors should be included in the NM. This included independent samples t-tests (α = 0.05), Pearson’s correlations, and forward stepwise linear regressions predicting ChPV from age using different covariates. Model evaluation considered multicollinearity, statistical significance (p), explained variance (R², R² changes), and the Akaike Information Criterion (AIC). The NM was then trained and validated using Stan for R (v2.32.2) via the brms package (v2.22.0). ChPV was modeled with age, sex, TIV, and LVV as fixed effects, and dataset as a random effect: ChPV~Age+Sex+LVV+TIV+(1|Dataset). NMs used a Student’s t-distribution and were compared using Bayesian pseudo-R² and Bayes Factor (BF). The main output, Z-scores, quantified individual deviations from the normative posterior distribution. For HCs, Z-scores were computed using 5-fold cross-validation. For the MS and DEP cohorts, NM discriminative performance was assessed on Z-scores using ANOVA and the Area Under the Curve (AUC).

The statistical analysis revealed no significant age differences between sexes. ChPV, LVV, and TIV differed significantly by sex (p<0.001), while Dataset-related differences were most pronounced for ChPV (Fig.1, Tab.2). Pearson’s correlation analysis showed statistically significant associations (p<0.001) between ChPV and age (0.35), LVV and age (0.57), ChPV/LVV and age (-0.55), ChPV and LVV (0.55), and ChPV and TIV (0.36). The optimal regression model included all variables as predictors, selected for the higher R² value (0.39) and lowest AIC. No multicollinearity was detected. Age, LVV, and sex emerged as the most influential predictors (R2 changes: 0.13, 0.13, 0.08). The NM including all covariates significantly outperformed simpler versions (BF>100, pseudo-R²=0.408) (Fig.2). Based on Z-scores distributions, ANOVA reported significant differences between groups (p<0.001), and the AUC was significantly greater than 0.5 (p<0.001) between HCs and both MS (0.69) and DEP (0.78) (Tab.2).

This study presents a NM of ChPV across the adult lifespan, developed using a large cohort of HC and validated on two clinical populations. Based on high-quality segmentations from ASCHOPLEX, the model uses a hierarchical Bayesian framework to account for inter-scanner variability via partial pooling and shrinkage, enabling generalization to new scanners without the need for retraining. Statistical analysis confirmed the significant influence of age, sex, LVV, and TIV on ChPV, in line with prior findings [5]. The substantial effect of MRI acquisition protocols supports modeling the dataset as a random effect [18]. Importantly, the results show that normalizing ChPV by LVV or TIV does not improve interpretability. The selected NM explains approximately 40% of the variance in ChPV among HCs and effectively identifies individual deviations in clinical populations, consistent with existing literature [3,8,19].

The NM of ChPV across adulthood introduced in this study effectively identifies individual deviations in clinical populations with known ChPV alterations. The results underscore the model’s potential for clinical application and support further investigation of ChPV as a biomarker in both research and diagnostic contexts.
Valentina VISANI (Padova - Basel, Italy), Marco PINAMONTI, Alessio GIACOMEL, Manuela MORETTO, Maria Giulia ANGLANI, Agnese TAMANTI, Julia SCHUBERT, Federico TURKHEIMER, Alessandra BERTOLDO, Massimiliano CALABRESE, Mattia VERONESE, Marco CASTELLARO
13:30 - 15:00 #47838 - PG521 MRI Beyond Structural Narrowing in Spinal Stenosis: Quantifying Disc, Vertebral, and Age-Related Tissue Variation.
PG521 MRI Beyond Structural Narrowing in Spinal Stenosis: Quantifying Disc, Vertebral, and Age-Related Tissue Variation.

Lumbar spinal stenosis (LSS) is commonly diagnosed using MRI with qualitative or basic quantitative methods, such as dural sac cross-sectional area. While these clinical measures primarily reflect structural narrowing, they offer limited insight into tissue changes in discs and vertebrae, and their interpretation varies across institutions in the absence of standardized imaging criteria [1, 2]. Quantitative MRI-based metrics of disc and vertebral composition may capture additional tissue characteristics at clinically relevant levels, offering complementary information to current diagnostic practices. This study evaluates whether such quantitative MRI-based features can detect tissue differences in discs and vertebrae at spinal levels identified as most stenotic (index levels) or selected for surgical decompression in LSS.

The cohort included 350 patients with LSS (mean age 66.7 years; 184 male) from the multicenter Norwegian Degenerative Spondylolisthesis and Spinal Stenosis (NORDSTEN) study. Preoperative sagittal T2-weighted MR images were analyzed for discs and vertebrae between L1 and L5, using the full image volume. For each spinal level, the analysis covered the entire intervertebral disc and the full superior and inferior vertebral bodies. Tissues were segmented using MONAI, and disc spatial variation was assessed by dividing each disc into five equal-width anterior–posterior subregions with MATLAB. Quantitative features included mean signal intensity (SI), standard deviation (SD), disc degeneration (Δµ [3, 4]), and vertebral entropy (signal disorganization). Images were normalized to the cerebrospinal fluid SI to reduce inter-scan variability. Statistical differences were tested between index and non-index levels, and between surgical and non-surgical levels. Associations with age were evaluated using Pearson’s correlation coefficient (r).

SI, SD, and Δµ tended to be lower in discs at index and surgical levels, with statistically significant differences particularly in central subregions (2–4) of the nucleus pulposus (p < 0.04; Table 1). SD and entropy were generally higher for vertebrae adjacent to surgical levels than at non-surgical levels, particularly in the lower spine (p < 0.02; Table 1). In contrast, vertebrae adjacent to index levels tended to show lower entropy in caudal segments. Entropy also showed a stronger association with index level than SI, SD, or Δµ, with significant correlations at multiple levels (|r| ≥ 0.13, p < 0.01; Table 1, Figure 1). At most spinal levels, disc degeneration increased with age, reflected by decreasing Δµ values, except at L4/L5, where no significant correlation was found. Vertebral entropy consistently decreased with age across all levels (r ≤ −0.21, p < 0.01), with no level-specific dependency (Figure 2).

LSS patients showed measurable tissue changes at clinically relevant spinal levels. Metrics in the nucleus pulposus showed the strongest differences at index and surgical levels, suggesting a central role in LSS. While these patterns are consistent with known disc degeneration mechanisms, our results quantitatively confirm this association with LSS. Nucleus degeneration may reduce disc height and alter load distribution, increasing stress on surrounding structures and promoting joint degeneration and ligament thickening, both contributors to stenosis. Vertebral metrics also differed, with lower entropy at index levels, especially in the lower spine, while entropy and SD were higher at surgical levels. These patterns suggest that marrow organization varies along the spine and may reflect disorganization or compositional changes relevant to LSS. The lack of age-dependent disc degeneration (Δµ) at L4/L5 suggests that mechanical or anatomical factors may contribute more to degeneration at this segment. This supports the hypothesis that age alone does not explain lumbar tissue changes. Vertebral marrow heterogeneity may therefore offer additional insight. Entropy captures this variation, which has also been described using other imaging methods [7, 8], though its application remains largely unexplored. In this study, entropy consistently decreased with age across vertebral levels, possibly reflecting more homogeneous marrow due to fatty infiltration or evolving Modic transformations. While Modic changes are often visible, entropy may provide an objective measure of subtle marrow variations not captured by conventional imaging.

Quantitative MRI metrics, especially Δµ and vertebral entropy, identified tissue changes in the nucleus pulposus and adjacent vertebral marrow at levels affected by LSS. Entropy captured marrow characteristics beyond age-related degeneration, and findings suggest that current assessment practices might overlook clinically important variations. These imaging features warrant further investigation and may offer synergistic value in future AI-driven analyses to inform and improve treatment strategies for LSS patients.
Christian WALDENBERG (Gothenburg, Sweden), Ella NILSFORS, Erland HERMANSEN, Hanna HEBELKA, Hasan BANITALEBI, Helena BRISBY, Kari INDREKVAM, Kerstin LAGERSTRAND
13:30 - 15:00 #47002 - PG522 Regional cortical folding alterations in craniostenosis : an MRI-Based sulcation analysis.
PG522 Regional cortical folding alterations in craniostenosis : an MRI-Based sulcation analysis.

Craniosynostosis is a rare congenital disorder caused by the premature fusion of one or more cranial sutures, which can affect skull shape and brain development [1]. While its impact on overall brain morphology is known, effects on cortical folding remain poorly understood. This study aimed to quantify regional sulcation patterns in different craniosynostosis subtypes (Apert, Crouzon, Muenke, and non-syndromic) using MRI-based surface analysis.

The study included 65 patients with craniosynostosis, imaged at Hôpital Necker-Enfants Malades (mean age=5.46 years; 38 males, 25 females). The patient group comprised 33 individuals with Crouzon syndrome (16 pre-operative and 7 post-first surgery), 4 pre-operative Apert patients, 6 post-operative Muenke patients, and 23 post-operative non-syndromic patients. A control group of 130 typically developing children (mean age=5.99 years; 72 males, 58 females) was also included. Control data were obtained from Hôpital Necker-Enfants Malades, the Baby Connectome Project [2], and Neurospin, with 24.6% of controls scanned at Necker to ensure partial site matching. All participants were imaged with high-resolution 3D isotropic T1-weighted MRI scans. Images were processed using the Morphologist pipeline from BrainVISA [3] to extract cortical sulcal surfaces from eight hemispheric regions, defined according to cranial sutures (anterior and posterior coronal, temporal, and posterior lambdoid, on both mesial and lateral surfaces shown in Figure 1). The hemispheric hull surface was also computed. To reduce inter-site and sex-related variability, the cortical surfaces were harmonized using ComBat. A sulcation index was calculated for each region as the ratio between the regional sulcal surface area and the corresponding hemispheric hull surface area. A sulcation index was also calculated for each hemisphere. Normative developmental trajectories were modeled in the control group using power-law growth functions. Patient data were compared to this normative model to identify atypical sulcation, defined as values falling below the 10th or above the 90th percentile (Fisher's test). Statistical comparisons of residuals were performed using shuffle and split tests to assess group-level differences.

No significant differences in hemispheric sulcation were observed between any disease group and controls. Regarding regional sulcation, age-adjusted comparisons with controls revealed the following findings. In Crouzon syndrome, increased sulcation was observed in the temporal region (corrected p-value=10^-5 for the left hemisphere, 0.01 for the right) and in the posterior lambdoid region (left hemisphere, corrected p-value=10^-5 for the right hemisphere) but a decreased sulcation in the left hemisphere (corrected p-value=10^-2) . In Apert syndrome, no significant differences were found, likely due to the small sample size. In Muenke syndrome, decreased sulcation was observed in the anterior coronal region (corrected p-value=0.04 for the left hemisphere, 0.007 for the right), posterior coronal regions (corrected p-value=0.03 for the left hemisphere, 0.007 for the right), and an increased sulcation for the temporal (left hemisphere, corrected p-value=10^-8) and internal temporal regions (left hemisphere, corrected p-value=10^-8). Finally, in the non-syndromic group, increased sulcation was observed in the posterior coronal region (left hemisphere, corrected p-value=0.01).

Our findings reveal no significant differences in hemispheric sulcation between any disease group and controls. However, significant regional differences in sulcation patterns across craniosynostosis syndromes, with Crouzon and Muenke patients showed alterations compared to controls. Increased sulcation in regions such as the temporal and posterior lambdoid in Crouzon syndrome, as well as the anterior and posterior coronal in Muenke syndrome, suggests that these patterns may reflect neurodevelopmental differences associated with cranial malformations and their respective management. In Apert syndrome, no significant differences were observed, likely due to the small sample size, highlighting the need for larger cohorts to better characterize sulcation patterns in this group. For Crouzon syndrome, the variability observed in sulcation patterns may be related to the genetic and suture closure diversity of the mutations involved. The non-syndromic group exhibited increased sulcation in the posterior coronal region, although the underlying cause of this effect remains unclear.

Regional sulcation alterations were identified in Crouzon and Muenke syndromes, despite the absence of global gyration differences. Regional sulcation alterations were identified in Crouzon and Muenke syndromes, despite preserved global gyration. These results confirm that localized cortical folding changes can occur in craniosynostosis and may reflect underlying neurodevelopmental variability specific to each syndrome, beyond the effects of skull shape alone.
Ombline DELASSUS (Paris), Lucas CHOLLET, Barbara YOUNGUI, Giovanna PATERNOSTER, Roman Hossein KHONSARI, David GERMANAUD, Jean-François MANGIN
13:30 - 15:00 #47565 - PG523 Case Study on Quantitative MRI in a 71-Day-Old Rat Brain with Cortical Malformation.
PG523 Case Study on Quantitative MRI in a 71-Day-Old Rat Brain with Cortical Malformation.

Quantitative MRI (qMRI) is a non-invasive technique that investigates the alterations in the microstructure of the tissues by estimating relaxation times such as T1, T2, and T2*, and derived metrics like R2* [1]. Quantitative Susceptibility Mapping (QSM), is another qMRI technique that estimates the magnetic susceptibility of the tissues and gives information about iron accumulation, calcium, and myelin content [4]. These parameters are sensitive to changes in water content, iron accumulation, and myelination. Quantitative MRI can be used to detect biomarkers that characterize neuropathology [2]. Rodent models are used in preclinical studies due to their genetic similarities to humans. Rodent models can be used for aging studies due to their short lifespan, which allows for efficient data collection and longitudinal studies [3]. In this study, we aimed to use qMRI techniques to analyze a 71-day-old rat with a cortical malformation and compare its quantitative measurements, including those from adjacent and periventricular parenchyma, to those of age-matched healthy controls.

The data is acquired from an ongoing preclinical aging study. The study includes eighteen female Wistar rats (mean age: 74.2 ± 8.2 days; weight: 178.2 ± 11.6 g) scanned using a 7 Tesla preclinical MRI scanner (MR Solutions Ltd., UK). T1-weighted (T1w, Fast Spin Echo (FSE), TR/TE: 1000/11 ms, FA: 90°, Resolution: 0.125 × 0.125 × 0.8 mm³), T2-weighted (T2w, FSE, TR/TE: 2500/40 ms, FA: 90°, Resolution: 0.125 × 0.135 × 0.8 mm³), Multi-Echo Multi-Slice (MEMS, TR/TE: 4000/150 ms, FA: 90°, Resolution: 0.16 × 0.31 × 1 mm³), and Multi-Gradient Echo (MGE, TR: 1620 ms, FA: 60°, Resolution: 0.36 × 0.36 × 0.36 mm³, Min/Max TE: 4/21.12 ms, 9 echo times). The FLAIR sequence was also acquired for the case with cortical malformation. These sequences are used to calculate the quantitative parameters, including T1, T2, T2*, and R2* maps. One Wistar female rat (71 days old) spontaneously exhibited a schizencephaly-like cleft extending from the cortical surface to the ventricles, establishing communication with the ventricular system in the right hemisphere. The cleft demonstrated CSF-equivalent signal intensity across all imaging sequences (Figures 1,2). It is located across both cortical and subcortical regions, including parts of the somatosensory cortex, insular cortex, and deep white matter. Associated findings include right-sided asymmetric hydrocephalus and inward displacement of the corpus callosum. This animal was selected for case analysis, and the region with the cleft was analyzed. Five age-matched female rats with no visible abnormalities were selected as controls for comparison. For the quantitative analysis, first, skull stripping was done on the subjects using an in-house UNet model (presented on ISMRM 2025). Then, voxelwise maps of relaxation parameters were computed using custom codes in Python to fit standard signal models. Voxel-wise relaxation maps (T1, T2, T2*, and R2*) were computed by fitting standard signal models for each sequence: inversion recovery for T1 (IR-FLASH), multi-echo spin echo for T2 (MEMS), and multi-echo gradient echo for T2* and R2* (Figure 3). SEPIA (v1.2.2.3) [6] in MATLAB was used to generate QSM. GRE phase and magnitude data were processed using Laplacian unwrapping (STI suite) [9], VSHARP [8] for background removal, and star-QSM [7] for dipole inversion. After generating the maps, they were registered to the Sigma rat brain atlas [5]. With guidance from a radiologist, the corresponding anatomical labels were then used to identify regions containing the lesion.

The quantitative values extracted from the cleft region showed marked deviation from age-matched healthy controls. The T2 values in the cleft region were notably higher (171.33 ms, case; 59.22 ± 1.04 ms, controls). Similarly, T1 relaxation time was prolonged (2582.36 ms, case; 1566.08 ± 33.12 ms, controls). The T2* value was also increased (4.48 ms, case; 0.07 ± 0.0035 ms, controls), while R2* showed a reduction (10.21, case; 14.90 ± 0.51, controls). Lastly, QSM values were slightly lower in the cleft (0.0019 ppm, case; 0.0023 ± 0.0007 ppm, controls). In contrast, values from unaffected brain regions were consistent with age-matched healthy controls.

Quantitative maps revealed increased T1, T2, and T2* values in the cleft, indicating increased water content and reduced tissue complexity and myelination. On the other hand, R2* decreased, suggesting decreased magnetic susceptibility effects. QSM values were slightly decreased, supporting the presence of CSF-like fluid and altered microstructure.

This case study demonstrates how qMRI enables the detection and characterization of brain abnormalities in preclinical models. Acknowledgments: This research is supported by TÜBİTAK 1004 Grant (No. 22AG016).
Leen HAKKI (Istanbul, Turkey), Öykü YEŞILOĞLU, Belal TAVASHI, Uluç PAMUK, Oğuzhan HÜRAYDIN, Esin ÖZTÜRK IŞIK, Pınar Senay ÖZBAY
13:30 - 15:00 #47688 - PG524 Volumetric MRI Analysis in 3-Month-Old Wistar Rats: A Baseline for Longitudinal Studies.
PG524 Volumetric MRI Analysis in 3-Month-Old Wistar Rats: A Baseline for Longitudinal Studies.

Aging is a natural process, and with the increase in human lifespans, research into the effects of normal aging on brain structures and volume has become increasingly important [1]. Magnetic resonance imaging (MRI) is a commonly used noninvasive method in the literature for studying aging. Rodent models are widely used in preclinical studies because of their genetic similarities to humans and their short lifespan, allowing for efficient data collection and longitudinal studies [2]. This enables researchers to analyze the aging effect within the same individuals at different time points. Volumetric analysis of brain structures is important in characterizing age-related morphological changes. Regions such as the striatum, thalamus, corpus callosum, subiculum, and hypothalamus are known to undergo structural alterations with age [3]. Furthermore, measures of gray matter (GM), white matter (WM), cerebrospinal fluid (CSF), and total intracranial volume (TIV) provide an overview of overall brain structure [4]. As part of an ongoing aging study, we performed a baseline volume analysis on a group of same-aged Wistar rats (~3 months old) using anatomical MRI images. While the full longitudinal data is not yet available, this first time point provides a reference for key brain regions and tissue types. These measurements will be used to track volume changes related to aging in future time points. In addition, tissue probability maps will be used for voxel-based morphometry (VBM) to examine whole-brain differences.

This study includes eighteen same-aged female Wistar rats (mean age: 74.2 ± 8.2 days; weight: 178.2 ± 11.6 g) scanned using a 7 Tesla preclinical MRI scanner (MR Solutions Ltd., UK). T1-weighted (T1w, Fast Spin Echo (FSE), TR/TE: 1000/11 ms, FA: 90°, Resolution: 0.125 × 0.125 × 0.8 mm³), T2-weighted (T2w, FSE, TR/TE: 2500/40 ms, FA: 90°, Resolution: 0.125 × 0.135 × 0.8 mm³), Multi-Echo Multi-Slice (MEMS, TR/TE: 4000/150 ms, FA: 90°, Resolution: 0.16 × 0.31 × 1 mm³), and Multi-Gradient Echo (MGE, TR: 1620 ms, FA: 60°, Resolution: 0.36 × 0.36 × 0.36 mm³, Min/Max TE: 4/21.12 ms, 9 echo times). T2w images were used for the volumetric analysis. To prepare the data for analysis, the skull stripping was done using an in-house U-Net model with a 19-convolutional layer (VGG19) encoder developed especially for rat MRI scans (presented on ISMRM 2025) (Figure 1). For generating tissue probability maps (TPM), first, the volumes were affinely registered to the Sigma Brain Atlas [5] using ANTsPy [6], followed by segmentation with SPM8 [7]. For regional volume calculation, inverse nonlinear registration was performed, where the atlas was nonlinearly warped to each subject’s native space, and the volumes of striatum, corpus callosum, thalamus, hypothalamus, and subiculum were assessed.

The TIV was 3557.7 ± 63.8 mm³. Among the tissue probability maps, GM showed the highest volume (1580 ± 31.2 mm³), followed by the WM (994.7 ± 32.5 mm³) and cerebrospinal fluid (CSF: 983.0 ± 18.2 mm³). The regional volume measurements showed that the largest structure was the striatum (97.6 ± 5.6 mm³), followed by the corpus callosum (76.6 ± 5.2 mm³), thalamus (57.8 ± 3.8 mm³), hypothalamus (33.2 ± 3.2 mm³), and subiculum (16.2 ± 1.2 mm³). The box plots of the distribution of regional volumes and TPM-based tissue volumes are shown in figures 3 and 4.

In this study, we developed and implemented a preprocessing and analysis pipeline to support longitudinal analysis of age-related brain changes in Wistar rats. The current work focuses on the baseline time point, providing volumetric measurements of global brain tissues and selected regions of interest, which include GM, WM, CSF, and key brain regions known to be affected by aging. Our pipeline combines automated brain extraction using a deep learning model, atlas-based registration with ANTs, tissue segmentation with SPM8, and regional volume estimation via inverse warping of the atlas. This approach can be used for a consistent longitudinal assessment of regional volumes in the same animals.

This study provides baseline volumetric data for early adult Wistar rats and establishes a pipeline for future longitudinal analysis. The results presented offer a reference for tissue maps and regional brain volumes, supporting future investigations for detecting structural changes related to the aging process. Acknowledgments: This research is supported by TÜBİTAK 1004 Grant (No. 22AG016).
Leen HAKKI (Istanbul, Turkey), Belal TAVASHI, Uluç PAMUK, Oğuzhan HÜRAYDIN, Esin ÖZTÜRK IŞIK
13:30 - 15:00 #46433 - PG525 Quantitative MRI of exogenous Pulmonary Surfactant Distribution: Ex-vivo and In-vivo Studies.
PG525 Quantitative MRI of exogenous Pulmonary Surfactant Distribution: Ex-vivo and In-vivo Studies.

Respiratory Distress Syndrome (RDS) remains a major cause of morbidity and mortality in preterm infants, primarily due to pulmonary surfactant deficiency. Administration of exogenous surfactant is a cornerstone of neonatal intensive care. Furthermore, pulmonary surfactant shows promise as a drug delivery vehicle for targeting lung diseases such as inflammation and infections (1,2). This study evaluates the potential of Magnetic Resonance Imaging (MRI) for imaging and quantifying the distribution of exogenous surfactant in preclinical rabbit models, both ex-vivo and in-vivo, mimicking the pulmonary characteristics of preterm infants.

Ex-vivo experiments were conducted on isolated rabbit thoraxes (N=6) ventilated under pleural depression and Positive End Expiratory Pressure conditions (3). In-vivo studies used anesthetized 6-week-old rabbits (1 kg body weight, N=6). In both cases, 2 mL of Curosurf (Chiesi Farmaceutici) surfactant solution mixed with 0.2 mL of Dotarem (Guerbet) contrast agent solution were instilled in the lungs using the clinical standard Less Invasive Surfactant Administration approach (4) (Fig. 1a-b, Fig. 2a). 3D UTE (Ultra-short Echo time) MRI scans were acquired on a 3T whole-body magnet (Vantage Centurian, Canon Med. Sys.). T1 maps of the surfactant were generated using a Variable Flip Angle approach (5) and then concentration maps were generated. Central airways, peripheral lung regions and Total lung volume were segmented with the nnU-Net deep learning framework (6) for ex-vivo images and manually for in-vivo images.

In ex-vivo experiments, MRI signal enhancement reached up to 1900% (Fig. 1c–d), with 84% of the instilled surfactant distributed to distal lung regions, occupying 32.5% of the total lung volume. In-vivo imaging showed signal enhancements up to 1700% (Fig. 2b–c), with the surfactant distribution remaining stable over a one-hour period and no signal enhancement observed outside the pulmonary regions. Gd³⁺ concentration maps (Fig. 3a, 3d) revealed surfactant presence along the walls of the large airways and demonstrated inhomogeneous distribution between the left and right lungs in both ex-vivo and in-vivo experiments. Segmentation of the central airways and lung volumes (Fig. 2b–c, 2e–f) enabled quantitative assessment of the contrast-enhanced surfactant distribution, showing variation along the ventral to dorsal direction with lungs in the supine position during surfactant administration and MRI studies. (Fig. 3a, 3c), as well as notable asymmetry between the right and left lungs (Fig. 3b, 3d).

These results demonstrate the feasibility of using MRI to visualize and quantify the distribution of the surfactant within the lungs both in-vivo and ex-vivo. The marked inhomogeneity observed between the left and right lungs suggests that surfactant delivery can be uneven, potentially influenced by factors such as anatomy or the animal's position during administration. The lack of signal enhancement in other tissues or blood vessels indicates that the contrast agent remained co-localized with the surfactant into the airspaces. Additionally, the minimal change in surfactant distribution over time suggests stability of the administered surfactant within the lung during the imaging period.

This study validates the use of MRI for the quantitative evaluation of pulmonary surfactant distribution in both ex vivo and in vivo models. The proposed approach is currently being used to improve surfactant administration techniques for premature infants, and it also holds promise for evaluating the distribution of therapeutic agents using surfactant as a drug carrier. Overall, this new method offers broader implications for optimizing drug delivery and enhancing treatment strategies.
Oumaima MARFOUK (Bordeaux), Rémy GÉRARD, Ghalia KAOUANE, Lara LECLERC, Fanny MUNSCH, Bei ZHANG, Stéphane SANCHEZ, Noël PINAUD, Mickaël FAYON, Sophie PÉRINEL-RAGEY, Jérémie POURCHEZ, Eric DUMAS DE LA ROQUE, Yannick CRÉMILLIEUX
13:30 - 15:00 #47891 - PG526 AI-based volumetric analysis of brain oedema in experimental cerebral malaria.
PG526 AI-based volumetric analysis of brain oedema in experimental cerebral malaria.

Cerebral malaria (CM) is the most lethal complication of Plasmodium falciparum infection that occurs in 1-2 % of cases and affects mostly children under 5 years in sub-saharan Africa. This encephalopathy that has a 15-20% fatality rate is characterized by seizures, altered consciousness and coma. Brain swelling is considered as a major predictor of death [1]. The mouse model of CM obtained with P. berghei ANKA (PbA) is a clinically relevant model of the disease characterized by massive brain swelling [2]. The aim of this study was to identify the brain structures most affected by vasogenic oedema in both male and female mice which could lead to a better understanding of the neurological sequelae in survivors. To this end, we imaged the mice before CM induction and at the peak of the disease using anatomical MRI. Images were analysed using a tool developed in-house based on AI for the automatic segmentation of brain structures.

27 male and 15 female C57Bl/6J mice aged 8 to 10 weeks were imaged before inoculation with 2x10^6 erythrocytes parasitized with PbA and at the peak of CM (d5-6 post inoculation). The clinical monitoring included the assessment of neurological signs, body weight, temperature and parasitaemia. MRI experiments were carried out on a Bruker AVANCE 500 WB system @11.75 T equipped with a volume T/R coil for the mouse brain and a heating blanket, under isoflurane anaesthesia (1-2%/air) and physiological monitoring. Images were acquired using the RARE sequence: TR/TE: 5000/9.21 ms, RARE factor 8, 4 av, FOV 15x15 mm2, 194x194 matrix, 31 contiguous slices of 0.5 mm. The images were segmented using the nnU-Net framework [3] and a training database of 18 2D mouse brain MR images manually segmented by experts. The automatic segmentation produced 28 parcels including the brain mask. For each mouse, the volume fraction (FV) of each structure with respect to the whole brain volume was calculated as: FV = Vstr/ Vbrain.ctrl. Vstr is the volume of the structure at each time point and Vbrain.ctrl the volume of the whole brain before CM induction. For each mouse, the volume variation of each structure caused by the disease (delta was calculated as: delta = [(Vstr.peak - Vstr.ctrl)/ Vstr.ctrl] * 100. Statistics: two-way ANOVA followed by Šidák’s multiple comparison test, significance: p<0.05.

93% of the males and 74% of the females developed CM. Twelve males and two females reached a humane endpoint before imaging and had to be withdrawn from the study. The weight loss appeared from day 2 after PbA inoculation in males and a day later in females, while the neurological signs pathognomonic of the severe stage of CM occurred between d5 and 6. Hypothermia, a well-known feature of murine CM resulted in an average drop in body temperature of 13% at d5-6 in both sexes. Parasitaemia at d5 was between 5 and 16% with no significant difference between males and females. Both sexes presented significant brain swelling on MRI particularly visible along the dorsoventral axis and at the level of the cerebellum whose fissures were less distinguishable. Oedema was associated with micro-haemorrhages that were more numerous in males than in females. The total brain volume increased by 4-5% at the peak of CM (males: Vctrl = 474.2 ± 14.4 mm3, Vpeak = 494.7 ± 17.6 mm3; females: Vctrl = 467.7 ± 14.2 mm3, Vpeak = 491.2 ± 11.6 mm3). Both males and females presented significant augmentation of the volume of the pons, cortex, and striatum (Fig 1). Cortex was responsible for ca 50% of the increase (average cortical increase of 9.9 ± 5.6 mm3 in males and 11.0 ± 8.8 mm3 in females) (Fig 1-2). Other volume changes were specific to one sex. Males presented a significant increase of the cerebellum, ventricles, inferior colliculus and periaqueductal gray, and a reduction of the superior colliculus whereas females presented a significant increase of the midbrain.

The volumetric study of 27 brain structures enabled the identification of structures that are equally affected in both sexes such as cortex, pons and striatum, as well as sex-dependent differences in other structures including the superior colliculi, cerebellum or midbrain. A downregulation of pro-inflammatory cytokines by oestradiol in females and the immunosuppressive effect of testosterone in males could partly explain the differences between males and females [4].

CM causes a cerebral syndrome that affects females and males differently. These sex-linked differences, reflected in some regional prevalence studies in endemic areas, also appear at the peak of experimental CM at the level of the clinical signs and the distribution of the oedema in specific brain structures. This is the first description of the regional development of oedema in CM and the first imaging-based demonstration of sex differences in CM. This study could help advance the understanding of brain damage in CM according to sex and encourage the search for sex-specific adjunct therapies.
Alicia COMINO GARCIA-MUNOZ (Marseille), Isabelle VARLET, Oumaïma MARFOUK, Constance MICHEL, Ludivine GUYOT, Emilien ROYER, Teodora-Adriana PERLES-BARBACARU, Angèle VIOLA
13:30 - 15:00 #47869 - PG527 Predicting histological features in human sclerotic and non-sclerotic hippocampi using frequency-dependent multidimensional diffusion-relaxation MRI.
PG527 Predicting histological features in human sclerotic and non-sclerotic hippocampi using frequency-dependent multidimensional diffusion-relaxation MRI.

Magnetic resonance imaging (MRI) is key for evaluation of patients diagnosed with drug-resistant epilepsy[1]; however, current clinical MRI methods lack specificity to distinguish histopathological changes[2] associated with the development of epileptogenic tissue, which significantly impacts the accuracy and effectiveness of surgical resection. Frequency-dependent multidimensional diffusion-relaxation correlation MRI (ωMDR-MRI) offers a novel analysis framework to disentangle sub-voxel information, providing specificity on heterogeneous cellular environments[3]. In this work, we performed a regression analysis to predict cell morphological features of sclerotic and non-sclerotic hippocampi using the diffusion and relaxation properties provided by ωMDR-MRI at high resolution in five patients with focal drug-resistant epilepsy. This approach offers a new analytical method to improve the accuracy of non-invasive studies of the hippocampal state in these patients.

Five patients with focal drug-resistant epilepsy underwent anterior temporal lobectomy. Four hippocampi were diagnosed as hippocampal sclerosis (HS) and the remaining one was non-sclerotic. A portion of the resected hippocampi were imaged using a 11.7 T vertical Bruker scanner (gradient strength 3000 mT/m). The multidimensional images were obtained using a segmented Spin Echo-Echo Planar Imaging (SE-EPI) sequence customized to acquire diffusion with general gradient waveforms. The multidimensional acquisition consisted of 352 images with isometric voxel size of 150 μm3 varying b-value (0.436-9.21·109 sm–2), centroid frequency ωcent/2π (32-252 Hz), normalized anisotropy bΔ (–0.5, 0, 0.5, and 1), orientation (Θ,Φ), repetition time TR (800-3500 ms), and echo time TE (11-65 ms). We obtained the parameter distributions derived from ωMDR-MRI analysis (Diso, DΔ2, R1, R2, Δ????/2π Diso and Δ????/2π DΔ2) with their corresponding per-voxel means and bin-resolved maps as in previous studies (Fig. 1). Cell bodies were segmented from two Nissl micrographs (Fig. 2A-C) per sample using a fine-tuned version of the vision transformer Segment Anything Model (SAM)[4]. Then, we extracted cell shape measurements from each detection, such as the area, minimum and maximum diameter, and solidity (Fig. 2D-F). The segmented slices were down-sampled to match the MRI voxel size creating histological reference quantitative maps (Fig. 2G-I). Each pair of segmented slices per subject were aligned and registered to its corresponding MRI slice (Fig. 3). Then, we performed a regression analysis using the random forest (RF) approach[5] and obtained the training R2. Separated RF models were trained with different MRI parameters (Fig. 1): Diffusion tensor imaging (DTI), 2 maps; ωMDR per-voxel means, 6 maps; and ωMDR bin-resolved, 18 maps. We evaluated the prediction accuracy and performance with leave-one-out cross-validation (LOO-CV) and metrics such as Q2, and MSE[6].

Fig. 4 shows a comparison of the three regression models on the histology target variables of cell density and area. We found in both representative sclerotic and non-sclerotic hippocampi that ωMDR bin-resolved predict more accurately the ground truth (shape measurements derived from cell segmentation). Regions with high cell density, such as the granule cell layer were underrepresented in the DTI predictions, with improvements seen in the ωMDR bin-resolved predictions. The opposite effect was present in regions with lower cell density, such as the subiculum, where the predictions overrepresent the cell count. The overall performance of the RF regression model (Table 1) showed that DTI has the lowest area prediction accuracy among all variables, with an R² value of 0.57. An improvement of R² was obtained (R²=0.79) using ωMDR per-voxel means. The highest value of R² = 0.86 was reached with ωMDR bin-resolved predictions. A similar trend was observed for the remaining target variables. The LOO-CV metric Q² shows that the predictions remained positive for all target variables across all three models, except for cell density.

ωMDR-MRI better predicts morphological cell features extracted from the Nissl staining compared to DTI. This demonstrates the relevance of frequency-dependent [7–9] and bin-resolved tensor-valued encoding diffusion[10–12] to better characterize the cell morphology. While the relaxation properties might have also weight in differentiating water populations within each voxel[13]. Our results showed that even with a limited dataset from five hippocampi, good regression performance was achieved; however, it is needed to explore the regression with additional MRI and histological hippocampi slices and more resected hippocampi.

The use of multiple parameters obtained from ωMDR-MRI on ex vivo resected hippocampal tissue to predict histological results presents new opportunities to in vivo translation which could enhance diagnostic specificity, surgery planning and monitoring of patients with drug-resistant epilepsy.
Omar NARVAEZ (Kuopio, Finland), Jenni KYYRIÄINEN, Maxime YON, Sara GRÖHN, Saana ELAY, Tuomas RAURAMAA, Mastaneh TORKAMANI, Arto IMMONEN, Ville LEINONEN, Henri ERONEN, Reetta KÄLVIÄINEN, Daniel TOPGAARD, Tarja MALM, Jussi TOHKA, Olli GRÖHN, Alejandra SIERRA
13:30 - 15:00 #47322 - PG528 The effect of electroconvulsive therapy and transcranial magnetic stimulation on brain volumes and perfusion in depression.
PG528 The effect of electroconvulsive therapy and transcranial magnetic stimulation on brain volumes and perfusion in depression.

Major depressive disorder (MDD) is characterized by persistent low mood, anhedonia, and functional impairment without a history of mania or hypomania [1][2]. In bipolar disorder, depressive episodes are phenotypically similar but occur in individuals with a history of manic or hypomanic episodes. [3]. Electroconvulsive Therapy (ECT) and Transcranial Magnetic Stimulation (TMS) are treatment options for treatment-resistant depression [4][5] and bipolar disorder depression [6]. Volume changes in anatomical structures such as the hippocampus are consistently reported following ECT [7]. There are fewer studies of volume change after TMS, but volume changes in the hippocampus have been reported [8]. Studies on brain perfusion, or Cerebral Blood Flow (CBF), when assessed by Positron Emission Tomography (PET) and Single-Photon Emission Computed Tomography (SPECT) have shown changes in relative CBF both during and after ECT [9]. The aim of the current study was to investigate a potential association between changes in brain MR perfusion using arterial spin labelling and volume changes in selected brain structures. The hypothesis was that the ECT and TMS treatment will lead to increased volume in the selected brain structures and that the same structures will experience a change in perfusion.

The MRI images were acquired on a GE Discovery MR750w 3.0T, using 3D MP-RAGE (TE/TR/TI=3.1/7.4/1060ms, 1mm3) for the T1 images and 3D-ASL (pcASL, TE/TR=10.5/4888ms, 1.875x1.875x4 mm3) for the perfusion images. FreeSurfer [10] and FSL BASIL [11] were used to analyze the images. FreeSurfer was used for image segmentation and volume quantification, while FreeSurfer and FSL BASIL were used for perfusion quantification. At the time of analysis, the data consisted of 28 participants from the GEMRIC study [12], where 9 had received ECT, 10 had received TMS and 9 were healthy controls (Figure 3). MRIs were collected at five timepoints for the patients: 1 hour before, 1 hour after, 14 days after, 3-8 weeks after and 7-8 months after first treatment, and four timepoints for the healthy controls over the same time span, lacking the MRI at 3-8 weeks, as described in the study protocol [13] (Figure 4).

The results showed a statistically significant volumetric increase from scan 1 (before treatment) to scan 4 (3-8 weeks after first treatment) in the left (2.8%, p=0.0043) and right hippocampus (4.3%, p=0.0001), right amygdala (4.3%, p=0.0002), and right thalamus (1.8%, p=0.0202) for the ECT group. However, only the right hippocampus and right amygdala passed a Bonferroni correction (p<0.0026). The TMS group showed a statistically significant volumetric increase in the right hippocampus (1.8%, p=0.0342) and right thalamus (1.5%, p=0.0482), but none of the areas passed the Bonferroni correction. As the perfusion has large normal variation, the small masks of the hippocampus, amygdala, and thalamus (HAT) were combined in each hemisphere for the perfusion analysis. There were no statistically significant changes between the participant groups at baseline perfusion, and none of the groups showed a statistically significant longitudinal change. There were also no statistically significant differences across the hemispheres. Although not significant, there were trends showing a longitudinal decrease in perfusion in the ECT group. Similarly, in the TMS group, trends showing a slight decrease followed by an increase in perfusion were observed. There were also trends showing an increased baseline perfusion for the ECT group compared to the other participant groups in both hemispheres. See Figure 1 and Figure 2 for volume and perfusion results, respectively.

A volumetric increase in several of the selected anatomical structures was found for the patient groups despite the relatively low number of participants. In the ECT group, the left and right hippocampus, right amygdala and right thalamus showed a significant increase after treatment. The patients in the TMS group only had a significant increase in the right hippocampus and right thalamus, and the increases were smaller and less significant. This may indicate that the stronger ECT treatment will lead to a larger volumetric increase than the weaker TMS treatment. The trend of a higher baseline perfusion for the ECT group in the left and right hemisphere, as well as the indicative changes in perfusion in the selected brain structures, will be interesting to explore in future analysis and larger data samples.

MRI structural and perfusion images from healthy controls, ECT and TMS participants in an ongoing clinical study were analyzed. The study found a volumetric increase in selected subcortical brain structures after treatment, with more pronounced effects in the ECT treated participants than in the TMS group. These findings are in consistency with literature. Additionally, the study found trends in perfusion changes in these same structures which will be further explored in a larger patient sample.
Ingrid Kleive ANDERSEN (Bergen, Norway), Erling ANDERSEN, Frank RIEMER, Ute KESSLER, Leif OLTEDAL, Renate GRÜNER
13:30 - 15:00 #47146 - PG529 Multimodal MRI Biomarkers of Therapeutic Response in Depression Remission: Insights from Acceptance and Commitment Therapy.
PG529 Multimodal MRI Biomarkers of Therapeutic Response in Depression Remission: Insights from Acceptance and Commitment Therapy.

Depression remains a leading cause of suicide worldwide, contributing to over 700,000 deaths annually. Traditional antidepressant treatments often fail to address suicidal ideation, particularly in high-risk patients. Acceptance and Commitment Therapy (ACT), a third-wave cognitive behavioral therapy, has shown efficacy in reducing depression and suicidal ideation by targeting emotional regulation through mindfulness. Neurobiological models suggest that ACT may exert therapeutic effects by modulating brain networks such as the Default Mode Network (DMN) and the Salience Network (SN), which are implicated in rumination and emotional processing. This study aimed to identify MRI biomarkers of therapeutic response to ACT in adults with a history of suicide attempts.

We conducted a multimodal MRI study on adults undergoing either ACT or relaxation training (Relax), both in addition to standard treatment. MRI data were acquired before and after a 7-week intervention period. Data included structural MRI, diffusion tensor imaging (DTI), arterial spin labeling (ASL), and resting-state functional MRI (rs-fMRI). Using the Schaefer 400-parcel atlas, we extracted functional connectivity and cerebral blood flow (CBF) metrics, with a focus on DMN, SN, and ventral attention networks. A principal component analysis (PCA) was applied to clinical scores (depression, hopelessness, and psychological pain) to derive a single “negative component” representing symptom severity. Associations between imaging metrics and changes in this composite score were analyzed using linear models corrected for multiple comparisons (pFDR).

A total of 87.5% of participants were female, with a mean age of 40 ± 12 years. At baseline, 81% were experiencing a major depressive episode. No significant group-by-session interaction effects were observed for anatomical or graph theory-based functional metrics. However, across both groups, clinical improvement (i.e., reduction of the negative component) was significantly associated with: (1) increased modularity within the Salience Ventral Attentional Network (r = –0.476, pFDR < 0.05), particularly in right medial cortical regions; (2) increased CBF in the right mid-cingulate cortex (r = –0.5, pFDR < 0.05); and (3) decreased functional connectivity between the left anterior cingulate cortex and the right superior frontal gyrus (T = 4.72, pFDR < 0.05).

These findings support a neurobiological model in which therapeutic response in depression is linked to a reorganization of salience-related functional networks. Increased modularity within the Salience Ventral Attentional Network suggests a more functionally segregated and specialized brain organization following therapy. The observed changes in CBF and connectivity further highlight specific right medial brain regions as potential nodes of therapeutic plasticity.

Improvement in depressive symptoms and suicidal ideation following ACT or relaxation training appears to be associated with functional reorganization within the Salience Ventral Attentional Network. This reconfiguration, marked by increased modularity and region-specific changes in CBF and connectivity, may enhance emotional and cognitive regulation, thereby supporting clinical remission.
Guillaume CLAIN (Montpellier), Jeremy DEVERDUN, Manon MALESTROIT, Olie EMILIE, Veronique BRAND-ARPON, Deborah DUCASSE, Philippe COURTET, Emmanuelle LE BARS
13:30 - 15:00 #47607 - PG530 Multimodal 7T MRI and Machine Learning for Stratifying ALS Progression in Small Cohorts.
PG530 Multimodal 7T MRI and Machine Learning for Stratifying ALS Progression in Small Cohorts.

Amyotrophic Lateral Sclerosis (ALS) is a rare, progressive neurodegenerative disorder with notable heterogeneity in clinical presentation and disease progression [1]. Accurate early diagnosis and prognosis are critical for effective patient management and treatment personalization. Current diagnostic methods largely depend on clinical evaluation, often leading to delays in diagnosis and prognostication [2]. Recent advances in ultra-high field (7T) MRI enable acquisition of structural, diffusion, and metabolic information at higher spatial resolution, potentially improving ALS characterization through imaging analysis [3,4]. Our study evaluates the use of such multimodal 7T MRI via suitable machine learning (ML) approaches to identify imaging biomarkers capable of differentiating healthy individuals from ALS patients, and further stratifying patients into slow and fast progressors.

The study enrolled 30 subjects, comprising of 16 ALS patients, and 14 healthy controls. We employed advanced 7T multimodal neuroimaging techniques, including structural, diffusion tensor imaging (DTI), and sodium imaging to obtain 270 MRI-based parametric samples. The parametric maps consisted of quantitative T1 (qT1), fractional anisotropy (FA), mean diffusivity (MD), axial diffusivity (AD) and radial diffusivity (RD), total sodium concentration (TSC), sodium T2*short (T2s) and T2*long (T2l) relaxation times, as well as the sodium signal fraction (fNa), representing the sodium signal from the short component [5]. The brain was parcellated into 332 regions of interest (ROIs), incorporating both gray matter (GM) and white matter (WM). Mean ROI values across the nine imaging parameters were extracted per subject, resulting in a high-dimensional feature space. The ML pipeline was developed after thoroughly evaluating various step configurations. A nested cross-validation framework was adopted using leave-one-out cross-validation (LOOCV) for robust performance estimation, and compared against chance-level predictions. Classification tasks included: (i) controls vs ALS patients (2-class), (ii) controls vs slow vs fast progressors (3-class), and (iii) slow vs fast ALS progressors.

Based on our systematic analysis of ML pipeline design, a multinomial logistic regression (MLR) classifier with L2 regularization was selected, with standard scaling feature normalization and hyperparameter tuning. As seen in tables 1 and 2, unimodal analyses showed that among the imaging markers, TSC, MD and RD were most informative, particularly when WM ROIs were included in the analysis. Multimodal fusion helped improve the classification outcomes, with the 3-class setup achieving 70% accuracy and a Z-score of 5.2 when using the full GM+WM parcellation. Classification between slow and fast progressors improved from 69% (Z=1.74) to 88% (Z=3.96) when healthy controls were included during training. Fig. 1 illustrates the outcome of feature importance analysis, revealing that sodium imaging parameters contributed 60% of top selected features, followed by DTI-derived features (30–40%). Structural qT1 imaging provided limited discriminative value. The analysis highlighted both GM and WM ROIs, thereby emphasizing the need for whole-brain evaluation.

This study demonstrates the feasibility and clinical utility of integrating multimodal 7T MRI with machine learning to classify ALS patients and predict disease progression in a small-cohort setting. White matter alterations, as captured by DTI metrics (RD, MD) and metabolic dysregulation indicated by 23Na imaging (TSC, fNa), emerged as dominant biomarkers. The inclusion of healthy controls during training enhanced the model's robustness in stratifying ALS progression, likely by providing contrast for learning disease-relevant patterns. Conventional structural imaging (qT1) showed limited value, underscoring the added value of advanced imaging modalities, thereby confirming the choices made for the ongoing multimodal dataset acquisition. The study also established that extensive pipeline optimization yielded only marginal improvements, emphasizing the greater impact of data enrichment strategies such as multimodal fusion.

Our findings highlight the potential of combining advanced 7T MRI modalities with classical machine learning approaches to identify robust imaging biomarkers for ALS diagnosis and prognosis in small cohorts. Sodium imaging and DTI-derived features offer substantial discriminative power, especially when both gray and white matter brain regions are analyzed. Importantly, integrating healthy controls during training and leveraging multimodal MRI data enhances the model’s ability to stratify ALS patients by progression rate. This work lays a methodological foundation for future studies in rare neurodegenerative diseases, advocating for data enrichment and multimodal integration over complex pipeline tuning when dealing with limited sample sizes.
Shailesh APPUKUTTAN (Marseille), Aude-Marie GRAPPERON, Mounir Mohamed EL MENDILI, Hugo DARY, Maxime GUYE, Annie VERSCHUEREN, Jean-Philippe RANJEVA, Shahram ATTARIAN, Wafaa ZAARAOUI, Matthieu GILSON
13:30 - 15:00 #47916 - PG531 Brain resting-state fMRI signal complexity in temporal lobe epilepsy (TLE) patients.
PG531 Brain resting-state fMRI signal complexity in temporal lobe epilepsy (TLE) patients.

Temporal lobe epilepsy (TLE) is the most common form of focal epilepsy in adults, characterized by seizures originating in the temporal lobe [1]. Antiepileptic medications can effectively control symptoms in 70–80% of patients, but accurate diagnosis remains challenging [2]. Many conditions mimic epileptic seizures, and routine anatomical magnetic resonance imaging (MRI) and electroencephalography (EEG) often yield normal results in TLE patients due to subtle or absent structural abnormalities and the limited spatial resolution of EEG. Resting-state functional MRI (rs-fMRI) may be a promising alternative method for detecting TLE. This technique measures spontaneous, low-frequency fluctuations of the blood oxygen level–dependent (BOLD) signal, which indirectly reflects local neural activity while the subject is at rest, in the absence of a task/stimuli [3]. Complexity analysis, often quantified by the Hurst exponent, can be used to assess the temporal self-similarity and predictability of rs-fMRI signals [4]. This approach has shown utility in identifying and classifying certain neurological disorders, as reduced brain complexity has been consistently associated with disease [5,6]. Thus, the objective of this work was to evaluate whether a similar analytical approach would be of diagnostic value for patients with TLE.

High-resolution T1-weighted spoiled gradient echo 3D structural images and rs-fMRI data from 9 participants with TLE (22.1 ± 1.9 years old; 5 males and 4 females) and 10 age- and sex-matched healthy controls (22.3 ± 1.9 years old; 5 males and 5 females) were accessed from the Epilepsy Connectome Project (ECP) database [7]. Clinical and diagnostic features of the TLE group are summarized in Table 1. Rs-fMRI data were acquired on a 3T GE Discovery MR750 MRI with the following parameters: GE-EPI, 2mm isotropic, FOV=20.8cm, TE/TR=33.5/802ms, and 377 time points per run. Rs-fMRI preprocessing steps were performed using FSL [8,9]. This included (1) discarding the first five functional volumes to allow for magnetization equilibrium, (2) eddy current and motion correction, (3) spatial smoothing with Gaussian kernel and FWHM=5mm, (4) 4D global normalization, (5) brain extraction, (6) registration to MNI standard space, and (7) high-pass temporal filtering at 0.01Hz. The Hurst exponent was then computed voxel-wise in grey matter using rescaled range (R/S) analysis [4,10]. Group differences were evaluated using a linear mixed-effects model (3dLME in AFNI) to assess the effects of sex and disease status.

Our analytical approach identified sizable regions of interest (ROIs) in the left superior temporal gyrus and the right hippocampus and amygdala (Fig. 1), where TLE patients showed reduced rs-fMRI signal complexity compared to healthy controls, indicated by a significantly higher Hurst exponent (Fig. 2). According to the ECP database [7], neither of these regions showed evidence of sclerosis or other abnormalities on standard clinical MRI, suggesting that the observed complexity reduction occurred in the absence of overt structural changes.

We observed a reduction in rs-fMRI signal complexity in several temporal lobe regions in TLE patients. The healthy brain is best described as a complex system, and reduced rs-fMRI signal complexity may reflect a diminished capacity to adapt to dynamic demands [3]. In TLE, this loss of complexity could indicate disrupted or less flexible neural dynamics resulting from recurrent seizure activity or network reorganization [11]. Our findings support the idea that complexity analysis can capture functionally meaningful and spatially specific changes in the BOLD signal, in regions that appear normal on conventional anatomical imaging. While previous studies have reported reduced signal complexity in TLE using EEG, this is, to the authors’ knowledge, the first to examine these alterations using rs-fMRI, which offers superior spatial resolution for localizing brain activity.

This approach may offer new insights into how epilepsy affects brain organization and communication. It could also potentially represent a novel biomarker for TLE diagnosis, especially in cases where structural imaging appears normal. Our next step will be to increase the sample size and apply subject-level analyses to evaluate whether this method can support personalized diagnosis.
Molly ARMSTRONG (Hamilton, Canada), Alejandro AMADOR-TEJADA, Michael NOSEWORTHY
13:30 - 15:00 #47767 - PG532 Quantifying and correcting axonal shrinkage in transmission electron microscopy: cryo-fixation vs. Epon-embedding.
PG532 Quantifying and correcting axonal shrinkage in transmission electron microscopy: cryo-fixation vs. Epon-embedding.

Axon diameter and g-ratio are key microstructural parameters modulating saltatory conduction velocity (CV) in white matter tracts [1]. However, different tissue processing methods and imaging modalities yield varying axonal diameters, leading to divergent interpretations of CV properties [2]. Diffusion MRI (dMRI) enables in vivo estimation of axon diameter but relies on biophysical models for summary statistics. Validation often uses transmission electron microscopy (TEM) or synchrotron X-ray nano-holotomography (XNH) [3-5]. Tissue preparation for these modalities often involves dehydration and resin embedding, causing significant but poorly understood shrinkage (0-65% [2]). In contrast, cryo-fixation uses high-pressure freezing (HPF) of fresh tissue to preserve cellular integrity and extra-axonal space, as shown in the cortex [6]. Here, we use deep-learning-based segmentation to quantify axon diameter and myelin thickness in the rat corpus callosum (CC) for HPF cryo-fixed and regular Epon-embedded tissue, quantifying and correcting the well-known tissue shrinkage effect in resin-embedded samples.

Eight young male Sprague-Dawley rats (NTac:SD-M; 4 weeks old) were used [2]. In each rat’s midsagittal slice, the CC midbody was sampled using a 1 mm biopsy punch. N=4 samples underwent cryo-fixation via HPF followed by freeze-substitution, and N=4 underwent standard resin embedding. TEM (Philips CM100) was performed at 4200x magnification, 11.9 nm isotropic pixel size, and ∼25 µm x 25 µm field of view. In total, 287 Epon and 299 cryo 2D TEM images were collected. For segmentation, images were downsampled fourfold for computational efficiency. Axons and myelin were segmented with a U-Net, trained separately on 15 manually corrected images per modality with an expert-in-the-loop procedure. Initial segmentation used AxonDeepSeg [7]. Blob-based analysis isolated axons; inner diameter and myelin thickness were estimated from the minor axis of a fitted ellipse to account for eccentricity.

Fig. 1 shows representative axon and myelin segmentations for cryo- and Epon-TEM images. Total histograms of axon diameter and myelin thickness modality-dependent differences are shown in Fig. 2. Larger axons, in the tail of the distribution (90th quantile), shrink more than the smaller axons near the mode. In contrast, myelin thickness histograms overlap, indicating no shrinkage. The axon diameter Q-Q plot (Fig. 3a) reveals non-linear shrinkage in Epon-TEM: small axons are linearly underestimated up to the mode, whereafter underestimation of larger axons is non-linear. Axon diameters in Epon-TEM shrink by up to ∼50% relative to cryo-TEM, while myelin thickness shrinkage remains <11%. In contrast, myelin thickness (Fig. 3b) exhibits a near-perfect linear correspondence between cryo- and Epon-TEM, indicating minimal shrinkage. Fig. 4 shows the application of a uniform 40% correction (commonly used in the literature [2]) vs. a non-linear correction derived from the 100-bin Q-Q analysis. The linear 40% correction cannot take into account the non-linear shrinkage effects observed.

Our data confirm significant non-linear axonal shrinkage in Epon-embedded samples versus cryo-fixed tissue, assumed to be closer to the in vivo state. Cryo-TEM exhibited a broader tail in the axon diameter distribution, reflecting better preservation of large axons. Q-Q analysis revealed near-linear shrinkage near the mode and stronger non-linear underestimation farther from it, indicating diameter-dependent shrinkage as a result of the resin embedding sample preparation. Myelin thickness showed negligible shrinkage across modalities, consistent with its low water content and structural rigidity. Despite shrinkage, segmentation of small axons succeeded in both modalities, unlike dMRI, which cannot resolve fine structures due to hardware limits. Interpolating the Q-Q curve, we corrected Epon-TEM axon diameters, aligning them closer to cryo-TEM and dMRI estimates. However, conventional linear corrections (0-65%) do not ensure accurate correction for shrinkage and risks underestimating large axons. This may contribute to the widely known issue that dMRI-based axon diameter estimates tend to overestimate axon diameters, even after applying 40% linear shrinkage correction to Epon-TEM histograms and accounting for dMRI’s volume-weighted metrics [2-3].

To assess axon diameters, tissue-processing-induced shrinkage must be considered. Modality-specific non-linear corrections enhance quantitative accuracy and structure-function predictions. Larger axons, likely due to higher water content, are more prone to dehydration shrinkage during Epon embedding, while myelin, with its low water content, remains more stable. Our findings stress the importance of accounting for non-linear shrinkage in structural components for robust morphometric comparisons across modalities.
Miren Lur BARQUIN TORRE (Copenhagen, Denmark), Christian S. SKOVEN, Mariam ANDERSSON, Tim B. DYRBY
13:30 - 15:00 #47366 - PG533 White matter damage of the cbgtc loop in progressive supranuclear palsy.
PG533 White matter damage of the cbgtc loop in progressive supranuclear palsy.

Progressive Supranuclear Palsy (PSP) is a rare neurological disease caused by damage to nerve cells controlling body movements. Often misdiagnosed as Parkinson’s Disease (PD), PSP falls under the classification of atypical Parkinsonism, displaying various differences in symptoms and pathology. Previous MRI studies have revealed distinguishing signs that can identify this disease in patients. However, such signs only display after advanced disease progression, lending it little value for use in clinical prognosis. The present study sought to enhance the understanding of the progression of PSP though fixel-based analysis (FBA). By isolating unique tracts affected by the disease, the authors hope to provide further directions for research into early identifying markers of PSP before it progresses to an advanced stage.

Images from 23 patients diagnosed with PSP (8 men and 15 women; mean age: 67.8 ± 6.5 years) and 23 healthy controls (8 men and 15 women; mean age: 67.2 ± 5.9 years) were analyzed. Participants were recruited from the outpatient clinics of the Department of Neurology of a tertiary medical center. PSP presence was established by senior neurologists using the criteria outlined by Litvan et al. (4) and supported by nuclear medicine examinations (i.e. TRODAT). Severity was evaluated using the Unified Parkinson Disease Rating Scale (UPDRS), and disease staging was assessed by the Modified Hoehn and Yahr Staging (MHY) scale. Postural impairment and gait disorder staging (PIGD) was calculated based on their respective scores in the UPDRS. Patients with PSP were divided into 2 groups based on disease duration: long (>5 years, N=10) and short (≤5 years, N=13). Diffusion-weighted images were acquired from a 3T MR scanner (Magnetom Trio; Siemens, Erlangen, Germany) using a spin-echo echo planar imaging (SE-EPI) sequence with these parameters: repetition/echo time = 5700/108 ms, voxel size=2×2×3 mm3, flip angle=90°, acquisition matrix=96×96, FOV=192×192 mm2, 40 slices to cover the brain above the cerebellum. 160 contiguous axial T1-weighted images were acquired with the magnetization-prepared rapid acquisition gradient echo (MPRAGE) sequence with these parameters: repetition/echo/inversion time = 2000/2.63/900 ms; flip angle=9°, acquisition matrix=224×256, FOV=224×256 mm2, with 1×1×1 mm3 resolution. FBA was conducted with MRtrix3 (version 0.3.15, www.mrtrix.org). Multi-tissue constrained spherical deconvolution was utilized to estimate the fiber orientation distribution function (FOD) of each voxel. The FOD was normalized across all participants using symmetric diffeomorphic non-linear transformation FOD-based registration with a study-specific template. Fixel-specific measures were computed from each voxel. Statistical analysis was performed with SPSS. Age differences were evaluated by the Student’s t-test with a significance level of p<0.05. Statistical analyses of images were done in MRtrix3, with both age and sex used as covariates. Connectivity-based fixel enhanced (CFE) and non-parametric permutation testing were used to evaluate the differences in fixel-based metrics, while linear regression between fixel-based metrics and clinical assessment scores (UPDRS-III, LEDD, and PIGD) was carried out with the general linear model. The statistical significance threshold was set at a FWE-corrected p < 0.05.

Patients with PSP displayed a reduction in FD (fiber density), FC (fiber cross-section), and FDC (fiber density & cross-section) in the bilateral superior cerebellar peduncle, cerebral peduncle, posterior limb of internal capsule, and left corticospinal tract, and reductions in FD and FDC were seen in the bilateral posterior thalamic radiation, posterior corona radiata, retrolenticular part of internal capsule, and splenium and body of corpus callosum compared to controls. Compared to the short-term group, patients with a disease duration of >5 years displayed significant differences in UPDRS scores, as well as more widespread affected brain regions. Reductions in FD and FDC were observed in the corpus callosum, bilateral superior and posterior corona radiata, posterior limb of internal capsule, posterior thalamic radiation, and cingulum. A significant correlation was found between clinical parameters and fixel-based metrics in all patients compared to control.

By isolating affected tracts, the findings of this study provide future directions for research into the identification and management of PSP. This study was constrained by a small sample size due to PSP's rarity. In addition, due to the asymptomatic nature of early-stage PSP, the patients from which PSP data was collected was limited to those who exhibited clear symptoms. Therefore, more longitudinal research is needed to collect data from patients during the early period of PSP.

Through FBA, significant white matter tracts implicated in PSP were isolated, with significant differences observed between long-term and short-term groups.
Benjamin CEDERBERG (Taoyuan, Taiwan), Chih-Chien TSAI, Jiun-Jie WANG
13:30 - 15:00 #45750 - PG534 Alteration in hippocampal subfields and thalamic and amygdala nuclei volume and their association with cognition in mild cognitive impairment and glycemic state.
PG534 Alteration in hippocampal subfields and thalamic and amygdala nuclei volume and their association with cognition in mild cognitive impairment and glycemic state.

Alzheimer’s disease (AD) is the most prevalent neurodegenerative disorder in older adults. Mild cognitive impairment (MCI) is recognized as an intermediate stage between normal cognition and mild dementia, characterized by memory deficits(1). Hippocampus, amygdala and thalamus are responsible of cognitive functions. Moreover, recent studies suggest that there is a link between Alzheimer disease and hippocampal atrophy and insulin resistance(2,3). To investigate this, we conducted magnetic resonance (MR) volumetry of healthy control and Mild Cognitive Impairment patients. Mini Mental State Exam (MMSE) was assessed and fasting glycemia and Hemoglobin A1C (HbA1c) were measured, and we conducted the correlation analysis between volumetry and theses parameters.

25 healthy control (22f/3m), age 70.1±6.1, 33 patients (30f/3m) diagnosed as MCI, age 70.1±7.3, participated the study. Mini Mental State Exam (MMSE), HbA1c and fasting glycemia were measured. Study was performed by 3T MR system (PrismaFit) using a 64-channel head coil (Siemens Healthcare, Germany). T1-weighted MPRAGE was acquired for the volumetry of the hippocampal and amygdala subfields and thalamus nuclei with the voxel size 0.83mm3. Freesurfer version 7.4.1 was used. Additional T2w-FLAIR was acquired and used for the segmentation of the hippocampal and amygdala subfields(4). Thalamus nuclei segmentation was conducted(5,6). We conducted the Mann-Whitney U test by SPSS (version 29.0.2.0) to see the difference in volumetry between two groups. Spearman correlation analyses were performed using R (version 4.4.3) to assess associations between brain volumetric measures and cognitive/metabolic variables, including MMSE, fasting glucose, and HbA1c. Missing data were present across variables: MMSE (2 HC, 2 MCI), fasting glucose (3 HC, 2 MCI), and HbA1c (5 HC, 4 MCI); analyses were conducted using pairwise deletion.

The Mann-Whitney U test revealed significant volumetric reductions in Left Basal nucleus, left Accessory Basal nucleus, Left Anterior amygdaloid, Left Central nucleus, Left whole amygdala, Right Basal nucleus, Right Accessory Basal nucleus, Right Anterior amygdaloid, Right Central nucleus, Right paralaminar nucleus and Right whole amygdala from Amygdala nuclei in MCI group. Regarding the Hippocampal subfields, Left presubiculum head, Left CA1 head, Left GCMLDG head, Left CA3 head, Left CA3 head, Left whole hippocampal head, Right hippocampal fissure, Right presubiculum head and Right whole hippocampal head showed significant reductions in MCI group. Regarding the thalamic nuclei, Right LD showed significant decrease. The results of the correlation analysis are displayed in Figure (A),(B), and (C).

Significant reduced volumes in both sides of the amygdala and hippocampus were reported in MCI group, on the other hand there was no significant reduction in thalamic structures. It is a contradiction to one study stating that the early loss of the thalamic volume in the MCI group is the early sign of the disease(7). Several Amygdala nuclei and Hippocampal subfields structures show mild to weak correlations to MMSE, while glucose metabolic markers only showed a few correlations. Recent study suggested the reductions of right side of Amygdala nuclei are hallmark of the MCI(8). Regarding the Hippocampal subfields, one review says that there is a heterogenicity of the structural difference between MCI and control group, and from our study, bilateral presubiculum corresponds to the review consensus(9). Regarding the thalamus, structures in right thalamus were negatively correlated to the level of HbA1C and fasting glucose although the structures on the left thalamus did not show the significant correlation. This could be related the dominance of the bran and the difference of the blood flow, as well as the lateralization preference of the formation of atherosclerosis due to the higher glycemia level.

Significant reductions of the volumes in the amygdala nuclei and hippocampal subfields were observed in MCI group while no reductions were observed in thalamus structures in MCI group. Amygdala and Hippocampal structures showed mild to weak correlations to cognitive functions although there are not many correlations between these structures and glycemic markers. On the other hand, Thalamic nuclei in the right side showed mild to weak negative correlations to HbA1C and fasting glucose, while only a few correlations were observed between MMSE and the volumetry of the thalamic structures.
Kanji CHO (Vienna, Austria), Radka KLEPOCHOVA, Barbara UKROPCOVA, Josef UKROPEC, Lucia SLOBODOVA, Martin KRSSAK, Ivica JUST, Florian FISCHMEISTER
13:30 - 15:00 #45944 - PG535 Postmortem in-situ MRI of the medulla oblongata in amyotrophic lateral sclerosis: Assessing relaxation and DTI parameters.
PG535 Postmortem in-situ MRI of the medulla oblongata in amyotrophic lateral sclerosis: Assessing relaxation and DTI parameters.

Amyotrophic lateral sclerosis (ALS) is a clinically heterogeneous, fatal neurodegenerative disease. Its vast heterogeneity poses a challenge to the development of reliable disease-modifying therapies, which remain unavailable [1]. Sensitive biomarkers are urgently needed to enable successful clinical trials [2]. Although brainstem pathology is a hallmark feature of ALS [3], it has not yet been extensively investigated in imaging studies [4]. This study aimed to explore potential MRI biomarkers in the brainstem, particularly in the medulla oblongata, by assessing relaxation and DTI parameters. Postmortem (PM) in-situ MRI enables the assessment of end-stage ALS without fixation-related alterations seen in ex-situ measurements [5]. Another advantage is the possibility of direct comparison with histological data for validation.

All procedures were approved by the local ethics committee. PM in-situ (brain not extracted from the skull) whole-brain MRI scans were performed on six deceased male patients with clinically definite ALS, as defined by the revised El Escorial criteria [6], and on eight deceased individuals (five males, three females) with no known neurological conditions, who served as healthy controls (HC). The ALS and the HC groups were matched for age (ALS: 63.2 ± 8.2, HC: 69.4 ± 17.9. p = 0.30) and postmortem interval (ALS: 46.75 ± 20.0, HC: 28.3 ± 19.5. p = 0.14). Prior to the scan, the deceased subject was placed in a cooling chamber at 4 °C. Based on a temperature correction model developed in another study [see abstract #45942], the MD and T1 parameters were adjusted to a reference temperature of 20 °C to facilitate comparison between ALS and HC. The scans were performed at 3T (Siemens MAGNETOM Prisma), including the following sequences: • MP2RAGE [7]: 176 slices per slab, FoV = 240 × 256 mm, TR = 5000 ms, TE = 2.98 ms, TI = 700 and 2500 ms, flip angle = 4° and 5°, GRAPPA acceleration factor 3, isotropic resolution of 1 mm3. Used for masking and T1 maps. • DTI: b = 2000 s/mm2, 64 isotropically distributed diffusion directions, 3 b = 0 s/mm2, TE = 109 ms, TR = 18700 ms, 100 slices, isotropic resolution of 1.8 mm3. Used for FA and MD maps. • Multi-contrast spin-echo: 12 TEs, TR = 5720 ms, 44 slices, slice thickness 4 mm, in-plane resolution 1x1 mm2. Used for T2 maps. Sequence only performed for four ALS cases, but all HC cases. • Multi-echo gradient-echo: 12 TEs, TR = 68 ms, flip angle 20°, 44 slices, slice thickness 4 mm, in-plane resolution 1×1 mm2. Used for T2* maps. Sequence only performed for five ALS cases, but all HC cases. The masks for the medulla oblongata were manually created using 3D Slicer [8]. After correcting for eddy currents, FSL’s dtifit command was used to generate FA and MD maps. T1 maps were computed using a publicly available python script [9], while T2 and T2* maps were generated using a voxel-wise two-parameter mono-exponential single decay fit. Comparisons between ALS and HC were conducted using the Mann-Whitney U test and visualised with box plots (using python). Due to the limited sample size, no significance level was defined.

The comparison of relaxometry and DTI parameters between six ALS patients and eight HC suggests increased T1 values in the medulla oblongata of patients with ALS (see Figure 1). While median values for FA, MD, and T2 differed between groups, the corresponding p-values do not support clear differences between ALS and HC.

The objective of this PM in-situ study was to explore potential MRI biomarkers in the medulla oblongata by comparing relaxation and DTI parameters between six patients with ALS and eight HC. The ALS group showed potentially increased T1 in the medulla oblongata. Visual inspection further suggested lower FA (p = 0.08) and higher MD values (p = 0.11) in patients with ALS. Increased T1 and MD, along with reduced FA, has been shown to indicate reduced myelin density [10]. However, the small sample size in the current study limits the ability to draw definitive conclusions. Further validation in larger cohorts, ideally incorporating histological confirmation as the ground truth, is necessary to support this hypothesis.

The exploratory findings of this study could aid in the development of novel MRI biomarkers for ALS, which is a crucial prerequisite for successful clinical trials. However, studying larger cohorts along with corresponding histological validation is required to confirm the current findings.
Dominique NEUHAUS, Dominique NEUHAUS (Basel, Switzerland), Maria Janina WENDEBOURG, Eva SCHEURER, Regina SCHLAEGER, Claudia LENZ
13:30 - 15:00 #47356 - PG536 Peripheral Metabolite 3-Oxooctadecanoic Acid Correlates with Brain Microstructural Changes and Cognitive Impairment in End-Stage Renal Disease.
PG536 Peripheral Metabolite 3-Oxooctadecanoic Acid Correlates with Brain Microstructural Changes and Cognitive Impairment in End-Stage Renal Disease.

End-stage renal disease (ESRD) not only imposes systemic metabolic stress but also contributes to central nervous system dysfunction, particularly cognitive impairment. Previous studies have identified metabolomic alterations related to inflammatory and neurochemical changes in ESRD, such as elevated indoxyl sulfate [1], increased lipid metabolites [2], and altered phosphatidylcholine levels [3]. However, the role of peripheral blood metabolites in mediating cognitive dysfunction remains unclear. This study investigates the relationship between specific serum metabolites and brain microstructural changes associated with cognition in ESRD patients, using advanced metabolomic profiling and neuroimaging techniques.

Thirty-seven participants were enrolled in the study, including 14 healthy controls (mean age: 60.1 ± 10.7 years; 10 men), ESRD patients with normal cognition (mean age: 67.0 ± 6.5 years; 6 men), and ESRD patients with cognitive impairment (mean age: 73.5 ± 9.9 years; 6 men). MRI acquisition was performed using a 1.5T scanner and included T1-weighted magnetization-prepared rapid acquisition gradient echo sequences and diffusion-weighted imaging. Serum samples were subjected to untargeted metabolomic profiling using SYNAPT G2-MALDI mass spectrometry, identifying PC(18:2(9Z,12Z)/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)), 3-Oxooctadecanoic acid, and 10-alpha-methoxy-9,10-dihydrolysergol, which related to lipid metabolites and phosphatidylcholine levels alteration. Diffusion tensors were reconstructed using the Diffusion Kurtosis Estimator, generating tensor-derived metrics including mean diffusivity, radial diffusivity, axial diffusivity, and fractional anisotropy. Correlation analyses were conducted between metabolite concentrations and DTI metrics. A p-value of less than 0.05 was considered statistically significant, with Bonferroni correction applied for multiple comparisons.

Among the three metabolites—PC(18:2(9Z,12Z)/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)), 3-oxooctadecanoic acid, and 10-alpha-methoxy-9,10-dihydrolysergol—only 3-oxooctadecanoic acid exhibited a statistically significant difference across the three groups (Figure 1). In addition, 3-oxooctadecanoic acid exhibited a consistent and robust correlation with diffusion tensor imaging metrics across multiple brain regions implicated in cognitive function. Specifically, elevated serum levels of 3-oxooctadecanoic acid were associated with increased mean diffusivity, axial diffusivity, and radial diffusivity in frontal, insular, and temporal areas. For mean diffusivity, significant correlations were observed in the middle frontal gyrus (MFG_A46, r = 0.579), inferior frontal gyrus (IFG_IFS, r = 0.601), insular gyrus (INS_dId, r = 0.577–0.588), and inferior temporal gyrus (ITG_A20cv and ITG_A20il, r = 0.599) (Figure 2). Similar trends were found for axial diffusivity in the middle frontal gyrus (r = 0.583–0.585), inferior frontal gyrus (r = 0.599), and inferior temporal gyrus (r = 0.585–0.637) (Figure 3). Radial diffusivity also showed significant correlations in the inferior frontal gyrus (r = 0.603), inferior temporal gyrus (r = 0.599), and insular cortex (r = 0.591) (Figure 4).

This study identifies 3-oxooctadecanoic acid as a potential peripheral biomarker associated with microstructural brain alterations in patients with end-stage renal disease. Significant correlations were observed between serum levels of this metabolite and diffusion tensor imaging metrics in brain regions integral to cognition. These regions include the middle frontal gyrus and inferior frontal gyrus, which are involved in executive function; the insular cortex, associated with interoception and emotional regulation; and the inferior temporal gyrus, a key area for semantic memory and visual recognition. The positive correlations between higher 3-oxooctadecanoic acid levels and increased diffusivity suggest potential axonal degeneration or demyelination processes, which align with known cognitive and structural changes observed in ESRD. The metabolite’s consistent association with multiple DTI parameters across these regions supports its role as a marker of widespread white matter integrity loss. Additionally, the gradation in these effects across groups stratified by cognitive status further underscores the clinical relevance of 3-oxooctadecanoic acid in neurocognitive outcomes among ESRD patients.

By integrating untargeted blood metabolomics with advanced neuroimaging, this study provides novel evidence linking elevated 3-oxooctadecanoic acid levels to region-specific brain microstructural abnormalities related to cognitive function in ESRD. These findings highlight the potential of peripheral metabolites as non-invasive biomarkers for early detection and monitoring of cognitive impairment in this high-risk population. Moreover, targeting the implicated metabolic pathways may offer new therapeutic strategies aimed at protecting brain health in patients with ESRD.
Chih-Chien TSAI, Yi-Chou HOU, Ruei-Ming CHEN, Jiun-Jie WANG (TaoYuan, Taiwan)
13:30 - 15:00 #47557 - PG537 Substantia nigra and posterior putamen MRI asymmetries reveal distinct pathology and explain motor symptom lateralization in Parkinson’s disease.
PG537 Substantia nigra and posterior putamen MRI asymmetries reveal distinct pathology and explain motor symptom lateralization in Parkinson’s disease.

MRI-based markers in the Substantia Nigra (SN) and Posterior Putamen (PP) offer promise for linking structural brain changes to motor dysfunction in Parkinson’s Disease (PD). Motor symptom asymmetry is a hallmark of early PD. Currently, the relationship between the different brain structures asymmetry, and their distinct contributions to symptom asymmetry, remains incompletely understood. Prior studies have used the ratio between T1-weighted (T1w) and T2-weighted (T2w) images to assess PP asymmetry while mitigating scanner variability [1]. Here, we demonstrate that when properly harmonized across visits and sites, T2w – and in combination, T1w and T2w – yield stronger and more interpretable associations of the SN and PP asymmetry with motor symptoms.

We analyzed data from 157 PD patients from the Parkinson’s Progression Markers Initiative (PPMI), totaling 402 MRI sessions. Each session included T1w, T2w, and proton density-weighted (PDw) scans acquired on 3T Siemens Trio TIM systems across 8 imaging centers. MRI preprocessing involved bias field correction and normalization using 3D polynomial fitting within white matter. SN was segmented using nonlinear transformation of the MASSP atlas [2]. The putamen was segmented using the FSL FIRST [3], and the PP was specifically delineated using mrGrad (https://github.com/MezerLab/mrGrad), as previously described [1]. Asymmetry indices (asym) were computed as left-right differences for each structure and modality. Motor asymmetry was assessed using MDS-UPDRS Part III (UPDRS3_asym) scores. We tested relationships between UPDRS3_asym and MRI-derived_asym using linear regression. Control analyses included volumetrics, field bias analyses, and alternative regions (e.g., thalamus), to rule out global or artifactual effects. DaTSCAN data were included to compare MRI-derived asymmetries with dopaminergic deficits and assess MRI’s added explanatory value. All results were replicated within single visits.

Harmonization substantially reduced inter-visit and inter-subject variability, enabling direct comparison of image intensities across visits and sites (Fig. 1). Consistent with prior work [1], T1w/T2w_asym in the PP was correlated with UPDRS3_asym (r = 0.47, R² = 0.22, p < 10-23). Here, we also tested this association in the SN, which showed a significant correlation as well (r = -0.41, R² = 0.17, p < 10-18). We then extended the analysis by examining T1w, T2w, and PDw images separately. These separate analyses revealed that T2w_asym alone accounts for most of the observed associations, offering slightly stronger and more interpretable results than the T1w/T2w ratio. Specifically, T2w_asym in SN and PP were associated with UPDR3_asym, in opposite directions: SN positively (r = 0.42, R² = 0.18, p < 10-19; i.e., lower T2w contralateral to more affected side; Fig. 2a), and PP negatively (r = -0.47, R² = 0.22, p < 10-23; i.e., higher T2w contralateral; Fig. 2b). A combined SN–PP contrast (SN_asym − PP_asym) yielded a stronger association (r = 0.56, R² = 0.31, p < 10-34; Fig. 2c). Multiple analytical approaches, including regression, PCA, and log-ratio transformations, converged on the same SN–PP contrast structure. PDw_asym yielded similar but weaker and oppositely signed effects, compared to T2w, in the SN and PP. T1w_asym showed a significant effect in the PP but not the SN. Importantly, combining both T1w and T2w asymmetries in the PP using multiple regression outperformed their ratio (R² = 0.26, p < 10-26), suggesting that T1w and T2w carry additional information over T1w/T2w. A multimodal model including SN_T2w, SN_volume, PP_T2w, and PP_T1w explained the most variance in UPDRS3_asym (R² = 0.37, p < 10-38; Fig. 3). Results were robust in single-visit analyses and remained significant beyond volumetric effects. Interestingly, MRI asymmetries measures explained unique variance beyond DaTSCAN, indicating complementary independent value.

Findings support distinct pathological sources: in SN, T2w hypointensity likely reflects iron deposition; in PP, T2w hyperintensity and T1w hypointensity may reflect gliosis, atrophy, or microstructural disorganization. Robust harmonization of the raw T1w and T2w signals, outperformed traditional T1w/T2w ratios. The SN–PP contrast offers a biologically grounded and cumulative marker of lateralized pathology. Effects were specific to PD-relevant regions, robust across methods, and not explained by global asymmetry or preprocessing artifacts. Significant associations beyond DaTSCAN and volumetrics position multi-contrast MRI as a unique structural biomarker in PD.

A contrast-based, region- and modality-specific MRI asymmetry model, focused on SN and PP, offers a robust and biologically interpretable marker of motor symptom lateralization in PD. Harmonized T1w, T2w, and PDw imaging captures complementary pathology beyond dopaminergic or volumetric measures.
Elior DRORI (Jerusalem, Israel), Aviv A MEZER
13:30 - 15:00 #47622 - PG538 Adapting a social reciprocity task for 7T-fMRI for the purpose of autism research.
PG538 Adapting a social reciprocity task for 7T-fMRI for the purpose of autism research.

Differences in social-emotional reciprocity are a hallmark of autism. The DSM-5 defines these differences as ranging from atypical social approach and conversational exchange, to reduced sharing of interests, emotions, or affect [1]. To assess these behaviors, the Interactive Drawing Task (IDT) was developed as a language-free measure of social reciprocity. Drawing does not require developed language skills or a high IQ and is therefore feasible in a wide range of individuals. The IDT has consistently revealed reduced reciprocal behavior in both autistic children and adults [2,3]. However, the neural substrates supporting the behaviors tied to social reciprocity remain unclear. In this study, we have adapted a digital version of the IDT (DIDT) for use in an MRI environment.

Participants (N=6, 2 women, mean age = 35 ± 9 years) underwent scanning on a 7T Philips Achieva MRI scanner using an 8Tx/32Rx head coil. During the 8.5-minute DIDT functional run, the participant and an examiner took turns contributing to a joint drawing using an MRI-compatible touchpad and pen. An MRI-compatible button box, operated with the left hand, allowed participants to initiate or suppress drawing input. The drawing task was implemented using a custom MATLAB code. Turn-switching was initiated by clicking the “Switch Turn” panel at the bottom of the screen (figure 1G), with the system recording drawing onset, durations, and a screen capture. Prior to the drawing task inside the MRI, participants had a practice session in the mock scanner to familiarise with drawing in this setting. For practise, participants were shown a screen with strings of letters or numbers to trace over (figure 1A-F). Participants selected a pen color (purple or orange), while the examiner always drew in black. Functional data were acquired using a 3D-EPI sequence (1.8 mm isotropic; TR/TE/TA = 44ms/17ms/1.37s; flip angle = 13°; SENSEyz = 2.6×3.27; FOV = 200×200×176mm³; 98 sagittal slices), along with a top-up scan for distortion correction. For coregistration purposes, high-resolution anatomical images were acquired using MP2RAGE (0.55 mm isotropic; TI1/TI2 = 1000/3000 ms; TR/TE = 6.3/2.9 ms; flip angles = 8°/8°; SENSEyz = 2.3×2.1). Participant turn durations and drawing onset times were modeled as regressors in individual-level GLMs, followed by group-level analysis using FEAT. Specifically, we examined BOLD responses during participant drawing turns versus passive observation of the examiner’s drawing, and separately compared drawing onset to turn-switch events (onset > turn-switch). Motion correction was performed with MCFLIRT. 3D activation maps were normalized to MNI space; cerebellar activity was projected to a SUIT flatmap [4,5].

The DIDT was well-tolerated and rated as enjoyable by all but one participant, who reported a neutral experience. Data from one participant were excluded due to excessive head motion, the remaining five participants were included in the analysis. On average, participants completed 11.6 ± 3.91 drawing turns, with 11 ± 4.32 handovers back to the examiner. The average duration of each turn was 26.02 ± 8.72 s for participants and 16.97 ± 4.36 s for the examiner. Head motion during the fMRI runs was generally low across included participants (mean displacement: 0.93 ± 0.5 mm), supporting the task’s feasibility in most cases. Significant BOLD responses during participants’ drawing turns were observed in primary motor and somatosensory cortices, as expected (Figure 2A). Additionally, the anterior insula was engaged bilaterally (Figure 2B). In contrast, passive observation of the examiner’s drawing yielded responses in the visual cortex (Figure 2A), which was expected, as well as in the temporo-parietal junction (TPJ), and cingulate gyrus (Figure 2C)—regions implicated in social cognition and mentalizing. Bold response in the putamen was observed right at the drawing onset (Figure 2D). The BOLD response in the cerebellum (Figure 3) extended beyond the motor regions involved in right-hand movement towards areas implicated in working memory, divided attention, and emotional or narrative processing as identified with a multi-domain task battery [5].

The DIDT robustly engages cortical and cerebellar regions implicated in social-affective cognition. BOLD response in the insula, cingulate, TPJ, and cognitive cerebellar zones indicates that this nonverbal collaborative task successfully engages a broad social-affective neural network [5–8]. While one participant's data was excluded due to motion artifacts, the task was successfully completed and tolerated by the remaining participants, supporting its general feasibility in the high-field MRI scanner environment.

This pilot study supports the DIDT’s potential as a nonverbal, high-field fMRI tool for mapping reciprocity-related processes. Future work in autistic populations will help elucidate how individual differences in social cognition are reflected in cortical and cerebellar engagement.
Amina ZIDANE BURGESS (Amsterdam, The Netherlands), Dylan VAN DER WAAL, Ryan MUETZEL, Sander BEGEER, Tineke BACKER VAN OMMEREN, Wietske VAN DER ZWAAG
13:30 - 15:00 #47710 - PG539 Brain network reorganization after adapted cognitive-behavioral therapy and immersive virtual reality in autism spectrum disorder with intellectual disability.
PG539 Brain network reorganization after adapted cognitive-behavioral therapy and immersive virtual reality in autism spectrum disorder with intellectual disability.

Individuals with autism spectrum disorder (ASD) and comorbid intellectual disability (ID) often show severe social anxiety (1), linked to atypical interactions among key brain networks: default mode (DMN), salience (SN), and dorsal attention (DAN) (2-4). Effective cognitive-behavioral therapy (CBT) in this population requires specific adaptations. This pilot study evaluates a novel intervention combining adapted CBT (ACBT) with immersive virtual reality (IVR) to improve social anxiety (5-7), examining changes in resting-state functional connectivity (rsFC).

Ten participants with ASD, mild ID and social anxiety (DSM-V-TR) were assessed at baseline and post-intervention. Combined ACBT-IRV intervention program spanned 12 weeks, comprising 24 sessions evenly divided into 6 weeks of individual therapy and 6 weeks of group therapy, including four blocks: Psycho-education, Social Skills Training, Behavioral/Cognitive Restructuring, and Systematic Desensitization/Exposure. A three-month follow-up was conducted to assess outcomes. At baseline and post-intervention sessions, social anxiety (Social Phobia Inventory), self-esteem (Rosenberg), and cognitive variables, including attention (d2) and planning (Tower of London) were evaluated using standardized tests, and functional data was acquired using a 3T MRI scanner rsFC analysis focused on ROI-to-ROI correlations between DMN, DAN, SN nodes, and bilateral hippocampi/amygdalae (HCP-ICA atlas). Preprocessing and ROI-to-ROI analyses used the CONN toolbox. Between session effects (baseline - post-intervention) ROI-to-ROI rsFC changes were assessed using paired t-tests. Graph-theoretical metrics were computed on a subnetwork of selected ROIs (edges with z-score > 2.5). Associations between rsFC changes and emotional and cognitive changes were tested using linear models with delta-change scores. Secondary models examined baseline connectivity's predictive value for behavioral outcomes. Significance was set at p < 0.05, uncorrected due to the exploratory nature.

After ACBT-IVR intervention, the left intraparietal sulcus (IPS, DAN) showed increased rsFC with SN nodes and decreased rsFC with DMN and hippocampal regions. Connectivity within the hippocampi–amygdalae cluster also increased. In addition, graph-theory analysis revealed increased global efficiency, degree, and betweenness centrality for the left IPS, suggesting a more central network role in the ASD/ID participants. Conversely, DMN nodes (medial prefrontal and lateral parietal cortices) became more functionally segregated, showing higher eccentricity and lower closeness centrality. rsFC changes correlated with cognitive improvements (p < 0.01). Improved planning, assessed via the Tower of London test, was inversely associated with rsFC changes between DAN and SN, and between DMN and DAN. Increased perceived precision in the attention test d2 correlated with enhanced rsFC between lateral parietal cortices, DMN, and left amygdala nodes. Self-esteem improvements showed a negative association with internal SN rsFC. Baseline interhemispheric hippocampal rsFC strongly predicted social anxiety reduction (p < 0.001, R² = 0.85), with higher baseline connectivity linked to greater symptom improvement. Including post-intervention rsFC changes improved model fit (R² = 0.88). Only the bilateral hippocampal connection exhibited both significant post-intervention change (p < 0.01) and association with behavioral outcomes.

Results suggest that the ACBT-IVR intervention is associated with rsFC reorganization in participants with ASD/ID. The dorsal attention network (DAN) became more integrated, while the default mode network (DMN) became more segregated, potentially reflecting enhanced external attention and reduced self-referential processing, consistent with neural correlates of reduced social anxiety (6,8). The left intraparietal sulcus (IPS) emerged as a key hub, and cross-network decoupling (e.g., DMN–DAN) was linked to improved cognitive performance, suggesting reduced attentional interference enhances executive function. Baseline interhemispheric hippocampal rsFC strongly predicted social anxiety reduction, indicating its potential as a biomarker of intervention effectiveness. This pilot study provides preliminary evidence that ACBT-IVR modulates rsFC in key social cognition networks in ASD/ID. Changes in DMN–limbic connectivity may reflect improved self-referential and emotional processing (9,10).

A targeted intervention combining ACBT and IRV drives adaptive brain network reorganization in individuals with ASD and mild ID. By enhancing attentional network integration and reducing default mode network interference, this approach yields significant cognitive and emotional improvements. Baseline hippocampal connectivity emerges as a promising biomarker for predicting therapeutic success. These compelling findings pave the way for transformative interventions and call for rigorous validation in larger, controlled trials.
Elena DE LA CALLE (Girona, Spain), Melissa SAMANIEGO-REINOSO, Carles BIARNÉS, Oren CONTRERAS-RODRÍGUEZ, Victor PINEDA, Laura VERGÉS, Susanna ESTEBA-CASTILLO
13:30 - 15:00 #47781 - PG540 Diffusion Tensor Imaging assessment of offspring brain neurodevelopment in mouse model of diet-driven Autism Spectrum Disorder.
PG540 Diffusion Tensor Imaging assessment of offspring brain neurodevelopment in mouse model of diet-driven Autism Spectrum Disorder.

Clinical and preclinical studies, highlight the impact of maternal obesity and exposure to a high-fat diet (HFD) during pregnancy and lactation on an increased risk of symptoms of autism spectrum disorder (ASD) in the offspring. However, little is known about the processes by which an inappropriate environment of intrauterine and early childhood development interferes with normal development and brain function in offspring. The aim of this work was to use magnetic resonance diffusion tensor imaging (DTI) and a mouse model of diet driven ASD, to find quantitative indicators of alterations in offspring’s brain structure influenced by mother exposure to HFD.

Obesity in C57BL/6J mice was induced by administering a high-fat diet (HFD) containing 45% energy from fat, while the control group received a standard control diet (CD) with 10% fat. After 8 weeks on the diet, females were mated to males and then kept on CD or HFD during pregnancy and lactation. After weaning, the offspring were kept on a standard diet for the remainder of the study. Male animals at the age of 58 weeks were used in this study. The number of the CD and HFD offspring was 9 per group. After anesthesia, the animals were subjected to intracardiac perfusion with ice-cold phosphate-buffered saline (PBS) followed by 4% paraformaldehyde (PFA). The perfused brains were dissected immediately after perfusion and placed in an icy 4% PFA overnight, then the brains were rinsed three times in PBS. The brains were cryoprotectively fixed in an increasing gradient of 10-30% sucrose solution. DTI imaging was performed on an MR 9.4T scanner, (Bruker BioSpin MRI GmbH), using DtiStandard SpinEcho pulse sequence with the settings: TE/TR of 20.3/5000 ms and / of 10/5 ms. A DTI scheme with 30 diffusion sampling directions at a b-value of 2297.5 s/mm² was used to obtain images with an in plane resolution/layer thickness of 0.1/0.2 mm, scaled to an 3D isotropic resolution of 0.1 mm. DSI Studio (http://dsi-studio.labsolver.org/) was used to calculate diffusion anisotropy indexes and perform tractographic analysis.

Fig. 1 shows examples of cross sections through DTI scans for control and high fat diet brains. Fig.2 shows comparison of fractional anisotropy values for brain structures where statistically significant differences between control and high fat diet brains were found.

Fractional Anisotropy: The result of the intergroup difference in 6 out of 9 structures examined was statistically significant (p < 0.05), which is consistent with the observations in human infants, as know from scientific literature. After birth, general brain hypertrophy is observed at the early childhood stage, which is confirmed by magnetic resonance imaging in cohort of longitudinally examined infants aged 6 to 24 months (Shen, M. D., et al. 2013). Tractography: Only for three structures did the results of intergroup differences come out statistically significant. In the case of the entire brain structure, the HFD group showed a higher result of the degree of elongation of nerve fibers (axonal packages) and a lower value of the diameter of nerve tracts.

Statistically significant differences in values of Fractional Anisotropy were found between offspring’s brains, depending on the mother’s diet during pregnancy.
Artur RYŚ, Krzysztof JASIŃSKI, Katarzyna KALITA, Dawid GAWLIŃSKI, Władysław WĘGLARZ (Kraków, Poland)
13:30 - 15:00 #47810 - PG541 Quantitative analysis of the neuromelanin signal for differentiation In ams patients vs controls: a multiparametric approach.
PG541 Quantitative analysis of the neuromelanin signal for differentiation In ams patients vs controls: a multiparametric approach.

Multisystem atrophy (MSA) is a neurodegenerative disease that is often confused with Parkinson's disease (PD) due to similar clinical symptoms, complicating diagnosis and delaying patient management. Recent advances have identified neuromelanin (NM) as a potential biomarker for PD [1]. Our research therefore focuses on studying the NM signal between patients with AMS (N=38) compared with control subjects (SC) (N=20) in order to validate a biomarker for AMS.

Multicentre MRI and Dat Scan protocol (9 french reference centres) 1.Acquisition and mapping: -Sequence dedicated to NM: Optimised T1 spin echo (TR = 900ms; TE = 10ms; 0.7x0.7x1.4). -T1 and T2* gradient echo (TR= 50ms; ∆TE = 5 :5 :35ms; DFA= 5° - 20°; 0.7x0.7x1.4). These sequences were used to generate T1 and T2* maps with the hMRI toolbox [2]. -SPECT sequence with low-dose CT (110mA, 120 kV, slice thickness 3.75mm and a pitch of 1.1) 2.Segmentation MRI: Sisyphe software was used for bi-operator segmentation of the NM. A logical And operation was then used to extract the area common to the segmentations. The Dice coefficients, 0.76 for control subjects and 0.70 for AMS patients, confirmed a good match between the segmentations. Dat Scan: Segmentation of the striatum and analysis of volumes using DaTsoft3D software, developed by Pierre Gantet [4]. Use of DaTsoft3D software [4] to quantify the density of dopamine transporters (DaT) in the striatum and measurement of a binding potential (BP) resulting in a ratio of activity concentration between the striatum and a non-specific zone. 3.Extraction of radiomics Use of 3D Slicer for radiomics extraction. These are extracted from the optimised T1 NM spin echo, R1 and R2* at AMS and SC. Two types of radiomics are studied here: shape radiomics and first-order radiomics. Shape radiomics provide volume information. First-order radiomics, on the other hand, are based on the histogram, such as the mean, variance, energy and entropy, indicating local variations in intensity within the ROI. 4.Data analysis To validate the radiomics, two-tailed T-tests were performed. A P value < 0.05 indicates significance between groups.

NM signal: No significant difference observed in T1 signal intensities or R1 values between groups, suggesting preservation of the longitudinal relaxation properties of NM. Significant difference (p = 0.0009) observed in the median R2* values. NM radiomics: Radiomic analysis revealed characteristics that distinguish our two groups, such as energy (p=0.01) and entropy (p=0.009). NM volume: A 23% decrease in absolute NM volume was measured (p<0.001) in AMS patients compared with SC patients. This observation was also made on Dat Scan images (p<0.001). Furthermore, the binding potential in the striatum was significantly reduced in AMS compared with SC (p<0.001).

NM signal: The difference in the R2 signal indicates an alteration in the transverse relaxation properties, possibly linked to changes in the concentration of paramagnetic metals within the NM in AMS patients. NM radiomics: The resulting significant radiomics converge towards a single interpretation. In SCs, the NM appears to be a complex, detailed and heterogeneous structure. In contrast, in AMS, the NM tends to lose its heterogeneity, becoming a simpler, smoother and more homogeneous structure. These results are consistent with quantitative signal analysis[3]. NM volume: The decrease in volume reflects possible neuronal degeneration or loss of NM pigment. In addition, a positive correlation was observed between NM volume and striatal BP on Dat Scan images. These parameters could therefore represent a relevant proximal Dat Scan marker for AMS, reflecting underlying dopaminergic denervation.

Our study reveals significant differences in R2* values, NM volume and striatal BP between our groups. These results suggest that the morphological approach, combined with the analysis of magnetic relaxation and hypofixation properties, is promising for the identification of specific biomarkers of AMS. In addition, the radiomic features extracted from the radiomic analysis offer innovative prospects for early detection and characterisation of the disease.
Camille BRUN (Toulouse), Germain ARRIBARAT, Patrice PERAN, Sabrina HOUIDEF
13:30 - 15:00 #47865 - PG542 Structural alterations of Human hypothalamic nuclei in isolated REM sleep behavior disorder .
PG542 Structural alterations of Human hypothalamic nuclei in isolated REM sleep behavior disorder .

Isolated REM sleep behavior disorder (iRBD) is considered a potent early marker of synucleinopathies, such as Parkinson’s disease (PD). Studies mapping brain circuits in rodents have shown that the hypothalamus (HT) plays a central role in regulating sleep and wakefulness, containing both sleep-promoting and wake-promoting neurons that act as 'switches' for sleep-wake transitions [1]. However, few studies account for the HT when investigating sleep-related disorders in humans. In this preliminary study, we combined the use of high-resolution quantitative 3D-T1 MRI sequences with a super-resolute atlas of HT nuclei [3] to uncover macro and microstructure variations of HT nuclei, and their association with the disease duration in well-characterized cohorts of iRBD participants. 

We included 8 controls (age: 67 ± 9,22 [46-76]) and 19 iRBD participants (age: 72 ± 7,45 [50-77]; duration: 60 months ± 45,79 [15-156]) meeting the diagnostic criteria for iRBD [4] with polysomnographic confirmation. Subjects were scanned with a 7T MR scanner (TERRA, Siemens) using a (1TX/32RX) Head coil (NOVA). Anatomical data was obtained using a 3D-MP2RAGE sequence (TR=5.000ms/TE=3ms/TI1=900ms/TI2=2.750ms, 256 slices, 0.6mm isotropic resolution, TA= 10min12s). Unbiased T1 maps and T1-w-UNIDEN images were generated after B1+ inhomogeneity correction [5]. T1-weighted volumes; as well as the Neudorfer template/atlas (0.5mm isotropic voxel) [3], were cropped in a similar manner, before an optimal spatial registration using the antsRegistration procedure [6] was performed (Figure 1) [7]. Volumes and T1 values of HT nuclei were extracted using ITKSNAP [8]. The volumes of HT nuclei were normalized by intracranial volume (ICV) [9] prior to group comparisons. The Wilcoxon test (JMP®, Version 18. SAS Institute Inc., Cary, NC, 1989–2023.) was performed to evaluate the modulation of macro and microstructure of individual HT nuclei by iRBD. Partial correlations were performed to study the associations between HT nucleus metrics and disease duration.

No significant differences in age (puncorr= 0.096), ICV (puncorr= 0.097) or whole HT volume (zscore: 0,472; puncorr= 0,318) were observed between the two groups. Relative to controls, iRBD participants showed lower T1 values in the left dorsal periventricular hypothalamus (DPEH) (zscore: -1.861; puncorr= 0.031) and right zona incerta (ZI) (zscore: -1.75; puncorr= 0.04) and lower volume of right dorsomedial hypothalamic nucleus (DM) (zscore: -1.694; puncorr= 0.045) (Figure 2). However, iRBD participants showed higher volume of the left paraventricular nucleus (Pa) (zscore: 2.31; puncorr= 0.011) and right medial preoptic nucleus of the hypothalamus (MPO) (zscore: 2.194; puncorr= 0.014) (Figure 2). Partial correlation accounting for age showed significant association between the disorder’s duration and the T1 value of the left DPEH (β: -0.392, puncorr= 0.047) and the volume of the right DM (β: 0.414, puncorr= 0.036). 

In this preliminary study (control recruitment still ongoing), we identified alterations in the microstructure and macrostructure of several HT nuclei involved in sleep homeostasis.   First, T1 values of the right ZI and left DPEH were found to be lower in iRBD participants. The decrease in T1 values supports the hypothesis of iron accumulation associated to neurodegeneration of the nuclei. Interestingly, ZI promotes sleep through a subset of GABAergic neurons that are active during REM sleep, anticipate sleep onset, and can shift states of consciousness when stimulated [10-11]. DPEH, for its part, plays a central role in autonomic regulation due to its extensive connections throughout the HT and brainstem. This might contribute to neurogenic orthostatic hypotension frequently observed in synucleinopathies.   Macroscopically, we observed a significant atrophy of the right DM, a HT nucleus contributing to the proper regulation of the circadian sleep cycle [14]. In contrast, we observed increases in the volume of the right MPO and the left Pa. The MPO plays a crucial role in sleep regulation by housing GABAergic sleep-active neurons that inhibit arousal-promoting regions like the locus coeruleus, thereby promoting the onset and maintenance of both REM and NREM sleep [12]. The Pa participates in the promotion and maintenance of wakefulness [13]. Finally, we found a significant correlation between the disease duration and the T1 values of the left DPEH and the volume of the right DM, supporting their impairment in the neurodegenerative process. 

Our findings suggest that structural changes in hypothalamic sleep-regulating regions may contribute to iRBD and serve as early biomarkers of its underlying pathology. By extending insights from rodent studies to humans, our research highlights the hypothalamus' role in sleep homeostasis and underscores the need for early biomarkers, as most iRBD patients develop synucleinopathies within ten years [15].
Coleen ROGER (Marseille), Camille COMET, Hugo DARY, Marie-Pierre RANJEVA, Maxime GUYE, Jean-Philippe RANJEVA, Alexandre EUSEBIO, Stephan GRIMALDI
13:30 - 15:00 #47320 - PG543 Structural and microstructural characterization of corpus callosum integrity in paediatric-onset Huntington Disease.
PG543 Structural and microstructural characterization of corpus callosum integrity in paediatric-onset Huntington Disease.

Huntington disease (HD) is an autosomal dominant disorder, caused by expanded Cytosine–Adenine–Guanine (CAG) repeated mutations (>35 CAGs) in the huntingtin gene (HTT)[1,2], diagnosed by genetic testing. The typical onset occurs in adulthood (adult-onset HD, AOHD) while pediatric-onset HD (POHD)[3,4,5] emerges before age 18, when CAG repeats exceed 55-60, with symptoms such as rigidity and bradykinesia, contrasting with chorea, observed in AOHD. Research suggests more severe subcortical damage in POHD, while cortical involvement occurs in later stages of the disease; extensive evidence also suggests severe white matter (WM) involvement in HD, whether this happens to a different extent between AOHD and POHD remains largely unknown. This study focuses on comparing the structural integrity of the corpus callosum (CC) in POHD, AOHD, and healthy controls (HC) to explore potential differences in cortical region impact between adult and pediatric HD.

We enrolled 21 patients with HD (5 POHD and 16 AOHD) and 27 HC stratified by age to serve as control groups for AOHD and POHD respectively (AHC, 16F/2M; mean age ± standard deviation = 51.9 ± 12.2 years; PHC, 7F/2M; mean age ± standard deviation = 25.3 ± 2.1 years). Each participant underwent 3T PET/MRI (Biograph mMR, Siemens Healthineers, Forchheim, Germany) using a 16-channel PET-transparent head/neck coil and the protocol included: whole-brain T1-weighted and echo-planar diffusion-weighted imaging sequences. All images were processed using Freesurfer, FSL and an in-house software to analyze the corpus callosum (CC) profile[6,7]. Using Freesurfer’s standard recon-all pipeline, we extracted for each subject a binary mask of the CC, as well as the volumes from the 5 subdivisions equally spaced along the postero-anterior direction (Figure 1A) and these subdivisions roughly resemble Witelson’s parcellation of the CC as well as the histological distribution of callosal fiber types (Figure 1B and C). All CC masks were also visually checked for segmentation errors that, if present, were manually corrected using Fsleyes. The final mask was then fed to the in-house software for automated extraction of the callosal thickness profile, already described and validated in Caligiuri et al. previous[6,7]. Diffusion-weighted scans were processed using FSL’s DTIFit to obtain maps of fractional anisotropy (FA) and mean diffusivity (MD). For each subject, FA map was nonlinearly registered in subject’s T1-space using FLIRT and FNIRT tools of FSL; the estimated transformation matrix was then saved and applied to MD map, thus obtaining anatomical correspondence across different images of the same subject. In all analyses we investigated the volumes from the 5 CC subdivisions, obtained via Freesurfer, as well as thickness, FA and MD values from all 50 midsagittal CC points. Statistical analysis was conducted on the structural and diffusion metrics across subdivisions, with comparisons between i)AHC and AOHD, ii)PHC and POHD, and iii)AOHD and POHD using ANOVA or non-parametric tests based on residual normality (significant threshold was set to p=0.05).

Volume reductions in AOHD compared to AHC were observed in posterior(p=0.004), middle posterior(p=0.007), central(p=0.004) and middle anterior(p=0.05) CC (Figure 2) while when comparing the two HD forms, AOHD showed decreased volume in posterior CC (p=0.009) compared to POHD (Figure 2). No significant differences were found in thickness. When comparing FA values, we observed decreases of the metric along the entire profile between AOHD and AHC; no differences were observed between POHD and PHC; FA decreased in middle posterior(p=0.05), central(p=0.01) and anterior(p=0.05) CC (Figure 3) between AOHD and POHD. When comparing MD values, we observed a large increase in posterior(p<0.001), middle posterior(p<0.001), central(p<0.001) and middle anterior(p=0.002) CC between AOHD and AHC; no significant differences between POHD and PHC nor in AOHD versus POHD (Figure 4).

To the best of our knowledge, this is the first report of DTI measures in POHD, hence these findings provide precious insights regarding in vivo disease-related alterations across cerebral WM. Overall, our results suggest that CC is substantially preserved in POHD compared to both PHC and AOHD patients with similar disease severity. On the other hand, all structural and diffusion measures were altered in AOHD across most of the antero-posterior profile of CC compared to age- and sex-matched HC (AHC).

Our data suggest the CC to be a key neuropathological structure in the development of HD and could help to differentiate AOHD from POHD due to different characterization along CC profile. These could stimulate further research investigating the CC as a potential brain biomarker of HD disease.
Maria Celeste BONACCI (Catanzaro, Italy), Maria Eugenia CALIGIURI, Ferdinando SQUITIERI, Umberto SABATINI
13:30 - 15:00 #47577 - PG544 A Machine Learning Approach Based on Quantitative MRI White Matter Lesion’s Features for the Identification of Progression Independent of Relapse Activity in Multiple Sclerosis.
PG544 A Machine Learning Approach Based on Quantitative MRI White Matter Lesion’s Features for the Identification of Progression Independent of Relapse Activity in Multiple Sclerosis.

Quantitative MRI (qMRI) techniques are sensitive to microstructural tissue damage and can provide insights into disability accumulation in neurodegenerative and demyelinating conditions such as Multiple Sclerosis (MS). Progression independent of relapse activity (PIRA) is a slow accumulation of disability occurring in the absence of inflammatory acute attacks, and represents the major cause of physical and cognitive disability in MS. We hypothesize that qMRI enables the detection of the subtle neurodegenerative/neuroinflammatory changes white matter lesions (WML) associated with PIRA in MS. Thus, in this study, we assessed whether a machine learning (ML) based approach on qMRI-derived WML features can distinguish MS patients with and without PIRA.

MS patients with (PIRA) and without PIRA (No-PIRA) were neurologically identified based on longitudinal Expanded Disability Status Scale (EDSS) follow-up. Mann-Whitney U-test was used to assess demographic differences across the two patients’ classes. All patients were acquired on a 3T Philips (Elition S) with a multiparametric protocol to estimate semi-quantitative and quantitative MRI features. The MR acquisition protocol and qMRI metrics estimation approaches are shown in Table 1. WML were manually segmented on Fluid Attenuated Inverse Recovery images (3D FLAIR: TR/TE: 3000/260 ms, voxel size 1 mm³ iso) and divided in three lesion types based on their location: isolated, juxtacortical and confluent lesions (Fig.1). Quantitative features were extracted from each lesion and summarized using median values. QSM images were used to identify Paramagnetic Rim Positive Lesions (PRL+), lesions identified by hyperintense iron accumulation at the lesion border and included as a categorical feature in the model. After a model selection strategy implemented in Pycaret [9], the Extra Trees Classifier model was identified as the one maximizing the accuracy metric. A robust evaluation was conducted through 1000 random permutations used for the initial subject-wise split into test and train datasets, with fixed subject percentages of 13% and 87%, respectively. In each permutation the WML of 12 random subjects were reserved for testing, while the WML of the remaining training subjects were pooled balancing the distribution of both lesion classes (PIRA=1; NoPIRA=0) and lesion types using a stratified undersampling. Extra Trees classifier was applied to predict lesion classes in each permuted test set. Performance was evaluated at the lesion level and at the subject level using major voting, where the predicted class for each subject was determined by the most frequent prediction among their lesions. Feature importances were extracted from the model in each permutation. Final performance metrics (lesion and subject levels) and feature importances were then calculated by averaging results across all 1000 permutations to provide a robust aggregate assessment.

A total of 1,634 WMLs were segmented from 96 MS patients. Table 2 outlines detailed dataset description. PIRA patients were older, had longer disease duration, and greater disability (EDSS) than NoPIRA patients (p<0.001 for all comparisons). The obtained model achieved: a lesion-level accuracy of 69.6% averaged across the permutations (mean of 205 lesions predicted for each permutation) and a subject-level accuracy (major voting) of 69.7% on average (12 subjects evaluated per permutation). Figure 2 shows the top 10 most important qMRI features averaged from the Extra Trees classifier across all 1000 permutations.

Utilizing a machine learning approach with an Extra Tree classifier, qMRI lesion features demonstrated the ability to effectively discriminate WML associated with PIRA in Multiple Sclerosis. This framework, by aggregating lesion-level predictions through a majority voting strategy, also enabled classification at the subject level. Despite including only white matter qMRI features and addressing the particularly challenging task of detecting subtle disability progression, our approach achieved a good performance. These results highlight the potential of qMRI-derived metrics to capture tissue microstructural differences which may contribute to enhance the understanding of mechanisms most representative of progression in MS.

qMRI features enabled effective ML classification of PIRA patients . These findings suggest that incorporating advanced imaging biomarkers into routine clinical workflows could support more precise monitoring of disease activity. Future work should validate the model across independent cohorts, explore the longitudinal evolution of these qMRI features and understand the neuropathological correlates of these alterations to develop in-vivo markers specific to progression.
Francesco GUARNACCIA (Verona, Italy), Agnese TAMANTI, Nicola DALL'OSTO, Valentina CAMERA, Laura PASTORE, Rachele BONETTI, Samuele QUAGLIOTTI, Teresa MALTEMPO, Arianna CAVAGNA, Sophia CAMERER, Marco CASTELLARO, Roberta MAGLIOZZI, Francesca Benedetta PIZZINI, Massimiliano CALABRESE
13:30 - 15:00 #47728 - PG545 Glymphatic system impairment in relapsing-remitting multiple sclerosis: Diffusion along perivascular spaces index correlation with volume fraction metrics using multishell diffusion MRI.
PG545 Glymphatic system impairment in relapsing-remitting multiple sclerosis: Diffusion along perivascular spaces index correlation with volume fraction metrics using multishell diffusion MRI.

The glymphatic system (GS), which facilitates the cerebral waste clearance[1], can be evaluated noninvasively using diffusion tensor imaging (DTI) along perivascular spaces (ALPS) index.[2] Previous studies showed an reduced ALPS index in patients with relapsing remitting multiple sclerosis (RRMS) compared to healthy controls[3]. Also, microstructural changes in normal appearing white matter have previously been demonstrated in RRMS patients.[4] However, the impact of the changes in microstructure on the ALPS index have not yet been investigated in RRMS patients.

Participants and MRI-Application In 42 RRMS cases (35.2 ± 8.5 years; 11 males, no relapse for 3 months, expanded disability status scale (EDSS) < 4). We performed a multishell-DTI with 82 diffusion directions and 5 b-values (0, 300, 700, 1000, 2000 s/mm2) using a 64-channel head coil in 3T (Magnetom Vida, Siemens Healthiness Erlangen, Germany). The local ethical commission approved the study. Post processing The DWI data underwent 5 corrections steps in the post-processing stage: truncation artefact by mrtrix3 [5, 6], motion artefacts, magnetic field inhomogeneities, eddy currents and variation in spatial intensity (FSL group: FAST, topup, Eddys). [7, 8, 9] Afterwards, we did a multi-shell multi-tissue constrained spherical deconvolution (MSMCSD) analysis to estimate fiber orientation distribution[10]. Whole-brain tractography was then generated using 2nd order integration over fiber orientation distributions algorithm implemented in Mrtrix3.[11]. Then, we used a stick-zeppelin-ball model [12] to calculate the intracellular (IC), extracellular (EC) and isotropic (ISO) volume fraction (VF) using COMMIT.[13] ALPS index calculation and correlation with VF For analysis, we loaded the following images in DSI studio: (1) susceptibility weighted image (SWI) to identify that the vessels are perpendicular to the ventricles. (2) FLAIR to ensure, that the regions of interest (ROI) were not placed in white matter lesions, and (3) the different volume fraction images for ICVF, ECVF, and ISOVF. We placed the ROIs for the ALPS index calculation in the projection (corona radiata) and association areas (superior longitudinal fasciculus), avoiding white matter lesions (Fig. 1). We calculated the left and right ALPS index using the diagonal elements of tensor matrix in DSI studio[14] . We used jamovi for statistical analysis. Spearman’s correlations between ICVF, ECVF, and ISOVF of association and projection fibers and the ALPS index were examined in both hemispheres.

The ALPS index was 1.47 ± 0.18 in the left and 1.42 ± 0.18 in the right brain hemisphere, showing no significant interhemispheric differences. A significant moderate positive correlation was found between in ICVF and the ALPS index in projection (Spearman's ρ = 0.5, p < 0.001) and association area (Spearman's ρ = 0.5, p < 0.001) of the left hemisphere. For the association fiber of the right hemisphere, ICVF and ALPS index showed a significant weak to moderate correlation (Spearman's ρ = 0.35, p = 0.02). There is no significant correlation between right ALPS index and ICVF in the projection fibers (Spearman’s ρ = 0.28, p = 0.08). For the ISOVF and the ALPS index, there was a moderate correlation in the left projection fibers (Spearman’s ρ = -0.44, p = 0.004). No further significant results were found. The significant results of the correlation between the ALPS index and the ICVF are shown in Fig. 2.

The ALPS index did not correlate with either ECVF or ISOVF, suggesting no evidence for accumulation of osmotically active waste products. Given the positive correlation between ICVF and the ALPS index (Fig. 2), we suggest that a reduced ICVF could be indicative of microstructure damage[4]. This may be associated with a lower ALPS index, reflecting impaired GS function in RRMS[2]. Our patient cohort consisted of patients with a low EDSS. This could explain the lack of further associations. Also, we suggest that a larger sample size to provide more definitive conclusion.

We demonstrate a relationship between changes in the IC compartment and the ALPS index, which may serve as an indication of GS impairment in RRMS. This can help to understand the influence of microstructure changes in the meaning of the ALPS index.
Janina KREMER (Lübeck, Germany), Andreas Martin STROTH, Katja HUMMEL, Norbert BRÜGGEMANN, Philipp J. KOCH, Peter SCHRAMM, Patricia ULLOA
13:30 - 15:00 #48022 - PG546 Application of BBB-ASL in MS: Initial Experience.
PG546 Application of BBB-ASL in MS: Initial Experience.

Multiple Sclerosis is an autoimmune disease of the central nervous system and is characterised by demyelination and neurodegeneration [1]. Breakdown of the blood-brain barrier (BBB) is one of the hallmarks of MS [1]. T1-weighted (T1w) MRI acquired after an injection of gadolinium-based contrast agents (GBCA) has been utilized to identify leakage of the BBB in MS [2]. However, due to gadolinium’s higher molecular weight, post-contrast T1w MRI might miss subtle BBB changes. BBB Arterial Spin Labelling (BBB-ASL) MRI is a new technique to assess BBB water permeability, and it has been studied in healthy volunteers and patients with brain tumors [3-5]. This study is an initial effort to investigate BBB permeability in MS patients, focusing on both lesions and normal-appearing white matter (NAWM) using BBB-ASL.

Seven people with MS (pwMS) and two healthy volunteers were scanned on a clinical 3T MRI scanner (Prisma, Siemens Healthineers, Erlangen, Germany) using a 32-channel head coil. A combination of single-TE and multi-TE Hadamard-encoded pseudo-continuous (pCASL) sequences, implemented using the vendor-independent MRI framework gammaSTAR [7], with 3D GRASE readout and two FOCI inversion pulses to suppress background with T1 values of 700 and 1400 ms, was used. A single-TE Hadamard-8 matrix was acquired with a sub-bolus duration of 400 ms, post-labeling delays (PLD [ms]) of 600 and 800, TE=13.2 ms, TR=4000 ms, resulting in two sets of seven inflow times (TI [ms]) [1000:400:3400] and [1200:400:3600], respectively. Additionally, a multi-TE Hadamard-4 matrix was acquired with a sub-bolus duration of 1000 ms, PLD of 500 ms, TR 4500 ms, eight TEs [13.8:27.6:207 ms], resulting in datasets with three TIs [1500:1000:3500 ms]. Pre- and post-contrast 3D T1w MPRAGE (TR=2300 ms, TE=2.26 ms, TI= 900ms, flip angle=8, slice thickness=1 mm) were acquired as structural references. A 3D fluid attenuated inversion recovery (FLAIR) sequence (TR=5000 ms, TE=388 ms, slice thickness=0.9 mm) was acquired. Cerebral blood flow (CBF) and water exchange time (Tex) maps were quantified using ExploreASL [8]. Bias field correction and brain extraction were performed on FLAIR images using FSL FLIRT and BET [9-10]. The Lesion Prediction Algorithm (LPA) of the Lesion Segmentation Toolbox (LST) was used to obtain lesion masks automatically [11]. White matter (WM) and gray matter (GM) tissues were segmented on T1w images using CAT12. The lesion masks of the patients were excluded from the corresponding WM masks to obtain normal-appearing WM (NAWM) masks of the patients. All masks were registered to the ASL space using SPM12. The histogram values of the CBF and Tex maps were assessed using MATLAB 2024 (Natick, MA). A Wilcoxon signed-rank test was used to compare CBF and Tex values between the histogram values of the FLAIR lesions and NAWM, using a single representative value per subject per region.

This study included seven pwMS, a mean age of 21.29±11.01y, F/M=5/2 (seven relapsing remitting MS (RRMS)), and two healthy volunteers with a mean age of 34±8.5y, two females. Table 1 summarizes the mean, 10th percentile, and 90th percentile values of the CBF and Tex maps in volunteers. The mean CBF values of volunteers in NAWM were 25.7 and 21.05 ml/100g/min, while the mean Tex values in NAWM were 154.2 and 159.6 ms. Figure 1 shows the mean, 10th, and 90th percentiles of the CBF values at the lesion and NAWM. The mean CBF values in the lesions (31-74 ml/100g/min) were higher than those in the NAWM (26-68 ml/100g/min)(p=0.0156). Similarly, the 10th percentile values at the lesion (9-35 ml/100g/min) were elevated compared to NAWM (7-21 ml/100g/min)(p=0.0312). The 90th percentile of CBF values was slightly higher in the lesions (52-142 ml/100g/min) than in the NAWM (54-122 ml/100g/min)(p=0.0156). Figure 2 presents the mean, 10th, and 90th percentiles of the Tex values in lesions and the NAWM. Overall, the Tex values of NAWM were lower than those of lesions. While the difference in Tex values did not reach statistical significance, the trend between the values was observed.

In this initial study, the BBB-ASL method was used to evaluate CBF and Tex values in the lesions of seven pwMS, providing a non-invasive approach for assessing BBB permeability. The finding of increased CBF in FLAIR lesions compared to NAWM is consistent with previous literature [12]. Although the increased Tex values in FLAIR lesions compared to NAWM align with prolonged mean transit time (MTT) findings reported in the literature [13], this difference did not reach statistical significance and needs further investigation. Future studies will aim to evaluate the utility of the BBB-ASL method for assessing perfusion metrics in a larger patient cohort, with consideration of lesion activity and T2 heterogeneity.

The BBB-ASL method can non-invasively capture the difference between lesional and normal-appearing WM in MS patients.
Ayse Irem CETIN (Istanbul, Turkey), Gulce TURHAN, David R VAN NEDERPELT, Ahmed Serkan EMEKLI, Amnah MAHROO, Beatriz E. PADRELA, Simon KONSTANDIN, Daniel Christopher HONKISS, Nora-Josefin BREUTIGAM, Vera KEIL, Frederik BARKHOF, Klaus EICKEL, Henk MUTSAERTS, Matthias GÜNTHER, Dilaver KAYA, Alp DINÇER, Jan PETR, Esin OZTURK-ISIK
13:30 - 15:00 #46770 - PG547 Integrating BMAT and FA Imaging for Improved Classification of Multiple Sclerosis: A MachineLearning Perspective.
PG547 Integrating BMAT and FA Imaging for Improved Classification of Multiple Sclerosis: A MachineLearning Perspective.

Multiple sclerosis (MS) affects both cognitive and physical functions, making an accurate diagnosis essential for effective management (1). While cognitive tests like the Brief Memory and Attention Test (BMAT) help track delayed working memory (2), they may miss early cognitive changes and are influenced by examiner expertise. Magnetic resonance imaging (MRI) is the most effective tool for diagnosing MS, but does not always correlate with clinical symptoms (3). To address these limitations, this study combines cognitive assessment (BMAT), MRI-derived Fractional Anisotropy (FA), and machine learning (ML) techniques (4–6) to enhance MS classification by cognitive status and develop a more robust diagnostic framework.

Diffusion-weighted and T1-weighted images were acquired in a 3T MRI scanner (Philips Ingenia) in 41 HC (59% female) and 58 RRMS patients (67% female). The local ethics committee approved the study, and RRMS patients were diagnosed according to the 2017 McDonald's criteria. All patients were evaluated with an Expanded Disability Status Scale (EDSS) and verbal memory assessment using BMAT. All test scores were normalized in Z-scores. Using the Z-score, patients and healthy controls were categorized as HC-CP and RRMS-CP with a Z-score ≥ -1.5 and RRMS-CI with a Z-score < -1.5. Diffusion-weighted images were processed to obtain FA maps using DTI. T1-weighted images were used as an anatomical reference. All preprocessing steps were performed in SPM12. We used the LNAO-SWM79 U-fiber atlas as a mask to obtain the mean FA map for each subject's U-fiber. The preprocessing step was done through an in-house MATLAB toolbox. An ML model was designed to predict those regions whose FA values adequately discriminate between HC-CP, RRMS-CP, and RRMS-CI classes. The model was built using Python and employed Random Forest (RF) with Sequential Forward Selection (SFS) for feature selection. The RF’s hyperparameters and evaluation of the performance of the classification model were implemented using stratified 5-fold cross-validation. The RF fine-tuned parameters that minimized the mean absolute error were: max_depth = 10, max_leaf_nodes = 5, min_samples_split = 11, and n_estimators = 299. We evaluated feature selection and the RF performance according to the number of features selected and their importance with the higher score with optimal features.

Figure 2 shows the accuracy performance of the RF model concerning the most relevant hemodynamic features selected by SFS. U-fibers that connect different brain regions categorized forty-four (Figure 3): frontal lobe regions connected with (rostral anterior cingulate, medial orbitofrontal, superior frontal area, pars triangularis and pars opercularis), parietal lobe regions with (inferior parietal, superior parietal, and supramarginal gyrus), temporal lobe regions with (middle temporal, superior temporal, and inferior temporal), insular and cingulate with (insula and posterior cingulate), and occipital lobe with fusiform area. They resulted in an accuracy of 80.89 ± 7.88% (precision: 91.01 ± 2.14%, recall: 80.98 ± 5.01%, F1-score: 85.05 ± 5.01%). The RF decision trees for each classification problem are shown in Figure 4.

The identified features from key brain regions are critical in improving MS classification accuracy. By leveraging the diverse functions associated with areas such as the frontal lobe (involved in executive functions and emotional regulation), parietal lobe (related to sensory integration and spatial awareness), and temporal lobe (crucial for memory and language processing), we gain deeper insights into the cognitive and neuroanatomical impacts of MS. The involvement of insular and cingulate regions highlights the importance of emotional and interoceptive awareness in MS patients, as these areas are linked to the disease's psychological and cognitive challenges (7, 8). Additionally, the role of the fusiform area underscores the significance of visual processing, which may be affected in MS (7). These findings align with previous evidence suggesting that MS-related cognitive deficits are associated with widespread structural and functional brain alterations, particularly in regions supporting high-order cognitive and emotional functions.

The classification of MS based on neural features offers valuable insights into disease progression and underlying neurobiological mechanisms. This approach can enhance early diagnosis and guide treatment strategies. Integrating machine learning techniques with neuroimaging data holds strong potential for developing targeted interventions aimed at mitigating cognitive decline in MS patients.
Cristian MONTALBA, Cristian MONTALBA (Santiago, Chile), Pamela FRANCO, Raúl CAULIER-CISTERNA, Macarena VASQUEZ, Claudia CÁRCAMO, Ethel CIAMPI, Marcelo ANDIA
13:30 - 15:00 #47807 - PG548 Assessment of microcirculatory changes in normal-appearing white matter and in the gray matter of the brain in patients with multiple sclerosis by perfusion MRI.
PG548 Assessment of microcirculatory changes in normal-appearing white matter and in the gray matter of the brain in patients with multiple sclerosis by perfusion MRI.

Purpose: to evaluate perfusion changes in normal-appearing white matter (NAWM) and in the gray matter of the brain with demyelinating lesions of the central nervous system using the method of dynamic susceptibility contrast (DSC).

The MR study was carried out on a MR-scanner "Ingenia" ("Philips") 3 Tesla using the method of dynamic susceptibility contrast (DSC). The study included 30 healthy volunteers and 80 patients with demyelinating disease of the central nervous system (9 patients with CIS, 66 patients with RRMS and 5 patients with SPMS) over the age of 18 up to 48 years (average age was 34.6 ± 8.02 years). Quantitative and qualitative assessment of CBF, CBV, MTT, TTP in normal-appearing white and gray matter in the frontal, parietal, temporal and occipital lobes of the brain.

In all groups in NAWM, a significant decrease in CBF and CBV was observed in all lobes of the brain, and the severity of these changes increases with the progression of the disease: in patients with CIS CBF is reduced to 13.7% and CBV to 7.3%; the most pronounced decrease in perfusion was observed in patients with SPMS: CBF by 40% and CBV by 24.8% (p <0.001); with a moderate increase in TTR and MTT by 15%. Similar changes are visualized in the gray matter of the brain: in patients with CIS CBF is reduced to 14.7% and CBV to 6.9%; the most pronounced decrease in perfusion was observed in patients with SPMS: CBF by 36.5% and CBV by 28.2% (p <0.001); with a moderate increase in TTR and MTT by 15.8%.

In patients with CIS, the increase in perfusion parameters is more pronounced, which indicates the predominance of inflammatory changes, which likely cause clinical manifestations. At the same time, in patients with a secondary progressive course, in whom an increase in the degree of disability is clinically observed, hypoperfusion is observed, probably associated with hypoxia developed against the background of prolonged inflammation and with a reduced metabolic demand, which indicates neurodegeneration. Thus, we can conclude that in the initial stages of the disease, inflammatory changes predominate, while as the disease progresses, neurodegeneration predominates.

Assessment of cerebral perfusion allows you to take a fresh look at the role of the vascular component in the pathogenesis of multiple sclerosis. Perfusion data complements routine MRI and provides a comprehensive assessment of changes in brain matter. We thank the Russian Science Foundation for supporting this work (№ 23-15-00377).
Liubov VASILKIV, Yulia STANKEVICH, Olga BOGOMYAKOVA, Denis KOROBKO, Vladimir POPOV, Nadezhda MALKOVA, Andrey TULUPOV (Novosibirsk, Russia)
13:30 - 15:00 #47687 - PG549 Non-contrast quantitative perfusion MRI in multiple sclerosis.
PG549 Non-contrast quantitative perfusion MRI in multiple sclerosis.

Non-contrast MR perfusion (arterial spin labeling, ASL) can detect areas of altered cerebral perfusion in patients with multiple sclerosis (MS), even in the absence of focal lesions [1]. This method offers advantages such as non-invasiveness [2] and short acquisition time. The use of ASL in MS patients is important for diagnosis, treatment strategy, and disease prognosis, but this area remains insufficiently studied [3]. The purpose is to optimize the algorithm and investigate cerebral perfusion changes using ASL in patients with multiple sclerosis compared to a control group.



This prospective study included 15 patients with MS and 15 age- and sex-matched healthy controls. All participants underwent 3.0T MRI (Philips Ingenia) with a standard protocol (T1-WI, T2-WI, FLAIR, DIR, post-contrast T1-WI) supplemented by pseudocontinuous arterial spin labeling (pCASL, FOV:240x240x99; TR:4550; TE:16; LD:1800; PLD:1800) for cerebral perfusion assessment in ml/100g/min. To address computational challenges in ASL quantification, we developed an optimized processing pipeline incorporating Radiant, FSL (BASIL) and MriCroGL. We calculated cerebral perfusion in the BASIL (FSL) program. Nonparametric statistical methods were used for data analysis.



Healthy controls demonstrated median gray matter perfusion of 51.9 mL/100g/min (IQR: 51.4-53.6) and white matter perfusion of 16.8 mL/100g/min (Fig. 1, IQR: 15.1-18.8). In MS patients, gray matter perfusion was significantly reduced (43.7 mL/100g/min, IQR: 42.8-44.5), as was white matter perfusion of 14.7 mL/100g/min (Fig. 2, IQR: 14.0-15.2) both p<0.001 vs. controls (Fig. 3, 4). Focal demyelinating lesions showed severe hypoperfusion (9.7 mL/100g/min, IQR: 5.3-13.2).



Our study demonstrates that optimized pCASL reliably quantifies both focal and diffuse perfusion abnormalities in MS, revealing significant hypoperfusion in gray matter (15.8%) and normal-appearing white matter (12.5%) compared to controls. These findings align with growing evidence of microvascular dysfunction as a key pathophysiological mechanism in MS [4, 5]. The observed perfusion reductions in structurally intact tissue may precede visible lesions, suggesting ASL’s potential as an early biomarker for disease progression. Future studies should correlate ASL metrics with clinical disability scores and explore longitudinal perfusion changes.



The developed pCASL processing algorithm enables comprehensive perfusion assessment in multiple sclerosis patients, quantifying both demyelinating lesions and normal-appearing white matter. Our results demonstrate a significant (p<0.001) reduction in perfusion within normal-appearing white matter (12.5%) and gray matter (15.8%) compared to healthy controls. 

We thank the Russian Science Foundation for supporting this work (№ 23-15-00377).


Andrey TULUPOV (Novosibirsk, Russia), Vladimir POPOV, Lyubov VASILKIV
13:30 - 15:00 #46082 - PG550 MRI-based mapping of disease evolution in a preclinical model of multiple sclerosis.
PG550 MRI-based mapping of disease evolution in a preclinical model of multiple sclerosis.

Experimental autoimmune encephalomyelitis (EAE) is well-established model characterized by presenting neurological deficits that closely resemble those observed in individuals with multiple sclerosis. The aim of this study was to characterize the temporal evolution of brain and spinal cord pathology in EAE using ex-vivo magnetic resonance imaging (MRI).

EAE was induced using the 35-55 myelin oligodendrocyte glycoprotein peptide. Animals were scored daily for neurological signs on a 6-point scale. At baseline, day 15 (inflammatory phase) and day 50 (neurodegenerative phase), six animals per time-point were euthanized and their brains and the spinal cords were removed and fixed in 4% paraformaldehyde. MRI was acquired on a Brucker 7.0 T system. The protocol included: T1 and T2 multi-echo mapping, diffusion-weighted (fractional anisotropy (FA)), and magnetization transfer ratio (MTR). Quantitative measures were obtained for each modality, based on a parcellated brain atlas and the Spinal Cord Toolbox for spinal grey/white matter. Differences between time points were assessed using ANOVA followed by Tukey’s post-hoc test (p<0.05).

All brains except two could be analyzed, while in the spinal cord, measures in partial segments could be obtained in 50% of the animals. The reasons for exclusion were tearing and shearing of the tissue, especially at later time points. In the brain, T1 values significantly increased from baseline to day 15 in 10 out of 14 regions (5-8%, p<0.01 in all regions), with no further changes by day 50. MTR showed a similar profile, though differences over time were not significant. No changes were measured in T2 mapping. FA showed significant reductions in 5 of 14 regions at day 50 compared to earlier time points (6–13%, p=0.01–0.045). In the spinal cord, FA decreased significantly at day 50 compared to baseline (17% reduction, p=0.003), while no significant differences were found in T1, T2, and MTR.

Early T1 elevation in brain regions likely reflects inflammation or edema, while later FA reductions suggest neurodegeneration, which could reflect axonal loss or demyelination. Further studies incorporating histopathological correlation will help to further elucidate and appropiately interpret these findings.

Ex-vivo MRI can be processed using established analysis pipelines, offering quantitative insights into EAE progression. This approach is particularly valuable, as it enables histopathological analysis to be performed on the same animal, allowing direct correlation with imaging findings. However, careful tissue handling is essential to preserve data quality.
Laura MARTÍNEZ, Imane BOUTITAH, Arnau HERVERA, Mariam CORIS-ERROUICH, Àlex ROVIRA, Herena EIXARCH, Carmen ESPEJO, Deborah PARETO (Barcelona, Spain)
13:30 - 15:00 #47611 - PG551 Deep Learning for Multiple Sclerosis Prognosis: Longitudinal MRI and Multimodal Data Integration to Predict Disability Progression.
PG551 Deep Learning for Multiple Sclerosis Prognosis: Longitudinal MRI and Multimodal Data Integration to Predict Disability Progression.

Multiple Sclerosis (MS) is a chronic, neuroinflammatory disease of the central nervous system and a leading cause of disability in young adults. It is characterized by heterogeneous clinical trajectories and a variable rate of disability progression. While MRI plays a central role in MS diagnosis and monitoring, predicting disability progression remains a clinical challenge owing to due to the disease's diverse manifestations and multifocal pathology [1]. Advancements in artificial intelligence (AI), particularly deep learning (DL), offers much promise for extracting subtle patterns from multimodal data to improve individualized prognosis. Our project aims to develop a robust, interpretable DL framework capable of predicting MS progression using longitudinal multimodal MRI data and clinical metadata, thereby facilitating personalized treatment strategies.

Our study leverages a rich and thoroughly characterized longitudinal dataset comprising 193 relapsing-remitting MS patients followed yearly over 10+ years for a total of 1536 visits [2]. For each visit, we have access concomitantly to various conventional MRI modalities, such as T1w and T2w, and FLAIR images, alongside clinical data such as the EDSS and MSFC scores, and demographic metadata. All data were acquired at the same center, using harmonized protocols and expert-validated progression labels. The DL model architecture consists of two main components: (1) a spatial feature extraction module using 3D ResNet CNNs to identify representations from MRI data and associate them with clinical scores, (2) a temporal feature extraction module employing bidirectional Gated Recurrent Units (GRUs) with a Time-Aware Attention mechanism to model progression across visits. Training is accordingly performed in two stages: first, learning to associate spatial features with EDSS/MSFC at single time points, followed by prognostic modeling using triplets, with two visits as input, one future visit as target. Interpretability of the model outcomes is ensured via Grad-CAM and saliency maps [3], and generalization is addressed through modular training and balanced sampling.

Initial experiments using 865 visits from a subset of 104 patients showed promising results. As shown in Figs. 1 and 2, a model trained on all triplets (N=10166) yielded 86% training and 74% validation accuracy, but suffered from overfitting due to data imbalance. The large variance in the number of total visits between the patients, ranging from 3 to 17 (see Fig. 3) was a cause of concern as it had implications for repetition of data during the training process. After limiting analysis to a maximum of 8 visits per patient (N=4280 triplets), performance improved significantly, achieving 90% training and 88% validation accuracy, with more stable validation loss curves. This highlights the need for balanced data distribution to enhance better generalization of model predictions, especially when dealing with very high dimensional data. The model reliably predicted future confirmed disability accumulation (CDA) using MRI and clinical data from prior visits.

Our findings demonstrate the value of integrating longitudinal multimodal MRI and clinical data using deep learning approaches for MS prognosis. The incorporation of MRI patterns alongside clinical scores provides a much-needed holistic representation of the patient’s state, enabling the model to extract meaningful biomarkers more effectively. Modular preprocessing and training pipeline enables reproducibility and scalability to larger datasets. Our next steps will focus on minimizing the issue of overfitting even further and enhancing model generalization, while making optimal use of all the available data. This involves a redesign of the model architecture, to enable the use of modularized components that can be trained individually. Ongoing work explores further developments in uncertainty quantification and explainability to increase clinical trust in our AI-generated predictions.

Our study takes a step forward towards precision medicine in MS care. By integrating longitudinal MRI and clinical data into a single predictive framework, it aims to enable an interpretable and scalable solution to predict MS progression at the level of individual patients. By employing a variety of clinical data alongside EDSS, such as the MSFC and Rao’s Brief Repeatable Battery [4], completed by MRI-based measures for the patients on each visit, our models would be better trained to capture various forms of disability accumulation. The objective is to target deployment as a clinical decision support tool, with interactive visualizations allowing neurologists to explore lesion-level contributions to predicted outcomes. This work has strong implications for early intervention, treatment planning, and patient counseling in MS.
Shailesh APPUKUTTAN (Marseille), Adrien AMBERTO, Bertrand AUDOIN, Muhammad BILAL, Mounir Mohamed EL MENDILI, Ismail ZITOUNI, Audrey RICO, Hugo DARY, Maxime GUYE, Jean-Philippe RANJEVA, Jean PELLETIER, Wafaa ZAARAOUI, Matthieu GILSON, Adil MAAROUF
13:30 - 15:00 #47725 - PG552 Investigating the link between glymphatic function and white matter microstructure in multiple sclerosis.
PG552 Investigating the link between glymphatic function and white matter microstructure in multiple sclerosis.

The glymphatic system (GS) is a pathway that facilitates the movement of cerebrospinal fluid from the subarachnoid space into brain parenchyma, where it mixes with interstitial fluid to remove metabolic waste through the perivascular space[1]. GS dysfunction contributes to central nervous system pathology and it has been shown that neurological diseases like multiple sclerosis (MS) are linked to an abnormal accumulation of neurotoxic compounds. A non-invasive method to evaluate GS characteristics is the diffusion tensor image analysis along the perivascular space (DTI-ALPS)[2], where the ALPS index is computed from diffusion-weighted images in a region of interest (ROI) in the periventricular white matter (WM), providing a proxy for glymphatic activity and the efficiency of waste clearance from the brain. Despite its utility, traditional DTI-derived metrics have limitations in detecting microstructural changes, especially in regions with complex fiber architecture common to WM connections. Fixel-based analysis (FBA) overcomes these limitations by providing a more detailed estimate of microstructural changes within a population of fibers in a single voxel (fixel), yielding three metrics: fiber density (FD), fiber-bundle cross-section (FC), and their combined effect (FDC). These metrics allow for a more refined assessment of pathophysiological changes, such as fiber loss or atrophy, on a microscopic level, by capturing intra-axonal volume changes (FD) and macroscopic alterations in fiber bundle size (FC). In this study, we conducted and correlated DTI-ALPS and FBA to investigate the association between glymphatic function and WM microstructure integrity in healthy controls (HC), clinically isolated syndrome (CIS) and relapsing-remitting MS (RRMS) patients.

T1- and diffusion weighted image data of 165 adult MS patients (30 with clinically isolated syndrome; 17 of which female; and 135 relapsing-remitting MS, 91 female) and 57 healthy age- and sex-matched subjects (HC) were included in this retrospective study. Scanning was performed on a Magnetom Trio 3 T Siemens scanner. A T1-weighted MPRAGE was used with the following parameters: Voxel size=1x1x1 mm, repetition time (TR)=1900 ms, echo time (TE)=2.52 ms, flip angle=9°, field of view (FOV)=256*256 mm. The T2-weighted echo-planar imaging sequence used to obtain the diffusion-weighted image data had the following parameters: Voxel size 2x2x2.5 mm, TR=9000 ms, TE=102 ms, flip angle=90°. 30 diffusion directions at b=900 s/mm² as well as one image at b=0 s/mm² were acquired. The DTI-ALPS index was calculated automatically for each individual using four spherical ROIs in standard space. FBA metrics (FD, FC, FDC) were computed using the MRtrix3 framework including preprocessing, response function estimation, and population template creation. Group comparisons were performed using connectivity-based fixel-enhancement with non-parametric permutation testing. In addition, correlations between mean FBA metrics and ALPS index values were assessed using Pearson correlation.

A multiway ANOVA showed significant differences between the three groups regarding the left (p=0.0047), right (p=0.0151) and mean ALPS index (p=0.0039), and a post hoc test showed, that there was a statistically significant decrease of the ALPS index of RRMS patients compared to healthy controls (Fig. 1) for the left side (p=0.0032), the right side (p=0.0115) and as a mean (p=0.0025). Statistically significant differences between HC and RRMS groups were found for all FBA metrics. Especially regarding FC and FDC, the fixels that differ significantly (after FWE, p<0.05) between the two groups were located in the superior corona radiata (Fig. 2 & 3). Additionaly, left, right and mean ALPS index values showed significant correlations with mean FD, FC and FDC in basal ganglia and thalamus ROIs.

Our preliminary results indicate that glymphatic dysfunction, as reflected by a reduced ALPS index, may contribute to or reflect microstructural WM degeneration in MS. In particular, the frequent occurrence of significant fixels in the superior corona radiata, which also plays a role in determining the ALPS index, suggests that there could be a connection between the state of the glymphatic system and the structural integrity of the WM microstructure in said area. The differences between groups found in the basal ganglia and thalamus, which are known to experience atrophic changes over the course of MS [3], may be associated with altered glymphatic function, supporting the hypothesis that axonal damage contributes to MS pathogenesis [4]. However, further work is needed to gain deeper insights into this context.

Our findings suggest a link between glymphatic dysfunction and WM degeneration in RRMS. Reduced ALPS index and FBA-derived changes, particularly in the superior corona radiata, basal ganglia, and thalamus, indicate that impaired glymphatic function may contribute to MS-related microstructural damage or vice versa.
Sascha D. SANTANIELLO (Mainz, Germany), Gabriel GONZALEZ-ESCAMILLA, Markus JANKO, Marc A. BROCKMANN, Sergiu GROPPA, Ahmed E. OTHMAN, Andrea KRONFELD
13:30 - 15:00 #47809 - PG553 Evaluation of changes in perfusion and white matter volume in the brain in clinically isolated syndrome.
PG553 Evaluation of changes in perfusion and white matter volume in the brain in clinically isolated syndrome.

Clinically isolated syndrome (CIS) is the initial stage of multiple sclerosis development, has a symptom complex identical to multiple sclerosis, but does not satisfy all the criteria of dissemination in time and space. According to the literature, 30% of patients showed conversion of clinically isolated syndrome to multiple sclerosis within 1 year and about 50% after 5 years; however, Bates et al. found that early treatment of patients with CIS accelerates recovery and can delay the development of multiple sclerosis. Early initiation of effective therapy with DMDs (disease modifying drugs) is a topical issue, which raises the question of when to start it. Purpose: To assess changes in perfusion and volume of brain tissue in clinically isolated syndrome (CIS).

The MR study was carried out on a MR-scanner "Ingenia" ("Philips") 3 Tesla. The study included 12 healthy volunteers and 6 patients with demyelinating disease of the central nervous system - with clinically isolated syndrome (CIS) and 13 patients with multiple sclerosis. To assess perfusion, the dynamic susceptibility contrast (DSC) method was used. Quantitative and qualitative assessment of CBF and CBV in the white and gray matter of different lobes of the brain. To assess morphometry, the obtained T1-WI and FLAIR images were loaded into an automated system for calculating the volumes of brain structures, based on the segmentation method. The volumes of the white matter of the brain (relWMV) and gray matter (relGMV) were relatively calculated based on the total intracranial volume as a percentage.

A moderate correlation was found between the decrease in the volume of white matter of the brain and the severity of focal changes (r-Spearman correlation coefficient 0.4, p≤0.05); compared to CIS, in patients with relapsing-remitting multiple sclerosis in the remission stage and secondary progressive form of MS (SPMS), relCBF was significantly reduced by 32% and 40% (p≤0.05); compared to the CIS group, in patients with RRMS (exacerbation stage) and RRMS (remission stage), the volumes were significantly reduced by 8% and 11% (p≤0.05), respectively.

Based on the data obtained, it follows that the pathogenesis of CIS and MS is based on identical processes - changes in perfusion and neurodegeneration, which begin at the earliest stages of the disease. We thank the Russian Science Foundation for supporting this work (№ 23-15-00377).
Liubov VASILKIV, Yulia STANKEVICH, Olga BOGOMYAKOVA, Denis KOROBKO, Nadezhda MALKOVA, Vladimir POPOV, Andrey TULUPOV (Novosibirsk, Russia)
13:30 - 15:00 #46081 - PG554 Assessing the integrity of the optic nerve using conventional magnetic resonance imaging.
PG554 Assessing the integrity of the optic nerve using conventional magnetic resonance imaging.

Optic neuritis is one of the most common manifestations of multiple sclerosis (MS). A complete assessment of the optic nerve requires the acquisition of dedicated sequences. The T1-weighted to T2-weighted ratio (T1/T2) has been proposed as a feasible alternative to assess tissue integrity. Current automated segmentation approaches for T1-weighted magnetic resonance imaging (MRI) do not include the optic nerve parcellation. The aim of this study was to explore the integrity of the optic nerve, based on the T1/T2. For that purpose, a deep-learning approach was developed to segment automatically the optic nerve from conventional 3D T1-weighted MRI.

The cohort included healthy controls (HC, n=18) and people with MS with previous history of optic neuritis (ON, n=16) and without (MS-nONn=17). MRI were acquired in a 3.0 T system (Prisma, Siemens), using a 64-channel head coil. Ground truth masks were generated manually outlining each optic nerve, for all subjects, based on the T1-weighted MRI. For the deep-learning task, a 2D U-Net architecture was implemented (patches 32x32 voxels, four encoding and decoding levels, batch normalization, ReLU activation, and a dropout rate of 0.2). The dataset was divided into training (70%), testing (15%), and validation (15%). To assess the model performance, the generated masks were compared to the ground truths by using the Dice coefficient. In parallel, T1/T2 images were generated and the mean value along the optic nerve profile was obtained over the generated segmentation masks. The mean value of T1/T2 of the optic nerve of the affected eye in ON was compared to the mean value in eyes of HC, MS and optic neuritis fellow eye by using the Kruskal-Wallis test followed by posthoc Dunn’s test (differences were considered significant if p<0.05). The presence of lesions in the optic nerve was assessed on double inversion recovery (DIR) MRI sequences.

The comparison between the ground truth and the generated masks reported a mean (SD) Dice = 0.51(0.15). The mean T1/T2 was significantly lower in the affected eye of ON patients with detectable MRI lesions on DIR when compared to the other groups: 0.760.08 for HC (p<0.001); 0.740.006 for MS-nON (p<0.001); 0.710.12 fellow eye of ON (p<0.001); 0.740.11 affected eye of ON patients with no detectable MRI lesions on DIR (p=0.44); 0.610.09 optic nerve affected eye with lesion at MRI.

Although the segmentation method yields a Dice coefficient that is not particularly high, it is acceptable given that the aim is not to measure the volume of the optic nerve, but rather to generate a mask over which to calculate the T1/T2 profile. On the other hand, when assessing small structures, even minor inaccuracies can lead to low Dice coefficients, as the metric is particularly sensitive to slight mismatches in small volumes. Validation in a cohort acquired using a scanner from a different vendor is necessary to confirm the generalizability of the proposed network.

Assessment of the integrity of the optic nerve appears to be a feasible option using conventional MRI sequences. Investigation of its potential clinical applications seems warranted.
Helena SÁNCHEZ-ULLOA, Paola AJDINAJ, Neus MONGAY-OCHOA, Eugenio FUNELLI, Manel ALBERICH, Gemma PIELLA, Àlex ROVIRA, Jaume SASTRE-GARRIGA, Deborah PARETO (Barcelona, Spain)
13:30 - 15:00 #47736 - PG555 Exploring Spinal Proprio-Motor Networks and Their Plasticity Using fMRI.
PG555 Exploring Spinal Proprio-Motor Networks and Their Plasticity Using fMRI.

Muscle proprioception, conveyed through spinal and supraspinal pathways, enables movement perception and control. Proprioceptive afferents relay muscle stretch information from the muscle spindles to the spinal cord, where direct connections between Ia afferents and motor neurons form the basis of the myotatic reflex. This sense can be manipulated using muscle tendon vibration, which selectively activates primary endings of muscle spindles and induces kinesthetic illusions in the absence of actual movement [Kavounoudias et al., 2023]. While proprioceptive integration has been widely investigated at the human cerebral level using neuroimaging approaches, its spinal mechanisms remain less explored, especially using non-invasive techniques. Post-mortem studies have mapped spinal cord anatomy, while its functional properties have been explored via electrophysiology, invasive epidural stimulation, and clinical observations. In the past decade, spinal functional MRI (fMRI) has overcome key technical challenges, emerging as a powerful, non-invasive tool for studying spinal circuits [Landelle et al., 2021].

We developed a protocol combining fMRI with proprioceptive vibration to investigate the spinal proprioceptive-motor circuits. Two studies were conducted: one investigating cervical spinal cord activity with bilateral upper limb muscle stimulation (at the wrist, elbow and shoulder levels) in 24 participants; A second study explored lumbar spinal cord activity with bilateral lower limb muscle stimulation (at the ankle, knee and hip levels) in 28 participants. The second study also assessed the effects of a two-week proprioceptive training program on spinal activation patterns. After acquiring MRI data using optimized sequences, spinal data preprocessing involved custom steps primarily using functions from the Spinal Cord Toolbox (SCT). Previously, normalization was based on vertebral landmarks, but for functional analysis, neural landmarks would seem more reliable. To improve the accuracy of overlaying individual data onto the template, we collaborated with the SCT team to develop a tool for identifying spinal rootlets, which enabled precise identification of individual spinal levels [Valosek, Mathieu, Schlienger et al, 2024]. These levels were then normalized to the PAM50 template. Additionally, we created a probabilistic map of spinal levels for our cohort, which better captures inter-participant variability.

Spinal activation patterns extracted from the upper limb stimulations showed lateralization of activity towards the ipsilateral and ventral hemicord, with clear functional distribution along the cervical axis. For example, anterior deltoid activity peaked at C5, biceps at C7, and wrist flexors at C8, demonstrating a rostrocaudal gradient linked to proximodistal muscle location. Secondary dorsal activation peaks were observed, likely corresponding to tactile afferent stimulation. Density maps showing the number of participants who activated each spinal level demonstrate that proprioceptive stimulation can engage multiple spinal levels simultaneously, with notable variability across participants. In some cases, participants activated several spinal levels during the stimulation, and this activation was often asymmetrical between the left and right sides. In the lower limb study, the left hip showed activation at T11, the knee at L3-L4, and the ankle at L5-S1, with consistent lateralization and ventral-side dominance. After two weeks of proprioceptive training of the left knee, proprioceptive stimulation of the trained knee yielded more focal & ipsilateral activation across the lumbar axis, suggesting an effect of training on synaptic excitability of the proprio-motor circuit.

This work provided detailed insights into spinal cord activity during proprioceptive stimulation, confirming the feasibility of spinal fMRI as a tool for investigating proprioceptive motor circuits. The findings align with recent literature on proprioceptive processing but also highlight significant inter-participant variability in spinal cord functional organization. The use of spinal fMRI to capture multiple activation sites along the cervical and lumbar axes offers a more comprehensive understanding of spinal activity compared to traditional methods like electrophysiology. The observed plasticity after proprioceptive training suggests that the spinal circuits underlying proprioception can be modulated by targeted interventions, which may have implications for neuroplasticity in spinal injuries or rehabilitation.

In laying out a network-level map of proprioceptive-motor circuits using non-invasive fMRI, we reveal activation patterns and inter-individual variability, which challenge traditional views of spinal cord functional organization. This variability accross participants highlights the potential of spinal fMRI to offer deeper insights into human spinal functional organization and its plasticity, both in health and disease.
Raphaëlle SCHLIENGER (Marseille), Caroline LANDELLE, Sergio D HERNANDEZ-CHARPAK, Daniela M PINZON-CORREDOR, Julien SEIN, Bruno NAZARIAN, Jean-Luc ANTON, Grégoire COURTINE, Anne KAVOUNOUDIAS
13:30 - 15:00 #47723 - PG556 B₀-corrected single-shot spiral MRI of the cervical spinal cord at 7 Tesla.
PG556 B₀-corrected single-shot spiral MRI of the cervical spinal cord at 7 Tesla.

Many advanced neuroimaging techniques, such as fMRI and diffusion-weighted imaging, depend on fast acquisitions, which are most commonly achieved with single-shot EPI [1-3]. Spiral imaging offers several theoretical advantages over EPI, including shorter TE, increased robustness to flow and motion, and more efficient usage of the gradients [4,5]. However, spiral sampling is inherently sensitive to imperfections in the gradient system and B₀-field inhomogeneities, causing image blurring. While great advances have been made to address these challenges for spiral imaging of the brain ([4]), comparable progress for the spinal cord remains limited. In this work, we aim to implement high-resolution single-shot spiral imaging of the cervical spinal cord at 7 Tesla, focusing on B₀-map estimation and correction during image reconstruction.

Single-shot spiral images were acquired in a healthy volunteer on a 7T Terra MR system (Siemens Healthineers) using a 1Tx, 24Rx cervical spine coil (MRI.TOOLS). Four spirals of varying resolution and acceleration factor were acquired (parameters in Fig.1), each including 20 repetitions of a single transverse slice at C3 mid-vertebral level. For coil sensitivity- and B₀-map estimation, a dual gradient echo (GRE) scan of the same slice was performed prior to the spiral acquisitions (parameters in Fig.1). Images were reconstructed with a CG-SENSE algorithm ([6]) using the open-source pipeline GIRFReco.jl ([7,8]), with and without B₀-correction. The trajectories were corrected with the system gradient impulse response function (GIRF) ([9,10]), measured with a phantom-based method [11]. B₀ field maps were estimated with a regularized method ([12]) using varying regularization parameters (β = 0.0005–0.05) to investigate the trade-off between noise and precision. The resulting spiral image reconstructions were visually assessed, posing particular attention to the cord region. Finally, time series of all repetitions were reconstructed using a B₀-map with β = 0.01. Mean images and maps of temporal signal-to-noise ratio (tSNR) were computed, and mean tSNR values within a spinal cord region of interest (ROI) were extracted using MRIcroGL.

Uncorrected spirals acquired with low acceleration (R = 1-3) were strongly blurred and distorted by off-resonance (Fig. 2a). After B₀-correction (Fig. 2b), blurring was visibly reduced, particularly around the spinal cord and CSF. The corrected spirals with 1.08/1.00 mm resolution enabled particularly clear identifiability of anatomical features. The spiral with highest acceleration (R=4) showed minimal off-resonance effects, but suffered from noise, and B₀-correction had little effect on improving image quality. Figure 3 shows B₀-maps estimated with varying regularization parameters together with the corresponding spiral image reconstructions. With increasing β, the B₀-profile became smoother and extreme values were reduced (black arrows). Correspondingly, spiral images reconstructed with low β were noisier. With increasing β, the pixelation was reduced and image quality increased, but at the cost of increased blurring. At β = 0.05, reconstructions became overly smooth, with reduced contrast between the spinal cord and CSF. For the spirals with 1.08/1.00 mm resolution, β = 0.01 appeared to offer a sweet spot between noisy and blurred appearance. The mean images of the time series (Fig. 4a) showed satisfactory image quality for the spirals with R=1-3, although the lowest resolution (1.71 mm) with limited anatomical detail. The corresponding tSNR maps (Fig. 4b) revealed a mean tSNR within the spinal cord ROI of 20, 12, and 9 for the 1.71, 1.08, and 1.00 mm resolution images, respectively. For the image with 0.74 mm resolution, the mean tSNR was 11.2, but overall image quality remained suboptimal, consistent with earlier findings.

This work demonstrated the feasibility of single-shot high-resolution spiral imaging of the spinal cord at 7 Tesla. Acquisitions with resolution up to 1 mm and acceleration factors of up to 3 yielded good visual image quality, and a mean tSNR of around 10. In comparison, EPI fMRI studies ([1]) reported tSNR up to 14.6 in the spinal cord. Correction for static B0 inhomogeneity in the image reconstruction was shown to be essential. The choice of regularization parameter in the field-map estimation also proved to have a strong impact on image quality. The investigation was performed in one subject, in a single slice, and was meant as proof-of-principle. Further work is required to evaluate the robustness of the method across multiple slices and subjects, and to optimize the B0 correction. Single-shot spiral imaging has the potential to replace single-shot EPI in applications such as fMRI and diffusion-weighted imaging of the spinal cord, addressing limitations like poor image quality and SNR, particularly at 7T. The improved acquisitions could ultimately facilitate functional and microstructural investigations of the spinal cord.
Maria Leseth FØYEN (Oslo, Norway), Laura BEGHINI, Lars KASPER, Signe Johanna VANNESJÖ
13:30 - 15:00 #46000 - PG557 White matter atlas of the in vivo human spinal cord.
PG557 White matter atlas of the in vivo human spinal cord.

The current knowledge of spinal cord white matter anatomy is based on a combination of data from animal models, and physiological and histological human studies. However, it has never been described in vivo in humans. This study aims to differentiate spinal tracts and create a spinal cord white matter atlas in humans, in vivo, using diffusion tensor imaging.

High angular resolution diffusion imaging (HARDI) of the spinal cord was acquired using a 3T MRI scanner in 49 healthy subjects, with opposed-phase encoding directions. Distortion corrections were performed using the FSL software package. Diffusion tensors were reconstructed using the generalized q-sampling imaging method. The tensor components from each subject were then registered onto a reference subject’s data. The registration utilized the Symmetric Normalization transformation type, combining both global transformations and local, more complex non-linear deformations. Mutual information (MI) was employed as the optimization metric to ensure accurate alignment. The tensor fusion was achieved by averaging the transformed diffusion tensors using the Log-Euclidean metric. Regions of interest were drawn specific to each spinal projection tract. Tractography was performed using a deterministic approach with DSI Studio.

The main parameters influencing the MI were grad_step, reg_iterations, aff_iterations, and aff_sampling. With the adjustments, the mean MI value increased from -0.5 (default settings) to -0.67 (optimized settings). A spinal cord white matter atlas was built: the corticospinal tract was located in the lateral funiculus at the edge of the ventral horn; the rubrospinal tract overlapped with the corticospinal tract in the lateral funiculus; the reticulospinal tract was located in the ventral funiculus; the ventral and dorsal spinocerebellar tracts overlapped in the dorsal part of the lateral funiculus and the dorso-lateral part of the dorsal funiculus; the spinothalamic tract was located around the ventral horn, while the dorsal columns were in the dorsal funiculus of the spinal cord.

The process of image registration and fusion across a cohort of 49 subjects offered a robust solution to the challenge of inter-individual variability, which is a notable limitation in many existing studies. By generating a composite spinal cord model, the present study captured the common structural features across a diverse population, leading to a more generalized and reliable anatomical reference.

HARDI, combined with advanced image registration and fusion techniques, offers significant advantages for the precise mapping and differentiation of spinal tracts in the in vivo human spinal cord, establishing a new standard for spinal cord mapping.
Corentin DAULEAC (Lyon), François COTTON, Frindel CAROLE
13:30 - 15:00 #47689 - PG558 Imiomics in lumbar spinal stenosis.
PG558 Imiomics in lumbar spinal stenosis.

Lumbar spinal stenosis (LSS) is a common condition affecting about 20 % of the population aged 50 to 69 years [1]. However, currently MRI findings have a low correlation to patient’s disability level [2]. This gap highlights the need for new imaging approaches that may better reflect clinical symptoms. Imiomics is an image analysis method that aligns individual MR images to a common reference, enabling detailed, voxel-wise comparison of anatomical differences between cohorts [3]. This approach may offer new insights into the structural changes associated with LSS, which can be complex and spatially distributed. This study aimed to evaluate Imiomics as a proof of concept for identifying anatomical differences between patients with LSS and healthy controls using lumbar spine MR images.

Two datasets were used: one comprising subjects from the LSS cohort of the Norwegian Degenerative Spondylolisthesis and Spinal Stenosis (NORDSTEN) study [4] and one dataset consisting of healthy controls (77 individuals), examined at the Carlanderska Hospital in Gothenburg [5]. For each subject, a whole T1w and a T2w sagittal lumbar spine image volume was selected. From the LSS cohort two cases were selected. All vertebrae, intervertebral discs and central spinal fluid (CSF) were segmented using TotalSpineSeg [6], a tool based on the deep learning model nnU-Net [7]. All images were masked to a convex region enclosing the vertebrae. One randomly selected healthy control was used to define a common coordinate system and all remaining images were registered to this reference using the software Deform [8, 9]. The intensity images combined with the segmentation mask of the vertebrae and intervertebral discs were layered as input channels in the registration. Coordinates along the centerline of the spinal canal at each intervertebral disc level were used for initial image alignment and for further constraints during the registration. Since signal intensity values varied across the MR images due to differences in acquisition parameters, coil sensitivity, etc., intensity normalization was performed using the mean CSF signal intensity, followed by histogram matching to a selected reference image. One T1w and one T2w intensity atlas to characterize normal signal distributions was generated for the registered and normalized images of the healthy controls. For each voxel, the mean intensity and standard deviation were computed. To identify signal intensity deviations in individual LSS patients, voxel-wise absolute Z-scores were calculated by comparing patient intensities to the corresponding atlas distributions. Z-scores exceeding 1.96 were considered statistically significant, indicating abnormal signal intensity.

The image registration of the healthy controls yielded mean Dice scores of 0.76±0.04 (T1w) and 0.82±0.04 (T2w). The midsagittal slice of the intensity atlas characterizing normal intensity signal distributions is illustrated in Figure 1. Two LSS cases were selected to illustrate anomaly detection. In the first case (Figure 2), a patient with severe central stenosis (Schizas grade D at L2-L3 and L3-L4), Imomics correctly highlighted known stenosis at L2-L3 in the T2w image, and epidural fat loss in the T1w image. Images were registered with Dice scores 0.80 (T1w) and 0.84 (T2w). In the second case (Figure 3), a patient with preserved epidural fat and no or minor central stenosis (Schizas grade A), Imiomics did not depict any relevant anomalies in the midsagittal plane. The patient had foraminal stenosis, which is typically not visible in this this view. Dice scores for registration were 0.77 (T1w) and 0.78 (T2w).

One challenge when evaluating differences in intensities between MR systems and protocols is the lack of standardized voxel intensity values. Despite only simple intensity normalization and analysis being employed, the results demonstrate that Imiomics could be a feasible tool for detecting anomalies in lumbar spine MR images. Since Imiomics enables untargeted analysis and visualization of deviations between patient images and healthy controls, one potential clinical application could be as a decision support system for highlighting pathological changes that require more detailed analysis. Given the challenges in comparing intensity values between systems and scan protocols, future work should focus on developing more sophisticated atlases. A promising next step could be to combine Imiomics with tools from Radiomics, which enables quantitative analysis of MR images from different systems and scan protocols on a pixel-by-pixel level [10].

Imiomics demonstrates feasibility for detecting relevant changes in the lumbar spine of patients with LSS, compared to healthy controls. In the future with more refined atlases, Imiomics may serve as a valuable tool for identifying subtle pathological changes in LSS, potentially improving the correlation between MRI findings and patient-reported disability.
Alice NILSSON (Gothenburg, Sweden), Christian WALDENBERG, Erland HERMANSEN, Hanna HEBELKA, Hasan BANITALEBI, Helena BRISBY, Kari INDREKVAM, Kerstin LAGERSTRAND
13:30 - 15:00 #47707 - PG559 Multimodal MR Imaging of Brachial Plexopathy: Preoperative Diagnostic Value Across Conditions.
PG559 Multimodal MR Imaging of Brachial Plexopathy: Preoperative Diagnostic Value Across Conditions.

Brachial plexus pathology is a serious clinical concern that can result in long-term motor and sensory impairment of the upper limb. Diagnosing brachial plexopathy is challenging and requires a multidisciplinary approach involving neurologists, radiologists, neurosurgeons, and clinical researchers (1-2). Multimodal MR imaging—including MR neurography (MRN), diffusion tractography (MRT), and MR angiography (MRA) closely aligns with clinical and electrophysiological findings, helping to pinpoint lesion location, clarify the cause, and guide surgical planning. This makes it vital for effective preoperative evaluation and treatment of patients with brachial plexopathies.

Ten patients (7 males, 3 females; age range: 18–72 years) with clinically and electrophysiologically confirmed brachial plexopathy underwent MR imaging on a 3T scanner using an 18-channel phased-array body coil and a 64-channel head/neck coil. The imaging protocol included diffusion-weighted imaging with a multishell diffusion scheme (TR/TE: 5500/83 ms; 64 directions; 80 slices; in-plane resolution: 3×3 mm²; 9 b-values ranging from 0 to 950 s/mm²; scan time: 6 minutes 18 seconds) and coronal T2-weighted 3D short-term inversion recovery sampling perfection with application optimized contrast using varying flip angle evaluation (STIR-SPACE) sequences (TR/TE: 3000/2710 ms; inversion time: 230 ms; 144 slices; in-plane resolution: 1×1 mm²; scan time: 10 minutes 56 seconds). MR angiography was also performed. Diffusion data were corrected for susceptibility artifacts using reversed phase-encoding b0 volumes via TOPUP (Tiny FSL: http://github.com/frankyeh/TinyFSL) and processed through DSI Studio (http://dsi-studio.labsolver.org). Fiber reconstruction of the brachial plexus was performed using the Generalized Q-Sampling Imaging (GQI) algorithm (Generalized q-sampling imaging). MRN and volume rendering were completed using MEDINRIA (medInria). Etiologies included trauma (n=6), thoracic outlet syndrome (TOS, n=3), and inflammation (n=1).

Multimodal MRI findings matched clinical and electrophysiological diagnoses in 9 out of 10 patients (90%). In traumatic cases (n=6), MRN and DTI accurately identified root avulsions and neuromas, guiding surgical decision-making. In TOS cases (n=3), hyperintensities or trunk-level abnormalities were clearly visualized; however, one scan was compromised by severe motion artifacts. The inflammatory case demonstrated C6 root hyperintensity consistent with clinical findings. Representative MRN reconstructions and corresponding tractography are hown in Figure 1.

The results of our study in 10 patients with different aetiologies of brachial plexopathy highlight the crucial role that multimodal MRI techniques—specifically MRN, MRT, and MRA, can play when integrated with electromyography (EMG) and thorough clinical examination. This comprehensive diagnostic approach not only enhances the accuracy of lesion localization and characterization but also provides critical anatomical and functional information that is essential for tailored neurosurgical planning. The ability of these modalities to visualize nerve continuity, detect signal abnormalities, and assess adjacent vascular structures offers a significant advantage over conventional imaging. Our findings support the growing consensus that a multimodal diagnostic strategy should be considered a standard of care in the evaluation and management of complex peripheral nerve pathologies such as brachial plexopathies

Multimodal MR imaging, including MR neurography and diffusion tractography—shows strong concordance with clinical and electrophysiological findings in brachial plexopathy. It offers crucial preoperative insights across traumatic, compressive, and inflammatory causes, enhances lesion localization, and sharpens surgical targeting, making it an essential tool for surgical planning and management. Supported by the Ministry of Health of the Czech Republic in cooperation with the Czech Health Research Council under project No. NW 24-08-00086 and DRO (IKEM, IN 00023001). REFERENCES 1. Ibrahim I, Škoch A, Herynek V, Humhej I, et al. Magnetic resonance tractography of the brachial plexus: step-by-step. Quant Imaging Med Surg. 2022 Sep;12(9):4488-4501. 2. Jung JY, Lin Y, Carrino JA. An Updated Review of Magnetic Resonance Neurography for Plexus Imaging. Korean J Radiol. 2023 Nov;24(11):1114-1130.
Ibrahim IBRAHIM (Prague, Czech Republic), Ivan HUMHEJ, Antonín ŠKOCH, Theodor ADLA, Vlasta FLUSSEROVA, Dana KAUTZNEROVÁ, Simona KURKOVÁ, Dominik HAVLÍČEK, Jaroslav TINTĚRA
13:30 - 15:00 #47750 - PG560 Breast MRI: comfort evaluation of supine positioning and dedicated breast holder.
PG560 Breast MRI: comfort evaluation of supine positioning and dedicated breast holder.

MRI is commonly used for breast cancer diagnosis, especially for high-risk women and cancer staging [1]. Current breast MRI performed in prone position with breast positioned in a coil, is often perceived as uncomfortable [2]. Additionally, patient preparation and correct positioning increase the exam duration and contribute to anxiety and discomfort, finally reducing patient acceptance of the procedure. To enhance patient comfort and diagnostic specificity of breast MRI, we have developed a comprehensive approach performed in a supine position and relying on a dedicated breast coil ‘BraCoil’, motion sensors and motion correction algorithms [3-6]. To further improve comfort, we also designed an elastic breast holder to maintain the breast shape without compression during MRI. Since the success of MRI exams largely depends on the patient's cooperation, this study aimed to evaluate the comfort experienced by volunteers undergoing supine breast MRI with our technology, by collecting direct feedback after the MRI scan. Dedicated questionnaires were developed to evaluate perceptions related to the position and to the breast holder use.

11 healthy volunteers underwent breast MRI without contrast agent injection in two positions: prone and supine (Fig. 1). The order of the two examinations was alternated across participants. Before the supine MRI, each wore a personalized elastic breast holder shown in Figs. 2a & 2b, developed in collaboration with Bioserenity (France), suited to her morphology. A second supine MRI was performed afterwards without the holder. After imaging, participants completed two questionnaires: one comparing comfort, positioning, pain and anxiety between the two positions, and another assessing the breast holder's comfort, usability, and size suitability. Due to an organizational issue, one participant only completed the first questionnaire, yielding 11 responses for position comparison and 10 for holder evaluation. Investigation procedures were conducted under ethical protocol EDEN (NCT05218460). Comfort scores for the two positions (from "very uncomfortable" to "very comfortable") were compared using a one-sided sign test. Paired binary responses regarding pain or anxiety during the examination (Yes/No) in both positions were compared using McNemar's test. A p-value < 0.05 was considered statistically significant for all analyses.

Figure 3 shows the results for position comfort evaluation. The prone position was rated as moderately uncomfortable by 55.5% of the volunteers, whereas the supine position received 100% positive ratings. Overall, comfort scores were significantly higher for supine position compared to prone (p = 0.035). 82% of participants judged the supine position to be more comfortable than the prone. In terms of pain, 45.6% of volunteers reported discomfort in the prone position, compared to only 18.2% in the supine; however, this difference did not reach statistical significance (p = 0.180). On the other hand, the supine position was significantly more anxiogenic (p = 0.046), with 45.6% of participants reporting anxiety. Results from the breast holder evaluation are shown in Fig. 4. All volunteers found the holder easy or very easy to use. For 70%, it took less than one minute to put on. The majority (80%) of participants felt psychologically comfortable wearing the holder and 20% felt slightly embarrassed. The examination with the breast holder was rated as equally comfortable by 50% of the volunteers and as more comfortable by the remaining 50%. Visual inspection of MRI images with and without the holder showed that, as expected, the holder slightly improved the similarity between the supine and prone breast shapes, particularly in women with larger breasts (Fig. 2c).

Some studies showed supine MRI's feasibility for breast imaging, but women comfort has not been assessed [7]. Along with the gains in image quality and correlation with other procedures [5,8], the positive feedback from women on comfort and pain with our supine MRI protocol contributes to a higher acceptance of breast MRI, compared to prone exam, enabling its more widespread use for diagnosis of cancer. Nevertheless, anxiety is more commonly felt in the proposed supine protocol, primarily due to the view of the MRI tunnel. This can be managed by using sleep masks, mirrors or audio-visual sensory immersion devices to create a more comfortable scanning environment [9-10]. Meanwhile, the breast holder, found to be user-friendly, appears to provide only a slightly advantage in comfort. Further validation on larger cohorts and on patients with breast lesions is ongoing to allow for broader generalization of these findings.

The proposed supine breast MRI approach provides better comfort than the routine position, leading to a better acceptance of breast MRI by women. Using a specific breast holder further improves patient satisfaction, but its effect on breast morphology suggests that further evaluation is necessary.
Barbara FISCHER, Karyna ISAIEVA (Nancy), Lucile BASTIEN, Sarah EL-MAGHRANI, Guillaume DROUOT, Gabriela HOSSU, Nicolas WEBER, Samuel ROGIER, Philippe HENROT, Jacques FELBLINGER
13:30 - 15:00 #47926 - PG561 Hemodynamic Forces in ST-elevation myocardial infarction - anterior versus non-anterior.
PG561 Hemodynamic Forces in ST-elevation myocardial infarction - anterior versus non-anterior.

ST-elevation myocardial infarction (STEMI) is the most severe form om myocardial infarction, and whether the ischemic damage is localized anterior or inferior (e.g. non-anterior) can affect the prognosis. Ventricular remodelling may occur due to and scarring and fibroisis which affects all cardiac healing process and causes permanent changes in cardiac shape, geometry, size and function e.g. adverse remodelling. The cardiac magnetic resonance imaging (CMR) software tool Hemodynamic Forces enable retrospective analysis of the intracavitary gradient pressures direction during a heart cycle, a measurement of cardiac efficiency. A few studies have been published using this software, but none has compared patients with anterior and non-anterior STEMI with as high timely resolution as in this study. The purpose with this study is to visualize different patterns of the hemodynamic force after anterior and non-anterior STEMI over time.

This exploratory study was based in the Stunning in Takotsubo versus Acute Myocardial Infarction cohort (NCT04448639). During analyzation qualitatively, different pathological patterns appeared, Three patients with anterior STEMI and three patients with non-anterior STEMI with no history of cardiac disease were examined with CMR imaging at three time points after hospitalization, the acute , subacute, and chronic) phases. Based on CINE imaging, calculations of the hemodynamic forces proceed from endocardial border throughout the heart cycle, average mitral valve diameter 4, 2 and 3 chamber view and the aortic valve, 3ch (Fig. 1).

6 patients were included in the study based on infarct localization, presence of adverse remodelling, sex, and age and presentation of different longitudinal patterns from a larger cohort. Divided into anterior (A1, A2, A3) vs non-anterior (nA1, nA2, nA3), two males, one female each, two had no adverse remodelling, one female also one male (Fig. 2). In these few cases the curves show difference in appearance whether the infarcts are anterior or non-anterior despite infarction size (Figs. 3-4). Both A3 and nA3 had no adverse remodelling, cardiac function recovered, the appearance of the curves is lower in the acute phase and increase in force over time (Fig. 3). Plotting the peak value of force over time, the trend indicates that in these cases increased or preserved force led to adverse remodelling whilst a reduced initial force eventually recovers.

Our results show differences in the appearance of both anterior and non-anterior STEMI patients. For non-anterior STEMI, the time curve of the hemodynamic force may appear abnormal in the acute phase then recover until the subacute phase, in contrast to anterior STEMI were the hemodynamic curve have a normal appearance in acute phase but not the subacute. Similarly, for both of those with no remodelling the general peak force are lower in acute phase that accumulates over time. Is it posslble that a down regulation of the longitudinal forces during the systolic peak may affect the recovery and prevents adverse remodelling after STEMI, could changes in hemodynamic forces over time have a prognostic value in STEMI patients.

In present study we have identified different patterns of the hemodynamic forces depending on localization, anterior or non-anterior myocardial infarction also outcome adverse remodelling or not. These are only a few cases not enough to decide on any significance and a larger sample is necessary and further evaluation.
Christina PETTERSSON (Gothenburg, Sweden, Sweden), Björn REDFORS, Andersson AXEL, Christian L POLTE, Kerstin LAGERSTRAND
13:30 - 15:00 PG561 Hemodynamic Forces in ST-elevation myocardial infarction - anterior versus non-anterior. Christina PETTERSSON (PhD student) (Poster Displayed, Gothenburg, Sweden, Sweden)
13:30 - 15:00 #47861 - PG562 Uncovering the role of superior colliculus in rats dynamic vision with BOLD and ADC-fMRI.
PG562 Uncovering the role of superior colliculus in rats dynamic vision with BOLD and ADC-fMRI.

In the mammal brain, the perception of a recurrent visual stimulus involves both the primary visual cortex (V1) and the superior colliculus (SC). In rats, stimuli at a higher frequency than the Flicker Fusion Frequency (FFF) threshold led to continuity illusion and showed a specific pattern of positive and negative BOLD-fMRI responses [1-2]. To better understand the functional mechanisms behind this transition from static to dynamic vision, we compared the fMRI response to visual stimuli below and above the FFF threshold and investigated the effect of sex and magnetic field strengths. We also compared BOLD-fMRI to apparent diffusion coefficient (ADC)-fMRI responses[3-5], which relies on neuromorphological[6-7] rather than neurovascular coupling.

Twelve Sprague-Dawley rats (n=6 females) were scanned on a 14T Bruker MRI system with a volume transmit coil and a receive-only surface coil, and 6 additional females were scanned on a 9.4T Bruker MRI system with a volume transmit coil and a receive-only cryoprobe. Table 1 presents the acquisition parameters of the T2-weighted anatomical scan and of BOLD and ADC-fMRI timeseries (isotropic spherical diffusion encoding with alternating b-values of 200 and 1000 s/mm²). Rats were sedated using medetomidine following initial anaesthesia with isoflurane. fMRI acquisitions started 30 min after stopping isoflurane and consisted in blocks of 16s of stimulation (blue light flickering at a frequency of 1Hz or 25Hz) and 24s of rest, repeated 12 times. Two runs were acquired per frequency and per functional contrast. fMRI images were denoised[8] and corrected for Gibbs ringing[9], distortions[10], and motion[11]. ADC-fMRI timeseries were computed from the co-registered b200 and b1000 timeseries. Single-level GLM with boxcar function was performed on BOLD-fMRI and results were registered to a template for group-level GLM. To reduce assumptions on ADC-fMRI response, first-level GLM was performed with a boxcar function convolved with Finite Impulse Response (FIR)[12]. Responding voxels were pooled across rats and classified using a K-means clustering algorithm.

At 14T, in response to 1Hz stimulation, both sexes showed overwhelming bilateral positive BOLD response in the SC and V1 (Fig.1). In contrast, 25Hz visual stimulation elicited a negative BOLD response in V1 of all animals, and in the lateral SC of males. Plotting the average responses only showed a difference between males and females in the amplitude of the response to 25Hz stimulation in the SC. In females, the BOLD-fMRI activation maps and response shapes were overall very similar across different gradient strengths, although the signal amplitude was consistently lower at 9.4T (Fig 2). An exception can be noted for SC at 25Hz, as two peaks can be noticed at 14T only (Fig. 2G). ADC-fMRI response was very similar between 1Hz and 25Hz stimulation in females at 9.4T (Fig. 3). Clusters of voxels showing a negative ADC response were found in the medial part of the SC, in the hippocampus, and in the corpus callosum, in regions where BOLD response was positive. A positive ADC response, very similar to the BOLD one, was found in the lateral part of the SC.

At 25Hz, we reproduced the pattern observed by Gil et al. showing positive BOLD in the SC and negative BOLD in V1 [1-2]. In addition, our results highlight a difference between males and females, showing negative BOLD in the lateral SC in males. The activation maps derived from 14T and 9.4T MRI mainly showed an expected scaling of BOLD amplitude with field strength. In the SC at 25Hz, the shape of the responses differed at 9.4T, which may be attributed to the increase in small-vs-large vessel relative contributions at lower fields[13-14] . ADC-fMRI is a promising complementary approach to probe brain function independently of the hemodynamic response[15]. Interestingly, ADC-fMRI response showed opposite signs between the lateral and medial SC, even with 1Hz stimulation. In the white matter and in the medial SC, negative ADC response was measured in the presence of positive BOLD suggesting a neuromorphologically-driven contrast. However, in the lateral SC, the positive ADC response was very similar to BOLD and probably due to residual magnetic susceptibility contributions to the ADC timecourse.

We confirmed the key role of the SC in the visual perception of high frequency stimuli. The differences spotted in BOLD fMRI across sex and field strength suggested a separation between medial and lateral SC in the complex excitatory/inhibitory observed pattern. Using ADC-fMRI to probe brain function without vascular coupling could help better understand interactions between regions of the visual network and the white matter connecting them.
Jean-Baptiste PEROT (Lausanne, Switzerland), Andreea HERTANU, Arthur SPENCER, Jasmine NGUYEN-DUC, Nikolaos MOLOCHIDIS, Valerio ZERBI, Maxime YON, Ileana JELESCU
13:30 - 15:00 PG562 Uncovering the role of superior colliculus in rats dynamic vision with BOLD and ADC-fMRI. Jean-Baptiste PEROT (Postdoc) (Poster Displayed, Lausanne, Switzerland)
13:30 - 15:00 #47713 - PG563 Reproducible detection of fine-grained face selective patches in the human prefrontal cortex using high resolution fMRI at 9.4 Tesla.
PG563 Reproducible detection of fine-grained face selective patches in the human prefrontal cortex using high resolution fMRI at 9.4 Tesla.

The prefrontal cortex (PFC) is commonly associated with executive functions such as planning and working memory[1, 2]. And yet, both monkey and human PFC have been shown to contain regions that selectively respond to visual stimuli of faces versus other objects[3, 4, 5]. Recent studies using high-resolution fMRI in macaques revealed that these ”prefrontal face-patches” make up a small portion of the prefrontal cortex and possibly part of a larger area of fine-grained mosaic of object-specific patches[6, 7], similar to what has been found in the inferotemporal cortex[8, 9, 10]. Currently, there is no strong evidence of such a fine-grained topographic organization of visual objects in human PFC. We hypothesize that evidence of such a topographic organization in human PFC is washed out by a combination of population averaging and low resolution imaging. In this work, we used high-resolution fMRI at 9.4 Tesla, to investigate if fine grained face patches can be detected reproducibly in the PFC of individual humans.

Five subjects completed three scan sessions each. All participants provided informed consent prior to each scan, in compliance with local IRB regulations. The stimuli contained images of faces[11] and manipulable inanimate objects (MIO) including tools and food[12]. A counterbalanced block design was used (Fig. 1a). A one-back task was used to control attention (Fig. 1b). All functional data was collected at 9.4 Tesla (Magnetom Siemens, Erlangen, Germany) using the AC84 head gradient (333 T m−1s−1, 80 T m−1). The coil consisted of a 16-channel dual-row transmit array, with a 31-channel receiver array insert[13]. Functional data was collected using a slab-selective, three-dimensional echo-planar imaging (3D-EPI) sequence[14]. A 52-mm thick slab was placed true axial, just above the orbital gyrus, with a 192-mm square in-plane. The resolution was 0.75 mm isotropic. A 3-s volume TR and 19-ms TE were achieved using a 3 × 2 undersampling factor, with a CAIPI shift of 1 in the kz-direction and a shot segmentation factor of 2[14, 15]. Preprocessing was performed using AFNI[16]. GLM analyses were performed with and without smoothing (1.5 mm). The first 3 volumes of each run were removed.

The average task performance across subjects was 92±9%. Figure 2 shows the unsmoothed GLM result of the 2nd session of subject 1. Similar to previous reports[5], the areas responding strongly to faces were located around the inferior frontal sulcus in the right PFC. Interestingly, our face patches were much smaller than previously reported, probably due to the significant improvement in resolution (3.0 mm vs 0.75 mm iso). Notably, we also observed small patches that appear to show signs of selectivity towards images of MIO nearby. Figure 3 shows the activation pattern observed in both unsmoothed and smoothed results from all 3 sessions of subject 5. In this subject, both face- and MIO-clusters were observed in consistent locations throughout all sessions. Figure 4 shows smoothed results measured in all other subjects. The 3rd session of subject 1 and the 1st session of subject 4 showed weak or no evidence of face-selective activation in the right PFC. The location of the face patches in subject 1 appeared to be lower in the brain than the others. This is likely a visual effect due to a difference in head tilt. Relative to the face patches, the location of MIO patches differed considerably between individuals. In some subjects, MIO patches tended to lie near the sulcus, whereas in others they were closer to the gyrus. In the 2nd session of subject 3, MIO patches were found in both of these locations. Yet, session 1 only showed the sulcal patch, whereas the 3rd session only showed the gyral patch.

It is likely that these face- and MIO-selective cortical patches are not in the exact same spot across subjects in MNI space. Therefore, averaging across subjects could give the impression that these face-patches are larger, possibly overshadowing neighboring patches with specific selectivity for other well-defined features. To further investigate this hypothesis, we plan to coregister the data to T1-weighted anatomical images and conduct surface-based analysis. Future work should also consider expanding the range of object categories as well as separating tools and food into separate categories. This could allow a more complete mapping of the topographic organization in the PFC, as well as further validate the specificity of these patches with regards to other types of objects.

Our results indicate that face-selective cortical patches in the human PFC are very small, and can be reproducibly observed across sessions. In some subjects, MIO-selective patches were found nearby, suggesting that some additional topographic organization of objects may exist in the human PFC. More generally, these preliminary results highlight that, albeit challenging, reproducible high-resolution fMRI of category sensitivity in the human PFC is possible at 9.4 T.
Noriya ASAMI (Tokyo/Nijmegen, Japan), Desmond H. Y. TSE, Yoichi MIYAWAKI, Logan DOWDLE, Benedikt A. POSER, Wim VANDUFFEL, Timo VAN KERKOERLE, Martijn A. CLOOS
13:30 - 15:00 #47866 - PG564 Towards Layer-fMRI of the Human Insula During Pain Perception.
PG564 Towards Layer-fMRI of the Human Insula During Pain Perception.

The insular cortex, deeply folded within the lateral sulcus, has been repeatedly implicated as a central hub for pain processing in humans (Horing & Büchel, 2022; Segerdahl et al., 2015). Functional imaging studies suggest a gradient along its anterior–posterior axis: anterior regions encode cognitive-affective components such as pain anticipation, while posterior regions more closely track stimulus intensity. This functional axis aligns with cytoarchitectonic subdivisions observed in both humans and non-human primates (Cerliani et al., 2012), where different insular subregions exhibit distinct functional connectivity profiles. The dorsal posterior insula, in particular, receives lamina I spinothalamic input and serves as a primary cortical target for nociceptive afferents (Craig, 2009). To bridge the gap between insights from animal models and macroscopic human neuroimaging, recent advances in high-resolution fMRI allow investigation of cortical processing at the mesoscopic level—across cortical layers—enabling directional inferences about feedforward and feedback signaling. However, applying layer-fMRI to the insula remains technically challenging due to its curvature, depth, susceptibility to signal dropout, partial volume effects, and pronounced physiological noise. Here, we present the development of a well-powered study design with a MR protocol optimized for laminar fMRI of the insula during pain perception.

Participants received repeated thermal stimuli (48.5°C, 4.6 s plateau, 70°C/s ramp rate) on the left forearm using a CHEPS thermode connected to a TSA-2 system (Medoc). Each session consisted of 40 heat stimuli, with half presented as predictable—announced by a brief cue—and half as unpredictable. Seven healthy subjects were scanned on a Siemens Prisma 3T system equipped with a 64-channel receive head coil. Each subject participated in six scanning sessions across two separate days. Functional imaging was performed using a 3D gradient-echo EPI (GE-EPI) BOLD sequence (Stirnberger & Stöcker, 2021) with the following parameters: voxel size = 0.82 mm isotropic, TR = 2230 ms, TE = 28 ms, partial Fourier = 6/8, 26 sagittal slices. In addition, a SS-SI-VASO sequence with the same readout and resolution was used to generate T1-weighted images exhibiting the same distortions as the functional images. High-resolution anatomical reference images were acquired using a MP2RAGE sequence with matched voxel size. For the first three participants, both BOLD and VASO sequences were acquired to compare temporal signal-to-noise ratio (tSNR) and contrast-to-noise ratio (CNR). Based on these comparisons, subsequent sessions employed only the BOLD sequence for task-based fMRI, while the VASO sequence was retained for a short resting-state acquisition to generate distortion-matched T1-weighted images. All functional (BOLD) and resting-state (VASO) images were denoised using NORDIC (Vizioli et al., 2021) to reduce thermal noise and then motion-corrected in SPM12 using a spatial weighting mask of the insular cortex. Mean images of VASO series were used to compute a distortion-matched T1-weighted image. Co-registration was performed in two steps: first, the VASO-derived T1 image was linearly aligned to the mean BOLD image; second, the MP2RAGE anatomical image was non-linearly aligned to the VASO T1-weighted image. First-level GLMs were computed in SPM12, incorporating paradigm regressors, 24 motion parameters, and RETROICOR physiological noise regressors, all convolved with a canonical HRF.

In the first three subjects, we compared tSNR and CNR between four sessions (160 trials) of BOLD and VASO acquisitions. Across all subjects and both metrics, the BOLD time series outperformed VASO. Furthermore, activation maps based on the VASO sequence showed strong signal from large arteries, particularly the middle cerebral artery. Based on these findings, all subsequent sessions were conducted using the 3D GE-EPI BOLD sequence. In all seven subjects, the strongest activation for the pain contrast was observed in the dorsal posterior insular cortex or in an adjacent opercular region. This spatial pattern is consistent with the location of nociceptive input reported in macaque tracer studies (Craig, 2009). In four subjects, the contrast between predictable and unpredictable pain yielded significant activation, with foci located more anteriorly. However, these activations were less spatially consistent across subjects than the main pain contrast.

We established a robust and high-resolution (0.82 mm) protocol for investigating pain-related activity in the human insula using 3T fMRI. Our preliminary results are in line with anatomical findings from non-human primate studies, supporting the dorsal posterior insula as a key target for nociceptive input.

In the next phase, we will analyze these data at the laminar level to assess feedforward (nociceptive input) and feedback (predictability modulation) processes within the insular cortex.
Ole GOLTERMANN (Hamburg, Germany), Christian BUECHEL
13:30 - 15:00 PG564 Towards Layer-fMRI of the Human Insula During Pain Perception. Ole GOLTERMANN (Poster Displayed, Hamburg, Germany)
13:30 - 15:00 #47791 - PG565 Preliminary Evidence that Cold-Induced Pain Disrupts Functional Connectivity in Knee Osteoarthritis Patients with Chronic Pain: An rs-fMRI Study.
PG565 Preliminary Evidence that Cold-Induced Pain Disrupts Functional Connectivity in Knee Osteoarthritis Patients with Chronic Pain: An rs-fMRI Study.

Chronic pain in knee osteoarthritis (KOA) is associated with central nervous system changes, particularly in patients exhibiting widespread, nociplastic pain features. While resting-state fMRI (rs-fMRI) can detect intrinsic brain alterations, the effects of acute pain stimulation on functional connectivity remain underexplored. To address this, we employed the cold pressor gel test a validated, safe, standardized, and short-duration method for inducing acute pain (1,2) by applying cold gel to the non-dominant hand during scanning. This protocol allows for controlled investigation of pain-evoked neural responses. We hypothesized that patients with widespread nociplastic pain will exhibit greater disruptions in pain-related networks (e.g., thalamocortical, salience, sensorimotor) during cold stimulation, reflecting enhanced central sensitization and neuroplastic alterations.

Four patients with KOA and widespread pain (3 females, 1 male; mean age = 59.75 years) participated in the study. Each underwent MRI scanning on a 3T GE system, which included high-resolution anatomical and functional BOLD imaging. fMRI scanning consisted of three 8-minute fMRI sessions: resting state baseline (Rest), cold stimulation (ICE), and recovery. The cold pressor gel test involved applying cold gel to the non-dominant hand for two minutes during the ICE session. Preprocessing was performed using the CONN toolbox, including fieldmap-based realignment, slice-timing correction, normalization to MNI space, smoothing (8 mm FWHM), and CompCor-based denoising. Seed-based connectivity analyses were performed using a weighted-GLM on Fisher-transformed correlations. Seeds included bilateral thalamus, posterior cingulate cortex (PCC), anterior cingulate cortex (ACC), anterior insula, sensorimotor and visual cortices, brainstem, ICE vs. Rest contrasts were assessed at voxel-level p < 0.001 with cluster-level FDR correction (p-FDR < 0.05). All analyses were exploratory and interpreted cautiously due to the limited degrees of freedom.

ICE stimulation significantly effected connectivity between key seed regions and specific target brain regions involved in pain processing. Posterior cingulate seed connectivity decreased with the right occipital pole (T = –46.40; 21 voxels; p-FDR = 0.00022) (Fig.1 (a)). Anterior cingulate seed showed reduced connectivity with multiple regions. The most significant decrease was observed in the orbitofrontal cortex (T = –106.75; 18 voxels; p-FDR = 0.00014). Sensorimotor cortex seed connectivity declined with bilateral M1/S1 (e.g., T = –50.45, x = –22, –88, –18; 15 voxels; p-FDR = 0.00034) (Fig.1 (b)). Right thalamus showed increased connectivity with frontal pole (T = +38.41; 16 voxels; p-FDR = 0.00047), while the left thalamus and brainstem showed decreased connectivity with occipital and cingulate regions. All findings were thresholded at voxel-level p < 0.001 and cluster-level p-FDR < 0.05.

These preliminary results highlight how acute cold stimulation modulates (1,2) functional connectivity between key brain regions involved in pain processing, including thalamic, salience, sensorimotor, and brainstem networks. The observed alterations, particularly in thalamocortical and salience-related connectivity, may reflect underlying mechanisms of central sensitization and nociplastic pain in patients with KOA. We are continuing to recruit additional participants to further validate and expand upon these findings.
Mahnaz TAJIK (Hamilton, Canada), Bhanu SHARMA, Dinesh KUMBHARE, Michael D NOSEWORTHY
13:30 - 15:00 #47334 - PG566 Volumetric Study of Substantia Nigra on 3T MRI across different Movement Disorders.
PG566 Volumetric Study of Substantia Nigra on 3T MRI across different Movement Disorders.

Recent advances in magnetic resonance imaging (MRI) techniques have improved the evaluation of the substantia nigra (SN), a millimeter-sized structure in the midbrain that plays a fundamental role in modulating movement and reward functions¹. MRI studies have shown that, in patients with movement disorders, SN degeneration is characterized by loss of T2 hyperintensity signal, particularly in the dorsal region known as the nigrosome 1, also referred to as the “swallow tail sign”². This study aims to assess SN volume on Susceptibility Weighted Imaging (SWI) in healthy controls (HC) and in patients with normal pressure hydrocephalus (NPH), Parkinson's disease (PD), adult-onset Huntington's disease (HD), and juvenile-onset Huntington's disease (jHD).

SWI allows visualization of magnetic susceptibility changes due to iron accumulation following SN degeneration³ (Figure 1). The MRI protocol used in this study was acquired on a hybrid 3T PET-MRI scanner (Biograph mMR, Siemens Healthineers, Forchheim, Germany), including an SWI sequence targeting the mesencephalic region, optimally angled for better visualization of the SN (voxel size of 0.7x0.7x1.2 mm, TR (repetition time) = 29 ms, and TE (echo time) = 18 ms. Manual segmentation was performed using MRIcron software to obtain two volumes of interest (VOI), one for right SN(Figure 2). To limit the influence of individual head size and presence of artifacts, the three most representative slices were segmented for each subject. The analysis included 5 patients with normal pressure hydrocephalus (NPH), 7 patients with Parkinson's disease (PD), 6 patients with Huntington's disease (HD), 3 with juvenile Huntington's disease (jHD), and 10 healthy controls (HC).

The collected data showed the following average volumes and standard deviations for each volume: HC = 0.41 ±0.059 cm³; NPH = 0.35 ±0.068 cm³; PD = 0.34 ±0.066 cm³; HD = 0.33 ±0.059 cm³; jHD = 0.23 ±0.059 cm³ (Figure 4). The analysis indicates that the VOIs are larger in the HC compared to the other groups, with a particularly noticeable gap when comparing to patients with jHD. In PD, the VOIs are lower than those in the HD, NPH, and HC groups; however, these differences are not statistically significant. To assess statistical significance, a two-sample t-test was conducted with a threshold p-value<0.05. In table shown in Figure 5, the statistically significant values are highlighted in yellow. The following observations were made regarding the differences between right and left VOIs: between HC and PD, only the left VOI and total VOI show a significant difference; between HC and HD (both adult and juvenile), all differences in VOIs are significant; between HC and NPH, there are no significant differences; between PD and HD, all VOI differences are significant, while there are no significant differences between PD and NPH; between HD and jHD, only the right VOI and total VOI are significantly different, while the left VOI does not show a significant difference; and between jHD and NPH, all VOI differences are significant.

Various studies confirm primary damage to the substantia nigra in Parkinson's disease, characterized by the death of dopaminergic neurons, which leads to iron release and perpetuates the damage⁴. This results in movement disorders that can initially be treated with pharmacological therapies⁵, but ultimately compromise the patient’s quality of life. However, Parkinson's disease is not the only condition associated with movement disorders. In normal pressure hydrocephalus, these disorders are not due to primary alterations in the substantia nigra but rather to a down-regulation of dopaminergic transmitters⁶. In Huntington's disease, particularly in juvenile-onset cases, more pronounced parkinsonian symptoms are observed.

Overall, this study highlighted that the disorders causing primary involvement of the substantia nigra exhibited reduced volumes compared to healthy subjects. Patients with NPH showed volumes not significantly different from those in the PD and HD groups or healthy controls, likely because the mechanism in normal pressure hydrocephalus does not induce neuronal loss. The jHD group showed a marked volumetric reduction of the substantia nigra compared to all other groups, indicating significant involvement of this structure in the disease's pathogenesis. The results support the validity of assessing the volumetric alterations of the substantia nigra using SWI sequences, allowing for a more accurate characterization of various movement disorders. However, the study has some limitations, including the difference in age across groups and the limited sample size (both determined by the rarity of certain conditions and their clinical definition in terms of disease onset). It would be interesting to expand the case series by including additional disorders that cause movement disturbances and to evaluate the potential effects of therapies on the SN.
Ilaria CHIMENTO (Catanzaro, Italy), Mariaeugenia CALIGIURI, Emanuele TINELLI, Andrea QUATTRONE, Ferdinando SQUITIERI, Aldo QUATTRONE, Umberto SABATINI
13:30 - 15:00 #48020 - PG567 Definition of a Nigrosome-1 template for characterization of Parkinson’s disease at 3T.
PG567 Definition of a Nigrosome-1 template for characterization of Parkinson’s disease at 3T.

Parkinson’s disease (PD) is characterized by degeneration of dopaminergic neurons in the substantia nigra pars compacta (SNc). Within SNc, Nigrosome-1 (N1) is the first and most severely affected region in PD, with up to 98% of neuromelanin-rich dopaminergic neurons lost by time of diagnosis. In healthy brains, N1 appears as a hyperintense region surrounded by hypointense areas. This visual pattern is often described as the “swallow-tail” sign and can be identified in the dorsolateral aspect of the SN. In PD, this sign tends to be altered as N1 degenerates, making it a potential imaging biomarker for early diagnosis. However, identifying N1 on MRI, especially at fields lower than 7T, presents several technical and anatomical challenges that can affect diagnostic accuracy: a) small size and deep location in the brain, b) irregular, often asymmetric shape, c) loss of contrast due to artifacts or pathology. In this work, we exploited optimized N1 identification on susceptibility-weighted imaging (SWI) and registration between different acquisitions schemes to derive a N1 probability map to characterize susceptibility properties of the N1 region, and assess correlates of iron accumulation also in scans where the structure is not visible.

Forty-three patients with PD and 35 healthy controls (HC) underwent 3T brain MRI (Biograph mMR, Siemens Healthcare, Forchheim, Germany) using a 16-channel PET-transparent head/neck coil. The protocol comprised i) Three-dimensional T1-weighted magnetization-prepared rapid acquisition gradient-echo sequence (MPRAGE, 176 slices, 256×247mm2 field of view, voxel-size 1×1×1mm3, TR/TE/TI=2300/2.34/900 ms, flip-angle 8°, TA=5′12″); ii) susceptibility-weighted imaging (SWI, 56 transverse planes centered on the midbrain, voxel size 0.7×0.7×1.2mm3, TR=50 ms, 5 TEs=5.88/13.62/21.62/29.62/37.96 ms, 220x213 mm2 FOV, TA=6:23); iii) a second SWI acquisition to optimize N1 visualization using TR=29 ms, TE=18ms and same voxel-size and FOV. Manual segmentations of visible N1 were performed for all HC and 37 PD patients (26 unilateral, 11 bilateral) by two expert raters and a consensus mask was created. QSM data was processed as previously described (1). Both SWI and QSM scans of each subject were non-linearly registered to corresponding T1 scan, in turn coregistered to a symmetric study-specific atlas. All N1 manual segmentations were subsequently aligned onto the atlas, thus allowing creation of a symmetric N1 probability map. Regional χ values were extracted from N1: a) using the manually segmented masks of each individual subject, i.e., only were N1 was visible on SWI; and b) coregistering the N1 probability map in each subject’s space, thus extracting one value per structure independent of its visibility on SWI.

Coregistration of HC manual segmentations in a common space allowed for the creation of a probability map of a voxel belonging to the nigrosome region. Automatic and manual segmentations were highly in agreement in terms of location of the volume. Volumes on SWI scans and χ values from the QSM maps were automatically extracted using fslutils and compared between groups (Figure 1). In figure 2, we separate visible and non-visible nigrosome category, observing that results were highly comparable to manual segmentation for what concerns visible N1s. Moreover, the use of the atlas allowed us to extract χ values from regions were N1 is knowingly damaged, confirming higher QSM values than both visible HC and visible PD, suggesting greater iron accumulation and thus significant structural degradation.

Quantitatively characterizing N1 in PD and its mimics is of crucial relevance, especially in the early stages of the disease. Thanks to our efforts in optimizing the alingment between structural, susceptibility-weighted, and manually segmented images allowed us to extracting one value per structure, independent of its visibility on SWI. This has several potential application and development, such as it’s use to evaluate subjects with high-risk of PD or parkinsonian syndromes.
Angelina CATRAMBONE (Catanzaro, Italy, Italy), Ilaria CHIMENTO, Maria Celeste BONACCI, Emma BIONDETTI, Iolanda BUONOCORE, Umbero SABATINI, Aldo QUATTRONE, Andrea QUATTRONE, Maria Eugenia CALIGIURI
Poster hall
13:45

"Saturday 11 October"

Added to your list of favorites
Deleted from your list of favorites
A34
13:45 - 14:45

FT1 Oral - New MRI acquisition technology

Chairpersons: Caroline LE STER (Chairperson, Saclay, France), Maxim ZAITSEV (Chairperson, Freiburg, Germany)
13:45 - 13:55 #47634 - PG043 In vivo R2* and Quantitative Susceptibility Mapping on the 11.7T whole-body Iseult MRI System using Universal Pulses Transmission and Virtual Coil Reconstruction.
PG043 In vivo R2* and Quantitative Susceptibility Mapping on the 11.7T whole-body Iseult MRI System using Universal Pulses Transmission and Virtual Coil Reconstruction.

QSM at ultra-high field presents strong benefits due to an enhancement of the susceptibility effect [1]. However, B0 and B1+ field inhomogeneities make full exploitation difficult. Here we present the first in vivo R2* and magnetic susceptibility (QSM) maps obtained on a cohort of healthy subjects (PREMS cohort) acquired with the whole-body 11.7T Iseult magnet using universal pulses (UP) [2] and a virtual coil approach for coil combination [3]. Normative values of R2* and susceptibility (QSM) were derived in the basal ganglia using a combined manual and deep learning approach for tissue segmentation.

The in vivo protocol was approved by the national ethics committee and regulatory authorities (ANSM). Images were acquired in parallel transmission (pTx) mode using the UP for flip angle homogenization on nine healthy volunteers (mean age was 22.3 +/- 6.5 years old, 7 women /2 men) with no known neurological diseases. Data were acquired using the 11.7T Magnetom Iseult MRI with Siemens Healthineers VE12U software. A custom 8/32-channel pTx head coil was used for signal emission and reception [4]. Images were acquired using a whole-brain 3D Multi Echo Gradient Echo sequence with an isotropic resolution of 0.8 mm. Parameters were: FOV= 220x220x179 mm3, matrix size= 276x276x224, TR = 25 ms, TEs ranging from 3.50 to 17.36 ms with a ΔTE of 4.62 ms (4 echoes acquired), readout bandwidth = 430 Hz/pix. Flip angle was 10° and only one average was acquired. A 2x2 GRAPPA scheme and elliptical sampling were used to speed up the acquisition, leading to a scan time of 5 minutes 14 s. Raw data was saved for further processing. Magnitude and Phase images were generated offline, and coil combination was performed using a Virtual Coil approach using Matlab. Images of multiple echoes were combined using a root mean square along time dimension, thus providing both high SNR and T2*-contrasted images. Brain mask was obtained using “bet” (FSL). Transversal relaxation rate (R2*) was evaluated using a nonlinear fitting method in Matlab. Quantitative Susceptibility Mapping (QSM) images were reconstructed using several functions from the MEDI Toolbox [5-6] for both background field removal and dipole inversion, using respectively Laplacian Boundary Value (LBV) and a GPU modified L1-MEDI. Three templates of Magnitude, R2* and QSM were generated using Ants multivariate [7]. Regions of Interest (ROIs) were defined on the magnitude template using a deep learning model trained on synthetic data [8]. ROIs were then manually edited using 3D Slicer. Finally, ROI were back-projected to the subject space to provide subject-specific ROIs.

Figure 1 presents the images obtained in one of the volunteers using the proposed framework for anatomical T2*w, fitted phase image, miP-SWI, R2* and quantitative susceptibility maps. Virtual coil combination provided naturally unbiased and usable magnitude images (no normalization used). Moreover, no clear evidence of abnormal signal inhomogeneity due to bad RF shimming or coil combination were identified on these images. Figure 2 presents the defined ROIs overprinted on the magnitude template, as well as the R2* and QSM templates. R2* and susceptibility values are reported in Table 1 (Image 3) for Caudate Nuclei, Putamen, Globus Pallidus, Red Nuclei and Substantia Nigra. Interestingly, several phase singularities were detected in phase images before coil combination but did not interfere on the final computed susceptibility maps (not shown).

We report in this work the first R2* and susceptibility maps obtained at 11.7T on healthy subjects at 800 μm isotropic spatial resolution obtained in roughly 5 minutes. Universal pulses and virtual coil combination allowed to provide in vivo R2* and susceptibility maps without severe RF field inhomogeneity artefacts. The obtained R2* at 11.7T in basal ganglia subregions was approximately 2 times superior to the values reported in the literature at 3T [9]. Surprisingly the R2* values were two times lower than expected [10].

We now intend to compare the values obtained in the basal ganglia at 11.7T to those obtained at 3 and 7T using an age-matched cohort. We will also refine the MR acquisition protocol at 11.7T to enhance the image resolution to detect small details and that might not be visible at conventional field strength in vivo.
Mathieu SANTIN (Paris), Mélanie DIDIER, Franck MAUCONDUIT, Aurélien MASSIRE, Caroline LE STER, Romain VALABREGUE, Vincent GRAS, Michel LUONG, Alexis AMADON, Michel BOTTLAENDER, Nicolas BOULANT, Alexandre VIGNAUD
13:55 - 14:05 #46603 - PG044 Direct MRI of hard tissue in teeth.
PG044 Direct MRI of hard tissue in teeth.

Dental caries, the deterioration of the hard tissues (dental and enamel) in teeth, is the most pervasive noncommunicable disease and is a significant public health issue[1]. The growing interest in MRI as an ionizing radiation-free modality may serve as an alternative for x-ray imaging in dentistry[2]. Short-T2 methods have already been implemented to image the teeth, conveying bound water in enamel and dentin, which exhibits T2s on the order of 100s of µs[3-10]. However, MR signals of collagen (in dentin) and hydroxyapatite (in both dentin and enamel) have T2s on the order of 10µs[5, 6] and are yet to be imaged directly. Here, we report the use of custom short-T2 methodology and hardware[11, 12] to directly image and study the ultra-short T2 components in teeth. The free induction decay (FID) signal of a healthy human tooth specimen is analyzed. The same specimen, as well as a tooth with a dental filling, are subsequently imaged using a multi-echo acquisition to observe the signal behavior of hard tissues. Image subtraction between early echo times (TEs) is performed to isolate the shortest-living components. Finally, the approach is applied in vivo.

Two human teeth specimens were acquired from a local dentist and stored in a dry environment at room temperature prior to scanning. One specimen has no apparent pathologies or fillings and is considered a healthy tooth. The other tooth has a dental filling made of a resin composite. A high-performance insert gradient, with a strength up to 220mT/m at full duty cycle[13], and fast transmit/receive (T/R) switches[14] were deployed on a 3T Philips Achieva system. Tooth specimens were imaged using a 40mm diameter, proton-free T/R loop coil. In vivo imaging was performed using a proton-free T/R quadrature birdcage coil[15]. An FID of the healthy tooth was acquired to observe and characterize the signal behavior. Specimens and the in vivo case were imaged using the short-T2 PETRA pulse sequence[16]. For the specimens, a multi-TE protocol was used to capture the signal decay of the teeth with spatial localization. TE for PETRA is defined as TE = DT + 1/(2BW), with DT and BW being the dead time and imaging bandwidth, respectively[17]. To keep the central k-space gap constant, for increasing TE, BW is reduced and thus encoding time increases. Acquisition parameters are listed in Table 1.

Figure 1 conveys the FID for the healthy tooth specimen, where a rapidly decaying component with a T2* on the order of 10µs is observed. A dipolar oscillation is observed at 45µs, consistent with previous observations of collagen-rich specimens[11]. The slower decay of bound water dominates after the oscillation. Figure 2A presents in vitro images of both tooth specimens for selected TEs as well as the difference image between TE = 10.9µs and TE = 25.0µs. All images show high signal intensity, but considerable T2-blurring is observed except for TE = 25.0µs. This effect stems from significant signal decay over the encoding time: first the ultra-fast decay of hard tissue at TE = 10.9µs and then the decay of bound water at TE = 105.4µs. The difference images show the ultra-short T2 components, but there is little contrast between structures such as enamel and dentin. The dental filling decays rapidly and is no longer observable by TE = 105.4µs, indicating that its chief component is the short-lived signal. The pulp cavity does not clearly exhibit longer-lived components and is thus hypothesized to have dried out in the storage process. Figure 2B represents the intensity acquired from ROIs drawn on enamel, dentin, and dental filling as a function of TE for the tooth specimen with filling. All regions present an ultra-fast decaying component, with a notably higher contribution in dentin. Dipolar oscillations are observed in both the dentin and enamel regions, with a higher prominence in dentin. Apart from tissue structure, these differences are likely affected by partial volume effects and varied T2-blurring behavior on the edges. Thereafter (>50µs), dentin and enamel decay apparently monoexponentially. The dental filling shows a slowly decaying component with a low signal contribution. Figure 3 shows in vivo MRI of the teeth for two TEs as well as the accompanying difference image. Long-living, water- and fat-based signal components have been suppressed by the subtraction, leaving only the hard tissues in the teeth.

This work presented the analysis of ultra-fast decaying MR signals in human teeth. Through both FIDs and multi-echo acquisitions with appropriate short-T2 hardware, hard tissues which decay on the order of 10µs were successfully identified and directly imaged. However, spatial resolution is limited by an encoding time still too long with respect to the signal decay. Resolution improvements are expected from further optimization on both the acquisition and processing side.

Direct MRI of the hard tissues of teeth is possible and introduces avenues for numerous applications to explore.
Jason Daniel VAN SCHOOR (Zurich, Switzerland), Markus WEIGER, Emily Louise BAADSVIK, Klaas Paul PRÜSSMANN
14:05 - 14:15 #47026 - PG045 Frequency-dependent diffusion-relaxation correlation MRI: in vivo 2D multi-slice and ex vivo 3D sparsely-sampled acquisitions.
PG045 Frequency-dependent diffusion-relaxation correlation MRI: in vivo 2D multi-slice and ex vivo 3D sparsely-sampled acquisitions.

Diffusion MRI indirectly depicts the tissue’s microstructure at a few micrometers scale and characterizes it with quantitative metrics such as fractional anisotropy, mean diffusivity, or mean diffusion direction. However, its limited spatial resolution, coarser by 1 to 3 orders of magnitude than the diffusion extent, leads to voxel-averaged parameters and ambiguities in their interpretations. This length scale gap can be bridged using a diffusion tensor distribution (DTD) to describe the heterogeneity of the microstructure at a sub-voxel level[1]. Tensor-valued diffusion encoding eases the DTD determination by separating the isotropic and anisotropic contributions of the observed diffusivities[2]. Frequency-dependent diffusion encoding can also be added to the tensor-valued diffusion encoding to separate the restriction effects and account for the intrinsic frequency dispersion of the gradient waveforms[3,4]. The DTD can be correlated to the T1 and T2 relaxation times by using a variable TR and TE acquisition[5]. However, the concomitant sampling of all these parameters requires the acquisition of long series of one to several hundred contrasts, requiring single or few-shot EPI acquisitions to perform in vivo 2D or ex vivo 3D high-resolution imaging. Here, we intend to exemplify the possibilities offered by frequency-dependent diffusion-relaxation correlation to provide a specific description of the tissue microstructure of in vivo[6] and ex vivo brain at a sub-voxel level, allowing MRI to challenge histology. We also intend to present various strategies for multi-slices and sparsely sampled acquisitions of such a massively multidimensional dataset.

Frequency-dependent diffusion-relaxation correlation datasets were acquired in vivo on rat brains at 7 T and ex vivo on mouse and pig brains at 11.7 and 4.7 T, respectively. Fig. 1a presents the SE-EPI sequence customized with tensor-valued diffusion encoding and variable echo and repetition times. Gradient waveforms for different encoding anisotropies (bΔ = -0.5, 0, and 1) and increasing modulation orders 0, 1, and 2 associated with their diffusion spectra are presented in Fig. 1b. The use of 0 and 1st order waveforms allows designing an acquisition protocol of 389 images leading to an acquisition duration of 17 minutes shown in Fig 1c compatible with in vivo conditions. Even with a gradient strength of 760 mT/m, diffusion frequencies can reach 100 Hz for b-values up to 2.1 ms/µm2 with the use of 1st order modulated gradient waveforms. The 10 and 90 percentiles of the frequency range achieved in vivo correspond to 18 and 92 Hz and are presented in Fig. 1d.

Fig. 2 illustrates the diversity and the high quality of the quantitative parameter maps acquired with the Fig. 1 protocol on an in vivo rat brain at 7 T. The acquisition time was 1 hour and 10 minutes due to the use of two segments and reversed blip acquisitions, allowing top-up correction of B0 inhomogeneity artefacts. Diffusion frequency dependence is especially prominent in the cerebellum and olfactory bulb gray matter. Fig. 3 shows a slice of an ex vivo mouse brain acquired at 11.7 T in 3D at 150 µm isotropic resolution. To decrease acquisition time, the dataset was undersampled from 100 to 12.5 % retrospectively to test the efficiency and accuracy of a locally low rank reconstruction performed with BART. Fig. 4 compares various acceleration factors on 3D phase-encoded SE-EPI image series by using kY, kZ sampling along the echo train on a pig brain and regularization in the spatial and contrast dimensions.

Frequency-dependent diffusion-relaxation correlation can be performed in vivo on rat brains and leads to a large diversity of parameter maps enhanced by the possibility to bin the solution space and discriminate intra-voxel component specific to white matter, gray matter, and cerebrospinal fluid, even in heterogeneous voxels[6]. Ex vivo, acquisition times of 10 to 20 hours are extended to get isotropic high-resolution phase-encoded 3D images. Still, the use of SE-EPI remains mandatory to acquire a series of a few hundred images required by frequency-dependent diffusion-relaxation correlation. A factor of 8 in acceleration is possible even with a single-channel volume coil. The quantitative parameter maps are well preserved at such acceleration, even if the decrease in SNR hampers the quality of the parameter maps with the lowest dynamic range, such as the Δω/2πE[Diso] map. Such high acceleration factors can be used for reducing the echo train length, increasing acquisition bandwidth, and thus decreasing T2* broadening and B0 inhomogeneity artefacts in sparse-sampled SE-EPI images.

Frequency-dependent diffusion-relaxation correlation increases MRI specificity by quantifying and correlating parameters at a sub-voxel level, allowing MRI to compete with histology. We believe that fast acquisitions allowed by EPI sequences and sparse acquisitions can be the key to broadening its applications and usability.
Maxime YON (Rennes), Omar NARVAEZ, Pierre-Antoine ELIAT, Alejandra SIERRA, Daniel TOPGAARD
14:15 - 14:25 #47921 - PG046 Agentic MR sequence development - Leveraging LLMs with MR tools and tests for physics-informed sequence development.
PG046 Agentic MR sequence development - Leveraging LLMs with MR tools and tests for physics-informed sequence development.

Magnetic Resonance Imaging (MRI) requires precise timing of radiofrequency pulses and magnetic field gradients. Traditional sequence development demands both physics expertise and programming skills, creating bottlenecks in MRI research. While Large Language Models (LLMs) can generate code, MRI's physical and hardware constraints present unique challenges, as demonstrated in our previous work [1]. Small errors in timing, gradients, or RF pulses can cause contrast issues, artifacts, or signal loss, making simple code generation inadequate for reliable sequences. We present an agentic workflow combining LLMs with MR-specific tools and tests. Similar to test-driven development, this system enables physics-informed sequence generation and validation using the `pypulseq` library, iteratively refining sequences until they meet all requirements.

Our agentic system (Figure 1) combines LLMs with MR physics knowledge and `pypulseq` (v1.4.2) expertise. The system uses a feedback loop with four key validation tools: 1. Code Execution: Catches syntax errors and hardware violations 2. Timing Analysis: Verifies hardware raster times and sequence parameters 3. k-space Analysis: Validates trajectory coverage and gradient moments 4. Image Simulation: Detects subtle artifacts and contrast issues The agent iteratively generates and refines code until meeting validation criteria, implemented in "Cursor AI". We evaluated the system using a standardized task: implementing a spin echo EPI sequence with 100ms TE. The goal was generating an artifact-free `.seq` file across different base LLMs. To evaluate the agentic workflow, we tested the task "Please, first read the LLM4MR instructions. Now, please code a spin echo EPI with a TE of 100 ms. Finish only when you are 100% sure it is properly implemented. Use the terminal to test the codes. Use all tools to validate the sequence." We measured success by counting user interactions needed to achieve a satisfactory sequence. Each interaction represents a hint or instruction for code modification. The ideal case requires only the initial task prompt.

While we must admit that this agent and the abstract was created very shortly before the ESMRMB deadline, we were quite surprised about the poor results of the agentic MR assistant, as shown by the results in Figure 2. Especially in the context of a much simpler setup tested recently (see https://www.mr-physik.med.fau.de/2025/03/03/mr-physicists-last-exam-llm4mr/), in which the LLMs were at least successful for some trials, without any additional tools. We still think it is interesting to share with the community that the additional tools seem to have confused the LLMs, and often lead to endless thoughts about errors reported by our timing or k-space trajectory tests. Thus we conclude that such a setup requires further refinement, which we will test until October. Coding errors were definitely solved always automatically, but sequence programming often got stuck when e.g. k-space sampling was off, see one intermediate outcome that it could never fix shown in Figure 3, even with all tools and tests.

Our presented agentic workflow, integrating an LLM with `pypulseq` and a suite of MR-specific analysis and simulation tools, was thought to be a viable path towards robust, physics-informed sequence generation. The iterative loop, leveraging feedback from k-space analysis, timing checks, sequence reports, and crucially, MR simulation, was thought to allow the agent to identify and correct errors that would render a sequence unusable. However, it turned out the tools helped eliminating coding errors, but otherwise lowered the performance of the pure LLMs strongly, which has still to be investigated in more detail. Better explanation for the LLM how to use the tools and to interpret errors, or using MPC connection and multiple agents might improve the performance.

We think agentic sequence development is the way to go and we have a promising toolbox and testbox, yet we could not yet get it to run properly and will be happy to report about our fails and progress at the meeting.
Moritz ZAISS (Erlangen, Germany), Jonathan ENDRES, Simon WEINMÜLLER
14:25 - 14:35 #47738 - PG047 Is PCASL suitable for assessment of myocardial perfusion?
PG047 Is PCASL suitable for assessment of myocardial perfusion?

The evaluation of regional blood flow in the heart muscle is important for clinical diagnosis of cardiac diseases. Various arterial spin labeling (ASL) techniques (pulsed ASL, velocity-selective ASL) have been used for non-invasive quantitative evaluation of myocardial perfusion [1-3]. We recently demonstrated that pseudo-continuous arterial spin labeling (PCASL) provides high quality perfusion images of the lungs [4]. In this work, we present the first results of PCASL imaging to measure myocardial perfusion using different labeling strategies.

Measurements were performed on a 1.5 T MR scanner (MAGNETOM Aera, Siemens Healthineers AG, Forchheim) using a PCASL sequence with ECG-triggered labeling pulses and a bSSFP readout. The labeling plane was placed nearly perpendicular to the left ventricular output tract (LVOT) and the labeling pulse was triggered by the scanner’s ECG device (Figure 1). Different labeling durations (LDs, 300-1200 ms) were used and the bSSFP readout was performed in diastole by using suitable post labeling delays (PLDs, 300-600 ms). Images of the short cardiac axis and of the LVOT were acquired. Each measurement, consisting of 16 label/control image pairs and a proton density weighted image, was performed with a repetition delay of ≥ 5 s under synchronized breathing conditions. Depending on the PLD and cardiac cycle, the measurement time was around 3-4 min. PCASL images were registered non-rigidly using an optical flow-based image registration approach [5]. Other sequence parameters were: TR of 2.3 ms, TE of 0.9 ms, 70° flip angle, 8 mm slice thickness, 2.5×2.5 mm2 pixel size, 128×96 matrix, 930 Hz/pixel bandwidth, 160 ms acquisition duration.

In Fig. 2, PCASL images of LVOT of a healthy subject are shown obtained with an LD of 300 ms and a PLD of 300 ms. The large difference in blood signal in the ascending aorta between control and labeling images indicates that the magnetization of the blood flowing through the LVOT is effectively inverted by the labeling pulse. A corresponding color-coded perfusion-weighted image is shown in Fig. 3 on the left. Due to the short LD and PLD, a “bolus” of labeled blood is generated in ascending aorta. In contrast, only a low perfusion signal (PWS) is observed in the myocardium, as the labeled blood has not yet been able to reach the heart muscle within a short PLD of 300 ms. With a longer LD of 1200 ms (covering two systoles), a relatively higher perfusion signal could be measured in myocardium, as more labeled blood reaches the heart muscle (Fig. 3, right). Fig. 4 shows a color-coded PCASL perfusion-weighted image of the heart short axis. A small but distinct difference between control and labeling signal values can be seen (Fig. 4, right).

About 5% of the cardiac output flows through the heart muscle. However, complex blood flow pathways, high pulsatility of flow as well as respiratory and cardiac movements make ASL measurements of myocardial perfusion a very demanding task. Our preliminary results show that the ECG-triggered PCASL bSSFP approach can effectively label the blood flow in the ascending aorta. We further found that longer LD is required to improve the measurement of myocardial perfusion.

PCASL bSSFP imaging of myocardial perfusion is feasible but further systematic measurements are needed to increase myocardial perfusion signal.
Petros MARTIROSIAN (Tübingen, Germany), Anja HANSER, Rolf POHMANN, Martin SCHWARTZ, Cecilia LIANG, Thomas KÜSTNER, Fritz SCHICK
14:35 - 14:45 #46517 - PG048 Proof of concept study for Deuterium Metabolic Imaging (DMI) in human breast.
PG048 Proof of concept study for Deuterium Metabolic Imaging (DMI) in human breast.

Breast cancer is the most common cancer in women and new therapeutic options require early and specific evaluation of treatment response. However, specific non-invasive imaging is still limited or technically demanding, preventing further implementation in the clinical domain. Deuterium metabolic imaging (DMI) is a new metabolic imaging technique where 2H MRSI is combined with the administration of 2H labeled substrates, that could potentially close this gap [1, 2]. In breast cancer, 2H MRS has been used to study [2H9]choline metabolism in an animal model and tumor cell death using [2,3-2H2]fumarate; but DMI has never been applied to the human breast to date to the best of our knowledge [3, 4].

Hardware: Experiments were performed at 7 T (Philips, Best, The Netherlands) using a double-tuned 2H/31P whole-body birdcage coil for 2H transmit integrated behind the bore of the MR system [5] and a single-tuned 2H loop coil for 2H receive tuned to 45.7 MHz. Two proton dipole antennas were used for transmit/receive for 1H MRI and B0/B1 shimming. Subjects were scanned in prone position (Fig. 1). Phantom/healthy subjects: A flask containing mostly water and a small fat phase of rice oil in an inner sphere served as phantom. In vivo measurements were performed on two healthy volunteers (26 and 36 years), one was only scanned at 2H natural abundance (NA), one was scanned at NA and after drinking of 0.75 g/kg body weight [6,6-2H2]glucose (Glc; Buchem, Apeldoorn, The Netherlands) after an overnight fast whereby two 2H MRSI scans were started 60 and 81 min after drinking. Measurements were approved by the local ethics committee and written informed consent was obtained. 1H MRI and DMI acquisitions: At first, B1 and 2nd order B0 shimming were performed with volumes of interests covering a small central portion of the breast and the entire breast. Axial and coronal T1-weighted anatomical reference images were obtained using 2D multi-slice gradient echo sequences matching the field-of-view and the number of slices of the 2H MRSI scan. Axial 2-point Dixon-type sequences were obtained. 2H MRSI were acquired using a 3D FID-MRSI sequence employing Hamming-weighted k-space sampling (TR/TE 100/1.37 ms, nominal flip angle 40°, NSA 20, FOV RLxAPxFH 420x220x340 mm³, nominal voxel size 20x20x20 mm³, spectral bandwidth 2750 Hz, spectral points 256, scan duration 21:01 min). 2H MRSI data were reconstructed by Fourier-transformation in the spatial and spectral domains with in-house written scripts in MATLAB R2020b (TheMathWorks, Natick, MA, USA).

Phantom measurements demonstrated the detectability of 2H water signal from NA (HDO), set to 4.7 ppm. In voxels containing water and rice oil, also small lipid signals (1.0-1.3 ppm) could be detected. In vivo 3D 2H MRSI measurements in healthy volunteers of the right breast showed different HDO/lipid signal ratios, depending on the voxel composition of fat and glandular breast tissue (Fig. 2). After oral administration of [6,6-2H2]Glc, a new signal (upfield shoulder peak) was detected in the right breast after 60 min at 3.8 ppm, corresponding to an overlapping Glc signal (Fig. 3). In Fig. 4 A/B, the 2H spectra of a breast voxel before and 60 min after Glc administration were superimposed and the difference spectrum calculated, with evidence of the resulting Glc signal. The increase in the lipid signal is most likely due to subtraction artifacts, since the Glc was administered after the NA scan outside the scanner. Fig. 4 C/D shows 2H spectra of the same voxel 60 and 81 min after Glc showing a further increase of Glc, an increase in HDO, and no signal detectable at the lipid position.

As previously in DMI studies in the brain or liver [1, 5], we were able to detect an HDO signal of 2H NA also in the breast. Furthermore, after oral ingestion of Glc, a corresponding Glc signal was detectable, overlapping with the HDO signal, demonstrating detectable Glc metabolism, consistent with results from 18FDG-PET [6]. Based on the SNR of the Glc in the breast, the pectoral or heart muscle and the relative spatial distances between them, the Glc breast signal cannot be explained by overlapping point-spread functions of signals from those tissues associated with low resolution MRSI. In contrast to previous DMI applications, in the breast, the 2H NA lipid signal is detectable in the organ of interest and not only in adjacent tissues. Due to the location of the lipid signal, this will particularly complicate the detection of lactate. However, without repositioning between the two 2H MRSI scans after Glc administration, we were unable to detect any subtraction artifact of the lipid signal. Thus, lactate detection could be feasible. A possible glutamate/glutamine Glx signal presumably overlaps with the left shoulder of the lipid signal.

Our results demonstrate the technical feasibility of DMI in the human breast as a starting point for initial measurements in patients with cancer, but requires further validation.
Claudius S. MATHY (Erlangen, Germany), Luka STAM, Mark GOSSELINK, Sonja VLIEK, Dimitri WELTING, Cezar ALBORAHAL, Michael UDER, Tobias BÄUERLE, Armin M. NAGEL, Jannie P. WIJNEN, Dennis W.j. KLOMP
Auditorium 900

"Saturday 11 October"

Added to your list of favorites
Deleted from your list of favorites
C34
13:45 - 14:45

FT2 Oral - Imaging advances
For clinical solutions throughout the body

Chairpersons: David BENDAHAN (CNRS Research Director) (Chairperson, MARSEILLE, France), Emeline RIBOT (PI) (Chairperson, Bordeaux, France)
ET2: Cycle of Clinical Practice
13:45 - 13:55 #45789 - PG049 Investigating the microscopic diffusion MRI properties of prostate tissue using MR microscopy.
PG049 Investigating the microscopic diffusion MRI properties of prostate tissue using MR microscopy.

Diffusion MRI (dMRI) plays a key role in the diagnosis of prostate cancer[1]. Current research is focused on quantitative dMRI techniques that use mathematical signal models to measure the diffusion properties of prostate tissue[2]. The measurements obtained through these techniques could act as quantitative biomarkers for prostate cancer. However, the relationship between the diffusion properties and histological features of prostate tissue is currently speculative and requires empirical validation. The key components of prostate tissue are epithelium, stroma, and lumen (ESL). Prostate cancer is associated with the proliferation of epithelial cells, with invasive growth into luminal space and stroma[3]. An improved understanding of the diffusion properties of each tissue component could help to improve the specificity of quantitative dMRI measurements to cancer. Previous studies have used optical microscopy of tissue samples to correlate dMRI measures with histological features[4–6]. However, this approach is constrained to two-dimensional analysis and is limited by image registration challenges[7]. Microscopic resolution MRI (MR microscopy) could alleviate these challenges, as it enables the structures of a prostate tissue sample to be resolved in 3D, in exact spatial alignment with the diffusion images used for modelling[8–10]. We aim to use MR microscopy to distinguish the ESL components of prostate tissue samples and study the diffusion properties of each component.

Nine samples of prostate tissue (~3mm diam. 4mm length) were obtained from prostatectomy surgery of two patients. Samples were fixed in formalin and equilibrated in 0.5ml/L Gadolinium solution. MR imaging was performed using a 16.4T Bruker system. Table 1 displays the sequence parameters for the images acquired of each sample. The DTI and MGE images (20µm and 40µm resolution, respectively) were used for ESL segmentation. Fractional anisotropy (FA) and mean diffusivity (D) maps were calculated for each sample. Regions with high DxFA were classified as stroma[9]. Lumen was classified as regions with MGE signal intensity (avg. over TE) similar to the surrounding medium. All other regions were classified as epithelium, provided the MGE signal intensity was above a minimum threshold. Figure 1 displays example ESL segmentations for two samples. Multi-b-value and multi-∆ dMRI images were acquired at lower resolution (480x480x320µm). For each image, the normalized signal intensity of each voxel was represented as a weighted linear sum of the ESL volume fractions calculated using the high-resolution segmentations. This linear model was optimized for all voxels within the samples; the optimized weights represent the average dMRI signal intensities for the ESL components. This was repeated for all images to obtain ESL dMRI signal measurements at varying b-value and ∆. Uncertainties on each signal measurement were estimated through bootstrapping. Five isotropic models were fit to the signal measurements for the ESL components using a least-squares fitting method (Table 2). Uncertainties in signal measurements were propagated into model parameter uncertainty using the Jacobian of the model fitting function. The Akaike information criterion (AIC) was calculated to compare the relative information content of models.

Epithelial (E) signals were found to be higher than stromal (S) signals (Figure 2), consistent with previous work[9]. For both E and S, higher signals were measured for sequences with long ∆, however this difference is larger for E. The sphere + ball models (4 and 5 param) provide the best fit to the measured signals (lowest AIC values). Within the 4 parameter model, the sphere radius estimates are similar for E and S (approx. 7µm), but a higher sphere volume fraction and lower diffusivity are observed for E (Table 2).

This project presents a novel method for separating dMRI signal contributions from the microscopic components of prostate tissue at varying b-value and ∆. The raised signals measured at longer ∆ reflect physical restriction of water diffusion within the tissue. Models including the ‘sphere’ function[11] depend on ∆ so can describe the measured signals better than the ADC and DKI models. These results could help to refine and regularize models used for in vivo quantitative dMRI (e.g. VERDICT[12], RSI[13], and HM-MRI[14]) and strengthen the link between dMRI measurements and the biological changes associated with cancer; however, the effects of tissue fixation (diffusivity reduction and cell shrinkage) need to be considered. Histological processing of the samples is in progress; this will enable the dMRI properties of E and S at different Gleason grades to be assessed. Further prostatectomy surgeries are scheduled in the coming months, from which more tissue samples will be collected and imaged.

Measured dMRI signals for epithelium and stroma indicate physical restriction of water diffusion and are best described by sphere + ball models.
Adam PHIPPS (London, United Kingdom), Nyoman KURNIAWAN, David ATKINSON, Panagiotaki ELEFTHERIA, Roger BOURNE
13:55 - 14:05 #46940 - PG050 A fast MRI-based HIFU beam refocusing method for optimized acoustic energy deposition in several locations.
PG050 A fast MRI-based HIFU beam refocusing method for optimized acoustic energy deposition in several locations.

Fanny Dabrin1, Stéphane Chemouny2, Pierre Bour 2, Bruno Quesson1 1 Univ. Bordeaux, CNRS, CRMSB, UMR 5536, IHU Liryc, F-33000 Bordeaux, France 2 Certis therapeutics, Pessac, France MRI-guided focused ultrasound (HIFU) is a non-invasive therapy. However, the speed of ultrasound propagation varies depending on the biological tissue (skin, muscle, fat, etc.). This can lead to suboptimal focusing at the target site. The aim of this work is to present an MRI-based calibration method for the correction of these aberrations. Displacement maps calculated from fast MR-ARFI images allow the calculation of amplitude and phase corrections to be applied to each transducer element of the HIFU device. These corrections are used to improve the focusing quality.

The MRI-ARFI sequence [1] is a single-shot echo planar imaging (68x64 matrix, 2.5x2.5x3 mm³ resolution, TE/TR=27/1500 ms, 70° FA, partial Fourier 6/7, 1.5T Avanto fit, Siemens Healthineers, Germany). It integrates a bipolar motion-encoding gradient (5 ms per lobe), the first lobe of which is synchronised with a 5 ms ultrasound pulse. The HIFU device consists of a 32-element transducer (f/D=13/13 cm, 1 MHz operating frequency, Imasonic, France). It is driven by a programmable generator (Image Guided Therapy SA, France). The amplitude and phase are adjustable for each channel. The experiments were carried out on an ex vivo muscle of the sheep. The sample was immersed in degassed water and positioned in front of the transducer. The calibration experiment was based on the Hadamard coding technique [2], in which 128 ultrasound pulses are applied and the resulting tissue displacements are imaged by means of fast MRI ARFI. An inverse method is then used to calculate the amplitude and phase corrections to be applied to each transducer element in order to refocus the HIFU beam at a desired location. This is shown in Figure 1. For this purpose, the displacement values measured in a single pixel for each ultrasound condition during Hadamard encoding are plotted and serve as input values for the calculation of the inverse solution for the calculation of the amplitude and phase corrections. A comparison was made of the displacement values at the target pixel during HIFU sonication, before and after correction.

Figure 2A shows the displacement map for the initial condition (no correction, focal spot positioned 3 cm beyond the imaging slice). From this image, three pixels intercepting the ultrasound beam and separated by 7.5 mm each were selected to refocus the beam at each location from a single Hadamard calibration experiment. HIFU focusing was systematically improved after phase correction (B, C, D), showing a smaller displaced spot compared to the initial experiment (A). The gain in displacement with respect to power was about 50% in all cases (F, G, H vs. E) when only phase corrections were applied, and reached 60% when both amplitude and phase corrections were applied.

The proposed calibration method allows the optimisation of the acoustic energy delivery at the desired location in combination with a fast MR-ARFI sequence in a clinical MRI scanner. By shortening the sequence repetition time (here 1.5 s to maximise SNR and evaluate the refocusing method), the total acquisition time of the calibration experiment (here 9 min 30 s) can be further reduced. The targeting of the focal spot beyond the position of the MR image slice during Hadamard encoding allows the calculation of different corrections in amplitude and phase to improve the focus at multiple locations (here over a distance of 1.5 cm, see Figure 2) from a single calibration experiment.

The proposed method may be valuable for improving the efficiency of MR-HIFU therapies by increasing the local acoustic energy deposition at the desired location. MR-ARFI in combination with Hadamard coding provides a non-invasive method to compute amplitude and phase corrections to be applied to each HIFU transducer element to compensate for propagation aberrations in a biological tissue. Since current clinical applications of MR-HIFU often require treatment of pathological regions larger than the focal spot dimensions, the ability to provide corrections at multiple locations from a single calibration experiment is of key interest. Furthermore, the delivery of excessive acoustic energy in the near-field of the HIFU beam, which can cause unwanted side effects such as skin burns, is avoided by optimising the quality of the focus.
Fanny DABRIN (Bordeaux)
14:05 - 14:15 #46031 - PG051 Intraepineurial fat fraction: A novel MR Neurography-based biomarker in Transthyretin amyloidosis polyneuropathy.
PG051 Intraepineurial fat fraction: A novel MR Neurography-based biomarker in Transthyretin amyloidosis polyneuropathy.

Hereditary transthyretin amyloid polyneuropathy (ATTRv-PN) is a rare, progressive axonal neuropathy, for which early detection is critical. However, standard assessments, including nerve conduction studies, often lack sensitivity for subclinical disease [1]. Quantitative MRI (qMRI) has emerged as a tool to monitor nerve and muscle changes in neuromuscular disorders [2,3], using metrics like fat fraction (FF), volume, and magnetization transfer ratio (MTR). While FF is widely used in muscle imaging, its application to peripheral nerves is rare [4]. Recent histological and biochemical studies revealed lipid droplets within amyloid deposits, especially in the endoneurium, and a key role for lipid–amyloid interactions in fibril aggregation [5,6]. These findings support the hypothesis that intraepineurial fat fraction (ieFF), measured by MR neurography, may reflect both amyloid-related lipid deposition and nerve fiber loss with epineurial remodeling, making it a promising imaging biomarker in ATTRv-PN. In this study, we aimed to determine if ieFF is a relevant and sensitive marker of early nerve damage, compare it to MTR and nerve volume, and evaluate its association with clinical and electrophysiological severity, assessing ieFF in sciatic and tibial nerves using qMRI in ATTRv-PN patients, asymptomatic carriers (ATTRv-C), and healthy controls (HC).

53 TTR mutation carriers (31 ATTRv-PN, 22 ATTRv-C) and 24 controls underwent lower-limb qMRI. Sciatic and tibial nerves were manually segmented (Figure 1), and Dixon based-ieFF, MTR, and volume were extracted. Clinical scores included ONLS, RODS, NIS-LL, MRC; electrophysiology included CMAP, MUNIX, SNAP. Univariate and multivariate models (adjusted for age and BMI) were used to assess the diagnostic and prognostic value of ieFF.

ieFF was significantly increased in ATTRv-PN nerves vs controls: sciatic (32.4% vs 22.3%) and tibial (13.7% vs 9.74%, p < 0.01). ATTRv-C also showed elevated ieFF (p < 0.05), despite normal clinical scores (Figure 2). In multivariate correlation model, ieFF was the only imaging marker independently associated with ONLS, RODS, MRC, and CMAP (Figure 3). In contrast, MTR and volume had no significant correlations with severity. ieFF also correlated with volume and inversely with MTR, reinforcing its biological plausibility. In ATTRv-PN, there was reduced tibial MTR and increased nerve volume, but these changes were not associated with severity. ATTRv-C displayed an intermediate profile: ieFF values close to ATTRv-PN, but normal MTR and volume, distinguishing them from both patients and controls.These findings highlight ieFF as a robust biomarker for diagnosis and monitoring, even in presymptomatic stages.

Intraepineurial fat fraction (ieFF) is a novel and sensitive qMRI biomarker in ATTRv neuropathy. It distinguishes symptomatic patients and asymptomatic carriers from healthy controls and correlates robustly with clinical severity. Unlike MTR and volume imaging markers, ieFF retained independent associations in multivariate analysis and appears to reflect early nerve involvement. Its histological plausibility, non-invasive acquisition, and strong correlations with functional impairment highlight its potential for clinical research. Importantly, ieFF reveals an intermediate imaging profile in ATTRv-C, not captured by MTR or volume metrics, supporting its value in characterizing subclinical stages of the disease.

The present results illustrate the interest of a multimodal qMRI imaging analysis of the whole lower limb in patients with ATTRv polyneuropathy while highlighting ieFF as a new sensitive biomarker. This parameter is able to distinguish ATTRv-PN and ATTRv-C patients from healthy controls and was highly correlated with the main electrophysiological and clinical severity scores. This nerve fat infiltration would likely illustrate the lipid droplets found in endoneurial amyloid deposits and the onset of axonal loss accompanied by a high-fat epineurial connective tissue replacement at a sub-clinical level.
Eva SOLE CRUZ (Marseille), Etienne FORTANIER, Constance P. MICHEL, Emilien DELMONT, Annie VERSCHUEREN, Marc-Adrien HOSTIN, David BENDAHAN
14:15 - 14:25 #47403 - PG052 Multiparametric quantitative MRI with oxygen extraction fraction: Prospective characterisation of soft tissue sarcomas, prediction of radiotherapy response and correlation with multiplex immunofluorescence.
PG052 Multiparametric quantitative MRI with oxygen extraction fraction: Prospective characterisation of soft tissue sarcomas, prediction of radiotherapy response and correlation with multiplex immunofluorescence.

Soft tissue sarcomas (STS) are rare heterogeneous tumors, with few predictive factors of response to neoadjuvant radiotherapy (nRT) despite important variations [1]. Hypoxia is a predictive and prognostic factor in many cancers, but its evaluation by nitroimidazole PET CT remains poorly available. Our interventional trial (NCT05684874) aims to evaluate the feasibility, characterization interest and predictive value of a multiparametric quantitative MRI (mpqMRI) including quantification of relative oxygen extraction fraction (rOEF) without contrast agent injection.

Adult limb and trunk STS patients were prospectively included and performed mpqMRI pre- and post-nRT. Acquisitions were performed on a Siemens MAGNETOM Vida 3T clinical MRI (Siemens Healthineers, Erlangen, Germany). The research protocol duration was 14 min and included 3 sequences. The first one was a chemical-shift encoded 3-dimensional fast low-angle shot multi-echoes gradient-echo sequence (3D FLASH CSE-MRI; n=10 echoes), with an echo spacing of 1.2 ms to properly separate fat and water [2]. It allowed measurement of R2*, magnetic susceptibility and proton density fat fraction (PDFF). R2* was calculated after correction of chemical-shift and B0 macroscopic inhomogeneity. Then a 2-dimensional turbo spin echo multi-echo (TSE) was acquired with 10 echoes ranging from 8 to 80 ms. To avoid R2 underestimation, the first echo was discarded before performing a mono-exponential fitting. The last sequence was a multi-b-values diffusion-weighted pulse sequence (n=10 b-values, from 0 to 800 s.mm-2), allowing Bayesian inference of IVIM parameters. Relative blood volume (rBV) was approximated by the perfusion fraction f of the IVIM model, corrected by T2 and normalized by water fraction (1-PDFF). To ensure consistent data acquisition and avoid registration and resampling uncertainties, the research sequences were acquired with identical geometry. rOEF and SvO2 (calculated by substracting rOEF to the pre-MRI digital SpO2) were evaluated by quantitative blood oxygen level dependant method (qBOLD) using an adaptation of the model proposed by Toth et al. [3]: rOEF=SaO2-SvO2= (R2*-R2)/(4/3·π·γ·Δχ0.Hct·B0.rBV) With Δχ0 the difference of magnetic susceptibilities between fully oxygenated and fully deoxygenated haemoglobin, B0 the magnetic field strength, γ the gyromagnetic ratio of the proton. The small vessel hematocrit Hct was approximated as 75% of the macrovascular hematocrit measured on a pre-MRI total blood count. Median value of each parameter in the volume of interest was recorded, and the correlation between these values and the percentage of viable cells on the surgical specimen (a prognostic factor) was calculated. Furthermore, 2 areas of the surgical specimen were identified for analyses in multiplex immunofluorescence (mIF), with a panel including, among others, CA9 and CD34 antibodies to stain hypoxic cells and endothelial cells, respectively.

Fifteen STS patients were included, and 3 of them were secondarily excluded due to surgical refusal (n=2) or metastatic progression (n=1). The mpqMRI protocol could be performed in every patient and without significant artefacts (Figure 1). Overall, the tumors were not hypoxic, with pretreatment median rOEF always <22%. This result was confirmed by mIF, with a single sample presenting a density of CA9+ cells >3/mm2 (Figure 2). After nRT, significant decrease of T2* and SvO2 and increase of R2’, ADC and Dslow were observed (Figure 3). The percentage of persisting viable cells tended to be predicted by the pretreatment median SvO2 (Rho=-0.53, p=0.08; Figure 4), and was correlated with post-nRT R2’, rOEF and SvO2.

These STS mpqMRI measures are the first available in literature but are consistent with usual biological data, reported in prostate or muscles. Measure of mpqMRI parameters modification during cancer treatment may help predict the treatment response and adapt patient management. This study has limitations. These preliminary results are reported from the median values of whole tumor, a regionalized analysis from each quantitative map will improve the constancy by accounting for tumor heterogeneity in the analysis. In addition, accuracy, reproducibility and repeatability are ongoing using Calimetrix® PDFF-R2* phantom, CaliberMRI® Diffusion phantom, and a T2 phantom made by Centre de Résonance Magnétique des Systèmes Biologiques (Bordeaux, France). Potential confounding factors that could influence R2’ and haemoglobin dissociation curve were not considered.

An mpqMRI protocole evaluating rOEF is feasible in limb or trunk STS in a clinically acceptable time. Some quantitative features being potentially predicitive of treatment response. These promising results could allow treatment personalization trials and imaging biomarker developments.
Benoît ALLIGNET (Lyon), Benjamin LEPORQ, Floriane IZARN, Amine BOUHAMAMA, Frank PILLEUL, Alexandra MEURGEY, Gualter VAZ, Alexandre BEIGE, Marie-Pierre SUNYACH, Waisse WAISSI, Olivier BEUF
14:25 - 14:35 #47563 - PG053 Reinforcing the generalizability of spinal cord multiple sclerosis lesion segmentation models.
PG053 Reinforcing the generalizability of spinal cord multiple sclerosis lesion segmentation models.

Spinal cord (SC) imaging has become increasingly central in the diagnosis and monitoring of multiple sclerosis (MS) [1,2]. SC lesions bear strong prognostic significance, with evidence linking their spatial distribution to clinical disability [3–5]. Accurate segmentation of SC lesions is essential for monitoring disease progression. Moreover, despite recent initiatives [6–9], there remains a wide variability in MRI acquisition parameters across institutions. Existing SC lesion segmentation methods lack accessibility [10–12], are typically contrast-specific and often fail to generalise to previously unseen imaging protocols [13–16]. Additionally, inter- and intra-rater variability hinders the precise tracking of lesion changes. Our objective is to develop a robust model for MS lesion segmentation on MRI scans that generalises across different contrasts and imaging parameters. We explore two methods to improve generalizability compared to the current state-of-the-art methods.

A multi-site dataset (20 sites, 1850 people with MS, 4430 scans) was selected based on the heterogeneity in acquisition parameters and sequences: T1w spin echo (n=23), T2w (n=3061), T2*w (n=548), PSIR (n=363), STIR (n=92), MP2RAGE-UNIT1 (n=343) acquired at 1.5T and 3T on GE, Siemens and Philips MRI systems. The field-of-view coverage varied across sites (brain and upper SC, or SC only), and acquisitions were either 2D (axial: n=2895, sagittal: n=1169) or 3D (n=366), with voxel dimensions ranging from 0.2x0.2x5 mm3 to 0.8x0.8x9 mm3. Manual segmentations were collected from expert raters across multiple institutions. We explore the following strategies: (i) Weighted batch sampling: In each training batch, images are sampled with probabilities inversely proportional to the square root of the number of samples in each contrast, thereby up-weighting under-represented contrasts [17] ; (ii) Pretrained model fine-tuning: We fine-tuned a foundational model, pretrained on over 10,000 CT scans [18], on our multi-contrast dataset. Models were trained under equivalent hyperparameters for fair comparison. Evaluation employed both voxel-wise metrics (Dice coefficient) and lesion-wise metrics (lesion-wise positive predictive value (L-PPV), sensitivity, and F1-score). The results were benchmarked against existing SC lesion segmentation tools available in SpinalCordToolbox (SCT): (a) sct_deepseg_lesion for T2w/T2*w [13], (b) sct_deepseg for PSIR/STIR [16], and (c) sct_deepseg for MP2RAGE-UNIT1 [19].

Both experiments performed better than the baseline model. The average Dice score increased from 0.42 (baseline) to 0.44 with weighted batch sampling (i), and to 0.50 with CT-pretrained model fine-tuning (ii). Fine-tuning yielded the highest performance across most metrics, including Dice, L-PPV and L-F1. Interestingly, weighted sampling yielded slightly higher lesion sensitivity, indicating a trade-off between precision and recall. Contrast-specific analyses revealed strong improvements on under-represented modalities. For PSIR (8% of the dataset), Dice increased from 30.6% (baseline) to 45.8% (ii); for STIR (2% of the dataset), from 27.9% to 59.4% (ii). Even high-frequency contrasts (T2w and T2*w) showed performance gains (+8.8% and +1.3%, respectively) with (ii). Compared to state-of-the-art models, (ii) outperformed (a) and (c) on their respective contrasts. However, it did not surpass (b), which had partial access to the test data during training.

Both weighted batch sampling and pretrained model fine-tuning independently improved generalisation, particularly benefiting under-represented contrasts. Our evaluation remains limited as methods (a), (b) and (c) were trained on some of the data used during testing, limiting fair comparisons. Moreover, Dice score, while widely used, is suboptimal for small lesions with uncertain boundaries [20]. Although lesion-wise metrics (L-PPV, L-F1) provide more lesion-centric insight, they rely on binary overlap thresholds and are susceptible to segmentation variability. In [21], we demonstrated that expert neuro-radiologist ratings, using a 1-5 Likert scale, often contradicted voxel-wise metrics: predicted segmentations were sometimes judged to better represent lesion presence than manual annotations, reflecting rater variability [11]. This highlights the need for complementary evaluation frameworks. In [21], we suggested that soft segmentations can improve clinical interpretability and enhance lesion detectability [21]. Nonetheless, expert review remains resource-intensive, emphasising the necessity of developing scalable surrogate evaluation metrics that better correlate with expert review.

Fine-tuning a pretrained CT-based model yielded the best segmentation performance across diverse MRI contrasts, demonstrating the feasibility of cross-modality transfer learning in SC MS lesion segmentation. The model and code will be released as part of SCT, promoting reproducibility and collaborative development.
Pierre-Louis BENVENISTE (Montréal, Canada), Lisa Eunyoung LEE, Alexandre PRAT, Zachary VAVASOUR, Roger TAM, Anthony TRABOULSEE, Shannon KOLIND, Jiwon OH, Michelle CHEN, Charidimos TSAGKAS, Christina GRANZIERA, Nilser LAINES MEDINA, Mark MUHLAU, Jan KIRSCHKE, Julian MCGINNIS, Daniel S. REICH, Christopher HEMOND, Virginie CALLOT, Sarah DEMORTIÈRE, Bertrand AUDOIN, Govind NAIR, Massimo FILIPPI, Paola VALSASINA, Maria A. ROCCA, Olga CICCARELLI, Marios YIANNAKAS, Tobias GRANBERG, Russell OUELLETTE, Shahamat TAUHID, Rohit BAKSHI, Caterina MAINERO, Constantina A. TREABA, Anne KERBRAT, Elise BANNIER, Gilles EDAN, Pierre LABAUGE, Kristin P. O'GRADY, Seth A. SMITH, Timothy M. SHEPHERD, Erik CHARLSON, Jean-Christophe BRISSET, Jason TALBOTT, Yaou LIU, Hervé LOMBAERT, Julien COHEN-ADAD
14:35 - 14:45 #47376 - PG054 Gadolinium-based contrast agents in the rat kidney: Insights from spatially resolved mass spectrometry and MRI.
PG054 Gadolinium-based contrast agents in the rat kidney: Insights from spatially resolved mass spectrometry and MRI.

Gadolinium-based contrast agents (GBCA) are routinely administered to enhance magnetic resonance imaging (MRI) and are generally considered among the safest classes of drugs. However, in the last decade, safety concerns have emerged due to prolonged presence of Gadolinium (Gd) in various organs, particularly in association with linear GBCA. [1] As primary organ of excretion, the kidneys generally showed more Gd presence than other organs [2, 3] but the exact location and speciation of renal Gd remains underinvestigated. This study aimed to map and quantify the spatial distribution of GBCA residues in rat kidneys following high-dose administration over the course of their elimination.

A total of seventy rats received one of six marketed GBCA (three macrocyclic GBCA [mGBCA], three linear GBCA [lGBCA]; cumulative dose: 4.8 mmol Gd/kg body weight) or saline (control). Rats were sacrificed at 5 days or 14 weeks (n=5 per group and time point). Right kidneys were snap-frozen in their native state, followed by analysis of Gd distribution and concentration using laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS) imaging and semi-automated multi-layer concentric sub-segmentation. Distributions of intact GBCA chelates were analyzed by matrix-assisted laser desorption ionization mass spectrometry imaging (MALDI-MSI). Left kidneys were fixed in 4% formaldehyde solution for ex vivo MR microscopy. T1 maps were acquired with a 2-channel volumetric transceiver RF coil on a 9.4T animal MR scanner (PharmaScan, Bruker BioSpin) by use of a rapid acquisition with relaxation enhancement (RARE) technique. Quantitative visualization and segmentation were performed using in-house developed software.

At day 5, LA-ICP-MS showed Gd predominantly localized in the renal cortex (Fig. 1). Depth profiles revealed peak concentrations of 2538±1163 nmol Gd/g for mGBCA and 1862±939 nmol Gd/g for lGBCA in the cortex, with 10- to 100-fold lower concentrations in the outer and inner medulla (Fig. 2). No significant difference was observed in the distribution pattern or concentration range of Gd between the classes of mGBCA and lGBCA. Results from MALDI-MSI largely agreed with those from LA-ICP-MS imaging, which supports that the species of the present Gd was intact GBCA chelate (Fig. 3). Parametric T1 mapping revealed substantial T1 shortening in ex vivo kidneys at day 5 following GBCA compared with controls, which was most pronounced in the renal cortex (Fig. 4). The T1 shortening obtained for lGBCA (ΔT1=-39%) was stronger than for mGBCA (ΔT1=-11%). Moreover, T1 shortening was also observed in the surrounding formaldehyde solution of GBCA kidneys but not of control kidneys. On one hand, this aligns with results from MALDI-MSI, indicating that Gd resides in form of the water-soluble intact chelate, which was washed out from the tissue into the supernatant during fixation and storage. The stronger T1 shortening in formaldehyde surrounding mGBCA kidneys suggest a more thorough washout compared with lGBCA kidneys. On the other hand, the washout of GBCA prevented any conclusions from being drawn regarding Gd content within the renal tissue by means of MRI. At week 14, LA-ICP-MS showed remaining Gd concentrations orders of magnitude lower in both cortex and medulla with greater elimination of Gd in the cortex - particularly in mGBCA kidneys (Fig. 1). Peak Gd concentrations in the cortex were 11±15 nmol Gd/g following mGBCA and 128±101 nmol Gd/g following lGBCA. In the medulla, peak concentrations were 16±11 nmol Gd/g following mGBCA and 17±11 nmol Gd/g following lGBCA (Fig. 2). Gd concentrations following mGBCA were significantly lower than following lGBCA. Notably, Gd distribution images showed relatively high concentrations in medullary areas following several GBCA (Fig. 1). In line with this, depth profiles confirmed relatively high concentrations in the region corresponding to the boundary area between the inner and outer medulla (Fig. 2). MALDI-MSI indicated residual Gd from mGBCA as intact chelate but remained inconclusive for lGBCA (Fig. 3).

GBCA residues in the kidney exhibited a non-homogeneous distribution pattern, which changed during continuous elimination over 14 weeks. Macrocyclic GBCA showed more thorough elimination resulting in in significantly decreased Gd presence compared with linear GBCA, likely due to the high-stability chelates, as shown by MALDI-MSI. Ex vivo T1 MR microscopy demonstrated the potential to aid research on contrast agent safety, but it requires dedicated sample preparation approaches to preserve analyte biodistribution. Despite their presence in the kidney observed in our study, no indications of renal impairment following clinical application of GBCA have been reported to date.
Luis HUMMEL (Berlin, Germany), Janina BOYKEN, Axel TREU, Hubertus PIETSCH, Thomas GLADYTZ, Ehsan TASBIHI, Thoralf NIENDORF, Erdmann SEELIGER
Espace Vieux-Port

"Saturday 11 October"

Added to your list of favorites
Deleted from your list of favorites
E34
13:45 - 14:45

MS4 - Innovation across scales in MRI RF coil engineering
From basic research to market transformation

Keynote Speakers: Jeremie CLEMENT (Keynote Speaker, Erlangen, Germany), Lena NOHAVA (Keynote Speaker, Vienna, Austria), Daniel WENZ (Research Staff Scientist) (Keynote Speaker, Lausanne, Switzerland)
Chairpersons: Özlem  IPEK (PhD), Andrew WEBB (Professor) (Chairperson, Leiden, The Netherlands), Irena ZIVKOVIC (PhD) (Chairperson, Eindhoven, The Netherlands)
Salle 76
14:45 TIME FOR A BREAK - Coffee and refreshments will be available at the cash bar.
15:00

"Saturday 11 October"

Added to your list of favorites
Deleted from your list of favorites
E35
15:00 - 16:00

MS7 - Multiorgan Quantitative T1 Mapping
In Systemic Inflammation

Keynote Speakers: Dan CUTHBERTSON (Keynote Speaker, United Kingdom), Giovanni MORANA (Keynote Speaker, Italy), Matt ROBSON
Chairperson: Michele PANSINI (Chairperson, Paradiso, Switzerland)
Salle 76

"Saturday 11 October"

Added to your list of favorites
Deleted from your list of favorites
A35
15:00 - 16:00

LT - Registered Reports and Project Abstracts

Chairpersons: Maria Eugenia CALIGIURI (PhD) (Chairperson, Italy), Patricia CLEMENT (Postdoctoral researcher) (Chairperson, Ghent, Belgium)
15:00 - 15:03 #48877 - PA01 Immuno-MRI: Proposal for the first european multicentric preclinical trial.
PA01 Immuno-MRI: Proposal for the first european multicentric preclinical trial.

Magnetic resonance imaging (MRI) is a promising modality for molecular imaging but remains limited by low sensitivity. Amplification strategies aiming at binding a large amount of contrast material to the molecular target are still necessary. To date, nanosized contrast agents such as ultrasmall particles of iron oxide (USPIO,10-50nm) have been the primary focus of molecular MRI studies. However, the low sensitivity, poor specificity, and long delay between administration and imaging have precluded the use of USPIO as targeted molecular imaging agents. More recently, larger microparticles of iron oxide (MPIO, up to 1μm) have been used as a new family of contrast agent for molecular MRI. MPIO display a higher sensitivity than USPIO thanks to higher iron content. We and others demonstrated the applicability of targeted MPIO for molecular MRI in several experimental models. Unfortunately, the MPIO used in preclinical studies are made of a polystyrene matrix and are not clinically compatible. This limitation prevents the clinical translation of molecular MRI. We recently described the production and characterization of a new class of contrast agent based on a previously unknown mechanism of self-assembly of dopamine-coated magnetite nanocrystals into microsized matrix-based magnetic particles (M3P). Thanks to a biocompatible, hydrophilic, and reactive polydopamine (PDA) matrix, M3P can be efficiently functionalized with targeting moieties such as monoclonal antibodies (methodology we called Immuno-MRI). By targeting vascular cell adhesion molecule–1 (VCAM-1) for instance, M3P allows tracking the immune response in a noninvasive manner (Figure 1). We demonstrate the applicability of this new Immuno-MRI platform for ultrasensitive molecular imaging of inflammation.

The aim of this project to validate the use of M3P particles in a multicentric preclinical trial. To that aim, we will target VCAM-1 using two different types of probes (the commercial non biodegradable MPIO and the biocompatible M3P) in different models of inflammation, including intrastrial injection of LPS (model of neuroinflammation) and intraperitonal LPS injection (model of systemic inflammation) (Figure 2). We plan to recrute at least 5 participating centers in Europe. We will prepare the contrast agent in a centralized manner and distribute it in the different participating centers. The content of each vial will be hidden to the investigators to maintain blinding throughout the study. Data analysis will be performed centrally. The experimental workflow, plan and experimental models are presented in Figures 3 and 4. Briefly, in each center, mice will be randomized between sham and LPS injection, either intraperitoneal or intrastriatal. Then each group of mice will recevied either control particles (MPIO or M3P conjugated to non-specific IgG) or VCAM-1 targeted particles. Brain MRI will be performed thereafter. This will allow to determine both sensitivity and specificity of the method in a unbiased manner. Moreover, this will demonstrate external validity of immuno-MRI.

We are currently looking for european partners to participate in the study.
Sara MARTINEZ DE LIZARRONDO (Caen), Denis VIVIEN, Maxime GAUBERTI
15:03 - 15:06 #48928 - PA02 Personalising radiation therapy for liver cancer using quantitative MRI biomarkers: The PRISM study.
PA02 Personalising radiation therapy for liver cancer using quantitative MRI biomarkers: The PRISM study.

Stereotactic body radiation therapy (SBRT) is an emerging treatment option for hepatocellular carcinoma (HCC), offering promising survival outcomes through precise delivery of high radiation doses to the tumour [1]. However, as liver tissue outside the tumour is also irradiated (Fig. 1A), there is a risk of liver function loss after treatment, which can be fatal for patients with poor baseline function. As a result, many patients with HCC cannot receive high-dose curative SBRT. Current liver SBRT guidelines assume uniform liver function and estimate the risk of post-treatment complications using global blood-based scores, which fail to capture spatial heterogeneity due to underlying cirrhosis and prior treatments. Hence, some liver regions may tolerate and recover from high radiation doses, while others are vulnerable to damage even at low doses. Quantitative MRI (qMRI) offers a non-invasive way to spatially map liver function. We hypothesise that incorporating qMRI into SBRT planning can enable personalised treatments where high-functioning regions are selectively spared, while low-functioning areas are sacrificed to allow high tumour doses (Fig. 1B). However, this approach is limited by the lack of validated qMRI biomarkers of liver function and an incomplete understanding of the dose thresholds that different regions can tolerate [2]. The Personalised liver SBRT using MRI (PRISM) clinical trial is investigating the feasibility of this qMRI-guided functional avoidance strategy. The study aims to – 1. Develop qMRI biomarkers of liver function, 2. Model the spatial dose-function response, and 3. Demonstrate that functional sparing is feasible without compromising tumour dose.

STUDY DESIGN: The PRISM study is a prospective clinical trial (ACTRN12622000371796) involving 30 patients with HCC or liver metastases undergoing SBRT. As patients with metastases usually have preserved liver function, their number is capped at 10 to capture a range of liver function in the study. Trial participants undergo MRI and 99m Tc-Mebrofenin SPECT-CT scans pre-, mid- (optional) and at 3-months post-treatment. Trial schema is shown in Figure 2. The study is conducted in three stages – Stage 1 (n=5): Optimisation of MRI and SPECT-CT protocols and study workflow; Stage 2 (n=10): Evaluation of the ability of MRI to distinguish high and low functioning liver and spatially define changes in liver function as a response to radiation dose; Stage 3 (n=15): Generation of PRISM SBRT plans using qMRI-derived pre-treatment liver function maps to spare high functioning liver. Mid-treatment liver function maps, where available, will be used to adapt SBRT plans to further optimise dose distributions. MRI PROTOCOL: A multi-parametric MRI protocol was iteratively developed on a MAGNETOM Prisma 3T scanner (Siemens Healthineers, Erlangen, Germany) consisting of T2w-HASTE with fat suppression for anatomical imaging, DIXON sequences for fat-water imaging, followed by DWI with 13 b-values (0, 10, 20, 30, 40, 50, 60, 70, 80, 100, 200, 400, 800 s/mm2) for IVIM modelling, variable flip angle T1 mapping (FA = 6.5, 15, 27°), B1 mapping for field inhomogeneity correction, and DCE-MRI with Primovist using 3D radial stack-of-stars with golden angle sampling and retrospective reconstruction of high temporal resolution DCE data for pharmacokinetic modelling. HEALTHY VOLUNTEER STUDY: 15 healthy volunteers were scanned with the MRI protocol. Test-retest data was collected for IVIM modelling and non-contrast DCE data was collected to evaluate image reconstruction.

The HREC approved study has recruited 3 (of 30) participants. Each participant has completed pre- and post-treatment MRI and SPECT scans. The healthy volunteer study is completed and qMRI modelling is underway(Examples in Fig. 3). The study is fully funded by grants from the Cancer Institute NSW (2022/ECF1462), Sydney Cancer Partners (2021/CBG0002), and the Sydney West Radiation Oncology Network Trust.

The PRISM study is in the early biomarker development and technical validation phase. Our team contains expertise on qMRI modelling, image processing and biologically targeted RT planning. With the healthy volunteer study completed and the patient study underway, we are seeking collaboration from the imaging research community for: QMRI BIOMARKER DEVELOPMENT: We seek peer review on IVIM and DCE-MRI modelling to obtain reliable quantitative liver function parameters. IMAGE PROCESSING: We welcome discussion on methods for deformable image registration of MRI and SBRT planning images, including planning CT and RT dose plans, potentially using the DCE-MRI data to extract motion information. DOSE-FUNCTION MODELLING: As traditional dose-response models do not consider spatial function we seek expertise on voxel-wise modelling of radiation dose to liver function response. COLLABORATION: We invite collaboration with clinical sites performing liver SBRT and interested in guidance using functional MRI.
Sirisha TADIMALLA (Sydney, Australia), Tim WANG, Fidel NAVARRO, Robert BARNETT, David FARLOW, Sheryl FOSTER, Alan MUI, Ian REYNOLDS, Val GEBSKI, Lauren INSKIP, Jonathan SYKES, Jacob GEORGE, Verity AHERN, Steven SOURBRON, Annette HAWORTH
15:06 - 15:09 #48959 - PA03 MagnetXplorers – A Fun Dive into Medical Imaging.
PA03 MagnetXplorers – A Fun Dive into Medical Imaging.

Modern imaging technologies such as ultrasound (US), X-ray, CT, and MRI have revolutionized medical diagnostics. However, widespread misconceptions and safety concerns persist – often due to a lack of background knowledge [1,2]. More broadly, trust in science and healthcare research remains limited, as highlighted by the Austrian Academy of Sciences [3]. The science communication project MagnetXplorers aims to provide an interactive experience (comparable to escape-room or mystery games) that allows high school students at the upper secondary level (i.e. 15-19 years old) to explore the world of medical imaging. The project also aims to strengthen trust in medical technologies and science in general, while highlighting the importance of interdisciplinary communication. Unlike earlier (Austrian) initiatives [4] and educational materials for younger audiences [5,6], MagnetXplorers focuses on older students and integrates STEM and medical topics to promote cross-disciplinary knowledge. The hands-on format centered around games and experiments [7,8] sets it apart from conventional approaches like web tutorials [9] or lectures. In a first step, students will access the game via workshops at the research facility (Vienna High-Field MR Center). Next, a standalone digital version is planned to ensure long-term educational use. Here, we outline the workshop concept and invite collaboration for further developments.

MagnetXplorers workshops are developed and organized for groups of approx. 25 people (typ. school class). The whole group is confronted with the task of diagnosing and curing the disease of a fantasy animal called “Arkynox”. The total workshop duration is 3 h, with 2 h reserved for the actual game. After an introduction phase, three subgroups are formed. Each subgroup will complete four 20-minute activities based around different imaging modalities, i.e. MRI, X-Ray & CT, and US (Fig. 1a). At the end of each successfully completed activity, students receive a modality-specific clue, e.g. jigsaw pieces of a CT image. After completing their four activities, the subgroups reunite for a final collective challenge: saving Arkynox. Together, they pool the gathered clues to draw conclusions (Fig. 1b). For instance: “All ultrasound clues rule out disease X.” By synthesizing the insights from each modality, students are able to find the correct diagnosis and appropriate treatment. Completing this final step marks the successful conclusion of the game. The development, testing, and analysis of the MagnetXplorers game follows the design-based research (DBR) approach [10]. Guided interviews are used for qualitative evaluation [11].

Regarding workshop organization, around 10 schools have been contacted, with time slots assigned from mid-September to end of December 2025. Experiments and tasks (details below) have been successfully designed, implemented and experimentally validated. Further workshop material, e.g. instruction sheets, bonus quizzes and a wrap-up hand-out for teachers, has been prepared. Currently, tests of all activities under realistic conditions are in progress to calibrate the length and phrasing for each section. MRI activity A is composed of a short introduction video on MRI and a simplified interactive Python MR simulator [12] (Fig. 2a). The instructional goal of this activity is to illustrate how different sequence parameters offer different contrasts to highlight particular morphological structures. Subsequently, in MRI activity B, a live measurement (3 T, Siemens, GER) is performed on the fantasy animal by MR professionals for the students to observe. The goals here are to demonstrate patient positioning and to convey basic principles of image analysis (contrast, object size), see Fig. 2b. The X-ray and CT activity comprises two experiments, where visible light and electrical current are used as substitutes for ionizing radiation, see Fig. 3. This activity addresses two key learning objectives: first, introducing X-ray imaging as a projection-based technique [13]; and second, presenting the concept of tomography based on radiation absorption and the associated image reconstruction [14]. The US activity, composed of two experiments and an image interpretation task, introduces the echo principle and general characteristics of wave propagation (velocity depends on medium, directionality, etc.), see Fig. 4.

Once the workshop concept is completed and tested, all materials will be made publicly available in multiple languages: German (original workshop language), English and French. To foster national and international collaborations, and to reach a larger audience, a digital version of the MagnetXplorers game including interactive screen experiments shall be developed and implemented. We invite the community to contribute by supporting the translation into additional languages, participating in the conceptualization and development of the digital version, and adapting the game for alternative target audiences.
Jean-Lynce GNANAGO, Nicole LIEMBERGER (Vienna, Austria), Miriam KAGER, Lena NOHAVA, Onisim SOANCA, Marianne KORNER, Roberta FRASS-KRIEGL
15:09 - 15:12 #48974 - PA04 ORMIR-MIDS: An open standard for curating and sharing musculoskeletal imaging data.
PA04 ORMIR-MIDS: An open standard for curating and sharing musculoskeletal imaging data.

Background and motivation: Quantitative imaging is becoming an essential tool for evaluating musculoskeletal (MSK) conditions; however, the diversity of modalities, sites, and vendors makes comparison and pooling of data virtually impossible without standardised, open-source post-processing pipelines. Several tools exist for processing and analysing such data, but these often rely on proprietary or vendor-customised file formats. To address this, we—the Open and Reproducible Musculoskeletal Imaging Research (ORMIR) community—are developing a new data format in the vein of the Brain Imaging Data Structure (BIDS) [1] and the derived Medical Imaging Data Structure (MIDS) [2]. Objectives: The “ORMIR-MIDS” project has three objectives: - to develop standardised guidelines on data and metadata formats for all applications of musculoskeletal imaging, which include (but not exclusively), qualitative and quantitative MR and CT images; - to develop a Python library to read and write ORMIR-MIDS datasets; - to develop an automated tool to convert commonly-used file formats (in the context of MR, DICOM images) to a standardised data format and structure. The output data in ORMIR-MIDS format could serve as the default input and output for MSK image-processing pipelines.

ORMIR-MIDS uses the Neuroimaging Informatics Technology Initiative (NIfTI) file format for image data and the JavaScript Object Notation (JSON) for metadata. It enriches BIDS by adding imaging modalities (computed tomography, plain radiography) and MSK-MRI-specific metadata. Like BIDS, our new standard organises data into specific folder structures with naming conventions to assist image identification and access. The structure comprises a participant-specific root folder containing subfolders describing the kind of data contained therein (CT, MRI anatomical). These data consist of one NIfTI image file, with a filename representing the participant and a filename suffix representing the acquisition, along with up to two standardised JSON header files: - A minimal header with parameters required for interpreting image data; and - An optional header with sensitive patient information. This will permit simple anonymisation or bidirectional conversion between ORMIR-MIDS and other image formats, which is important for interoperability. Our standard also adds participant health-related data to the BIDS participant description table (‘participants.tsv’) and the option to include raw clinical data in participant sub-folders.

ORMIR-MIDS currently defines a folder structure able to accommodate multiple modalities (currently MR, CT, and radiography), and multiple MR acquisition types and derived images (currently multi-echo spin- and gradient-echo, DESS, and T1 and T2 maps). The current full specification is available at https://ormir-mids.github.io/specs. The specification indicates the required JSON fields providing the necessary metadata for the interpretation and reproduction of the acquisition. The Python library is currently primarily used to load and save ORMIR-MIDS datasets, by automatically loading the NIfTI files and the JSON metadata and making them available as a data structure compatible with Numpy, based on Pyvoxel (https://github.com/pyvoxel/pyvoxel). It can be installed from the Python Package Index with pip. Based on this library, there is also an automated tool for the conversion of various DICOM images into ORMIR-MIDS format, based on a plugin-like structure of classes called “Converters”, which recognise the acquisition type and automatically populate the required JSON fields, for multiple vendor conventions. A Jupyter notebook is provided to showcase current functionality: https://ormir-mids.github.io/tutorials.html.

This project is in continuous development, and we are actively adding both to the specification and the converters based on the uses and requirements of our community. We are also seeking other interested parties or groups who could: - Provide use cases for this standardised data format (for example in Diffusion imaging). - Contribute to the specifications in areas that are still lacking, or propose improvements (for example, useful metadata). - Contribute with test datasets by vendors or acquisitions not yet covered by our test datasets. - Contribute with coding of the automated converters for cases not yet covered by our test datasets. - Use the format and the library for ongoing and future musculoskeletal imaging projects. - Integrate ORMIR-MIDS in existing data repositories. For more information, please contact ormircommunity@gmail.com.
Francesco SANTINI (BASEL, Switzerland), Serena BONARETTI, Michelle Alejandra ESPINOSA HERNANDEZ, Francesco CHIUMENTO, Yamina FOUNAS, Martin FROELING, Jukka HIRVASNIEMI, Gianluca IORI, Youngjun LEE, Sabine RÄUBER, Maria MONZON, Simone PONCIONI, Nanna SCHARFF POULSEN, Glenn WALTER, Donnie CAMERON
15:12 - 15:15 #48985 - PA05 Towards automated detection of late-life depression based on DTI.
PA05 Towards automated detection of late-life depression based on DTI.

Background and motivation Late-life depression (LLD) is common in older adults but underdiagnosed and undertreated [1], and linked to cognitive decline and dementia [2,3]. Early detection is crucial to prevent severe outcomes, including dementia or suicide. White matter (WM) abnormalities detected by diffusion tensor imaging (DTI) have long been associated with LLD [4]. We aim to develop and evaluate a machine learning (ML) pipeline that uses DTI-derived regional features to support earlier and more objective identification of LLD. Objectives and hypothesis Objective: build an optimized ML model that discriminates patients with LLD from matched healthy controls (NC) using DTI-derived regional WM metrics. Hypothesis: ML models trained on a systematically selected subset of informative DTI features can accurately distinguish LLD from NC and form the basis of an automated screening/decision-support tool.

Cohort and MRI acquisition We studied 26 inpatients with LLD (DSM-V; Geriatric Depression Scale ≥10) and 12 NC matched for age, education, and cognition (all MMSE ≥28). MRI was performed within one week of clinical exam on a 3T Philips Achieva TX with an 8-channel head coil. Diffusion Weighted Imaging protocol: single-shot EPI with SENSE (factor 2.5), TR ≈ 7200 ms, TE ≈ 74.5 ms, flip angle 90°. Volumes: 60–70 AC-PC aligned axial slices; one b0 and 32 diffusion coding directions, bmax = 700 s/mm²; isotropic voxel 2.2 mm³; matrix 96×96 (zero-filled to 256×256); FOV 212×212 mm. EPI acquisition was repeated twice to increase SNR. Processing pipeline and feature extraction Processing used an automated cloud-based pipeline (www.mricloud.org) [5] including: motion/eddy-current correction [6]; image corruption detection and pixel rejection [7]; tensor estimation by multivariate linear fitting. Segmentation applied a multi-contrast extension of multi-atlas likelihood fusion (MALF) [8] within an LDDMM framework [9]. Using 8 atlases, the pipeline performed: (i) b0→MNI alignment (12-parameter); (ii) atlas→target LDDMM using b0, DWI, FA, trace; (iii) fusion to create LV and brain masks; (iv) skull-stripping; (v) final LDDMM with skull-stripped input, producing a 168-parcel segmentation transformed back to native space. An FA>0.2 threshold excluded cortex while preserving peripheral WM [10]. After discarding 22 parcels, 146 ROIs remained. For each ROI, FA volume, mean FA, trace, axial diffusivity (AD), and radial diffusivity (RD) were measured, generating 730 features. Quantification used ROI-Editor [10]; ML analysis used WEKA [11]. Machine learning and feature selection We applied stratified 5-fold cross-validation; feature selection was confined to training folds to prevent leakage. A variance threshold (2nd percentile; mean≈1.15×10⁻⁹) removed 10–32 near-constant features per fold, retaining 698–720. Mutual information (MI) ranking identified the most informative features. The eight most recurrent features across folds formed a fixed training/testing subset: MidbrainLeftTrace, FornixLeftRD, NucleusAccumbensRightRD, ThalamusRightRD, PostcentralGyrusRightTrace, FornixRightAD, LingualGyrusRightTrace, FornixLeftTrace. Classification used a Random Forest (RF) classifier.

Status: This is an ongoing project [12,13]. Using the fixed 8-feature subset, RF yielded mean accuracy 0.786 ± 0.158, sensitivity 0.887 ± 0.104, specificity 0.567 ± 0.435, and F1-score 0.857 ± 0.099. Aggregate confusion matrix: 23 true positives, 3 false negatives, 5 false positives, 7 true negatives. Results suggest that a small, systematically selected DTI feature set can achieve promising sensitivity for LLD detection despite limited and imbalanced samples.

These promising preliminary results highlight the potential of DTI-based ML for the early detection of LLD. Next steps involve expanding the dataset with additional subjects and refining feature selection strategies, such as Particle swarm optimization and hybrid approaches. To advance this work, we seek partners from the ESMRMB community to support research funding, contribute to enlarging the clinical dataset, and collaborate on optimizing DTI feature extraction, clinical validation, and multimodal neuroimaging integration. Our goal is to scale the study and develop an MRI-compatible plugin that enables timely diagnosis and treatment planning in elderly patients. Our current contributions include a fully automated DTI processing and segmentation module (www.mricloud.org), an initial ML workflow, and preliminary results.
Christos KATSIS, Kostas SIARKOS (Athens Greece, Greece), Georgios VELONAKIS, Nikolaos SMYRNIS, Euripidis GLAVAS, Antonios POLITIS
15:15 - 15:18 #48986 - PA06 The SECURO project: Developing a deep learning tool to reduce the need for GBCAs in brain imaging.
PA06 The SECURO project: Developing a deep learning tool to reduce the need for GBCAs in brain imaging.

Post-contrast MRI is the gold standard imaging modality for visualizing oncologic and inflammatory brain lesions. But safety concerns emerged regarding gadolinium-based contrast agents (GBCAs) for health and environmental reasons. One concern is toxic gadolinium reaching measurable levels in water [1]. Kanda et al. [2] published a seminal paper on cerebral GBCA deposition motivating GBCA reduction in medicine expressed in efforts like ESMRMB's GREC working group. The European Medicines Agency (EMA) made recommendations to restrict GBCA [3]. These concerns and the rapid advancement of computer-aided approaches in medical imaging have led to attempts to synthetically generate post-contrast images from low- or zero-dose contrast images [4-7]. However, to this day, none of these attempts resulted in a reliable tool to be utilized in clinical settings. The SECURO project aims to develop deep learning software, SmartGAD, to estimate personalized GBCA doses for patients with various brain pathologies (Fig. 1). The project is a PPP of Amsterdam UMC, company Cerebriu and the MR-STAT working group of Utrecht UMC.

The to-be-developed eventually MRI-installed algorithm shall decide if GBCA can be omitted or reduced for the examination by synthetizing full-dose quality post-contrast brain MRI scans, while the patient is still in the scanner. SECURO involves the reuse of zero and 50% Dotarem images (n=312) from previous REDUCE study, and the prospective acquisition of 10% standard dose images (n=150) alongside MR-STAT-based synthetized images, as input for training/testing. Pathologies include primary and secondary brain tumors and multiple sclerosis. Visual validation of synthetized lesion enhancement by radiologists is necessary at all stages. All cases where synthetic images significantly differed from conventionally acquired post-contrast scans will be reexamined to investigate reasons for failure. Input sequence selection will be optimized to improve algorithm performance. Finally, we want to test software performance in at least five voluntary external centers.

REDUCE has recruited 200 patients. SECURO will start scanning 150 patients by November 2025. Human visual analysis of the raw 10%/50%/full dose data without software improvement will start by 2026. The initial prototype of SmartGAD has been created and will be trained further in 2026/2027 on REDUCE/SECURO data including MR-STAT based images.

Our current team brings expertise in AI and neuroradiology, but we seek input and community collaboration in the following aspects of the project: - Radiologists with various levels of experience in neuroradiology to evaluate the quality of synthetic post-contrast images compared to real full-dose images - Voluntary centers for external validation of software – if possible, bringing own reduced dose data for testing on the tool - Advice on execution and technology acceptance.
Katalin FARKAS (Amsterdam, The Netherlands), Akshay PAI, Silvia INGALA, Marko BAUER, Mads NIELSEN, Szabolcs DAVID, Alessandro SBRIZZI, Vera C. KEIL
15:18 - 15:21 #48988 - PA07 AURA: Building ‘A User Repository of Artifacts for Perfusion Imaging’.
PA07 AURA: Building ‘A User Repository of Artifacts for Perfusion Imaging’.

Perfusion MRI techniques such as Arterial Spin Labelling (ASL), Dynamic Susceptibility Contrast (DSC), Intravoxel Incoherent Motion (IVIM) and Dynamic Contrast-Enhanced (DCE) MRI offer unique insights into brain physiology, yet their wider adoption remains limited. A major obstacle is the frequent occurrence of artifacts, which reduce image quality and diagnostic confidence. While many artifacts are well known in principle, information is scattered across literature and online sources, often lacking standardized descriptions or practical guidance. The AURA project (A User Repository of Artifacts) addresses this gap by developing a community-driven, open-access tool to support researchers, MR physicists, and clinicians in artifact recognition.

AURA is developed within the ISMRM Open Science Initiative for Perfusion Imaging (OSIPI) and illustrated in Figure 1. A database framework for ASL, DSC, IVIM and DCE perfusion artifacts will be developed and fed with community examples. AArtifact entries, including explanations, sources, and possible solutions, are collected through literature review and expert discussions in the perfusion software user community. Each entry contains standardized information including artifact names, alternative name(s), clear explanations, visual examples, suggested remedies and diagnostic relevance. Additionally, a REDCap-based data-collection tool will be used to enable community contributions of artifact examples. The AURA database will be made publicly available via the OSIPI.org website

Currently, an initial database framework for ASL, including general and ASL-specific artifacts was drafted. The initial version already illustrates the potential of a centralized artifact resource and provides a solid basis for future expansion. Additionally, the data collection tool for community input is operational.

AURA aims to develop a community-driven educational and practical tool for the perfusion community. Therefore, community involvement is crucial. We seek experts in ASL, DSC, IVIM and DCE to join our team and evaluate the current database framework and content for ASL, contributing to the extension of the database to DSC, IVIM, and DCE MRI, and submitting real-world artifact examples. Planned developments include tagging and filtering systems, providing vendor-specific examples, and peer review to ensure accuracy. By pooling expertise, AURA aims to reduce time lost to uncertainty, strengthen quality, and accelerate the broader adoption of perfusion MRI.
Annelie HAEK (Ghent, Belgium), Soetkin BEUN, Henk-Jan MUTSAERTS, Luis HERNANDEZ-GARCIA, Jan PETR, David L. THOMAS, Petra J VAN HOUDT, Patricia CLEMENT
15:21 - 15:24 #48996 - PA08 Impact of modelling assumptions on blood-brain barrier water exchange estimates in multi-TE ASL, DP-ASL and BBB-FEXI.
PA08 Impact of modelling assumptions on blood-brain barrier water exchange estimates in multi-TE ASL, DP-ASL and BBB-FEXI.

Advanced MRI techniques to estimate blood-brain barrier (BBB) water exchange[1], show increasing promise to measure subtle BBB alterations. However, published studies consistently demonstrate discrepancies between exchange time (Tex) measures from multi-echo time arterial spin labelling (multi-TE ASL), and BBB water exchange rate (Kw) from diffusion-prepared ASL (DP-ASL) and filter exchange imaging (FEXI), particularly in cases with BBB alterations such as ageing[2-5](Fig 1). Models and assumptions (i.e. relaxation times or diffusivities) are likely to impact exchange measurements, but have not yet been rigorously evaluated. First, relaxation times may differ in pathology and influence the MR signal in all techniques, but are often fixed, or omitted from, the models used to measure BBB water exchange. Relaxation also differs in preclinical MRI, due to higher field strength, and may affect inferences with human data. We aim to elucidate strengths/limitations of current modelling paradigms for each method by 1) investigating their noise sensitivity in simulations; 2) assessing how relaxation may bias exchange time/rate estimates. We are keen to hear from the ESMRMB community for input and ultimately aim to provide recommendations for implementing and modelling different BBB water exchange techniques. Objectives and Hypothesis: To assess the noise sensitivity of multi-TE ASL, DP-ASL and FEXI protocols, and the impact of extravascular relaxation time modelling assumptions on exchange time (Tex; multi-TE ASL) and exchange rate (Kw; DP-ASL and FEXI) estimates.

For the first project phase we performed simulations to assess the methods, taking acquisition and model parameters from ongoing work and literature. Simulations were performed using Matlab (Mathworks), using four modelling paradigms: i) 2-compartment pCASL model simulating multi-TE ASL signals at 3T[6] ii) 2-compartment PASL model simulating rodent multi-TE ASL signals at 9.4T[7] iii) 3-compartment single-pass approximation model to generate DP-ASL signals at 3T and linear regression of logarithm (LRL) to estimate Kw[8], iv) 2-compartment model[9] to generate FEXI signals and apparent exchange rate (AXR) model[10] to estimate Kw. The MRI acquisition and simulation parameters for each technique are shown in Table 1. To assess noise sensitivity, ground truth signals were generated using the four respective models: noise was added to 10,000 signals independently to investigate the precision and accuracy of fitted parameters across signal-to-noise (SNR) levels. Extreme Tex/Kw fits (i.e. close to fitting bounds) were discarded. The coefficient of variation (CoV=100x(standard deviation/mean) of Tex/Kw fits across the 10,000 signals at a given noise level) was calculated for each SNR. To evaluate biases from tissue T2 model assumptions, noise-free signals were simulated by varying the ground truth tissue T2 value by ±20%, relaxation effects were included in DP-ASL and FEXI models. The models were then fitted back to the signals; for multi-TE ASL the tissue T2 was fixed to the ground truth value and standard LRL DP-ASL and AXR FEXI models were used. The bias in Tex/(Kw) values was estimated as 100x(Texfit – Texgt)/Texgt.

This study is ongoing. Following the simulations, we will seek funding to evaluate in vivo data across the techniques (e.g. ARUK Pilot Project £70k). To achieve an acceptable CoV=15%, for the implemented protocols we need SNR>25(multi-TE ASL 3T), SNR>20(multi-TE ASL 9.4T), SNR>24(DP-ASL), SNR>425 (FEXI)(Fig 2). These results are heavily protocol-dependent (e.g. number of repetitions/volumes acquired); future work will harmonise the number of volumes or scan time across techniques to allow more direct SNR requirement comparisons. Fig 3 shows the impact of changes in ground truth tissue T2 values on Tex/Kw estimate accuracy. For multi-TE pCASL at 3T, a ±20% T2 variation incurred a -35.6% to 107.8% bias in Tex(Fig 3a); for DP-pCASL, the bias in Kw was -48.5% to -54.4%(Fig 3b); for multi-TE PASL at 9.4T, the Tex bias was 15.3% to -12.4%(Fig 3c) and for FEXI, -42.0% to -21.1%(Fig 3d). This suggests that concomitant tissue T2 alterations (i.e. owing to pathology) may influence estimated exchange times/rates, and inferences on BBB integrity, regardless of the technique. This finding may help explain some of the reported differences between the methods.

This is work in progress and we have several avenues yet to explore. For example, how does blood deoxygenation along the arterial tree influence MRI signals and can we adjust T2-based models to exclude its potentially confounding effects? What other physiological changes might influence exchange estimates (i.e. CBF)? Our expertise is primarily in multi-TE ASL, FEXI and diffusion imaging; we therefore seek expertise from the ESMRMB community in brain physiology and physiological modelling to help approach these questions, along with expertise relating to DP-ASL for advice on modelling assumptions.
Elizabeth POWELL, Lena VACLAVU, Yolanda OHENE (Manchester, United Kingdom)
15:24 - 15:27 #49003 - PA09 Structural changes in tendon tissue detected by direct collagen mri.
PA09 Structural changes in tendon tissue detected by direct collagen mri.

Background and Motivation Collagens are highly abundant proteins found in the extracellular matrix of connective tissues [1] such as tendons, ligaments, skin, vasculature, or meniscus [2]. Disruption of collagen in these tissues can lead to various diseases [3]. In tendons, this leads to tendinopathies which are characterized by fragmented collagen fibers and disorganized collagen bundles, causing pain and impaired function [4] and thus account for a significant proportion of musculoskeletal appointments [5]. A common way to induce tendinopathy in animal models is by injecting collagenase [6-8], which selectively cleaves the collagen triple helix under normal physiological conditions [9]. Alternatively, collagen can be denatured by heating the tissue, breaking hydrogen bonds that stabilize its triple helical structure [10]. Magnetic resonance imaging (MRI) is the gold standard to evaluate tendon diseases [11, 12]. However, as collagen protons have extremely short transverse relaxation times (T2*) on the order of ~10 µs [13], conventional MRI sequences cannot visualize them directly [11, 13]. Instead, collagen in tendons is assessed indirectly via the bound water [13, 14] that has a longer T2* of ~0.6 ms [15]. Only recently the direct observation of collagen was reported using dedicated, advanced hardware and short-T2* methods [16-19]. Objective To employ the direct collagen MRI approach to evaluate its sensitivity to collagen changes in tendon tissue. Hypothesis We hypothesize that changes in the collagen structure, that were induced by enzymatic degeneration or heat denaturation, are detectable in direct collagen MRI via altered signal amplitudes and T2* values.

Two procedures are employed to alter collagen in tendons: enzymatic degeneration and heat denaturation. The resulting structural changes are visualized using direct collagen MRI. All samples are imaged before and after the intervention to get a sample-specific control image, with consistent positioning to minimize orientation effects. Direct collagen images (DCIs) are computed by subtracting later-echo images where collagen has fully decayed from earlier-echo images that still contain short-T2* collagen alongside longer-T2* bound- and free-water. While this subtraction has previously been shown to isolate collagen and visualize intact structures [16, 17], this study investigates its application for detecting collagen disruption. Signal intensities are compared across acquisitions and interventions, and multiexponential fitting is applied to assess signal decay characteristics related to the collagen structure.

Preliminary results have been obtained, which show decreased signal intensities after collagenase degeneration (Figure 1) and after heat denaturation, demonstrating the ability of MRI to detect related structural changes. Histopathological examination was performed on 10 mg/ml and 20 mg/ml collagenase-treated tendons (Figure 1) and confirmed the collagen breakdown.

Bovine Achilles tendons are cleaned and cut into ~1x1x2 cm^3 pieces. To induce collagen alterations, the tendon samples are either injected with PBS (control) or collagenase type I [20] (5-20 mg/ml), or heated in PBS (room temperature for control, 50-70 °C for intervention). All samples are imaged pre and post intervention. MR FIDs and imaging experiments are performed on a 3T Philips Achieva system (Philips Healthcare, the Netherlands) in combination with a high-performance insert gradient that reaches a strength of 220 mT/m at 100% duty cycle [18] and rapid high power transmit-receive switches [19]. A proton-free loop coil with 40 mm diameter is used [21]. Details on the acquisition parameters can be found in Table 1. Following the MR experiments, the samples are histopathologically examined to assess the collagen breakdown by staining with hematoxylin and eosin. Statistical Analysis Plan Primary Outcomes • Collagen change: Mean percentage change in collagen signal (from DCI or model fit) between pre and post intervention • Spatial localization: Voxel-wise statistical maps to detect regional changes Sample Size Justification • Preliminary data showed mean relative signal differences, calculated as (pre–post)/pre, ranging from 0.1 to 0.2 (heating) and from 0.4 to 0.6 (collagenase). Based on these effect sizes, 3 paired samples would provide 80% power to detect a 10% change after heating and a 40% change after collagenase versus control. Statistical Tests • Effect size: percent change per sample=100*(pre–post)/pre • Paired t-test: Asses pre vs post differences in ROI-averaged collagen signals Potential data confounders include tissue variability and dehydration during the 1h scan session. We seek expertise on reproducible collagen degradation in tendons, including post-breakdown dynamics, potential for re-assembly of collagen fragments, and in which pool degraded protons go. Further, we appreciate recommendations on performing robust tendon histology.
Darlina VON SALIS (Zürich, Switzerland), Jason VAN SCHOOR, Markus WEIGER, Emily BAADSVIK, Klaas PRÜSSMANN
15:27 - 15:30 #49007 - PA10 Decoding the female brain: Investigating cerebral white matter changes throughout the menopausal transition.
PA10 Decoding the female brain: Investigating cerebral white matter changes throughout the menopausal transition.

Peri-menopause is an endocrinological transition state that usually occurs in women aged 45 to 55. The transition begins with the dysregulation of the Hypothalamic-Pituitary-Gonadal Axis, 1 2 resulting in low oestradiol and progesterone and high FSH and LH.3 4 It comprises three stages: pre-, peri-, and post-menopause, which can span up to one-third of a women's life 5 and are often accompanied by vasomotor, urogenital, neurological and cognitive symptoms.2 Over the past decades, increasing evidence has shown the modulatory role of oestrogen and progesterone on brain structure, connectivity, and function throughout a women’s life.6 7 8 It is hypothesized that, during menopause specifically, endocrine aging accelerates chronological aging in the female brain, partly explaining women’s higher risk to Alzheimer’s Disease.9 However, research on the hormonally induced brain changes during menopause is still scarce. This research project aims at filling this knowledge gap, comparing measures of white matter (WM) integrity between the three menopausal phases using Diffusion-Weighted Magnetic Resonance Imaging (DW-MRI). Fractional anisotropy (FA) and mean diffusivity (MD) will serve as indirect measures of WM integrity. In addition, WM volume (WMV) will be quantified and compared between the three menopausal stages. Lastly, the relationship between fluctuating oestrogen levels and both WM integrity and volume will be assessed.

STUDY POPULATION Biologically female (assigned sex at birth) women between the age of 35-55 were included. Women with metabolic, cardiovascular, endocrinological, neurological or mental disorders, medication interfering with brain activation, pregnancy or breastfeeding within the last year, use of hormonal contraceptives or copper IUD within the last three months were excluded. All participants were divided into one of three groups based on their menopausal transition phase, as described by the STRAW criteria: PRE, PERI or POST. All PRE women were scanned twice, once during day 2-7 of their menstrual cycle (i.e. the early follicular phase; PRE-fNC) and once ±3 days around their ovulation (PRE-oNC). PERI women were scanned a second time as well, within an interval of 6 months, to investigate their progress in the menopausal transition. POST women were scanned only once. As of now, data has been collected in the following groups: PRE/NC (n = 21), PERI (n = 17), POST (n = 21). Data acquisition started in January 2024 and is still ongoing. DATA ACQUISITION Images are on a 3T Siemens MRI with 32-channel head coil. The protocol included localizer, anatomical T1, and diffusion-weighted images with PA correction. A high-resolution anatomical T1-weighted image (MPRAGE) was acquired, consisting of 208 sagittal slices [TR/TE = 2400.0/2.22 ms, TI = 1000 ms, resolution = 0.80 × 0.80 × 0.80 mm, FOV = 256 mm, FA = 8°]. TA high-angular-resolution diffusion-weighted imaging (HARDI) sequence was acquired with b=1200 s/mm2, in 74 diffusion gradient directions distributed uniformly on the unit sphere (TR/TE 2744.0/66.80ms). An additional image without diffusion-sensitizing gradient was acquired (“the b0 image”) as a baseline reference to compute diffusion signal attenuation. To correct for EPI distortion a reverse phase encoding scan was acquired separately. IMAGE PROCESSING All imaging data will be converted to BIDS. Anatomical MRI data will be pre-processed with FreeSurfer10 for motion correction, spatial normalization to MNI space, and parcellation to extract WMV. DWI data will be processed using MRtrix311. Processing steps include denoising, Gibbs correction, motion/Eddy correction, outlier removal, and bias field correction. Lastly, a brain mask will be created and the scalar measures FA and MD are derived. STATISTICS WMV will be compared across groups with ANCOVA (covariates: age, ethnicity, TIV). Linear regression will assess associations between oestrogen and total/regional WMV. FA and MD will be analysed across groups using ANOVA or Kruskal-Wallis, with multiple-test correction. Within-group correlations between hormones and diffusion parameters will be tested using Pearson or Spearman depending on distribution.

This study is part of the funded project “Reward and Sexual Health in Pre-, Peri-, and Post-Menopausal Women”, funded by the German Research Foundation (DFG). All necessary data has been acquired and we are currently developing the processing and analysis protocol for this specific study.

As the processing and analysis protocol is currently being developed, we are looking for expertise in research methodology (e.g. defining a research question, data analysis and statistics), as well as researchers experienced in working with large, existing datasets. We also welcome collaborators within the field of the female brain, who have access to longitudinal datasets of women going through menopause, as such data would enable a more rigorous investigation into the causal effects of oestrogen on the brain.
Kato HERREGODS (Ghent, Belgium), Franziska WEINMAR, Soetkin BEUN, Patricia CLEMENT, Ann-Christin KIMMIG, Birgit DERNTL
15:30 - 15:33 #48871 - RR01 Longitudinal MRI for tumor evaluation in two immunocompetent chicken chorioallantoic membrane (CAM) cancer xenograft models: A Registered Report.
RR01 Longitudinal MRI for tumor evaluation in two immunocompetent chicken chorioallantoic membrane (CAM) cancer xenograft models: A Registered Report.

BACKGROUND AND MOTIVATION: The chicken embryo chorioallantoic membrane (CAM) assay has emerged as a valuable preclinical model, significantly advancing the principles of the 3Rs (Replacement, Reduction, Refinement) in scientific research, with no ethical approval required in Spain if terminated by embryonic day (ED) 16. CAM models offer an alternative to traditional, immunocompromised, and costly animal models, providing robust and clinically relevant data [1]. In cancer research, the CAM assay is widely used, among others, for the study of tumor growth and metastasis, angiogenesis, drug acute toxicity and efficacy, enabling the evaluation of a wide range of therapeutics in a timely and cost-effective manner [2]. However, evaluations such as tumor volume or angiogenesis are performed only at endpoint, after excision of the tumors and surrounding tissues, lacking critical intermediate data, which could be highly relevant, especially in preclinical drug efficacy assessment. This registered report outlines our plan to evaluate the feasibility of non-invasive longitudinal MRI acquisitions in CAM-derived pancreatic cancer and lymphoma xenograft models, to gain intermediate insights into tumor progression. HYPOTHESIS: We hypothesize that applying MR-based approaches in longitudinal studies using the CAM model will enable to capture intermediate data that are currently missing from conventional methodologies.

OCI-Ly1 (Lymphoma) and PaTu (Pancreatic cancer) tumor cells are engrafted onto the upper chorioallantoic membrane of fertilized white Leghorn chicken egg on ED 9, using standard procedures [3]. MRI is performed at 7T (Bruker Biospec 70/30) on ED12 and ED16 (Figure 1). Following a 60-min incubation at 4 ºC to minimize embryo movements, the egg is placed in the scanner at room temperature, and an actively decoupled 15 mm diameter surface coil (SC) is affixed on the eggshell above the tumor site. The SC is used for signal detection, and a 72 mm volume coil for transmission.

In a recent pilot study (Figure 2), we have successfully conducted MRI on a pancreatic tumor and a lymphoma xenografts growing on a CAM membrane. MRI was performed after a 60-minute incubation at 4°C to minimize embryo movements, with no observable adverse effects on embryonic development. We acquired Double T2-weighted images in coronal and axial planes with a RARE sequence (TEeff, 36 ms and 132 ms; TR, 5 s; 1.5&0.5 mm slices; MTX 256x256; FOV, 5x5 cm2). T2w images showed that the pancreatic tumor grew more deeply, while the lymphoma grew more superficially. Additionally, pancreatic tumors exhibited increased vasculature branches compared to lymphoma.

STUDY PROTOCOL. We will conduct a two-part validation study: (1) MRI protocol optimization including T2w, DTI and MRS within the 30–40-minute window of reduced embryo motion post-cold incubation. (2) Longitudinal MRI/MRS assessment on ED12 and ED16. At endpoint (ED16), tumors, surrounding tissues and organs will be removed for genotypic (qPCR-mediated quantification of hAlu sequences) and phenotypic (immunohistochemical labelling of tumor cells and blood vessels) analyses, which will be correlated with MRI results. All scans will be performed on a 7T MRI system (Bruker Biospec 70/30) with a 72 mm volume coil for transmission and 20 mm surface coil as receiver. The protocol will include: T2w acquisitions, DTI_EPI and single voxel PRESS. STATISTICAL ANALYSIS PLAN Primary Outcomes: 1. Tumor volume over time. 2. ADC values over time. 3. Tumor volume, and ADC differences between lymphoma and pancreatic tumor groups. Secondary Outcomes: 1. Correlation between tumor volume measured by MRI and Tumor weight, tumor cell abundance and angiogenesis at endpoint. 2. Correlation between ADC and T2w with post-excision genotypic and phenotypic analyses. 3. Exploratory analysis of differences in pattern spectral over time. Sample Size Justification: We estimate that a correlation of 0.7 might be achieved between the proposed assessments and outcomes. Power analysis indicates that 20 subjects per xenograft model will provide 80% power to detect effects at α=0.01 (Bonferroni-corrected for multiple outcomes). We may allocate up to 25% additional individuals to compensate for potential growth failure and/or defective egg batches.
Núria PROFITÓS-PELEJÀ, Margarida JULIÀ-SAPÉ, Ana Paula CANDIOTA (CERDANYOLA DEL VALLÈS, Spain), Gaël ROUÉ, Silvia LOPE-PIEDRAFITA
15:33 - 15:36 #48982 - RR02 A deep learning approach for direction-aware diffusion-diffusion correlation imaging.
RR02 A deep learning approach for direction-aware diffusion-diffusion correlation imaging.

Magnetic resonance imaging (MRI) enables the non-invasive differentiation of tissue structures based on their physical properties. However, this differentiation is fundamentally limited by the spatial resolution, with voxels containing multiple tissue compartments. These can be distinguished using multidimensional correlation imaging to obtain microstructural information [1-7]. However, information about fiber directions was so far only captured with tensor-valued diffusion encoding, and reconstructed with a Monte Carlo inversion in 5D+ [8-11]. In this study, we build upon promising deep learning predictions of multicomponent spectra [12-14]. Extending this concept, we focus on multidimensional diffusion data, emphasizing the value of directional information for microstructure assessment. Our method aims to leverage standard multi-shell diffusion acquisitions to reconstruct direction-aware 3D diffusion-diffusion spectra with deep learning.

To later use a suitable amount of training data, we aim to generate a synthetic dataset, using the pipeline shown in Figure 1. Each data sample contains the MRI signal for different b-values and a correlation spectrum. Tensor eigenvalues are randomly chosen based on the typical value ranges of the eigenvalues of WM, GM, and CSF [15]. Under the condition λ₁ >= λ₂ >= λ₃, the distributions are mixed such that a high variation of eigenvalue combinations is obtained. For the orientation, we predefined 30 fixed directions distributed over a Fibonacci sphere, from which one direction is chosen per tissue type. The diffusion tensor D is formed out of a diagonal eigenvalue matrix E and an orthogonal orientation matrix Q [16,17]: D = Q @ E @ Qᵀ The signal is then simulated from these tensors. For each sample, the described process is carried out for each compartment. After that, random weights are assigned to the compartments, and the weighted signals are averaged to yield the final MRI signal. For the correlation spectrum, we considered the mean diffusivity as well as the fractional anisotropy, which are shown on the axes of the lower graphs in Figure 2. The peak sizes represent the weights. In addition, the exact direction of the voxel is color-coded. The information in this spectrum is going to serve as ground truth for the subsequent deep learning.

Using the previously described pipeline, we are already able to generate synthetic pairs of diffusion-weighted imaging (DWI) signals and their corresponding 3D spectra. Our scanning protocol is based on an in vivo dataset, which is available to us and already proved to enable relaxation-diffusion correlation imaging [18]. We intend to evaluate the model on these real measurements at a later stage. Nevertheless, we remain flexible to incorporate additional datasets if needed. Currently, the synthetic data are generated with between one and five compartments, covering all possible variations within this range. To demonstrate the versatility and realism of our generated data, Figure 2 presents several examples illustrating the diversity of diffusion signals and their associated correlation spectra. These examples exhibit distinct patterns corresponding to different tissue compartments and their orientations. They include both realistic samples, such as graph (2a) reflecting the characteristics of a CSF voxel, and highly randomized samples, such as (2c). This diversity in the synthetic dataset provides a robust basis for developing and evaluating our deep learning approach.

Through the development of a synthetic dataset with broad variability, we have established a solid foundation for applying deep learning. Such diversity is expected to improve model generalizability. The dataset can be further refined by introducing additional constraints to better approximate realistic tissue characteristics, and Gaussian noise will be added to enhance the robustness of the trained network [13]. The next step is training a model to predict multidimensional correlation spectra. Previous studies have employed multilayer perceptrons [12,13], which we adopt here while planning to evaluate alternative architectures in future work. Our network will be trained to take, for each voxel, diffusion-weighted MRI signals at multiple b-values as input and to predict the 3D spectra generated by our simulation pipeline. To optimize performance, we investigate two strategies: discretizing spectra and framing the task as classification, or treating them as continuous variables in a regression setting. Discretization may reduce the data’s complexity. Accurate predictions would enable the identification of distinct microstructural compartments, while incorporating directional information could further allow detection of multiple fiber populations within a voxel, facilitating fiber crossing identification and improving tract reconstruction.
Johannes SCHLUND (Ingolstadt, Germany), Sebastian ENDT, Marion I. MENZEL
15:36 - 15:39 #48983 - RR03 ¹H-MRSI Detection of metabolite changes in amyotrophic lateral sclerosis within intrinsic connectivity networks.
RR03 ¹H-MRSI Detection of metabolite changes in amyotrophic lateral sclerosis within intrinsic connectivity networks.

Amyotrophic lateral sclerosis (ALS), the most common motor neuron disease, causes progressive neurodegeneration [1] and is typically diagnosed between ages 55–75 [2]. Global ALS prevalence is projected to increase by 69% by 2040 due to population aging [3]. The average life expectancy following diagnosis is about five years [4]. Despite extensive research, no definitive biomarkers exist for early detection, and there is no universally effective treatment, making ALS a major clinical challenge [5]. Proton magnetic resonance spectroscopic imaging (¹H-MRSI) is a non-invasive method used to detect potential metabolic biomarkers of diseases [6]. MRSI studies in ALS often target brain regions involved in motor control and sensory integration, including the caudate, putamen, insula, and thalamus. These regions are components of intrinsic connectivity networks (ICNs), which exhibit synchronized activity during rest and are thought to underlie cognitive, sensory, and motor functions [7]. This registered report presents a study using Oryx-MRSI [8], a ¹H-MRSI data analysis software, to assess metabolic alterations in ALS patients. The goal is to evaluate and compare metabolic profiles across brain regions and ICNs. We hypothesize that ALS patients will exhibit lower total N-acetylaspartate (tNAA)/total creatine (tCr) and glutamate (Glu)/tCr ratios, and higher myo-inositol (mI)/tCr ratios, at different brain regions of ICNs compared to healthy controls (HCs).

Twenty-nine ALS patients (average age: 57.34 ± 9.36 years; 16 females, 13 males) with various onset regions, including bulbar (n = 10), cervical (n = 9), and lumbosacral (n = 10), along with 27 healthy controls (HC, average age: 48.44 ± 10.47 years; 16 females, 11 males) were included in this study. Written informed consent was obtained from all participants, and the study received approval from the local Institutional Review Board (IRB). ¹H-MRSI data were acquired using a 16x16 multivoxel sLASER sequence (TR=1700 ms, TE=40 ms, NS=1, VOI=80x80x15 mm³) at a clinical 3T Siemens scanner. T1-weighted (T1w, TR=515 ms, TE=10 ms) and T2-weighted (T2w, TR=6750 ms, TE=104 ms) MRI were also acquired. Oryx-MRSI, developed in MATLAB in 2020, was recently adapted to read and process Siemens MRS (.rda) data format. LCModel [9] was used for metabolite quantification. T1w and T2w MR images were converted to the NIFTI format, and FSL-BET [10] was used for skull stripping. Spectroscopic data and anatomical images were processed using Oryx-MRSI.

Preliminary results have been obtained for five ALS patients and five healthy controls. Metabolite ratios were measured at the thalamus, insula, putamen, and caudate regions. Group comparisons were conducted using a Wilcoxon rank-sum test, with significance set at p < 0.05. The ALS group exhibited significantly higher mI /tCr and lower total choline (tCho)/mI ratios at the insula and putamen (p = 0.032 for both).

The spectral quality will be checked using full width at half maximum (FWHM), signal-to-noise ratio (SNR), Cramér–Rao lower bound (CRLB), and cerebrospinal fluid (CSF) fraction thresholds in Oryx-MRSI. Tissue segmentation and image registration will be performed using the Oryx-MRSI pipeline (Figure 1). Spectroscopic voxel locations will be overlaid onto T2w MRI to create binary metabolite masks. Metabolite maps will be generated, corrected for partial volume effects, and saved in NIFTI format. These maps will then be registered to MNI space, combined across scans, and analyzed across ICNs to calculate metabolite ratios for group-level statistical analysis (Figure 2). Detection and quantification of metabolite ratio alterations within ICNs in ALS patients constitutes the primary outcome while examining demographic effects, associations with clinical variables, and the spatial distribution of metabolic abnormalities across brain regions are the secondary outcomes. The sample size aligns with previous MRSI studies [11, 12] in ALS and demonstrates the feasibility of recruitment, considering the rarity of ALS and the challenges of imaging these patients. Previous studies [13] reported mid to large effect sizes (Cohen’s d > 0.5) in smaller groups of subjects for alterations in tNAA, tCho, and Glu in affected motor regions. The differences in metabolite ratios relative to tCr and mI will be compared across ICNs between HC and ALS patients using a Wilcoxon rank-sum test. Group comparisons for demographics (e.g., age, education, metabolite levels) will be conducted between HC and ALS onset subtypes (bulbar, cervical, and lumbosacral) using a Kruskal–Wallis test, followed by a Dunn’s post hoc test for pairwise comparisons. Gender differences will be analyzed with a chi-square test. Associations between metabolite ratios and clinical measures, including disease duration and onset type, will be examined using Spearman correlation analysis.
Arda CANBAŞ (İstanbul, Turkey), Sevim CENGIZ, Gökçe Hale HATAY, Barış İŞAK, Alpay ÖZCAN, Alp DINÇER, Esin ÖZTÜRK IŞIK
15:39 - 15:42 #48987 - RR04 Optimizing 7T fMRI Denoising: Comparing Deep Learning Versus Traditional Methods.
RR04 Optimizing 7T fMRI Denoising: Comparing Deep Learning Versus Traditional Methods.

High-resolution laminar fMRI provides a unique window into cortical organization by resolving activity across different layers of the cortex. This is highly relevant for advancing our understanding of human brain circuitry and pathology, but requires submillimeter spatial resolution, which is challenging to achieve in practice. At ultra-high field strengths such as 7T, fMRI suffers from physiological noise, B0/B1 inhomogeneities and shorter T2* [1]. These limitations compromise statistical power and interpretability of laminar activation maps, often forcing a trade-off between spatial and temporal resolution. Post-acquisition denoising approaches have therefore become essential for preserving both sensitivity and specificity. While traditional methods such as PCA/ICA focus on removing structured noise, newer deep learning (DL) techniques show promise for recovering fine-scale signals without sacrificing resolution. The goal of this project is to systematically compare established denoising methods with a newly developed DL model tailored to laminar fMRI, with the aim of enabling faster, more reliable acquisitions in both research and clinical contexts.

We will evaluate five representative strategies for fMRI denoising. (1) Nordic, a PCA-based method, removes components with variance indistinguishable from Gaussian noise and has become widely used in recent fMRI studies [1]. (2) ICA-AROMA, a component-based approach, classifies independent components as motion-related or neural based on temporal and spatial features, regressing out the former while preserving signal of interest [2]. (3) AIReconDL (GE Healthcare) is a proprietary reconstruction-time DL algorithm based on fully convolutional networks applied in k-space [3]. (4) STIR-Net, originally developed for CT perfusion, is a multi-branch CNN that jointly addresses denoising, temporal interpolation, and resolution enhancement [4]. (5) An in-house U-Net–based model will be designed and trained on fMRI-specific data, allowing control over architecture, temporal modules, and loss functions to preserve spatial detail and temporal correlations. All methods will be applied to the same raw 7T fMRI datasets. Activation maps will be generated using AFNI with identical GLM pipelines across methods, ensuring comparability. Evaluation metrics include tSNR, SNR maps, cluster z-scores, and Dice overlap with high-SNR reference data (registered anatomical images). Repeated-measures ANOVA and mixed-effects models will be used to compare methods across subjects and regions of interest, with motion and physiological noise included as covariates.

Pilot acquisitions have been performed on a 7T SIGNA scanner (GE Healthcare) in three healthy volunteers, using 2D gradient-echo EPI with 0.8 mm isotropic voxels and TR = 3s and with 1mm isotropic voxels and TR = 2.5s. Synthetic paired datasets for supervised DL training have also been generated from a public fMRI repository [5] by introducing synthetic noise, providing ground-truth data for model development. Preliminary activation maps from visual and motor tasks demonstrate preserved task-related activity after denoising, suggesting all methods are compatible with high-resolution laminar fMRI.

We will extend acquisitions to a larger group of healthy volunteers and subsequently to drug-resistant epilepsy patients scanned at 7T. Comparative evaluation of all five methods will focus on improvements in tSNR, SNR maps, and activation z-scores, as well as preservation of spatial specificity at the laminar level. We hypothesize that the custom U-Net–based approach will outperform existing techniques by better modeling the spatiotemporal characteristics of fMRI data. This work will provide practical guidance on denoising strategies for laminar fMRI and has direct implications for advancing high-resolution studies of cortical microcircuitry and for clinical applications in neurological and psychiatric disorders.
Thomas Alan LOBOY RAMOS (Munich, Germany), Marta LANCIONE, Ana Beatriz SOLANA SÁNCHEZ, Laura BIAGI, Brice FERNANDEZ, Florian WIESINGER, Paolo CECCHI, Graziela DONATELLI, Benedikt WIESTLER, Michela TOSETTI, Marion MENZEL
15:42 - 15:45 #48991 - RR05 Assessing Graft Quality by NMR in Heart Donation after Circulatory Death.
RR05 Assessing Graft Quality by NMR in Heart Donation after Circulatory Death.

1.1 Background and motivation Donation after Circulatory Death (DCD) offers a growing pool of donor hearts [2,5,8], yet current graft assessment during Ex-Situ Heart Perfusion (ESHP) remains limited. Clinical practice still relies on lactate profiling[1] and visual inspection[11], both insensitive and non-specific measures of viability. In our previous study [3], we used a porcine DCD model to evaluate circulating factors and metabolites in donor blood and Ex-Situ Heart Perfusion (ESHP) perfusate as biomarkers of recovery. We identified several candidates measurable with NMR spectroscopy. However, our previous analysis relied on Spearman correlations, which detects only monotonic associations [6] and evaluates metabolites independently [13]. This approach overlooks non-uniform relationships, temporal dynamics, and multicollinearity. Although the previous standard analysis of the NMR data predicted graft performances very well, the coordinated metabolic responses that characterise graft recovery remain underexplored. 1.2 Hypotheses This study builds on our previous work by introducing trajectory-based modeling as the main advance. Main Hypothesis: Data collected at multiple timepoints during ESHP enable trajectory-based modeling, which provides improved resolution of kinetic relationships compared to our earlier cross-sectional analyses. Hypothesis 1: Metabolite–recovery relationships do not follow a uniform trend; individual metabolites show dynamic or time-dependent associations. Hypothesis 2: Recovery indicators are intrinsically interdependent, and their covariance structure shapes metabolite associations. Hypothesis 3: Strong multicollinearity exists within both recovery indicators and metabolites, requiring models that account for correlated predictors.

The preliminary dataset originates from our previous work[3], linking dynamic metabolite profiles measured by 1H-NMR spectroscopy to cardiac recovery outcomes across ischemia and reperfusion phases in porcine DCD hearts. For method development, we apply a suite of interpretable machine learning and deep learning approaches to extract temporal and multivariate patterns from these data.

Orthogonal partial least squares (oPLS) confirmed significant group separation across ischemic durations (Q² = 0.88, p < 0.001)[3] and perfusion phases, indicating robust metabolic signatures of ischemic stress. Initial exploratory study results Correlation analyses further revealed that multiple metabolites significantly associate with recovery markers at 60 minutes ESHP, many in a time-dependent manner. These findings establish the feasibility of extracting biologically relevant, temporally resolved patterns and support the need for advanced multivariate and kinetic modeling as proposed in our methodology.

4.1 Study protocol Male Schweizer Edelschwein pigs (55±7kg) underwent anesthesia and circulatory death was induced. Hearts experienced 0–30 minutes of warm ischemia, followed by cold cardioplegia and 30 minutes of cold storage. Hearts were perfused ex-situ 3 hours unloaded [7], then 60 minutes loaded, to assess functional recovery [3]. Cardiac function was measured after loading, including Left Ventricular (LV) work, developed pressure, Cardiac Output (CO), maximal contraction and relaxation rates, and tissue edema. Injury markers included troponin I and Heart-type Fatty Acid Binding Protein (HFABP). Perfusate samples were measured by 1H-NMR spectroscopy. Spectra were processed, baseline-corrected, and calibrated to lactate at 1.324 ppm. 104 spectral regions were integrated, normalized to buffer volume and heart weight, scaled by unit variance, and merged per metabolite. This dataset links dynamic metabolite profiles to cardiac recovery outcomes across ischemia and reperfusion times. 4.2 Statistical Analysis Plan Primary and secondary outcome measures Primary: Cardiac outcome measures (eg. LV work, CO) and injury markers (Troponin I, HFABP) Secondary: Network metrics (accuracy, precision, recall, area under curve, loss, Root Mean Square Error)[4] Statistical tests • Hypothesis 1, Main Hypothesis: Potential of Heat-diffusion for Affinity-based Transition Embedding (PHATE) for dimensionality reduction, Temporal Convolutional Neural Network for multivariate regression of time-dependent metabolite–recovery relationships • Hypothesis 2: Graph Neural Networks to model dependencies within recovery indicators and metabolites[10, 9] • Hypothesis 3: Elastinet and MultiTask ElasticNet for collinearity [12] Sample size calculation Our analysis does not use raw spectra but a curated set of 34 metabolites measured across 5 timepoints, yielding 170 temporal metabolite features. With 20–23 pigs, this results in roughly 0.118-0.135 samples per temporal feature. This sample size is sufficient to train interpretable models with resampling (eg. cross-validation, bootstrapping).
Ambra JIN (Bern, Switzerland), Peter VERMATHEN, Sarah HENNING LONGNUS, Selianne GRAF
15:45 - 15:48 #48995 - RR06 Non-invasive determination of bile acid composition in gallbladder and liver tissue using ultra-high field MRI.
RR06 Non-invasive determination of bile acid composition in gallbladder and liver tissue using ultra-high field MRI.

The goal of our project is to establish ultra-high field MR spectroscopy (MRS) methods for determining non-invasively bile composition in gallbladder and liver. When successful this will be used to help diagnosis patients with liver cholestasis. Cholestasis is the stagnation of toxic bile in liver which leads to inflammation and fibrosis. With the lack of efficient treatment options, liver cholestasis is the indication for approximately 10% of all liver transplantations. The main composition of the bile are bile acids which are synthesized by the liver and play an important role in human fat metabolism, especially emulsification, digestion, and lipid absorption [1]. Improved diagnostic methods for bile and/or bile acid composition will provide deeper insights into cholestatic disease progression and treatment efficacy. Previously, we [2] and others [3-6] have demonstrated the potential of in vivo 1H-MRS for quantifying various bile acids in humans, primarily in the gallbladder. However, to our knowledge, bile acids in liver tissue and/or hepatic bile ducts have not yet been determined. Furthermore, most previous studies used 1.5T and 3T MR scanners, and there is great potential for enhanced spectral resolution and signal intensity with higher magnetic fields [6]. Therefore, the study aims to: • Set up and optimize MRS protocols for bile acid investigations in gallbladder and liver at 7T (Siemens, Terra); • Assess intra- and inter-subject variability; • Determine the short-term impact of food intake on bile acids. Based on these validation studies, we hypothesise that changes in bile acid composition and concentration can be detected in patients with liver cholestasis.

Previously, we performed single voxel measurements in the gallbladder with respiratory triggering, positioning subjects in prone position to reduce motion artifacts [2]. Reproducibility was determined in repeated measurements including assessment of physiological and technical variation. Spectral fitting for the previous study and preliminary current measurements (see below) was done performed using jMRUI. Assigned metabolites included glycine and taurine conjugated bile acids (GCBAs and TCBAs), phospholipids, the trimethylammonium group of choline-phospholipids (chol-PLs), olefinic lipids and cholesterol (OLC), and choline-containing phospholipids (CCPLs) [Fig. 1]. Preparation measurements at 7T in location phantoms and gallbladder used STEAM and semi-LASER sequences with reduced chemical shift artifact (CSA). Spectra were measured separately for up-field and down-field regions to further reduce CSA. Similarly, liver MRS has also been performed at 7T in several studies, although not mainly targeting bile acids.

Besides our mentioned initial gallbladder study [2], preliminary (unpublished) 3T 1H-MRS investigations evaluated the sensitivity of bile acid detection and their in vivo dynamics following fat ingestion. Three healthy slim male volunteers (S1-S3) underwent MRS examinations at three time points: baseline after an overnight fast, and 5 h and 24 h after fat ingestion (180 ml, ~ 800 kcal). The pilot results demonstrated that bile acid composition changes can be monitored. Selected results from the three volunteers are shown in Fig. 2. Values at 5 h and 24 h were normalized to the pre value, representing fold-changes relative to baseline. Lipid concentrations in bile metabolites increased significantly within 5 h after drinking lipids and recovered after 24 h. Furthermore, in preparation of the anticipated study, measurements of several bile acid solutions and ex vivo measurements of bile aspirates were performed using a 11.7T NMR-Spectrometer and the 7T whole body MR scanner. These measurements demonstrated the advantage of higher field strength to better separate different bile acids.

Based on our previous studies described above, the following investigations are anticipated according to the hypotheses and aims (the number of subjects are based on power analyses using the previous results): • Setting-up a protocol and enhancing the spectral quality at 7T in both, gallbladder and liver by methodological improvement (mostly concerning the magnetic field homogeneity) in measurements of 5 healthy volunteers. It is hypothesized that more bile acids can be separated, especially including the glycine- and/or taurine-conjugated resonances of the amide proton (NH) signals in the downfield region (7.8-8.1 ppm). • Seven healthy volunteers will be investigated back-to-back and three weeks separated as in our previous study at 3T [2] to determine intra- and inter-subject variability and technical and physiological variation. • Eight healthy volunteers will be investigated before and after a standardized meal on the same day using a standardized time protocol to evaluate the sensitivity of the method. These initial sub-studies are essential before proceeding to clinical investigations in patients with cholestasis.
Yue ZHANG (Bern, Switzerland), Peter VERMATHEN, Dino KRÖLL, Guido STIRNIMANN, Reiner WIEST, Deborah STROKA
15:48 - 15:51 #48998 - RR07 Leveraging pupil and heart rate signals to understand attention-related effects during cognitive tasks.
RR07 Leveraging pupil and heart rate signals to understand attention-related effects during cognitive tasks.

Background and Motivation Physiological signals influence fMRI BOLD via neuronal and vascular mechanisms, but correction approaches may remove meaningful attention variance. RETROICOR and RVT address cardiac/respiratory artifacts (Glover et al., 2000; Birn et al., 2009) but they do not adequately model central arousal mechanisms that directly impact cognitive task performance. Heart rate fluctuations correlate with global signal, reflecting arousal-linked cerebral blood flow and sympathetic activity (Chang et al., 2009). Pupil diameter reflects sympathetic arousal and locus coeruleus activity (Joshi et al., 2016), providing a more direct measure of attention states than cardiac indices. Yet, pupil- vs. HR-derived modeling in fMRI remains unexplored. We propose a comparative framework to test whether pupil regressors capture attention-related BOLD variance more effectively than HR measures, focusing on salience and dorsal attention networks. Hypothesis We hypothesize that pupil-derived indices (in addition to baseline RETROICOR+RVT) will outperform HR-based indices in modeling attention-related brain activity. We expect (1) higher variance explained (ΔR²) and 10–15% tSNR gains in salience/dorsal attention networks, (2) higher mean beta weights for pupil vs. HR regressors in insula, dACC, and IPS, and (3) 10–20% greater reduction in task-correlated voxels, reflecting improved modeling of arousal-related variance.

The framework incorporates pupil diameter (Joshi et al., 2016) and heart rate (HR) as physiological regressors (Chang et al., 2009) alongside respiration (Birn et al., 2009) in extended GLMs of task fMRI. Pupil regressors (diameter, velocity, dilation) were modeled at 0–3 s lags, consistent with pupil–BOLD coupling (Eren et al., ISMRM 2024). Data from n=4 healthy volunteers performing an arithmetic task on a 3T system (GE-EPI, TR=3 s, TE=36 ms, 2.5 mm isotropic resolution) were analyzed. Three models were tested: (1) RETROICOR+RVT, (2) RETROICOR+RVT+HR, (3) RETROICOR+RVT+Pupil. Group-level GLMs were computed to compare variance explained, tSNR, and task-evoked activation patterns in salience and dorsal attention networks.

Our multimodal pipeline has been validated in >15 fMRI sessions (rest/task) with synchronized pupillometry, EEG, PPG, and respiration, yielding ~75% usable pupil data. Preliminary GLMs show pupil regressors (0–3 s lags) correlate with BOLD in insula and IPS. Cross-correlations highlight strongest pupil–BOLD coupling in salience and dorsal attention networks. GLM tests (p<0.01, cluster ≥30, NN=2) reveal reduced task-correlated voxel counts in ROIs (insula, visual cortex, IPS) when autonomic regressors are added, strongest in insula. Comparison with RVT regressor indicates differential impact on task activation maps, with pupil consistently explaining additional variance in arousal-sensitive regions. Autonomic correction selectively reduced anticorrelated voxels near ventricles while preserving task-related activation patterns.

Study Protocol We are conducting a study with healthy volunteers, targeting N=20 participants with reliable pupil detection. All scans use a 3T MRI system with a 20-channel head coil. The protocol includes: Task-based fMRI (GE-EPI, TR=3 s, TE=36 ms, voxel=2.5 mm isotropic) Simultaneous EEG, ECG, respiration, PPG, and pupil recordings Data Analysis Plan Physiological noise correction will use RETROICOR (Glover et al., 2000) for cardiac and respiratory regressors. GLM analyses will then incrementally account for slow/autonomic components: RETROICOR+RVT: adds RVT for slow breathing fluctuations. RETROICOR+RVT+HR: adds HR from PPG as autonomic index. RETROICOR+RVT+Pupil: adds pupil diameter as arousal/attention marker. ROI analyses will focus on insula, dACC, and IPS, as key salience and dorsal attention nodes hypothesized to show differential sensitivity to autonomic vs. pupil-linked contributions. Statistical Analysis Plan Primary Outcomes ΔR² relative to RETROICOR+RVT Mean beta weights (pupil vs. HR) BOLD sensitivity: mean tSNR in ROIs Task preservation: voxel overlap and mean t-value differences in task-activated regions Sample Size Justification Preliminary voxel-count data show medium effects in IPS (13.5% reduction, 520→450 voxels, d=0.54) and large effects in total activation (26.8% reduction, 4100→3000 voxels, d=1.79). For the IPS outcome, n=20 provides >85% power to detect medium–large effects (d≥0.5) at α=0.05, accounting for within-subject correlations and data exclusion. These activation differences indicate n=20 is also sufficient for tSNR and variance explained improvements. Statistical Tests Paired t-tests for ΔR², mean beta weights, tSNR ANOVA for model comparisons FDR correction (q<0.05) for voxel-wise results Dice coefficient for task activation overlap
Şirin Yağmur ABACI (Istanbul, Turkey), Kübra EREN, Fatmatüzzehra UÇAL, Lina ALQAM, Cem KARAKUZU, Alp DINÇER, Pınar Senay ÖZBAY
15:51 - 15:54 #49004 - RR08 Investigating the feasibility of ihMT in short T1d samples on a clinical system.
RR08 Investigating the feasibility of ihMT in short T1d samples on a clinical system.

Inhomogeneous Magnetization Transfer (ihMT) [1], [2] is an advancement of the MT MRI technique that focuses on selectively probing local dipolar interactions. Unlike MT or T1rho [3] methods, ihMT is directly sensitive to the spatial organization and microstructural order of macromolecules, thus providing a direct measure of tissue integrity via the dipolar relaxation time (T₁d​). While its potential has been demonstrated in neuroscience (and its sensitivity to myelin has been validated with fluorescence microscopy[4]), the translation of ihMT to musculoskeletal imaging on clinical systems remains largely unexplored, presenting an opportunity for clinical innovation. Due to the highly ordered, anisotropic nature of collagen-rich tissues, we can hypothesise that they will generate ihMT contrast. Furthermore, ihMT's sensitivity to the dipolar order would make it a promising tool for early detection of degenerative changes in tissues long before they are apparent on conventional imaging, applicable for a variety of pathologies that affect connective tissue structure.

The proposed MRI methods will use the difference between two inhomogeneous Magnetization Transfer (ihMT) pulse sequences. The first, a cosine-modulated sequence, is designed to generate the unfiltered ihMT signal. The second sequence employs T₁d​-filtering, which selectively suppresses the signal from short T₁d species by using a longer switching time. The goal of this work is to verify that subtracting the two can isolate the signal from these short T₁d species. Based on the works of Varna et al and Prevost et al [2], [5] an ihMT-RAGE acquisition will be implemented due to its proven applicability in clinical systems.

A literature review of ihMT in musculoskeletal tissues has shown that, while feasible, it presents unique challenges [6]. Preliminary work has shown the feasibility of inhomogeneous magnetization transfer (ihMT) in muscle tissue [7] highlighting the importance of using a Dixon method to reduce the signal contribution from fat infiltration. Two ISMRM abstracts [6], [8] have shown ihMT's application with preclinical systems in a variety of collagen rich tissues indicating that the technique can generate contrast in these tissues. Furthermore, an NMR paper has investigated ihMT on tendon samples [9].These studies revealed that while ihMT is feasible in collagen-rich samples, unique challenges arise due to the progressively shorter T₁d relaxation times characteristic of such tissues. This phenomenon occurs because of dipolar order destruction at aqueous/non-aqueous interfaces[10]. T1d filtering [2] is a technique that manipulates the switching time (Δt) in order to filter out the ihMT signal from species with very short T₁d​ values. This is achieved by increasing the delay between alternating RF pulses, allowing the magnetization from these short T₁d components to decay back to equilibrium, while preserving the signal from components with longer T₁d​ values.

We hypothesize that our method can detect tissues with short dipolar relaxation times. To test this hypothesis, we will construct a composite phantom containing distinct regions with known long and short T₁d properties, using materials such as hair conditioner, 4% agar solution, and 3% and 7% gelatin solutions. All imaging will be performed on a clinical 3T MRI scanner (Magnetom Prisma, Siemens Healthineers, Erlangen, Germany). ihMT ratios will be calculated from the unfiltered and filtered acquisition as in figure 1, while ihMTR for short T₁d components is then determined by subtracting the normalized T₁d-filtered ratio from the normalized cosine-modulated ratio (see figure 2). We predict that the mean ihMTR short will be significantly greater than zero in phantom regions with short T₁d values. As a control, we expect the mean ihMTR short in long T₁d regions to be significantly lower than in short T₁d regions. Since the specific Δt values from preclinical studies may not be optimal for clinical systems, we will adapt these parameters during optimization. Initially, we will use the shortest possible switching time for our non-filtered, cosine-modulated acquisition, and a longer switching time for the T₁d-filtered acquisition. As this method has not been characterized in terms of natural variability in the considered samples, the nature of this project is exploratory. Our primary statistical tool will therefore be the description of the value distributions observed in the measured samples. We will also perform a reproducibility analysis of the methodology by scanning the phantom twice and calculating the repeatability coefficient of the methodology.
Marta Brigid MAGGIONI (Basel, Switzerland), Francesco SANTINI
Auditorium 900

"Saturday 11 October"

Added to your list of favorites
Deleted from your list of favorites
C35
15:00 - 16:00

FT3 Oral - Optimizing the MR Signal

Chairpersons: Beatrice LENA (Ph.D.) (Chairperson, Leiden, The Netherlands), Moritz ZAISS (Professor) (Chairperson, Erlangen, Germany)
15:00 - 15:10 #47867 - PG055 Breast Digital Twin: simulating with MR-zero.
PG055 Breast Digital Twin: simulating with MR-zero.

MR-zero is an MRI simulation framework based on Phase Distribution Graphs (PDG) [1]. In recent years, it has proved itself a very useful tool by providing realistic previews and optimizations of many sequences with phantom or even in-vivo digital twin setups [2,3]. Most proofs of concept for this simulation focused on brain MRI. With this work we propose to use MR-zero to simulate for the first time breast MRI, while also experimenting with the newest MR-zero extension: simulation of off-resonance RF pulses [4]. The proposed breast digital twin phantom allows to simulate several artefacts usually seen in breast MRI, such as chemical shift artefacts, fat-water interference, asymmetric B0 shimming and areas of high signal intensity near the breast surface due to the proximity of the receiving coil [5].

In this work, the Phase Distribution Graph Simulation within the MR-zero framework was used for simulation [1,4]. For simulation, an in-silico breast phantom or breast digital twin is required. To create this, we used a coarse segmentation of fat, fibroglandular tissue (FGT) and muscle based on a frequency selective 3D CEST MRI scan and the method presented in [6]. Using segmentation masks, we assigned to each voxel literature values for T1, T2, frequency shift and diffusion coefficient [8-12]. For the phantom voxels that contained fat, the corresponding voxels in the B0 map where set with the frequency shift of the main fat peak at 7 T (-3.4 ppm -> −1013 Hz). Additionally, the phantom was altered to reproduce (i) realistic B0 and B1+ field inhomogeneity using the corresponding B0 and B1+ maps measured in the subject at 7T, (ii) B1- coil sensitivities with stronger sensitivity in the left breast periphery, emulating closeness of the breast to the receiving element. In this work, a FLASH sequence coded with PyPulseq [7] is used with default parameters TE = 1.9 ms, TR = 8.16 ms, FOV = 350 mm x 350 mm x 4 mm, matrix = 128 x 128, flip angle = 8°, centric reordering and bandwidth = 800 Hz/pixel. This sequence was simulated in a first exercise in three flavours: (i) FLASH, (ii) fat-sat prepared FLASH, (iii) FLASH using binomial water excitation pulses. The setup of these preparations is the same as used in [4]. Then, we simulate the FLASH sequence with 4 multiplicative bandwidth factors to visualize the fat voxel shift in the readout direction. Finally, we modify the phantom to have voxels with overlapping fat and FGT. This phantom is used to simulate FLASH sequences with different echo times, with which we image with in-phase and opposed phase fat and water spins.

In Fig. 1, the parameter maps for the phantom used in simulations are shown. In the T1 and T2* maps, 3 different structures can be identified: fat, fibroglandular tissue and muscle tissue, segmented using the method in [6]. In Fig. 2(a-c), we see the simulation of the FLASH sequence for the phantom set up with homogeneous ∆B0, B1 and coil sensitivity. The images presented are the result of simulating a simple FLASH excitation and readout, the same sequence with fat saturation and, finally, with water excitation. In 2a, all tissues emit high signal, the higher signal in FGT being due to its higher apparent T2. In 2b and 2c, the absence of fat signal and the brightness of FGT, respectively, reveal that fat saturation and water excitation were effective. In Fig. 2(d-f), the effect of adding inhomogeneous conditions is shown. The more significant effect appears in Fig. 2f with the introduction of the coil sensitivity profile, where the right breast emits a higher signal than the left. In Fig. 3, the displacement of fat pixels with decreasing bandwidth is depicted, a common observation in real measurements. Finally, in Fig. 4, the phantom used for simulation is interpolated to have overlapping voxels of fat and FGT (Fig. 4a). When simulating for different TEs (Fig. 4b-c), in voxels with both tissues, we find signal variation due to the tissues’ different resonance frequencies. In Fig. 4b, the higher signal intensity reveals fat and water are in phase, while in Fig. 4c the reduced intensity reveals they are opposed.

With this work, the potential of MR-zero for breast MRI planning and testing was showcased. Different features were tested, revealing the simulation’s capability of recreating artefacts commonly seen in breast MRI such as fat pixel displacement, fat-water dephasing, and selective saturation/excitation effects. The new extension of the simulation presented in [4], which allows the use of off-resonant RF pulses, was used for the simulation of fat saturation and water excitation FLASH sequences, which produced results according to the expected. In conclusion, simulating realistic breast MRI acquisitions is now an easy extension to the work previously developed with MR-zero which, so far focused on brain MRI. Fast prototyping and testing of new (Pulseq) sequence approaches for MAMMA MRI is now possible with realistic and fast simulation feedback.
Magda DUARTE (Erlangen, Germany), Felix DIETZ, Tobias DORNSTETTER, Jonathan ENDRES, Simon WEINMÜLLER, Sebastian BICKELHAUPT, Moritz ZAIß
15:10 - 15:20 #45718 - PG056 Comparison of Retrospective Ripple Artifact Reduction Techniques for MR Images of Total Hip Arthroplasties.
PG056 Comparison of Retrospective Ripple Artifact Reduction Techniques for MR Images of Total Hip Arthroplasties.

Slice encoding for metal artifact correction (SEMAC) is commonly employed in MRI scans of total hip arthroplasties to mitigate metal artifacts [1]. However, the combination of spectral profiles during image reconstruction can result in ripple artifacts, which may impact diagnostic accuracy near the implants [2,3]. Wahlen et al. have shown with simulated SEMAC images that ripple artifacts exhibit a distinct distribution in the frequency domain [4]. The objective of this work was to compare filtering approaches in Fourier and wavelet domain for ripple artifact reduction in SEMAC images of patients with total hip arthroplasty.

Ripple Artifact Characteristics: According to MRI simulations by Wahlen et al. [4], ripple artifacts in SEMAC images have distinct spatial frequencies in the range of 0.5-2.0 cm^-1 (Figure 1a). MR Imaging: To verify simulated artifact behaviour with real measurements, we acquired images of a phantom that is comparable to the implants on the in-vivo SEMAC images. The implant phantom contained a total hip arthroplasty (titanium stem and cup, cobalt-chromium femoral head; Medacta, Castel San Pietro, Switzerland) embedded in a five-liter plastic container filled with gadolinium-doped water. Coronal SEMAC images of the phantom were obtained using a 3T MRI scanner (MAGNETOM Prisma; Siemens Healthineers AG, Forchheim, Germany) at Balgrist Campus, Zurich, Switzerland with a 32-channel spine-coil and an 18-channel body-coil. The imaging parameters were TR/TE: 2000/20ms, voxel size: 1.2x1.2mm2, bandwidth: 500Hz/Px, slices: 28, slice thickness: 5mm, SEMAC steps: 16. Additionally, we processed coronal compressed sensing-based STIR SEMAC images of one patient with total hip arthroplasty. The images were obtained using a 1.5T MRI scanner (MAGNETOM Sola; Siemens Healthineers AG, Forchheim, Germany) at Balgrist University Hospital, Zurich, Switzerland with a 32-channel spine-coil and an 18-channel surface-coil. The imaging parameters were TR/TE: 5000/37ms, TI: 145ms, voxel size: 1.0x1.0mm2, bandwidth: 539Hz/Px, slices: 28, slice thickness: 3.5mm, SEMAC steps: 12) [5]. The corresponding images and Fourier domains (FD) are shown in Figure 1b and c. Data Post-Processing: The in-vivo data was filtered in both domains, i.e. Fourier and wavelet domain, and image quality compared for both filtering techniques. Fourier Domain Filter (FD-Filter): To filter spatial frequencies related to ripple artifacts, we implemented a FD-Filter (Figure 2a): After applying the Fourier transformation (FT) to the manually drawn Region-of-Interest (ROI) with the artifact, we determined the radius r of the radial spectral energy density (RSED) distribution peak while neglecting low frequency components [4]. A Gaussian ring mask with radius r and adjustable width was then applied to the k-space data within the ROI, followed by an inverse FT. Wavelet Domain Filter (WD-Filter): Ripple artifacts exhibit a short wave-like pattern, making the wavelet domain (WD) appropriate for artifact filtering [6](Figure 2b). Three wavelets, Beylkin (beyl), Daubechies (db), and Fejer-Korovkin (fk), were used for the wavelet transformation (WT). Within the ROI, the detail coefficients linked to the ripple artifacts were nulled, using a variable threshold based on the peak WD signal. The filtered image was finally obtained by an inverse WT.

Applying the FD-Filter with varying Gaussian ring mask widths shows reduced ripple artifacts (Figure 3). While a larger width reduces more ripple artifacts, it also increases image blurriness. Furthermore, the ROI borders in the image are distinctly noticeable, particularly with the broader masks, which can disrupt the visual coherence of the image. The ROI's FD indicates that the distinct frequency distribution of the ripple artifacts can be effectively removed, however at cost of image quality. The WD-Filter with different wavelets significantly reduced ripple artifacts with no visible wave-like patterns remaining (Figure 4). The beyl and db wavelets introduced more blurring than the fk wavelet. Artifact removal is also visible in the FT ROI.

Both filters can reduce ripple artifacts, but the FD-Filter leaves residual artifacts and compromises image quality, making it unsuitable for clinical use. Precise filtering with optimal radius through RSED distribution is challenging, as the peak is often unclear in in-vivo images due to high k-space intensities overlapping with ripple artifact frequencies. In contrast, the WD-Filter effectively eliminates these artifacts without affecting image quality. We also noted the removal of frequencies corresponding to the artifact in the ROIs FD. Furthermore, individually adjusting the filtering threshold for specific artifacts allows for more adapted corrections.

Both approaches can effectively reduce ripple artifacts. However, the WD-filter outperforms the FD-filter in terms of image quality. This filtering method can be particularly beneficial for imaging patients with hip arthroplasties.
Jeanette Carmen DECK (Zurich, Switzerland), Reto SUTTER, Constantin VON DEUSTER
15:20 - 15:30 #45821 - PG057 On the influence of slice profile and flip angle on the signal of frequency-modulated bssfp sequences.
PG057 On the influence of slice profile and flip angle on the signal of frequency-modulated bssfp sequences.

BSSFP sequences offer the highest SNR per unit time of any known MRI sequence, coupled with short scan times. Their signal amplitudes are distinctly influenced by off-resonance and sensitive to alterations in T1, T2, flip angle and TR [1,2]. Various phase-cycled bSSFP approaches [3-5] for quantitative MRI are already exploiting this characteristic off-resonance profile [6]. The signal behavior in the complex plane is described by Eq. (1) – (4) [3-6] in Fig. 1. Thereby, M0 is the equilibrium magnetization, α the flip angle, and θ the spin phase evolution per TR. Current bSSFP-based mapping approaches require multiple phase-cycled image acquisitions to employ the elliptical signal model. A frequency-modulated (fm) method captures the entire phase cycle in a single measurement [2,7,8] by slowly shifting the phase of the pulse with each acquired k-space line. For slow shifts, the elliptical signal model can closely approximate the fm-bSSFP signal [7,9]. In 2D measurements, the slice profile of the RF pulse can distort the signal, which previously called for improved slice profiles [10]. In contrast, we propose a new fitting model (Fig. 1, Eq. (5)) that accounts for the slice profile by summing up the elliptical signal for N flip angles.

Measurements were performed on a 3T scanner (Magnetom Prisma Fit,Siemens Healthineers, Forchheim, Germany) with a 16-channel head coil, using turkey meat as test specimen with relaxation times similar to human tissue. Reference relaxation times were determined by inversion recovery (T1) and multi-echo spin-echo measurements (T2). Three Sinc pulses with different durations (RF_dur = 0.9, 2.16, 5.4 ms) and time-bandwidth products (tbp = 3.0, 7.2, 18.0) were applied in fm-bSSFP slice profile measurements and imaging with different flip angles (20°, 40°, 60°). First, fm-bSSFP signals were simulated using Bloch equations to illustrate the effect of slice profile quality on the complex signal. Then, signals with a range of T1 (300 ms < T1 < 2000 ms) and T2 (10 ms < T2 < 300 ms) were generated from the proposed model, including the measured slice profiles. After adding artificial white noise, the signals were fitted according to Eq. (5) and (1) and the fitted relaxation times were compared to the input. Other settings in this in silico study were similar to the measurements. 2D fm-bSSFP measurements were acquired using tiny golden angle radial sampling with settings: RF_dur = 0.9 ms, tbp = 3.0, RF-Bandwidth = 3.33 kHz, modulation rate = 0.01°/TR, FA = 20°, 40°, 60°, TR = 2*TE = 8.0 ms, resolution = 1.2 x 1.2 mm^2, slice thickness = 10 mm, bandwidth = 980 Hz/px, 36864 spokes, T_AQ = 4:55 min. Reconstruction included gridding and a sliding window reconstruction with 360 k-space lines per image, resulting in 100 images per phase cycle. The center of the measured signals was rotated to the positive x-axis using parts of the CELF [4] algorithm. Relaxation times and RMSEs from fitting according to Eq. (1) and (5) were compared.

Pulse shapes and measured slice profiles are shown in Fig. 2. Bloch simulations show that considering the slice profile results in severe deviations from the elliptical signal model (Fig. 3(a) and (b)). Fig. 3(a) illustrates that distortion of the signal shape is present for all pulses and strongest for the shortest pulse. Fig. 4 demonstrates how these distortions corrupt fitting T1 and T2 with the elliptical signal model over the simulated range of T1 and T2. Employing Eq. (1) results in severe systematic over- or underestimation (a-d,i-l). For (Eq. 5), the deviations stay within 10 % of the ground truth. However, deviations in T1 increase with increasing T1 (e-h), and in T2 with increasing T1 and T2 (m-p). Fig. 3 (c) – (e) show exemplary measured signals from the turkey meat specimen (reference: T1= (803 ± 24.3) ms and T2 = (37.9 ± 0.51) ms). Relaxation times obtained from the elliptical model (Eq. 1) show drastic underestimation for T1 (75 % to 92 %) and a smaller underestimation for T2 (17 % to 19 %). Taking the slice profile into account, T1 is underestimated by 3 % to 25 % and T2 by up to 9 % for the 20° pulse. The RMSEs are significantly smaller (factor 2) for the proposed model (Eq.5).

The signal of 2D fm-bSSFP shows clear deviations from the elliptical model (Eq.(1)) due to different flip angles across the slice profile. Model-based relaxometry thus either requires optimized pulses or an improved model, as proposed here. The latter allows a free choice of pulse shape and flip angle, enabling shorter RF pulses, TR and scan time reduction as well as SAR optimization. Future approaches should eliminate the necessity to measure the slice profiles, for example by working with estimated slice profiles based on the implemented pulse shapes. Furthermore, in vivo validation is necessary.

The proposed signal model, which considers the slice profile, provides a more accurate quantification of relaxation times with fm-bSSFP than models ignoring the slice profile.
Clemens MEY (Würzburg, Germany), Hannah SCHOLTEN, Herbert KÖSTLER, Anne SLAWIG
15:30 - 15:40 #47724 - PG058 Simulating how tissue microstructure affects multimodal MRI.
PG058 Simulating how tissue microstructure affects multimodal MRI.

MRI has many different contrast mechanisms that are sensitive to tissue microstructure, including diffusion-weighted MRI, susceptibility-weighted MRI, magnetisation transfer, and quantitative relaxometry. Many of these MRI modalities are sensitive to different aspects of the same microstructural components (e.g., myelin). Thus, combining information across modalities may provide a more comprehensive view of tissue microstructure. However, different modalities are usually analysed in isolation with each one coming with its own set of models and assumptions. Here we present a new Monte Carlo MR (MCMR) simulator[1] that aims to capture different ways in which tissue microstructure can affect the MRI signal evolution for a wide range of MRI sequences (Figure 1).

MCMR simulator was implemented in the Julia programming language[2]. It has both a Julia and command line interface, with comprehensive documentation and tutorials available for both. An overview of the simulator methodology is shown in Figure 2. Briefly, the user synthesises a tissue geometry (consisting of any combination of infinite walls, infinite cylinders, spheres, and arbitrary meshes), and defines one or more MR sequences for which the MR signal will be computed in parallel. These sequences can include finite or instantaneous radiofrequency (RF) pulses and gradients and can be flexibly defined by the user or directly read from pulseq files[3]. For each sequence the simulator predicts the MRI signal for a single voxel. The simulator uses a Monte Carlo approach, where for each simulated isochromat we consider (“Tissue Properties” in Figure 1): 1. The isochromat random walk hindered by tissue membranes (which might be permeable). 2. Longitudinal (T1) and transverse (T2) relaxation times, which can vary in individual cells/compartments. 3. The tissue magnetic susceptibility affecting the local magnetic field strength. 4. Surface relaxation and/or magnetisation transfer at the tissue boundary. All of these features are supported for simplified geometries of cylinders or spheres as well as full meshes. Parameters controlling these effects can be set per cell type, per individual cell, or even for a patch of membrane within a cell. More details on the methodology can be found in our preprint[1].

Figure 3 illustrates the simulator result for a diffusion MRI sequence and a magnetisation transfer sequence in a substrate made of randomly distributed parallel cylinders. While analytical approximations such as the Gaussian phase approximation[4] for diffusion MRI and the binary spin-bath model[5] for MT give accurate results in certain regimes, they cannot capture all effects, such as the attenuation at high b-values (Figure 3A) or at long mixing times within the free water compartment (red line in Figure 3B).

By combining the effects of diffusion, permeability (exchange), magnetic susceptibility, and magnetisation transfer in the MCMR simulator, we allow for a more coherent analysis of how the tissue microstructure affects the MRI signal across different modalities. For example, the simulator could be used to: • Identify how the various simulated features affect the estimates of modalities where they are not usually considered, such as the effect of permeability and magnetisation transfer on diffusion MRI measurements[6]. • Optimise acquisition protocols for specific aspects of the tissue microstructure[7]. • Model fitting for MR modalities for which no accurate analytical approximations exist, such as MR fingerprinting[8,9]. • Investigate how tissue microstructural changes affect the MRI signal across multiple modalities (Figure 4). This could be used to help interpret changes seen in multi-modal MRI acquisitions.

By supporting arbitrary sequences and multiple signal formation mechanisms, the new MCMR simulator[1] enables MR signal prediction across multiple MR modalities and the development of new MR sequences.
Michiel COTTAAR (Oxford, United Kingdom), Zhiyu ZHENG, Karla MILLER, Benjamin C. TENDLER, Saad JBABDI
15:40 - 15:50 #47975 - PG059 k-Space Representation of Arbitrary 3d Shapes for Signal Simulation.
PG059 k-Space Representation of Arbitrary 3d Shapes for Signal Simulation.

MRI signal simulation methods generate synthetic k-space data which can be used for testing new reconstruction methods or for educational purposes. In the past, k-space simulations of $2$d- objects have been integrated into the open-source software BART [1] by using the analytical Fourier transform of geometric objects [2,3,4]. In this work, we extend the simulation framework in BART by providing a generic implementation of the analytical Fourier transform of arbitrary shapes which are described by a triangulation of their surface. This triangulation can readily be obtained from 3D modelling or segmentation software by storing the geometry in the STL fileformat which is the standard fileformat in 3d printing. We demonstrate our simulation by generating k-space for the complex $3$d geometry of a human brain.

The extended BART k-space signal simulation framework generates for each tissue type an individual signal using the usual signal equation in parallel MRI (1) with $z$-component of the field as described by Eq (2). The magnetization function $M$ of one tissue type has a constant value over the geometric area where the tissue is present and tissue-specific properties like relaxation $R2 = 1/T2$ or tissue-dependent off-resonances can be pulled out of the integral (3). One obtains Eq. (4) using the convolution theorem and since the sensitivities are smooth functions, their representation in k-space decays rapidly which leads to Eq. (5). The surface of the volume $\Omega_M$ is decomposed into $M$ triangles. The segmentation was created with ITK-Snap [5] and containts grey matter, white matter, and CSF of a human brain of a healthy volunteer scanned on a 3T scanner (Siemens Healthineers, Erlangen) from a healthy volunteer with written informed consent. We acquired 3d data with MP2RAGE, MPRAGE and FLASH sequences. The Fourier transform of the indicator function of the triangulated volume can be simplified to a weighted sum over the Fourier transforms of the triangles over its surface according to Eq. (6). The Fourier transform for triangles was used in previous work [2,4]. For 3d simulation of the segmented tissue, the magnetization function M in (1) is the indicator function of the triangulated volume.

We found that the 3d MP2RAGE sequence with a voxelsize of isotropic 1mm is best suited for segmentation of grey matter, white matter, and CSF (TE 2.96ms, TR 5s, TI$_1$ 996ms, FA$_1$ 4 degree, TI$_2$ 2990ms, $FA_2$ 5 degree, resolution of 256x216x128). Figure 3 shows the resulting segmentations. For k-space signal simulation, Eq. (1) was evaluated on a 3d Cartesian lattice with matrix size 128x128x128. The resulting single-channel dataset was reconstructed using the 3d inverse discrete Fourier transform and showed typical ringing artifacts as shown in Figures 4 and 5. The implementation of Eq. (6) was parallelized and the computations were performed on a hardware with 256 cores AMD EPYC 7662 and took ca 4h for an STL file with ca 500000 triangles for 128x128x128 pixel.

The simulation of k-space signals for the segmentation volumes that are described by triangles was successfully implemented and the reconstructed images show realistic MRI-specific artifacts such as ringing due to the limited number of high-frequency k-space datapoints. The generic implementation of Eq. (6) as part of the BART simulation framework enables one to extend the simulation with arbitary k-space sampling trajectories, T2 relaxation, off-resonances, and coil sensitivity encoding as shown in Eq. (5) and described previously [2] and can be included to obtain even more realistic tissue simulation. The implementation of Eq. (6) can be further improved by making use of GPUs.

We extended the BART simulation framework by including the implementation of the analytical Fourier transform of generic shapes whose surface is described by triangulation. The k-space simulation of STL files obtained by segmentation of MRI images allows a direct comparison of the simulated k-space signals with MRI measurements.
Martin HEIDE (Göttingen, Germany), Martin UECKER
15:50 - 16:00 #47826 - PG060 Variable flip angle chemical shift encoded MRI for PDFF, T1 and R2* estimation in whole body imaging.
PG060 Variable flip angle chemical shift encoded MRI for PDFF, T1 and R2* estimation in whole body imaging.

Whole-body MRI (WB-MRI) is recommended for disease characterisation and treatment response assessment in metastatic cancers such as prostate, breast, and multiple myeloma [1]. A key component is fat-water imaging, with fat fraction maps being shown to outperform apparent diffusion coefficient in detecting early response in myeloma [2]. International guidelines for both advanced prostate cancer and myeloma recommend acquisition of a 2-point T1-weighted Dixon sequence as a compromise for combined morphological imaging and fat fraction estimation [3]. However accurate estimation of proton density fat fraction (PDFF) requires correction for several sources of error [4-9]. Fat quantification in bone marrow is sensitive to T1 bias, owing to the large difference in the T1 of the water and fat compartments [10]. Variable flip angle chemical shift encoded (VFA-CSE) MRI has been shown to minimize T1 bias in comparison to low flip angle approaches [11]. There is also potential for T1 to be a potential clinical biomarker for disease response. This study aimed to develop whole-body VFA-CSE MRI for accurate quantification of PDFF and T1 in bone marrow malignancies in the presence of significant T1 variation.

An in-house pulse sequence based on a 3D RF-spoiled gradient echo was used for VFA-CSE MRI. The manufacturer’s 6-point Dixon sequence from the LiverLab package was also run for comparison [12]. T1 validation was performed on the same scanner with using a relaxometry phantom [13]. B1+ maps were acquired with a Bloch-Siegert pulse sequence [14] to correct for transmit field inhomogeneities for the VFA-CSE approach. The nominal T1 values provided by the manufacturer of the vials were used as the reference without temperature correction. Volunteer whole-body scanning was performed as a proof of concept. The volunteer provided written consent to participate in the study. Validation of PDFF with MRS STEAM at 3T (for superior spectral separation) used a peanut oil phantom based on Zhao et al [15]. MRS was treated as the reference standard. Processing was performed in jMRUI using AMARES [16], with T2 correction prior to calculation of PDFF using a 7-peak model of bone marrow [17]. Details of sequence parameters are in Figure 1. Reconstructions were done in Python (3.12). A schematic flowchart of the approach is shown in Figure 2 [18]. To assess the value of including VFA in the signal model for PDFF estimation, the fit was completed with and without the second pass/joint fitting step. LiverLab data were reconstructed with the standard inline reconstruction, which assumes a fat spectrum of the human liver at body temperature. Comparisons for both T1 and PDFF with their respective gold standards were performed using Bland-Altman analysis. Volunteer data were acquired in five stations from skull vertex to mid-thigh and reconstructed to generate whole-body quantitative maps.

The proposed VFA-CSE MRI PDFF showed better agreement with MRS estimates than LiverLab in the phantom, as shown below in Figure 3. The vial with pure peanut oil was underestimated by VFA-CSE MRI compared to MRS (90.25% vs 100%). Considering only the first pass of VFA-CSE (PD-CSE), there is a nonlinear bias in PDFF, highlighting the importance of T1 correction. Similarly, inclusion of B1+ estimation into VFA-CSE reduces bias in T1 estimation from 14.0% to 6.5%. Coronal and sagittal reformats from the volunteer reconstruction are shown in Figure 4.

In this work, we have demonstrated VFA-CSE as a promising approach for PDFF and T1 estimation in a whole-body context. Superior agreement with spectroscopy can be achieved in tissues with large T1 disparities between fat and water, such as bone marrow, compared to a conventional PDFF reconstruction. The performance of the inline LiverLab reconstruction likely reflects the incorrect assumption of body temperature, which is known to be a significant confounder for magnitude-based fitting [19]. VFA-CSE MRI underestimated PDFF in the pure fat vial, though this fat fraction is not truly clinically relevant for treatment response in malignant bone disease [20]. The potential impact of partial spoiling was not modelled, which may explain part of the discrepancy in T1 following B1+ correction in the NIST phantom alongside temperature. For T1 to be used as an imaging biomarker, B1+ correction is necessary, particularly given the left-right variation in T1 seen in the volunteer’s pelvis and shoulders in Figure 2. Estimating it through signal modelling may require a third pass, as demonstrated by Roberts et al in liver [21]. This would necessitate an increase in the number of breath-holds or a reduction in the achievable resolution. Future work will investigate data-driven methods of B1+ estimation.

We have demonstrated a VFA-CSE acquisition and reconstruction for whole-body imaging in malignant bone disease, which corrects for T1 bias in PDFF measurements as well as providing T1 and R2* maps.
Azma YASSINE (London, United Kingdom), Pete J. LALLY, David J. COLLINS, Nina TUNARIU, Dow-Mu KOH, Christina MESSIOU, Geoff CHARLES-EDWARDS, Christina TRIANTAFYLLOU, Neal K. BANGERTER, Jessica M. WINFIELD
Espace Vieux-Port

"Saturday 11 October"

Added to your list of favorites
Deleted from your list of favorites
A35bis
15:00 - 16:00

Poster - Registered Reports and Project Abstracts

15:00 - 16:00 #48866 - PA11 In vivo tracking of mesenchymal stem cells using a novel fluoropolymer for 19F MRI.
PA11 In vivo tracking of mesenchymal stem cells using a novel fluoropolymer for 19F MRI.

Fluorinated polymers offer a highly versatile platform for MR probes, with tunable properties such as solubility, size, fluorine content, or responsiveness, allowing them to be tailored for specific imaging applications [1]. Therefore fluorine-19 magnetic resonance imaging (19F MRI) is a promising technique for non-invasive imaging due to its excellent specificity, as 19F isotopes do not naturally occur in biological tissues [2]. Among the various potential applications, the monitoring of mesenchymal stem cells (MSCs) using 19F MRI is promising due to their potential use in regenerative medicine and immunotherapy [3]. However, many existing fluorinated tracers are limited by low solubility, low fluorine concentration, or suboptimal biocompatibility. The aim of this project is to demonstrate the potential of a novel water-soluble fluorinated polymer that meets the criteria for long-term in vivo MSC monitoring after systemic administration.

A semi-fluorinated copolymer was synthesized via RAFT copolymerization of fluorinated TFEAM and hydrophilic HEAM monomer units [Fig. 1A]. The monomer ratio was optimized to balance fluorine content and water solubility for maximal 19F MR signal. The polymer’s hydrodynamic diameter was determined using dynamic light scattering (DLS). Sensitivity and relaxation times (T1 and T2) were evaluated using 19F MRI and magnetic resonance spectroscopy (MRS). Biocompatibility was assessed through AlamarBlue cell viability and hemolysis assays. Mesenchymal stem cells (MSCs) were isolated from rat tibiae and femurs, and their surface markers were confirmed via fluorescence-activated cell sorting (FACS). Cells were labeled with the novel fluoro-polymer (c = 10 mg/mL, 5×10⁶ cells) via endocytosis and subsequently visualized in both phantom and in vivo using a 7T MRI scanner following subcutaneous injection into the right flank of a mouse as a proof of concept.

The synthesized fluoro-polymer exhibited strong 19F signal and favorable relaxation times (T1 = 455 ms, T2 = 168 ms at 4.7T). Tracer was visualized even at low concentrations (0.625 mg/mL, [F] = 8 mM) in MR images and spectra [Fig. 1B, 1C]. To our knowledge, this is the first report of a biocompatible water-soluble 19F MRI polymer tracer successfully visualized at sub-mg/mL levels. Biocompatibility analysis showed no adverse effects on labeled cells. MSCs expressed positive markers and lacked negative markers. Injected labeled MSCs were visualized for up to 8 days using 19F MRI [Fig. 2], demonstrating the tracer’s potential for long-term cell tracking.

Building on these promising results, we are now focused on advancing to the non-invasive tracking at specific target sites (e.g., injured or inflamed tissues) after systemic administration of labeled MSCs. This transition presents new technical and biological challenges that require refinement across several components of the platform. Key areas of development include: • Chemical structure modification: We aim to find the optimal copolymer’s molecular architecture to optimize its biodistribution, fluorine density, and critically, particle size. Size plays a key role in cellular uptake, circulation time, and clearance. • Labeling strategies: Exploring improved cell labeling protocols to enhance endocytosis, intracellular retention, and functional viability of labeled MSCs after systemic administration, while minimizing tracer leakage. • Scan protocol optimization: Adapting optimized 19F MR protocols to maximize sensitivity for cell population detection. We welcome contributions from researchers with relevant experience, particularly those with a background in polymer chemistry and cell imaging.
Dominik HAVLICEK (Prague, Czech Republic), Ayca TUNCA, Andrea GALISOVA, Natalia JIRAT-ZIOLKOWSKA, Ondrej SEDLACEK, Daniel JIRAK
15:00 - 16:00 #48874 - PA12 Novel nanoparticles for dual labeling of pancreatic islets for luminescence and magnetic resonance imaging.
PA12 Novel nanoparticles for dual labeling of pancreatic islets for luminescence and magnetic resonance imaging.

Effective non-invasive monitoring of pancreatic islets is critical for their transplantation outcome and diabetes monitoring. Traditional imaging modalities offer either limited sensitivity or specificity when applied alone [1]. To overcome these challenges, multimodal imaging agents that combine magnetic resonance imaging (MRI) and optical modalities offer an integrated approach for high-resolution and high-sensitivity islet visualization. Lanthanide-based upconversion nanoparticles, particularly NaGdF4:Yb,Tb,Nd@poly(4-styrenesulfonic acid-co-maleic anhydride)-ethylene glycol (@PSSMA-EG) structures, have emerged as promising candidates for such applications due to their superior contrast in T2-weigthed MRI and strong upconversion luminescence properties [2].

NaGdF4:Yb,Tb,Nd@PSSMA-EG nanoparticles were synthesized and structurally characterized using transmission electron microscopy and dynamic light scattering. Relaxivity measurements were performed on a 1.5 T relaxometer to evaluate the T₁ and T₂ contrast properties of the nanoparticles [Fig. 1]. Isolated mouse pancreatic islets were incubated with nanoparticles and assessed for labeling efficiency and viability using fluorescence microscopy and viability assays. For in vivo validation, labeled islets were transplanted under the kidney capsule of recipient mice. Imaging was performed using 4.7T MRI to evaluate signal detectability and spatial localization [Fig 2].

The nanoparticles exhibited a uniform morphology and strong luminescent properties. MRI relaxometry and imaging confirmed relaxation properties suitable for both T₁- and T₂-weighted imaging. Islet labeling was efficient, and no adverse effects on islet viability or morphology were observed. In vivo experiments demonstrated successful high-resolution anatomical localization of transplanted islets under the kidney capsule using T₂-weighted MRI.

Following these promising results, future work will focus on improving in vivo sensitivity and extending the approach to systemic or portal vein transplantation models. Optimization of nanoparticle surface chemistry and islet loading protocols will aim to enhance biodistribution, retention, and signal stability. Further studies will also explore in situ labeling and real-time islet monitoring under pathological conditions (e.g., rejection or inflammation). Additionally, we plan to assess long-term biocompatibility and clearance of the nanoparticles, moving toward potential translational application. We welcome collaboration with researchers focused on nanoparticle engineering, cell imaging, and multimodal diagnostics.
Dominik HAVLICEK (Prague, Czech Republic), Oleksandr SHAPOVAL, Aminadav HALILI, Daniel JIRAK
15:00 - 16:00 #48918 - PA13 Fin2U 7T : the first Human 7T Research Center in Flanders, Belgium.
PA13 Fin2U 7T : the first Human 7T Research Center in Flanders, Belgium.

In January 2026, a new human 7T MRI research center will open at the Brussels University (VUB/UZB) Research Park in Zellik, Flanders, near Brussels, Belgium. The main objective is to make (happen) the transition from research to the clinic. Fin2U stands for Flanders Inter-University Ultra High Field and is the result of an unprecedented collaboration between all Flemish universities and university hospitals (5 universities and 4 hospitals). Funding is provided by the FWO (Flanders Research Foundation), the Flemish Ministry of Innovation, and all nine partner institutions: VUB & UZB (Brussels), KUL & UZL (Leuven), UG & UZG (Ghent), UA & UZA (Antwerp), and Hasselt University. The 7T scanner will be a full-option neuro and musculoskeletal (MSK) system. Body MRI and other applications will be made available later. Our facility will also be open to external academic and industrial collaboration proposals.

The 7T scanning schedule will be divided equally between internal academic research (conducted by the five partner universities) and external research, including industrial and non-medical projects. The governance structure for the Fin2U 7T MRI has been established, comprising a steering committee composed of the chairs of the involved university research departments. In addition, a scientific evaluation committee made up of MR scientists and radiologists from the five participating universities has been set up. Our 7T project is structured into six Work Packages (WPs), and will be conducted by a large multidisciplinary research team: WP1: Diseases of the Brain, WP2: Musculoskeletal Disorders, WP3: Renal and Abdominal Imaging, WP4: Cognitive and Motor Neuroscience, WP5: Machine Learning and Artificial Intelligence, and WP6: Ultra-High-Field MRI Image Optimization All external project applications will be assessed based on their scientific merit, practical implementation, and financial feasibility (w or w/o funding). Our 7T Research center will house a large number of MR Scientists, engineers, SW developers, statisticians, and medical specialists, from the 5 involved universities. Available at our 7T site : • Pulse sequence development, access to raw k-­space data & reconstruction • Access to GE developer and researcher network • Open source tools for engineering / pulse sequence development / reconstruction / image processing Collaboration projects may also be enhanced through partnerships with industry, such as GE HealthCare.

The 7T magnet is scheduled to be installed in October 2025. Scanning and the research program will commence in January 2026. The center is now open for project proposals in neurological, oncological and MSK-applications, as well as future abdominal 7T MRI applications. Local support (scan time, scientific man hours, post-processing) available on demand. Peculiarity : the list of authors represent all together more than 300 years of MR(I) experience. Contact: hubert.raeymaekers@uzbrussel.be

The 7T scanner is presented in the attachments (picture and one-pager).
Hubert RAEYMAEKERS (Brussels, Belgium), Johan DE MEY, Peter VAN SCHUERBEEK, Maarten NAEYAERT, Manon ROOSE, Stefan SUNAERT, Ahmed RADWAN, Ron PEETERS, Pieter VAN DYCK, Eric ACHTEN, Pim PULLENS, Koen CUYPERS, Jan CASSELMAN, Anja BRAU
15:00 - 16:00 #48967 - PA14 Residual Vision Transformer for Contrast-Enhanced MRI Reconstruction with Guided Enhancement Mechanism.
PA14 Residual Vision Transformer for Contrast-Enhanced MRI Reconstruction with Guided Enhancement Mechanism.

Brain tumors pose significant challenges when radiologists locate and identify them. Magnetic Resonance Imaging (MRI) is the most frequently used Imaging technique, providing fine-grained soft-tissue contrast [1]. Despite the advantages of MRI, limitations exist, such as low contrast and image artifacts, creating the need to use contrast agents when capturing an MRI image [2]. The use of chemical contrast agents is harmful in certain conditions and not feasible in some cases [3]. Therefore, the development of accurate non-invasive MRI contrast enhancement methods promises clinical benefits.

Previously, many methods [4] have been proposed for MRI contrast enhancement, including image synthesis and reconstruction tasks. Most of those methods belong to the Generative AI domain, demonstrating hallucination issues that are not acceptable in clinical diagnosis, where fine-grained and trustworthy details are needed. These methods are computationally expensive [5], sometimes generate unrealistic and unacceptable outputs, compromising the overall diagnosis [3]. Therefore, to overcome limitations, a promising self-supervised multi-modal MRI synthesis approach is proposed, utilizing readily available T1, T2, and FLAIR modalities to synthesize a contrast-enhanced T1ce-like image. In the proposed model, an uncertainty map is extracted using predicted and ground-truth maps and integrated into the generator loss as an auxiliary indicator.

Initial results on a public dataset, BraTS2021 (train=1696, validation=705, test=1387) showed 1% average SSIM (Structural Similarity Index and PSNR (Peak Signal-to-Noise Ratio) improvements over baseline methods. It highlighted the improved approach for structural fidelity in synthesized T1ce images. Although predicted results are not visually identical to ground-truth T1ce images, they achieve a greater visual similarity.

In the next phase, we are focusing on more self-supervised indicators to improve the results to meet the clinical needs. Furthermore, we are looking for neurosurgeons and radiologists to validate our work and to extend our work to apply to multi-centre datasets for robust deployment.
Talha MERAJ (Sligo, Ireland), Ian M. OVERTON, Michael MCCANN, Saritha UNNIKRISHNAN
15:00 - 16:00 #48997 - PA15 Dynamic myocardial T2* mapping as a marker of microvascular dysfunction in a mouse model of HCM.
PA15 Dynamic myocardial T2* mapping as a marker of microvascular dysfunction in a mouse model of HCM.

Background and motivation In HCM, microvascular dysfunction and altered oxygen dynamics are central disease mechanisms [1]. To probe these mechanisms noninvasively, T2* mapping offers a powerful imaging tool for assessing myocardial oxygenation. However, current T2* mapping approaches are typically limited to static, end-diastolic acquisitions due to low temporal resolution and motion artifacts, preventing dynamic assessment of myocardial oxygenation, especially in arrhythmic patients or small-animal models with high heart rates. Objective and Hypothesis Objective: To establish ΔT2*,norm derived from high-resolution 3D CINE T2* mapping as a novel imaging marker of microvascular dysfunction in the heart, by validating its sensitivity to alterations in myocardial oxygenation and iron handling compared to conventional mean T2*. Hypothesis: We propose that ΔT2*,norm is a more sensitive marker than mean T2* for detecting disease-related alterations. Such changes in myocardial T2* are expected to reflect compromised microvascular function, as impaired microvasculature alters tissue oxygenation and iron handling—both of which directly affect T2* relaxation times.

A total of 11 wild-type (WT) mice and 9 Mybpc3-KI mice, representing a genetic model of HCM, were included. 3D MGE readout was performed using a random gaussian sampling in ky-kz plane to densely capture the k-space center for spatial basis estimation [2]. To resolve both cardiac and respiratory dynamics, interleaved zero–phase–encoded scans were acquired (Fig.1). Flow artifacts from cardiac blood pools were reduced by incorporating flow-attenuation to the MGE sequence. An ICA-based retrospective gating was used for reliable binning of resp. and cardiac phases. Data was acquired using Bruker 9.4 T preclinical scanner. Motion-resolved 3D MGE images were reconstructed using a LRT framework [2]. To mitigate magnetic field inhomogeneities affecting T2*, second-order shimming was applied. Cine T2* maps were obtained by monoexponential fitting at apical, mid, and basal SAX-view. Myocardial blood flow (MBF) in mid-SAX was measured non-invasively using ECG-triggered cineASL CMR technique, which produced high-resolution dynamic myocardial blood flow maps [3]. Perivascular fibrosis fraction (PVF) was calculated from Sirius Red stained heart tissue sections to visualize collagen. The red-stained area around each vessel was quantified via digital image analysis and expressed as a percentage of the total perivascular area (vessel lumen plus surrounding tissue- Fig.3B). Statistical analysis was performed using the Mann–Whitney U test. Mean myocardial T2* and normalized dynamic T2* change (ΔT2*,norm: defined as T2* difference over cardiac phases, normalized to mean value) were evaluated across three standard SAX-views according to AHA17 for WT and Mybpc3-KI mice.

We did not detect a significant difference in mean myocardial T2* between the groups. Interestingly, ΔT2*,norm revealed clear differences between groups. while WT mice exhibited pronounced dynamic changes across the cardiac cycle, these fluctuations were blunted in HCM mice (ΔT2*,norm[%]: KI=18.8±4.6 vs. WT=23.2±7.3, P<0.05). In addition, mean MBF in mid-SAX was significantly lower in HCM mice (MBF[mL/g/min]: KI=5.8±1.6 vs. WT=8.2±1.1, p<0.05), with the same pattern observed in regional segments (Fig.2B). The combination of reduced ΔT2* dynamics and impaired perfusion suggests potential microvascular involvement in the HCM model. Sirius Red staining showed marked collagen accumulation, particularly in perivascular regions, in KI mice, indicating extensive fibrosis (Fig.3A). Quantitative analysis confirmed significantly higher PVF in Mybpc-KI (PVF[%]: KI=3.8±1.8 vs. WT=1.4±1.0, p<0.001). As shown in Fig. 3B, mid-septal data at rest demonstrated modest correlation between mean T2* and MBF (R²=0.39), while ΔT2*,norm showed a stronger link to PVF (R²=0.45), suggesting greater sensitivity to microvascular dysfunction. The strongest association was between MBF and PVF (R²=0.82), directly linking impaired perfusion to perivascular fibrosis.

Our results demonstrate the feasibility of 3D cine T2* mapping across the cardiac cycle in healthy and HCM mice. Both ΔT2*,norm and MBF revealed differences in myocardial tissue properties linked to microvascular dysfunction and fibrosis, as supported by histology and regression analysis. These findings suggest that ΔT2*,norm may serve as a noninvasive marker for early remodeling. Looking ahead, we aim to refine this approach and further validate its translational relevance. We particularly welcome contributions from researchers with expertise in MR physics, sequence development, and quantitative cardiac mapping.
Shahriar SHALIKAR (Berlin, Germany), Huang YUHENG, Malagi ARCHANA, Liu SIQIN, Laghzali OUMAIMA, Velasquez Vides JOSE RAUL, Berangi MOSTAFA, Waiczies SONIA, Carrier LUCIE, Kober FRANK, Niendorf THORALF, Yang HSIN-JUNG, Ku MIN-CHI
Poster hall
16:00 TIME FOR A BREAK - Coffee and refreshments will be available at the cash bar.
16:30

"Saturday 11 October"

Added to your list of favorites
Deleted from your list of favorites
A36
16:30 - 18:00

MANSFIELD LECTURE & CLOSING

Chairpersons: Jonathan  MCNULTY (Chairperson, Dublin, Ireland), Francesco SANTINI (Chair) (Chairperson, BASEL, Switzerland)
16:30 - 18:00 It’s the Magnet, stupid! Oliver SPECK (Keynote Speaker, Magdeburg, Germany)
Auditorium 900
18:00

"Saturday 11 October"

Added to your list of favorites
Deleted from your list of favorites
A37
18:00 - 19:00

ESMRMB Annual Business Meeting

Auditorium 900
19:00 CONGRESS DINNER